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Within this thesis sulfur oxides have been reacted under gold catalysis with alkynes allowing 
access to interesting and novel structures. 
The gold catalysed oxyarylation of alkynes with aryl sulfides has been employed, developing 
conditions for the use of dibenzothiophene-S-oxide as the oxidant for the first time, to enable 
an efficient way to modify these useful structures. Encompassed within this work is the 
extension of the methodology allowing disubstitution of dibenzothiophenes and a novel 
oxyarylation-cycloisomerisation cascade. Overall the method showcases very mild conditions 
and good chemoselectivity.  
Secondly a novel gold catalysed reaction of aromatic disulfur oxides with terminal and ester 
substituted internal alkynes has been developed. Fluorene and naphthalene derived sulfur 
oxides can be oxidised and functionalised in a single step with a range of terminal alkynes. 
The transformation successfully exploits rhodium carbene reactivity with alkynes and sulfur 
oxides. 
Finally a large series of alkynyl sulfoxides have been synthesised which can undergo an 
efficient gold catalysed intramolecular cyclopropanation with an external oxidant affording 
fused sulfur heterocycles. This work presents the first example of accessing cyclopropanation 
from an α-diazo sulfoxide, or equivalent. Attempts to access other carbene reactivity modes 
are discussed as well as the synthesis of highly enantioenriched alkynyl sulfoxides and their 
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1.1 Origins of gold reactivity in homogenous catalysis 
1.1.1 Relativistic effects 
The unique reactivity displayed by gold species and other π acids derives from relativistic 
effects. These effects explain the contraction of atomic s orbitals and the expansion of the d and 
f orbitals due to increased nuclear shielding. This phenomenon is most pronounced for gold and 
explains the gold ligand short bond lengths compared to other metals and the “soft” nature of 
the gold species.1 
1.1.2 Alkynophilicity 
Gold complexes to both alkenes and alkynes rendering them electrophilic and susceptible to 
nucleophilic attack. The strong preference for nucleophilic attack at the alkyne compared to the 
alkene allows for high selectivities.2 
The Dewar-Chatt-Duncanson bonding model helps describe the bonding situation found 
between an alkyne and a gold complex.3 Calculations have verified that for a ‘naked’ acetylene 
gold species the major bonding contributions are from the alkyne to metal σ bond which 
accounts for approximately 65% of the total (Fig 1). The other major bonding contribution is 
from the metal to ligand in plane π orbitals which constitutes 27% of the total interaction.4,5 
Half of the interaction is thought to be electrostatic in nature.4,5 
In gold carbenoids strong π back donation occurs from the gold to the carbene, compared to the 
weak interaction observed with back donation to the alkyne. This difference in bonding helps 




Fig 1. Major bonding interactions between gold and an alkyne and gold and a carbene. 
1.2 Gold carbenoids 
1.2.1 Generation of α-oxo gold carbenoids 
One area of particular recent interest involves gold activation of alkynes to access the reactivity 
patterns of α-oxo gold carbenes in a manner which avoids the use of diazo compounds and the 
issues associated with them. These concerns of extra synthetic steps and explosive nature make 
alternatives very attractive.6 An improved method is realised using a nucleophilic oxidant, such 
as a sulfoxide, pyridine N-oxide or quinoline N-oxide and a gold species, where attack onto the 
activated alkyne 1 forms a vinyl gold carbenoid 2 (Scheme 1). Related species have been 
isolated and characterised in work by Hashmi.7 Reaction of a nucleophile either 
intramolecularly or intermolecularly may occur next with loss of the leaving group. 
Alternatively extrusion of the nucleofuge may proceed first giving rise to an α-oxo gold carbene 
3. The nature of this species is widely proposed to be in between that of a metal carbene and a 
gold stabilised carbocation (Scheme 1).8,9 The gold species can react with various nucleophiles 
intramolecularly or intermolecularly which permits an excellent range of diversity. 
Scheme 1. Preparation of a gold carbene from an alkyne and an oxidant. 
4 
 
1.2.2 Bonding in gold carbenoids 
Unearthing the nature of the bonding in gold carbenoids is vital to enable a good understanding 
of reactivity. The large differences in the bonding between a gold carbene and a gold stabilised 
carbocation need to be rationalised. Several studies have showed a range of theoretical and 
experimental evidence to suggest the bonding is best represented by a gold stabilised 
carbocation.8 Successful intermolecular cyclopropanation by Echavaŕren and co-workers 
argued that an α-oxo gold carbene intermediate was more representative of the reactive 
intermediate.9,10 Toste provided strong experimental evidence for this phenomenon by 
performing a gold catalysed cyclopropanation with a variety of different ligands on gold 
(Scheme 2).11 In the first example, the proximity of the oxygen atoms on the dioxane 4 to the 
gold centre favour unproductive resonance contributions 4a to 4c with the positive charge 
stabilised on the oxygen and no reaction was observed. In a second example the influence of 
the ligand on gold was profound. Strongly σ-donating and weakly π-accepting ligands such as 
N-heterocyclic carbenes and alkyl substituted phosphines contribute electron density to the gold 
atom giving rise to the gold carbene 6b which results in efficient cyclopropanation. 
Alternatively strongly π-accepting ligands such as phosphites deprive the gold centre of 
electron density and the cationic gold resonance form 6a is preferred which is unreactive 
towards cyclopropanation. This seminal contribution which boasted theoretical studies backing 
up the experimental results, rationalises the reactivity changes observed with ligands on gold 




Scheme 2. Intermolecular cyclopropanation of cyclopropenes. 
1.3 Developments in reactions of oxygen based nucleophiles with 
alkynes under gold catalysis 
1.3.1 Use of sulfoxides as intermolecular and intramolecular oxidants 
Sulfoxides have been employed as intramolecular and intermolecular oxidants in a limited 
range of gold catalysed processes with alkynes. They often provide complementary reactivity 
to nitrogen based oxidants, allowing access to unique reactivity modes. 
The gold catalysed cycloisomerisation of enynes is a well-known reaction in which complex 
structures can be generated from simple starting materials.12 Toste et al set about trapping the 
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cyclopropane gold (I) carbene intermediate 8 formed in the cycloisomerisation of 1,6 enynes 7. 
(Scheme 3). Diphenylsulfoxide was selected as the oxidant to achieve this after 
dimethylsulfoxide was found to be ineffective for the transformation.13 A variety of 1,6-enynes 
7 underwent cyclisation affording cyclopropyl aldehydes 9 in high yield. The work was also 
expanded to other systems starting from both diazo compounds and alkynes affording a variety 
of rearrangement products. 
 
Scheme 3. Cyclopropyl aldehydes formation via trapping of a gold carbene 
Shin, under modified conditions demonstrated similar reactivity of diphenylsulfoxide in the 
preparation of a variety of cyclopropane carboxaldehyde derivatives 12 (Scheme 4) some of 
which were directly transformed to their corresponding alcohol 13 due to isolation difficulties.14 
Shin had established that terminal enynes 10 react via a 5-exo dig cyclisation and an excess of 
diphenylsulfoxide as the oxidant enables the trapping of the gold carbene 11 and limits 
formation of the undesired alder-ene derived products. Substitution on the alkene was shown to 
be well tolerated and the protecting group on nitrogen could be readily switched. Choice of 
oxidant was critical for this transformation with various pyridine-N-oxides being unsuitable, 
giving low yields and undesired side products. 
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Scheme 4. Terminal 1,6 enynes as substrates for cyclopropanation. 
Independently, both Toste15 and L. Zhang16 demonstrated that tethered sulfoxides 14 can add 
intramolecularly to a gold activated triple bond. The electronic bias on the alkyne can be varied 
to alter the regioselectivity of attack and allow the efficient formation of either 
benzothiepinones 16 or benzothiopines 18. In these initial communications, the reaction was 
proposed to proceed via an α-oxo gold carbene with Friedel-Crafts type reaction leading to the 
products. High functional group tolerance was observed with substitution at the propargyl and 
homopropargyl positions allowed (Scheme 5). 
Scheme 5. Benzothiepinones or benzothiopines. 
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Zhang showed that an o-chloro benzene substituent 19 blocks the Friedel-Crafts pathway (now 
found to involve a [3,3]-sigmatropic rearrangement as the key step) exploring the synthesis of 
21 utilising a semi pinacol rearrangement (Scheme 6).16 The reaction was efficient and could 
be used to furnish a variety of different ketones 21. 
Scheme 6. Incorporating a semi pinacol rearrangement upon oxidation. 
Davies and co-worker were able to successfully apply the intramolecular oxidation with 
sulfoxides 22 to generate sulfur ylides 24, which underwent a facile [2,3]-sigmatropic 
rearrangement.17 The reaction was proposed to proceed via an α-oxo metal carbene 23 with 
nucleophilic attack of the sulfur and [2,3]-rearrangement furnishing the 5 and 6 membered 
heterocycles 25 (Scheme 7). Either a Pt (II) or a Au (III) catalyst was employed with the choice 
important in some cases, substrate scope was good and yields were moderate to excellent. 
Scheme 7. Using oxidative gold catalysis to access a [2,3]-sigmatropic rearrangement. 
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Asensio et al investigated for the first time the intermolecular oxidation of terminal alkynes 26 
with sulfoxides 27.18 The expected mechanistic pathway involved oxidation of the alkyne 
leading to an α-oxo gold carbene which would be trapped intramolecularly by a Friedel-Crafts 
type electrophilic aromatic substitution. The formation of only the ortho substituted 
regioisomer 31 led the research group to undertake DFT studies to confirm the reaction 
mechanism. Following the anti-addition of the sulfoxide, intermediate 28 is formed and this 
undergoes a [3,3]-sigmatropic rearrangement to afford 29. Formation of 30 proceeds with 
protodeauration furnishing 31 giving a lower energy pathway than the alternate α-oxo gold 
carbene mechanism (Scheme 8). The overall result is a good method to selectively functionalise 
the ortho position of an aromatic sulfide. The study demonstrated the successful use of 
alternative aryl sulfoxides in an intermolecular reaction for the first time with electron deficient 




Scheme 8. The intermolecular gold catalysed oxidation with terminal alkynes. 
An efficient method of preparing cyclobutene derivatives 33, was reported by Liu utilising a 
gold catalysed oxidative ring expansion of cyclopropane derivatives 32 (Scheme 9).19 
Diphenylsulfoxide was found to be active unlike pyridine-N-oxide, amine oxide or imine oxide, 
with a large excess (5 equiv) required to achieve total conversion. Vitally the ring expansion of 
32 was more favourable than oxyarylation of 32. Although high temperatures were required the 
reaction was shown to be versatile with lots of functionality tolerated and aminocyclopropyl 
alkynes proved especially excellent reaction substrates. 
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Scheme 9. Formation of different cyclobutenyl compounds under gold catalysis. 
In the same report Liu exploited the known ring cleavage of cyclopropanes containing both 
donor and acceptor groups as vicinal substituents at the cyclopropane ring.20 Accordingly 
substrates were designed and these smoothly underwent an oxidative cleavage on changing the 
gold catalyst to afford several functionalised 2H-pyrans (Scheme 10).19 In the reaction 
mechanism a cyclopropyl migration occurs from intermediate 34a forming a stabilised cation 
34b. Cyclisation of 34b leads to the 2H-pyran 35. 
 
Scheme 10. Formation of different 2H pyrans. 
Liu attempted to expand the scope of this oxidative gold catalysed ring expansion by reacting 
n-pentyl and cyclobutyl aromatic alkynes 36.19 Instead though excellent yields of the ortho 
functionalised sulfides 37 were obtained (Scheme 11). These products result from the 
oxyarylation of alkynes and expand the reaction scope for that transformation with the 
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incorporation of internal alkynes. The reaction conditions employed for the oxyarylation were 
similar to those selected by Asensio, with higher temperatures and a more electron rich ligand 
than PPh3 being employed. Crossover experiments were performed, with the addition of a 
sulfide 39 into the reaction mixture (Scheme 11). Only the product 40 incorporating the aryl 
sulfide from sulfoxide was formed, resulting from oxyarylation onto the sulfoxide. 
 
Scheme 11. Internal alkynes in the gold catalysed oxyarylation. 
More recently, (in 2013) Li showed that treatment of a terminal ynamide 41 with 
diphenylsulfoxide 42 and a gold catalyst led to the formation of the oxyarylation product 44, 
instead of the desired cyclopropanation product, in a moderate yield (Scheme 12).21 The 
mechanism for the cyclopropanation was also proposed to proceed via the vinyl gold 





Scheme 12. Oxyarylation reaction of a terminal ynamide with diphenylsulfoxide. 
In 2013 L. Zhang published a detailed study containing both experimental, and theoretical 
evidence using DFT studies to rule out α-oxo gold carbenes as fleeting intermediates in his 
earlier work on the synthesis of benzothiepines.22 An alternative pathway, where intramolecular 
[3,3]-sigmatropic rearrangement is the key bond forming process was found to be significantly 
lower in energy. Diazo compound 45 was subjected to the optimised reaction conditions. In this 
case none of the benzothiepinone 47 was formed, instead a carboxylic acid 46 resulted, likely 
as the result of a Wolff rearrangement, followed by a hydration (Scheme 13).22 Interestingly, 
these results are in contrast to Davies’ work, where sulfur ylides were generated and underwent 
subsequent rearrangement (Scheme 12) with the only plausible mechanism involving metal 
carbenes.17 In this case no aryl groups are present so the lower energy [3,3]-sigmatropic 
rearrangement is implausible and in the absence of a lower energy reaction pathway the reaction 
proceeds via a gold carbene. 
 
Scheme 13. Reaction of a diazo compound showing the exclusion of the expected α-oxo gold carbene. 
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With this knowledge, the scope for the preparation of thiopineones 50 could be broadened and 
Hg(OAc)2 was found to be a good alternative catalyst for certain substrates, including an 
internal alkyne (Scheme 14). Some α-oxo gold carbene formation arises with the gold catalyst 
and an internal alkyne which leads to unwanted α-β unsaturated ketones 49. 
 
Scheme 14. Reaction outcome dependence on metal. 
1.3.2 Intramolecular nitrogen based oxidants in gold catalysis 
Amine-N-oxides and nitrones have also proven to be excellent intramolecular oxidants for gold 
catalysed processes enabling the formation of a wide range of heterocycles.23-32 An example of 
using an amine-N-oxide in this manner is displayed below where tetrahydrobenz(b)zepines 53 




Scheme 15. Synthesis of tetrahydrobenz[b]azepin-4-ones. 
1.3.3 Site specificity and double oxidation 
An important control factor is the regioselectivity of addition by the intermolecular oxidant. 
Controlling the regioselectivity is of paramount importance in order to access viable synthetic 
reactions.  
Additionally attack of a second oxidant molecule to the gold carbenoid can be considered as a 
double alkyne oxidation. This competing process when employing external oxidants also needs 
to be considered. 
Ynamides 54 have been employed in acid free intermolecular gold catalysed oxidations in work 
undertaken by Davies and co-workers. Participation of the nitrogen lone pair gives a gold–
keteneiminium resonance form 55 (Scheme 16). The highly electrophilic position allows site 
specific attack of the oxygen nucleophile.33 A 1,2-hydrogen shift and elimination of gold then 
furnishes the α,β-unsaturated imide derivatives 56. The tolerance of different functional groups 
is high (Scheme 15) and the yields are good (63 to 81%) with reasonable to excellent E:Z ratios 
of products. Furthermore ynol ethers are also suitable substrates. This method allows good 
access to α-imido and α-ester metal carbenoid reactivity. Notably a second transformation was 
achieved in the report, with an ynamide being doubly oxidised under alternative conditions. 
Later the same transformation was achieved under different conditions and extended to 
substituted diphenyl alkynes.34 
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Scheme 16. Intermolecular oxidation of ynamides. 
Achieving good regioselectivity with intermolecular oxidation of internal alkynes is a 
considerable challenge due to the small difference in electronic properties of the two alkyne 
carbons. Using a sterically bulky quinoline-N-oxide and a N-heterocyclic carbene ligand on the 
gold species, L. Zhang was able to address this issue and attained high regioselectivity in the 
preparation of α-β unsaturated carbonyls 59 from alkynes 57.35 The reaction proceeded with 
good chemoselectivity and in high yield. (Scheme 17).  




Propargylic acetates 60 were treated under gold catalysis with an oxidant and were shown to be 
excellent substrates for highly regioselective oxidation (Scheme 18).36 Chemoselectivity was 
high with the regiocontrol attributed to the effect of the electron withdrawing carboxy group 
and the E:Z ratios were generally high. The α-acetoxyenones 61 formed were proposed to be 
the result of a two-step 2,4 acetoxy migration (Scheme 18). 
 
Scheme 18. Gold catalysed oxidation of propargylic acetates. 
1.3.4 Intramolecular trapping of the α-oxo gold carbene 
Trapping of the gold species generated after initial attack of the oxidant onto the activated 
alkyne by intramolecular attack of an alcohol or amine nucleophile, has proven to be an 
excellent approach, to conveniently and mildly prepare a wide range of heterocycles (Scheme 
19).  
The α-oxo gold carbene could be trapped by an alcohol in both the propargylic and 
homopropargylic postions giving rise to oxetan-3-ones 64 and dihydrofuran-ones 65.37,38 Acid 
additives were required to achieve high yields, but otherwise mild conditions could be 
employed. Chiral propargyl carboxamides and homopropargyl carboxamides synthesised from 
Ellman’s chemistry also proved suitable substrates, delivering nitrogen heterocycles 67 and 68 




Scheme 19. Trapping of the α-oxo gold carbene with a pendant OH or NH nucleophile.  
C-H insertions are another type of common reactions of metal carbenes.41 In developing 
oxidative gold catalysed reactions involving a C-H insertion, exciting new structures have been 
prepared as well as novel catalysts and oxidants delivering further insight into this versatile 
field of organic chemistry (Scheme 20).42-46 Side reactions caused problems in these 
trnasformations which including deactivation of the catalyst by the pyridine leaving group. 
The solution involved further tuning of the catalyst and the oxidant. Very bulky oxidants were 
employed by Zhang and Gagosz to suppress unwanted reactions. After disappointing screening 
reactions with known catalysts Gagosz prepared a new class of ligands for gold which combined 
strong steric shielding of the gold centre with the required electron-withdrawing properties 
(Scheme 20). 
Similar transformations allowing access to multiple products have been developed in the last 
few years. Alkynes were employed with an external oxidant and a gold catalyst showcasing 




Scheme 20. Trapping of the α-oxo gold carbene with a pendant CH nucleophile. 
1.3.5 Gold catalysed intramolecular oxidative cyclopropanations  
Cyclopropanations are among the most common reactivity pathways of metal carbenes, with 
many examples of cyclopropanation from copper or rhodium carbenes generated from diazo 
compounds.58 This reactivity has been extended to gold more recently, using readily available 
alkynes and pyridine-or quinoline-based oxidants (Scheme 21). 
In 2011 Liu and co-workers reported a stereoselective oxidative cyclopropanation from 1,5 
enynes 69. The catalysis showed excellent chemoselectivity with benzene derived and non-
benzene derived substituents working well (Scheme 21).59 
J. Zhang and co-worker demonstrated in 2011 that electronically-biased 1,5 enynes 71 are 
capable of undergoing a gold catalysed oxidative intramolecular cyclopropanation sequence 
forming lactams and cyclopentanones 72.60 When an ester derived substrate was employed 
under conditions A no cyclopropanation was observed. Instead a product resulting from 
intermolecular trapping of the gold carbene with mesylate resulted. The highly charged gold 
carbene species would be preferentially attacked by a hard nucleophile such as mesylate 
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compared to the softer alkene nucleophile suggesting that the α-oxo gold carbene is the reactive 
intermediate in the catalysis.  
Ynamides 73 were transformed efficiently by Li into 3‑aza-bicyclo[3.1.0]hexan-2-ones 74 
utilising gold catalysis.21 A diazo compound which would be expected to lead to the same 
cyclopropanated product 74 via a gold carbene intermediate was prepared, but resulted in a poor 
yield of 74 when employed under the reaction conditions. If the reaction did proceed via an α-
oxo gold carbene a high reaction efficiency would be expected. As this was not the case the 
observed vinyl gold carbenoid intermediate was deemed to be involved. 
Alternative substrates were subjected to the intramolecular oxidative cyclopropanation by L. 
Zhang generating a wide range of bicyclic 76 and tricyclic cyclopropyl ketones 78 (Scheme 




Scheme 21. Gold catalysed oxidative intramolecular cyclopropanation reactions. 
Diazo chemistry has proven very amenable to enantioselective catalysis reactions via a metal 
carbene employing chiral ligands, yet few reports demonstrate asymmetric oxidative gold 
transformations. 
Choosing systems previously studied for oxidative cyclopropanation L. Zhang and co-workers 
and J. Zhang were able to effect a highly enantioselective reaction.62,63 L. Zhang found success 
with a modified P,N-C2 symmetric bidentate ligand creating a chiral environment around the 
gold centre, employing 8-methylquinoline-N-oxide at low temperature.62 J. Zhang on the other 
hand employed a phosphoramidite chiral catalyst under similar conditions which gave similarly 
impressive results (Scheme 22).63 From experimental evidence the vinyl gold carbenoid (see 2) 
is proposed to be the key intermediate, and this is the stage in which the enantioselectivity is 
determined. 
 




1.3.6 Use of intermolecular nucleophiles to trap the gold carbenoid  
Intermolecular trapping of the α-oxo gold carbene by halide abstraction was observed as early 
as 2009 by Davies.17 L. Zhang and co-workers developed a one-step sequence to access α-halo 
methyl ketones 84 from terminal alkynes 83 under oxidative gold conditions (Scheme 23). The 
proposed reaction mechanism involves the abstraction of a halide from the solvent via a 
halonium ion.65 The reaction efficiency was moderate due in part to the competitive trapping 
of the α-oxo gold carbene with mesylate.  
A second synthetic transformation utilising intermolecular trapping of the gold carbene with 
the reaction solvent exploited the reactivity of nitriles as the solvent allowing a desirable and 
efficient [2+2+1] annulation with alkynes 83 (Scheme 23).64 Most of the study was performed 
using the nitrile reagent in large excess as solvent. Limitations were observed when the 
substrate contained a functional group that could trap the metal carbene intramolecularly. 
Examples of this were seen with hydroxy substituted alkynes which preferentially afforded the 
dihydrofuranones prepared previously. Furthermore yields were poor with sterically bulky 
arylacetylenes. Employing 3 equivalents of nitrile still permitted moderate yields with longer 





Scheme 23. 2,5 Disubstituted oxazoles via a gold-catalysed intermolecular alkyne oxidation. 
Three main approaches have been employed in order to overcome the unwanted intramolecular 
reactivity, double oxidation and solvent interference for fully intermolecular reactions.  
Zhang has been able to develop a number of transformations in which a quinoline based oxidant 
is used alongside a gold catalyst to generate an α-oxo gold carbene 87 from a terminal alkyne 
86 which is subsequently trapped intermolecularly with a nucleophile (Scheme 24).66-69 These 
reactions allow access to diverse heterocycles 88 and 91 and proceed with high efficency  
To overcome the inherent difficulties associated with controlling the reactivity of the α-oxo 
gold carbene, catalysts were employed such as MorDalPhos (Scheme 24). A tricoordinate 
species is proposed 93a, b, creating a sterically shielded environment for the gold centre to 
suppress unwanted side reactions and allow high efficiency. Variations on these catalysts have 
been employed with a P,S analogue being the catalyst of choice in the sulfur ylide chemistry. 
Further catalyst optimisation highlighted that careful positioning of two methyl groups on the 
cyclohexyl ring lock the chair conformation of the complex, enabling strong steric crowding at 
all times and further reducing unwanted reactivity. As important as these new reports were, an 
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unsolved limitation was the requirement of the oxidant to be added by syringe pump over an 
extended period. 
Scheme 24. Controlling the electrophilicity of the gold carbene in an oxazole synthesis. 
Work by Davies and co-worker presented a second valid method for achieving intermolecular 
nucleophile addition to an α-oxo gold carbenoid.70 Ynamides 94 (Scheme 25) were utilised as 
diazo equivalents in a gold catalysed sequence of oxidation, ylide formation and [2,3]-
sigmatropic rearrangement to form highly functionalised sulfides 96. This approach allowed the 
efficient formation of a C-O, C-S and C-C bond in a single step under mild and convenient 
conditions with the oxidant introduced in one portion (Scheme 25). Selectivity for ylide 
formation over double oxidation was proposed to be dependent on using a strongly electron 
withdrawing phosphite catalyst which would form a vinyl gold carbenoid species, favouring S 




Scheme 25. Generation of complex quaternary centres from ynamides. 
Ye successfully employed indoles 97 to trap α-oxo gold carbenes generated from an ynamide 
98 and a pyridine-N-oxide in water (Scheme 26).71 This report highlights a third successful 
approach to achieving high reaction efficiency in intermolecular carbene trapping. These 
conditions allow a slow release of the water soluble oxidant, preventing the formation of 
undesirable double oxidation products. The reaction is extremely efficient and the reaction 
could be extended to anilines 101 which again proved excellent substrates for the reaction. 
 




The reaction of a gold activated alkyne with an oxygen containing nucleophile affords a gold 
carbenoid species which can be trapped intramolecularly or intermolecularly to afford a diverse 
range of products. The choice of catalysts can favour α-oxo gold carbene or vinyl gold 
carbenoid type intermediates and the differences in reactivity of these two extreme forms can 
impart a major influence on the reaction outcome. The use of different oxidants can control the 
reactivity observed with milder sulfoxide oxidants used to oxidise the gold carbene formed on 
initial cycloisomerisation or as substrates for oxyarylation with alkynes. Quinoline and pyridine 
based oxidants are now much more widely used and can be tuned in many cases to maximise 
efficiency.  
Various approaches have been successfully employed to control unwanted reactivity. These 
include limiting the rate of addition of the oxidant or its concentration by using its solubility, 
using more bulky catalysts which shield the gold centre and/ or employing electron-
withdrawing groups on the ligands to form a less electrophilic vinyl gold species  
The review clearly demonstrates a lack of investigations into the use of sulfoxides with alkynes 
in oxidative gold chemistry. This thesis will address these gaps in the literature with three 
different projects. 
In chapter 2 the gold catalysed oxyarylation of alkynes is developed for use with 
dibenzothiophene-S-oxides. Investigations into substrate scope, an iterative process and a 
cascade are presented. 
In chapter 3 disulfide oxides are investigated in gold catalysis with alkynes. Two systems are 
developed and the reactivity observed compared.  
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Chapter 4 uses alkynyl sulfoxides as α-carbene sulfoxide equivalents to develop an 

































Sulfoxides have been effectively employed as intermolecular oxidants in several gold catalysed 
reactions of alkynes including alkyne oxyarylation (Chapter 1). The mechanism for the gold 
catalysed oxyarylation has been modelled using DFT calculations and both internal and 
terminal alkynes have been successfully employed, although moderate to high temperatures are 
required (Scheme 27).18,19 Despite this, further uses of this potentially powerful transformation 
have not been documented. Notably industry useful aryl sulfide motifs haven’t been employed, 
generally simple sulfoxide nucleophiles have been used, only a limited range of alkynes have 
been employed and there are no reports on further modifications of the catalysis products. 
 
Scheme 27. Recap of progress in the oxyarylation field. 
Dibenzothiophenes are aromatic sulfides and could potentially be functionalised efficiently, 
mildly and selectively utilising a gold catalysed oxyarylation strategy. 
These structures are of high importance in materials science due to their optical, redox and 
conducting properties.72 Applications of dibenzothiophenes in medicinal chemistry are also 
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known.73 Further to this, dibenzothiophenes have been employed as precursors to triphenylenes 
and as transfer reagents for reactive species such as nitrenes, carbenes and atomic oxygen.74,75 
The major routes to functionalised dibenzothiophenes involve a final step formation of the 
dibenzothiophene core,76,77,78 or regioselective bromination of dibenzothiophene at the 2,8-
positions79 or the 3,7-positions of the corresponding S,S-dioxide.80 Substitution at the 4- and 6-
positions is possible but requires stoichiometric metallation using organolithium or 
organoaluminium reagents.81,82  
2.2 Aim and Objectives 
The aim was to investigate the oxyarylation reactions of dibenzothiophenes and related 
sulfoxides in order to probe structure activity relationships with sulfoxides as oxidants in gold 
catalysis and explore the wider synthetic potential of this method. The gold catalysed 
oxyarylation of alkynes with sulfoxides is of particular interest. Developing this reaction to 
incorporate synthetically useful aromatic sulfides may allow access to a novel strategy for 
functionalising these structures.  
2.3 Preliminary reactions as oxidants 
In order to begin the investigation several cyclic sulfoxides were synthesised by mCPBA 
oxidation of the relevant sulfide (Scheme 28). In the case of disulfide 105 both the mono 107 




Scheme 28. Preparation of fused cyclic sulfoxides. 
With the sulfoxides 103, and 106-108 in hand, preliminary studies focused on employing these 
species with alkynes or ynamides in different reported transformations.  
Liu’s optimised conditions for the ring expansion of alkynyl cyclopropanes 109 were employed 
while reducing the oxidant stoichiometry to 1.1 equivalents.19 Diphenyl sulfoxide 42 was then 
substituted for the prepared fused cyclic sulfoxides 103, 106, 107 and 108 in order to establish 
their activity. Dibenzothiophene-S-oxide 103 was shown to be a powerful oxidant for the 
reaction (Scheme 29). Diketone 111 was observed, however, originating as a product of the 
competing double oxidation. Other fused sulfoxides 106-108 were also tested and gave similar 
results to dibenzothiophene-S-oxide 103 but with lower conversion. These results were in 
contrast to diphenyl sulfoxide 42 where the alkyne was only converted to the desired 
cyclobutenyl ketone 110 under the catalysis conditions. This result showed dibenzothiophene-




Scheme 29. Effectiveness of various sulfoxides as oxidants in a gold catalysed reaction. 
The reaction of an ynamide 112 with a gold catalyst and an oxidant forming an α,β-unsaturated 
imide 113 was selected to compare the reactivity of the commonly used diphenyl sulfoxide 42 
and dibenzothiophene-S-oxide 103 (Scheme 30).33 Employing 1.1 equivalents of the oxidant 
resulted in complete conversion with dibenzothiophene-S-oxide 103, compared to only 
moderate conversion with diphenyl sulfoxide 42. In Davies’ study pyridine-N-oxide was chosen 
as the oxidant and dibenzothiophene-S-oxide 103 delivers a parallel result, however the ratio of 
E/Z isomers in the product is lower with the sulfoxides trialled (2.1:1) compared to pyridine-N-





Scheme 30. Effect of the oxidant in the site specific ynamide oxidation reaction. 
A final comparison of the two sulfoxides was made by employing them as oxidants for the 
double oxidation of a phenyl substituted ynamide 114 to afford 2-oxo-N,2-diphenyl-N-
tosylacetamide 115 (Scheme 31).33 Once again dibenzothiophene-S-oxide 103 was much more 
active than diphenyl sulfoxide 42 and these latter results demonstrate that dibenzothiophene-S-
oxide 103 may be considered as an alternative to pyridine-N-oxide for certain transformations. 
 
Scheme 31. Effect of the oxidant in the double oxidation of an ynamide. 
2.4 Optimisation of the oxyarylation reaction 
Dibenzothiophene-S-oxide 103 was next employed using Asensio’s optimal conditions for the 
gold-catalysed oxyarylation of alkynes with aryl sulfoxides.18 Hex-1-yne was selected as the 
alkyne for the screening process and an encouraging 37% NMR yield of the desired ortho-
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substituted dibenzothiophene 116 was observed (Table 1, entry 1). Conversion was excellent, 
however a large amount (49%) of dibenzothiophene 102 was present in the reaction mixture, 
potentially resulting from oxidation of the gold carbene (Scheme 32). The effect of solvent on 
the reaction conditions was then investigated. 1,2-Dichloroethane was employed to circumvent 
the requirement for a sealed tube, but this resulted in only a poor yield of the desired product 
116 and lots of degradation (Table 1, entry 2). Nitromethane gave a similar result to 
dichloromethane but was preferred due to its higher boiling point allowing reactions to be 
performed in Schlenk tubes (Table 1, entry 3). The air stable silver tosylate was tested, 
providing a slightly enhanced yield of the desired product (Table 1, entry 4). Varying the gold 
species and employing AuCl (Table 1, entry 5) or (AuPicCl2) (Table 1, entry 6) resulted in very 
low yields and significant formation of the unwanted dibenzothiophene 102. A more electron-
withdrawing phosphine gold species was employed with little change in yield of the desired 
product 116, however a large decrease in yield of dibenzothiophene was seen (Table 1, entry 
7). Electron-rich ligands XPhos and JohnPhos derived complexes instead favoured double 
oxidation (Table 1, entries 8 and 9). An electron-deficient phosphite catalyst, which would be 
expected to disfavour formation of gold carbene 118 from the vinyl gold species 117, was 
employed, giving the best yield of the desired substituted dibenzothiophene 116 (Table 1, entry 
10). Using the pre-formed air-stable acetonitrile complex of the gold species resulted in an 
enhanced yield, suggesting silver may retard the reaction to a small extent or result in other 
products being formed (Table 1, entry 11). The reaction time was shortened and the solvent was 
diluted resulting in a decrease in yield (Table 1, entry 12). When the temperature was reduced 
and the concentration reduced a large increase in yield was observed (Table 1, entry 13). 
Switching the solvent again at this stage to dichloromethane resulted in a large reduction in 
yield (Table 1, entry 14), with acetonitrile being an even less suitable solvent (Table 1, entry 
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15). Toluene proved to be an excellent solvent (Table 1, entry 16), and upon a further decrease 
in reaction temperature, an excellent yield of the substituted dibenzothiophene 116 was 
obtained (Table 1, entry 17). 
Table 1. Optimisation of the reaction conditions. 
 







103      116        102 
1 PPh3AuCl AgSbF6 CH2Cl2 70 1 0 37 49 
2 PPh3AuCl AgSbF6 1,2 DCE 70 1 (5)
b 20 30 
3 PPh3AuCl AgSbF6 CH3NO2 70 1 0 38 35 
4 PPh3AuCl AgOTs CH3NO2 70 1 10 41 25 
5 AuCl - CH3NO2 70 1 51 4 17 
6 Au-III - CH3NO2 70 1 45 4 20 
7 P(4CF3Ph)3A
uCl 
AgOTs CH3NO2 70 1 20 41 3 
8 XPhosAuCl AgOTs CH3NO2 70 1 50 10 20 
9 JohnPhosAu
Cl 
AgOTs CH3NO2 70 1 51 8 20 
10 DTBPPAuCl AgOTs CH3NO2 70 1 0 44 16 
11 Au-I - CH3NO2 70 1 5 49 16 
12 Au-I - CH3NO2 70 0.1 8 43 16 
13 Au-I - CH3NO2 RT 0.1 6 70 7 
14 Au-I - CH2Cl2 RT 0.1 0 39 11 
15 Au-I - CH3CN RT 0.1 0 28 3 
16 Au-I - Toluene RT 0.1 0 82 6 
17 Au-I - Toluene 0 0.1 0 92                 5
a Reactions performed on a 0.1 mmol scale and yields determined by crude NMR analysis using 1, 2, 4, 5 
Tetramethylbenzene as an internal reference standard. b As a result of degradation it was only possible to estimate 






Scheme 32 shows the mechanism leading to the formation of the desired substituted 
dibenzothiophene 116. Attack of the S-oxide 103 onto the internal position of the alkyne 
proceeds first. These catalysts are theorised to stabilise the gold carbene and favour its 
formation at the expense of the desired [3,3]-sigmatropic rearrangement and thus increasing the 
propensity for the unwanted nucleophilic attack of a second molecule of dibenzothiophene-S-
oxide (Scheme 32).70 Electron-rich ligands on the phosphine donate electron density to the π-
accepting gold atom leading to the α-oxo gold carbenoid species which could be quenched by 
attack of a second molecule of dibenzothiophene-S-oxide. Alternatively π acidic ligands such 
as phosphites would favour the vinyl gold species which is in the conformation to undergo a 
productive [3,3]-sigmatropic rearrangement to furnish the oxyarylation product.84 The 
substantial improvement in reaction outcome upon reducing the temperature could be related 
to the entropic cost associated with forming one molecule from two explained by the Gibbs free 
energy equation ΔG = ΔH – TΔS. As the temperature is reduced the entropy change is less 
relevant to the reaction outcome. Alternatively increased temperatures may promote rapid 
elimination of the dibenzothiophene nucleofuge in formation of an α-oxo gold carbene which 




Scheme 32. Rationale for observed reactivity 
2.5 Preparation of the starting materials 
The scope of the reaction was then explored requiring the preparation of several alkynes. Hex-
1-yn-ol 119 was protected in a good yield using the method of Carreira to provide alkyne 120 
(Scheme 33).85 Octanal 121 was converted into dec-1-yn-ol 122 in two steps. TMS acetylene 
was deprotonated and reacted with aldehyde 121 to give the propargylic alcohol 122 after 





Scheme 33. Silyl protection and synthesis of a propargylic alcohol. 
Three aryl alkynes were synthesised from the corresponding aldehydes by first preparing the 
dibromoolefins 123-125 and converting them into the alkynes 126-128 under strongly basic 
conditions (Scheme 34).86 
 
Scheme 34. Preparation of aryl substituted terminal alkynes. 
2.6 Preparation of 4-substituted dibenzothiophenes 
The oxyarylation of different alkyl alkynes using dibenzothiophene-S-oxide 103 was then 
investigated. Chloro, ether and silyl-ether derived substituents were all well tolerated (Table 2, 
entries 2, 4, and 6) providing the substituted dibenzothiophene 129, 131 and 132 in high yield. 
Hexyn-1-ol 119 was not a suitable alkyne however. Employment of a propargylic alcohol 
(Table 2, entry 9) could have been expected to result in significant formation of oxetan-3-one, 
however none was discovered upon analyzing the crude NMR spectrum which showed a high 
yield of substituted dibenzothiophene 135.27 An aryl-derived and phthalimido substituent were 
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also tolerated providing dibenzothiophenes 130 and 134 in a moderate yield (Table 2, entries 3 
and 7). The reactions were mostly fast and lower catalyst loadings could be employed at higher 
scales without adverse effect beyond increased reaction time (Table 2, entry 5 versus 4). The 
higher scale reaction to form 131 (Table 2, entry 5) was carried out under an atmosphere of air 




Table 2. Incorporation of alkyl substituted terminal alkynes 
 








Product Yield %a 
1 
 
0.2 5 0.75 116 87 
2 
 
0.2 5 0.75 129 79 
3 
 
0.2 5 0.75 130 62 
4 
 
0.2 5 0.75 131 87 
5b 
 
2.0 1 2 131 84 
6 
 
0.5 2 2 132 82 
7 
 




2.0 2 16 134 52 
9 
 
0.2 5 16 135 76 
a Isolated yields. b Reaction performed under an atmosphere of air with technical grade toluene. 
The use of phenylacetylene, in contrast to alkyl alkynes, resulted in significant quantities of 
dibenzothiophene 102 being formed under the standard conditions (Table 3, entry 1). To reduce 
the amount of this unwanted side product the temperature was reduced, requiring a higher 
dilution to maintain solubility of 103 (Table 3, entry 2). The NMR yield with phenylacetylene 
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was now good, however material was lost in the purification of the product 136. The modified 
conditions were then employed with other arylalkynes. A sterically bulky o-bromobenzene 
could be incorporated to give product 137. p-Methoxybenzene was a surprisingly poor 
substituent on the alkyne but still afforded a useful yield of the desired substituted 
dibenzothiophene 138. A thiophene was also tolerated providing 139 in a reasonable yield 
(Table 3, entry 5) 
Table 3. Incorporation of aryl substituted terminal alkynes. 
 
Entry R = Scale mmol Product Yield % 
1a 
 
0.1 136 47b 
2 
 
0.3 136 58 (74)b 
3 
 
0.2 137 40 
4 
 
0.2 138 42 
5 
 
0.2 139 62 
a Reaction conditions: Au-I (5 mol%), toluene 0.1 M, 0 oC, 1.5 h. b yields determined by crude NMR analysis using 
1, 2, 4, 5 tetramethylbenzene as an internal reference standard. 
 
A functionalised dibenzothiophene-S-oxide 141 was prepared to test its suitability for the gold 
catalysed oxyarylation. 2,8-Dibromo dibenzothiophene-S-oxide 141 was selected as an 
important substrate as it could undergo further functionalization via metal coupling chemistry.79 
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Bromination of dibenzothiophene 102 proceeded in a satisfactory yield (Scheme 35) and a low 
yielding oxidation step provided the target S-oxide 141.87,88 
 
Scheme 35. Preparation of 2,8-dibenzothiophene-S-oxide. 
Subjecting sulfoxide 141 to a terminal alkyne under modified conditions to allow for the poor 
solubility of the starting material, resulted in a good yield of the desired oxyarylation product 
142 (Scheme 36).  
 
Scheme 36. Incorporation of a substituted dibenzothiophene into the catalysis. 
Dibenzothiophene-S-oxide 103 was treated with internal alkyne 143 and complete conversion 
of starting material was observed after 3 hours although no oxyarylation product was observed. 
Instead a mixture of both E and Z isomers of the ene-one 144 was isolated (Scheme 37).89 Upon 
initial attack onto the alkyne with the formation of the gold carbenoid 1,2 H-insertion is more 
favourable than the [3,3]-sigmatropic rearrangement. An alkyl substituted ynamide 112 was 
subjected to the catalysis conditions and upon reaction completion 1,2 insertion product 113 
was isolated as well as oxyarylation product 145 which could not be sufficiently purified for 
full characterisation. When ynamide 114 was employed, no evidence of oxyarylation was seen, 
instead oxindole 146 was tentatively identified as well as an unidentified product. Finally when 
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an ester-substituted alkyne 147 was subjected to the catalysis conditions the reaction proceeded 
quickly and smoothly however, following purification, only a complex mixture of products 
were isolated. 
 
Scheme 37. Reaction of dibenzothiophene-S-oxide 90 with internal alkynes and ynamides. 
Other fused sulfoxides 106, 107 and 108 were then employed under the catalysis conditions 
(Table 2) with hex-1-yne. Although these sulfoxides were effective oxidants in gold catalysed 
oxidation processes (Fig 2) only trace amounts of the oxyarylation products 149-151 were 
observed upon analysing the crude NMR. Therefore attempts to prepare derivatives of these 




Figure 2. Catalysis products expected upon treatment of other cyclic sulfoxides under the optimised 
conditions. 
2.7 Cycloisomerisation vs oxyarylation 
A small series of terminal alkyne based enynes were prepared in order to test their reactivity in 
the oxyarylation reaction with dibenzothiophene-S-oxide 103 compared to the enyne 
cycloisomerisation pathway. Oxygen containing enynes 152 and 153 were prepared, with the 
low yields resulting from the volatility of these componds.90,91 Treatment of cinnamyl bromide 
with propargyl alcohol and potassium carbonate resulted in a moderate yield of the desired 
phenyl substituted enyne 154.92 N-Allyl-4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide 156 
was prepared in two steps from allylamine (Scheme 38).93 Tosylation to afford 155 proceeded 
in an excellent yield and propargylation using NaH also worked well providing the desired 




Scheme 38. Preparation of 1,6 enynes. 
With the enynes in hand they were employed as substrates in the catalysis reaction. Enyne 152 
with an oxygen linker and 156 with an N-tosyl linker efficiently underwent oxyarylation to 
afford functionalised dibenzothiophenes 158 and 160 with no evidence of competing 
cycloisomerisation (Scheme 39). Enyne 154 was one of the substrates employed by Toste with 
excess diphenyl sulfoxide 42 to effect cycloisomerisation followed by oxidation of the resultant 
carbene.13 With dibenzothiophene-S-oxide 103 trace amounts of oxidised cycloisomerisation 
product 163 was observed with no oxyarylation products. A similar result was observed with 
enyne 157. Shin had demonstrated cycloisomerisation and oxidation of the resultant carbene 
when employing enynes with a terminal alkyne and a propiolamide tether.14 Enynes with a high 
tendency to cycloisomerise are poor choices for oxyarylation. The results further highlight the 




Scheme 39. Oxyarylation with various enynes. 
2.8 Iterative Processes 
The feasibility of achieving selective functionalization of both 4- and 6-positions of 
dibenzothiophene by an iterative application of the gold catalyzed oxyarylation was explored 
Initial sulfoxide oxidation of 131 with urea hydrogen peroxide yielded predominantly the 
sulfone, and employing sodium metaperiodate resulted in only recovered starting material. 
Efficient oxidation of dibenzothiophene 131 was achieved with mCPBA providing sulfoxide 
166. Subjecting the sulfoxide under the standard oxyarylation conditions, with a higher dilution 
to allow for the reduced sulfoxide solubility furnished disubstituted dibenzothiophene 167 in a 
moderate yield (Scheme 40).  
 
Scheme 40. Double functionalisation of dibenzothiophene. 
158 was also selectively oxidized to sulfoxide 168 using mCPBA in a similarly high yield and 
pleasingly proved an effective reagent for oxyarylation (Scheme 41). Treatment of 168 with 
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enyne 152 furnished a functionalised, symmetrical 4,6-disubstituted dibenzothiophene 169 in 
high yield. Employment of enyne 153 with sulfoxide 168 resulted in formation of an 
unsymmetrical, disubstituted dibenzothiophene 170 in good yield. The reactions were slower 
than the comparable reactions with unsubstituted dibenzothiophene-S-oxide 103 but the high 
yields and mild conditions make this an attractive method of further functionalising these 
structures, especially considering the presence of keto and alkene functionality in the starting 
sulfoxide. Preparation of these disubstituted dibenzothiophenes allowed access to new and 
potentially interesting cyclic structures. Ring closing metathesis using Grubbs’ 2nd generation 
catalyst was successfully applied to furnish symmetrical and unsymmetrical macrocycles 171 
and 172 in high yields.  
Scheme 41. Preparation of a symmetrical and unsymmetrical dialkylated dibenzothiophene and 
preparation of a macrocycle. 
A crystal structure was obtained of the symmetrical macrocycle 171 (Fig 3). This confirmed 
that the geometry of the double bond was E. 1H NMR data of the unsymmetrical macrocycle 




Fig 3. Crystal structure for macrocycle 160. 
2.9 Further transformations 
Diynes 173 and 174 were prepared (Scheme 15) according to the method of Hashmi (Scheme 
42).94 
 
Scheme 42. Preparation of diynes. 
They were tested under the catalysis conditions in order to assess their reactivity and determine 
the effect of a second terminal alkyne group. Firstly diyne 173 was employed under the standard 
catalysis conditions with dibenzothiophene-S-oxide 103 and good conversion of starting 
material was observed. Unfortunately, however, the isolated spots from column 
chromatography degraded rapidly and no products were successfully isolated. On employing 
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diyne 174, two new spots were observed by TLC. Upon reaction completion these could be 
successfully isolated providing the diketone 177 in 17% yield and more interestingly the 
cyclohexanone 178 in 57% yield (Scheme 43). A likely explanation for this reaction outcome 
is consistent with the result observed by Davies and Detty-Mambo in their cycloisomerisation 
of alkynes tethered to unactivated enolisable ketones in the presence of cationic gold(I) 
species.95 Oxyarylation with the diyne provides substituted dibenzothiophene 175. Adventitious 
water in the reaction mixture hydrates the pendant alkyne 176 at which point tautomerisation 
and loss of the gold affords the diketone 177 which mostly reacts further participating in an 
intramolecular aldol condensation.  
 
Scheme 43. Reacting dibenzothiophene-S-oxide with a diyne. 
Preliminary screening was initiated in order to quickly determine if a number of other aryl based 
sulfoxides could be employed with diyne 174 to generate further functionalised 
cyclohexanones. While the cyclohexanone derived products were observed with diphenyl 
sulfoxide 42 poor reactivity was observed with methyl phenyl sulfoxide and no further 
exploration was done. 
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Treatment of dibenzothiophene 136 with phenyl hydrazine, TFA and acetic acid at a high 
temperature afforded indole 179 in a reasonably good unoptimised yield (Scheme 44). This 
reaction demonstrates that these products of catalysis can be readily further modified providing 
a new method to incorporate an indole in the 2- position. 
 
Scheme 44. Preparation of an indole-derived dibenzothiophene. 
2.10 Conclusion 
With dibenzothiophene-S-oxide 103 clear trends are observed with regard to the nature of the 
gold catalyst and the temperature influencing reaction outcome. Very different conditions have 
been successfully employed to efficiently facilitate the oxyarylation of various alkynes with 
other aryl sulfides.  
Dibenzothiophene-S-oxide 103 has been shown to be a very effective substrate for oxyarylation 
with terminal alkynes under mild conditions and with excellent chemoselectivity. Investigations 
into other cyclic sulfoxides proved unsuccessful but an iterative process was used to allow the 
extension of the current methodology. Macrocycles could also be prepared easily using this 
method. Other progress included a novel oxyarylation cascade and functionalization of 
products. With the high interest in dibenzothiophenes, this method could find many uses and 
demonstrates the versatility of this oxyarylation reaction. Preliminary tests and unsuccessful 
attempts to incorporate internal alkynes in the oxyarylation suggest the high reactivity of 
dibenzothiophene-S-oxide 103 and relatively low selectivity limits its applications or the 














Chapter 3: Gold catalysed processes from alkynes 





Thioacetals are traditionally prepared by the reaction of carbonyl compounds with thiols or 
dithiols under acidic conditions.96 Dithianes are used as carbonyl protecting groups and allow 
umpolung reactions to be performed. In the Corey-Seebach reaction 1,3 dithianes are employed 
as nucleophilic acylating reagents. An alternative preparation of thioacetals is by reaction of 
diazo compounds and thiols or dithiols. In the first report demonstrating this method, diphenyl 
diazomethane 180 was reacted with 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) 181 
followed by addition of the thiol or dithiol (Scheme 45). Utilising the dehydrogenating power 
of DDQ good yields of an acyclic dithioacetal 182 or a cyclic dithioacetal 183 were achieved.97 
Scheme 45. Preparation of thioacetals from diphenyl diazomethane and sulfides. 
In 1985, various cyclic disulfides including 184 and 187 were treated with carbenes, generated 
by copper catalysis, rhodium catalysis and irradiation with light.98 The study found that the 
method of carbene generation from the diazo species, had no effect on the reaction outcome. 
The factor found to determine the reaction outcome was the steric nature of both the carbene 
and the disulfide. In all cases sulfur ylide formation was proposed to proceed initially forming 
185 and 188 (Scheme 46). In cases where the substrate was less bulky, 1,2-rearrangement and 
cleavage of the disulfide bond occurred forming dithioacetals such as 186, often in high yield. 
On the other hand sterically congested substrates underwent desulfurisation through 188-190 




Scheme 46. Divergent reactivity of sulfur ylides from diazo compounds and cyclic disulfides. 
Generation of singlet carbenes is widely understood to be an important method for forming 
sulfur ylides.99 The mechanism for the reaction of triplet carbenes (diphenylcarbene and 
fluorenylidene) with sulfides and disulfides was studied by Alberti using electron paramagnetic 
resonance spectroscopy.100 Triplet diphenylcarbene was shown to react via its triplet state, 
undergoing a homolytic substitution process to yield the dithioacetal among other products. In 
contrast triplet fluorenylidene was found to access singlet carbene reactivity with the reaction 
proceeding proposedly via a sulfur ylide. 
Kawamura employed 193 with diaryl disulfides 194 forming mostly 197. The reaction was 
proposed to proceed via a double insertion, with monoinsertion products formed in negligible 
yield (Scheme 47).101 The most probable mechanism involved a double Stevens rearrangement 




Scheme 47. Double insertion of aryl disulfides 
Very recently, terminal alkynes 198 were transformed into triazoles 200 under copper catalysis 
upon treatment with azides 199 (Scheme 48).102 Addition of a rhodium catalyst led to nitrogen 
loss, and formation of a rhodium carbene 201 which reacted with aryl disulfides forming 
thioacetals 202 (Scheme 48). The imine moiety could be cleaved or reduced easily in situ to 
form either 1-(aryl(arylthio)methylthio)benzenes 203 or aryl-2,2-bis(arylthio)-N-
sulfonylethanamine 204 in high yields. 
Scheme 48. Generation of rhodium carbenes from triazoles in thioacetal formation. 
A report published in 1998 explored the reactions of two rigid aromatic cyclic disulfides 205 
and 209 with vinyl diazo compounds 206 and a rhodium catalyst.103 
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1,2-Dithiaphenanthrene 205 was treated under rhodium catalysis with 206a-b affording 
dithioacetals 208a-b selectively and in high yield from these reactions (Scheme 49).103 The 
reaction is proposed to proceed via a sulfonium ylide 207a-b with sulfur migration forming the 
thioacetal 208. 
 
Scheme 49. Reaction of vinylcarbenoids with naphthalene disulfide.  
In the same study Oshima reacted dibenzo[c,e][1,2]dithiin 209 with the same diazo compounds 
206a-b and rhodium acetate (Scheme 50). The isolated products were 1,3-insertion adducts 





Scheme 50. Reaction of 1,2-dithiaphenanthrene with a metal vinyl carbenoid. 
3.2 Aim and objectives 
The aim of this work was to explore the reactivity of disulfide oxides with alkynes under gold 
catalysis, led by a curiosity as to whether analogous insertion products to those formed with 
rhodium carbenes would be observed and whether selectivity could be achieved when several 
reasonable reaction pathways could be foreseen.  
A number of disulfide oxides 212-216 have been reported to be stable compounds, including 
the ditert-butyl disulfide 215,105 and dibenzo[c,e][1,2]dithiin monoxide 216,106,107 while the 
Grainger group introduced a range of naphthalene derived disulfide oxides 212-214 the 





Figure 4. Disulfide oxides. 
In this process it is desirable that the SO reacts with the alkyne to afford the gold carbene with 
release of disulfide (Scheme 51).17,34 Regioselective nucleophilic attack of the disulfide oxide 
212 onto the internal carbon of the activated alkyne would be expected to proceed initially.26,27 
The nature of the gold species could then be pivotal in determining reaction outcome. Vinyl 
gold species 217 may be expected to undergo [3,3]-sigmatropic rearrangement 218 to furnish 
the oxyarylation product 219 . Cleavage of the S-O bond would form the α-oxo gold carbene 
220 and disulfide 205 which could then react analogously to afford the sulfur ylide 221 as 
observed with rhodium carbenes.99,101,103 such formation from sulfoxides is often less effective 
than other competing pathways (oxyarylation/further oxidation), though in this case the 
disulfide nucleofuge may show a substantially different reactivity profile than a sulfide. 
Alternatively, sulfur ylide formation may proceed from the vinyl gold carbenoid 221 via attack 
of the second sulfur at the electrophilic carbon. Finally Stevens-type migration of the ylide 
carbon to sulfur would furnish the dithiane product 222. Tuning of the reaction outcome was 
predicted to be possible by choice of reaction conditions, gold ligand sphere and also the 




Scheme 51. Formation of products derived from an oxyarylation or an insertion. 
3.3 Preliminary studies and reaction discovery 
Three naphthalene derived disulfide oxides 212-214 (Fig 1) were chosen as initial test 
substrates. Naphthalene disulfide oxide 212 provides a direct comparison to naphthalene 
disulfide employed in Oshima’s study. The two di-tert butyl substituted sulfur oxides 213 and 
214 would be unable to undergo oxyarylation and also provide a sterically bulky environment.  
Disulfide 205 was prepared from 2-bromonaphthalene 223 using reported procedures by 
halogen metal exchange, followed by a selective deprotonation at the 8-position with heating, 
and subsequent quenching with sulfur (Scheme 52).83 Oxidation with mCPBA afforded the 
sulfur oxide 212. Friedel Crafts alkylation of naphthalene disulfide 205 proceeded smoothly 





Scheme 52. Preparation of disulfide oxides. 
The initial test towards the desired aim was performed using naphtho dithiole monoxide 212 
and hex-1-yne under the oxyarylation conditions previously developed (Chapter 2). The 
formation of a 1,1-insertion product 225 was observed in a modest yield alongside oxyarylation 
product 226 resulting from [3,3]-sigmatropic rearrangement on the initially formed vinyl gold 
species (Table 4, entry 1). Reducing the temperature gave a poorer yield of 225 (Table 4, entry 
2) which is consistent with the trends expected for oxyarylation. A small improvement in 
reaction outcome was observed at 40 oC (Table 4, entry 3). However, degradation was seen at 
higher temperatures (Table 4, entry 4). Changing from the phosphite-gold catalyst to a more 
electron-rich XPhosAuCl/AgSbF6 system tried to decrease the lifetime of vinyl gold carbenoid 
(or increase the likely formation of the gold carbene). Overall lower conversion was seen 
though an improved ratio toward the desired product 225 over oxyarylation 226 was observed 




Table 4. Reaction discovery and preliminary screening results. 
 
Entry Catalyst  Temp oC Time h Yielda  
212                    225 226 
1 Au-I rt 16 30 35 15 
2 Au-I 0 16 27 28 20 
3 Au-I 40 16 0 42 34 
4 Au-I 70 5 0 24 13 
5 XPhosAuCl/ 
AgSbF6 (2.5 mol%) 
50 16 60 20 8 
a Reactions performed on a 0.1 mmol scale and yields determined by crude NMR analysis using 1,2,4,5 
Tetramethylbenzene as an internal reference standard. Au-I = (2,4-di-tert-butylC6H3O)3PAu(NCCH3)SbF6. 
3.4 Reaction Optimisation 
With these promising results in hand, phenylacetylene was subsequently used for reaction 
optimisation as the degradation observed on moderate heating with hex-1-yne was not observed 
(Table 4, entry 4). 
Initially the reaction solvent was varied. Excellent conversion was observed with toluene (Table 
5, entry 1) yet the ratio of the two products was quite poor. Halogenated solvents proved suitable 
giving moderate conversion and a low yield of desired product 227 (Table 5, entries 2 and 4). 
1,4-dioxane and acetonitrile shut down the reaction (Table 5, entry 3 and 5). No conversion was 
seen with only the gold at an elevated temperature (Table 5, entry 6), triflimidic acid solely 
resulted in degradation on employment (Table 5, entry 7) and silver hexafluoroantimonate did 
not promote any reaction (Table 5, entry 8). 
The nature of the silver co-catalyst was instrumental in determining the reaction outcome. With 
the basic and tightly coordinating tosylate anion, no reaction was observed, and silver 
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tetrafluoroborate and silver triflate were also poor choices (Table 5, entries 9 and 11). An 
improvement in ratio was observed with silver triflimidate (Table 5, entry 12), but only silver 
hexafluoroantimonate facilitated high reaction efficiency (Table 5, entry 2). 
The electronic nature of the phosphine gold catalyst was not pivotal in determining the 
reactivity and selectivity of the system. Sterically bulky catalysts, such as XPhos and di-tert 
butyl phosphite, proved more effective (Table 5, entries 1 and 14), compared to 
triphenylphosphinegold(I) chloride (Table 5, entry 15). IPrAuCl was also ineffectual (Table 5, 
entry 18).  
The addition of a catalytic quantity of 4-methyl di-tert butyl pyridine, a non-nucleophilic base, 
resulted in total loss of reactivity (Table 5, entry 19). A negligible difference in reaction 
outcome was observed on switching from the phosphite catalyst to the pre-formed acetonitrile 
complex Au-I (Table 5, entries 16 and 17). Addition of 1.1 equivalents of methanesulfonic acid 
resulted mostly in degradation (Table 5, entry 20). 
Temperature was a less critical variable with complete conversion above 50 oC, and no change 
in the reaction outcome when the temperature was increased further (Table 5, entries 21 and 
22). Small peaks at 10-11 ppm were observed in the crude 1H NMR spectrum likely due to the 
small amount of regioisomeric product resultant from S-oxide attack at the external carbon of 
















Solvent 212a 227a 228a 
1 50 XPhosAuCl AgSbF6 2.5 Toluene 0 52 38 
2 50 XPhosAuCl  AgSbF6 2.5 CHCl3 25 42 29 
3 50 XPhosAuCl AgSbF6 2.5 Dioxane 90 0 0 
4 50 XPhosAuCl AgSbF6 2.5 DCE 24 33 22 
5 50 XPhosAuCl AgSbF6 2.5 CH3CN 90 8 3 
6 100 XPhosAuCl - 2.5 Toluene 100 0 0 
7 50 HNTf2  5 Toluene 88 <3 0 
8 50  AgSbF6 10 Toluene 90 0 0 
9 50 XPhosAuCl  AgBF4 2.5 Toluene 78 12 5 
10 50 XPhosAuCl  AgOTs 2.5 Toluene 95 0 0 
11 50 XPhosAuCl  AgOTf 2.5 Toluene 100 0 0 
12 50 XPhosAuCl  AgNTf2 2.5 Toluene 42 33 5 
14 50 SPhosAuCl AgSbF6 2.5 Toluene 20 42 26 
15 50 PPh3AuCl AgSbF6 2.5 Toluene 23 30 16 
16 50 L2AuCl AgSbF6 2.5 Toluene 42 39  12 
17 50 Au-I AgSbF6 2.5 Toluene 17 43 28 
18 50 IPrAuCl AgSbF6 2.5 Toluene 76 5 <3 
19b 50 XPhosAuCl AgSbF6 2.5 Toluene 95 0 0 
20c 50 XPhosAuCl AgSbF6 2.5 Toluene 12 8 <3 
21 rt XPhosAuCl AgSbF6 2.5 Toluene 12 44 32 
22 100 XPhosAuCl AgSbF6 2.5 Toluene 1 51 37 
a Reactions performed on a 0.2 mmol scale and yields determined by crude NMR analysis using 1, 2, 4, 5 
Tetramethylbenzene as an internal reference standard. b Addition of 5 mol% 2,6-di-tert-butyl-4-methylpyridine. c 
Addition of 1.1 eq. methanesulfonic acid. L2 = Au-I = (2,4-di-tert-butylC6H3O)3PAu(NCCH3)SbF6. 
 
3.5 Variation of the alkyne 
Sulfur oxide 212 was treated with a range of alkynes in order to better understand the 
chemoselectivity and the scope for the transformation. Ester substituted alkyne 230 was 




Scheme 53. Preparation of an internal alkyne. 
Due to the difficulties involved in isolating the pure products, and the generally poor to modest 
yields encountered, only NMR yields were obtained, except for the phenyl derivative, with the 
insertion product 227 isolated in a moderate 46% yield and the rearrangement product 228 in a 
9% isolated yield (Table 6. entry 1). 
Both electron rich and electron poor aryl substituted terminal alkynes were tolerated with the 
ester working as well as phenyl (Table 6, entries 1-4). A heteroaromatic thiophene was 
employed successfully in a reduced yield (Table 6, entry 5). However, an acetamide was mostly 
unreacted (Table 6, entry 6) highlighting the limited substrate scope for this transformation. 
Under the conditions developed for aryl substituents, alkyl substituents were largely unreactive. 
Hex-1-yne worked poorly, with cyclopropyl even worse (Table 6, entries 7 and 8). No reactivity 
was observed with an internal alkyne or with an ynamide (Table 6, entries 9 and 10). A diyne 




Table 6. Treatment of naphtho dithiole monoxide with a variety of alkynes. 
 




0 216 46b 217 9b 
2 
 
55 231 35 232 <3 
3 
 
0 233 54 234 36 
4 
 
50 235 35 236 <3 
5 
 
55 237 28 238 3> 
6 
 
80 239 7 240 3> 
7 
 
60 225 20 226 10 
8 
 
71 241 15 242 4 
9 
 
90 243 0 244 0 
10 
 
90 245 0 246 0 
11 
 
70 247 3> 248 3> 
     
a Reactions performed on a 0.1 mmol scale and yields determined by crude NMR analysis using 1, 2, 4, 5 
Tetramethylbenzene as an internal reference standard. b Reaction performed on a 0.4 mmol scale and Isolated yields 
after flash column chromatography 
 
Preliminary studies had showed hex-1-yne to be more reactive with the electron-withdrawing 
phosphite catalyst Au-I (Table 4, entry 4). These conditions were reinvestigated with secondary 
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and tertiary alkynes to see how that might affect the ratio of insertion products (225, 249 and 
241) and the oxyarylation products (226, 250 and 242). In all cases there is little effect on 
reaction outcome upon changing the sterics of the alkyl group and product selectivity remains 
poor. While naphtho dithiole monoxide 212 proved to afford the desired reactivity and afforded 
high conversion with a range of terminal alkynes, selectivity between pathways was low with 
competing oxyarylation causing low yields.  
Table 7. Preparation of alkyl substituted products. 
 
Alkyne Scale (mmol) Product  Yielda 207%  Product Yielda 212%  
 
0.3 225 36 226 33 
 
0.2 249 46 250 26 
 
0.2 241 38 242 20 
a Isolated yields after purification by silica gel chromatography. 
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3.6 Probing the reactivity of disulfide oxides 
The reactivity of the disulfide oxides in gold catalysis was first probed employing them as 
oxidants to replace diphenyl sulfoxide 42 in Liu’s oxidative ring-expansion of alkynyl 
cyclopropanes 109 to cyclobutenyl ketones 110.19 Interestingly, all three derivatives 
selectively transformed the cyclopropyl alkynes 109 into the desired cyclobutenyl ketones 110 
under Liu’s conditions (Scheme 54). The addition of the tert butyl groups resulted in much 
improved conversion with the crude yield of cyclobutenyl ketone 110 when employing sulfur 
oxide 214 being comparable to diphenyl sulfoxide 42. 
 
Scheme 54. Naphthalene based disulfide oxides as intermolecular oxidants in oxidative gold catalysis. 
Other disulfide oxides were then explored to see how structure would impact on selectivity. It 
was hypothesised that by blocking the ortho positions on the naphthalene ring, the formation 
of the undesired oxyarylation product would be eliminated. Employing the di-tert butyl variant 
of the sulfur oxide 213 and the vic disulfoxide 214 under the previous best conditions (Table 5, 
entry 6) resulted in no reaction. These two sulfur oxides were suitable as intermolecular 
oxidants in the ring expansion of alkynyl cyclopropane 109.  
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Di-tert butyl disulfide monoxide 215 was synthesised (Scheme 55) and tested under the reaction 
conditions. The starting material was consumed, although a complex mixture was observed.  
 
Scheme 55. Preparation of a more flexible disulfide oxide. 
3.7 Reactivity of a fluorene derived disulfide monoxide 
A system based on dibenzo[c,e][1,2]dithiin was considered as Oshima found success,  
generating different products to the naphthalene disulfide. The known preparation is many steps 
in length which is off-putting for a useful procedure.  
Recently a cyclic disulfide derived from fluorene has been prepared for the first time.110 
Bonifácio demonstrated an efficient synthesis for this compound and this methodology was 
employed by Figliola who reduced the length of the alkyl chain in preparing 226 which was 
selected as a test case for the disulfide variation approach.110,111  
Employing the aforementioned procedure, fluorene 251 was doubly alkylated upon treatment 
with KOtBu followed by the addition of butyl iodide in excellent yield. Combining 252 in 
refluxing THF with n-BuLi and TMEDA resulted in selective double deprotonation, and 
trapping with sulfur at low temperature furnished the required disulfide 253. The disulfide 253 
was then oxidised selectively to the target disulfide monoxide 254 in moderate yield using 
mCPBA at low temperature (Scheme 56). 
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Scheme 56. Preparation of a novel disulfide oxide from fluorene. 
Fluorene disulfide oxide 254 was then reacted with hex-1-yne under the best conditions found 
previously for naphthalene dithiole monoxide 212 with alkyl alkynes (Table 7). Formation of 
the 1,1 insertion product 255 was observed (Table 8, entry 1) with clear reduction in the 
proportion of the oxyarylation product 256 formed. 
Employing phenylacetylene under the conditions found previously to be optimum for aryl 
alkynes (Table 6, entry 1) led to only a very low yield of insertion product 257 (Table 8, entry 
2) but only traces of the undesired oxyarylation product 258. Reactions were performed with 
phenylacetylene and phosphite catalyst Au-I and the temperature varied (Table 8, entries 3-6). 
As expected the ratio of product 257 to 258 increased upon increasing the temperature following 
the trends seen in chapter 2. Preparation of pre-formed gold complex Au-II and an increase in 
temperature led to a better yield of the insertion product with phenylacetylene and the 
oxyarylation product 258 was effectively eliminated (Table 5, entry 8). The results show the 
fluorene-derived sulfur oxide 254 is less reactive than the naphthalene derived sulfur oxide 212 
but catalyst tuning effectively prevents formation of the undesired oxyarylation product 258. 
Oxyarylation is eliminated using an electron-rich catalyst favouring the α-oxo gold carbene, 
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which would give rise to the desired insertion product (Table 5, entries 6 and 8). Small peaks 
at 10-11 ppm were observed in the crude NMR spectrum likely due to the small amount of 
regioisomeric product resultant from S-oxide attack at the external carbon of the activated 
alkyne. 
Table 8. Optimisation of the desired reaction. 
 
 
Entry  R Catalyst Temp oC Time (h)    Yield% a 
254         255/7       256/8 
1 n-Bu Au-I 40 28 45 40 10 
2 Ph XPhosAuCl/ 
AgSbF6 
50 40 70 17 <3 
3 Ph Au-I rt 24 54 20 9 
4 Ph Au-I 40 24 46 32 12 
5 Ph Au-I 60 24 32 52 12 
6 Ph  Au-I 80 24 <10 45 7 
7 Ph  Au-II 60 24 30 59 0 
8 Ph  Au-II 70 24 <10 71 0 
9* Ph  Au-II 90 24 <5 73 0 
a Reactions performed on a 0.1 mmol scale and yields determined by crude NMR analysis using 1, 2, 4, 5 
Tetramethylbenzene as an internal reference standard. * Reaction performed after the first 4 examples were 
obtained. Au-II = (Acetonitrile) Dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl gold(I) 
hexafluoroantimonate.  
 
3.8 Substrate elaboration 
An investigation into the substrate scope for the transformation was carried out. First, several 
aryl based terminal alkynes were tested under the optimised conditions. Pleasingly, an ester, 
methyl and thienyl substituent were all well tolerated, providing the desired products 259 and 
260-261 in moderate to good yields (Scheme 57). 
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Employment of 5-chloro-1-pentyne under the optimised reaction conditions resulted in poor 
reactivity with only a 28% proton NMR yield of 262 observed. Notably reactions from this 
point were performed at 90 oC, with this temperature increase rationalised by improved 
reactivity (Table 9, entry 9). Gratifyingly, an ester derived internal alkyne reacted in good yield 
affording thioacetal 263. Bromophenylacetylene did not afford any desired product 264. TLC 
analysis of the reaction mixture showed very little reactivity with some degradation. 
 
 
Scheme 57. Preparation of a range of dithioacetals. 
The structure of 263 was rationalised by comparing the 13C NMR data of the carbonyl carbons 
against two known compounds 265 and 266 displaying the possible substitution patterns (Fig 
71 
 
5). 112,113  The difference in chemical shift suggests 263 rather than 267 is the correct compound. 
This conclusion also fits with the known literature where nucleophilic attack of the oxygen 
moiety occurs away from the internal ester carbon.27,52 A comparison was made of  the 13C 
resonances of the carbonyl carbon across the series of compounds 255, 257, 268, 259-262, 269-
270. For the phenyl substituted products the carbonyl peak appears at around 192 ppm. A 
thiophene substituent results in a decrease in chemical shift whereas the carbonyl is 
significantly more deshielded with a hexyl substituent resonating at 202 ppm.  
 




Table 9. Comparison of chemical shifts of the C=O bond in the catalysis products 











Alkylalkynes were studied using modified conditions providing a strategy to efficiently oxidise 
and functionalise alkynes in a single step because of the poor result observed using the 
conditions in Scheme 57. Under these conditions 5-chloro-1-pentyne was well tolerated (Table 
10, entry 2). Hex-1-yne was also incorporated to give 255 in a moderate yield (Table 11, entry 
1) and a silyl protected alcohol was also allowed 268, albeit in a lower 44% yield (Table 11, 
entry 3).  
Table 10. Preparation of alkyl substituted insertion products. 
 
Entry Alkyne Time h Product Yielda 
1 
 
22  255 57 
2 
 
22 262 66 
3 
 
22 268 44 
Reactions performed on a 0.1 mmol scale. a Isolated yield after purification by silica gel chromatography. 
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In addition to the interesting reactivity, this transformation potentially provides a strategy to 
efficiently oxidise and functionalise alkynes in a single step. To enhance this, the reagent 
stoichiometry was altered in order to make the alkyne the limiting reagent. 4-Bromo 
phenylacetylene proved to be a good substrate, delivering the insertion product 269 in high 
yield (Table 11 entry 1). The ester substituted alkyne tested previously provided a similar 
reaction outcome (Table 11, entry 2) and a 3-methoxy-substituent 270 was incorporated in a 
moderate yield (Table 11, entry 4). The most exciting results were obtained utilising the ester 
substituted internal alkynes. An excellent yield was obtained of dithioacetal 263 (Table 11, 
entry 3), higher than when the alkyne was employed in excess (Scheme 57). Alkyne 230 with 
a furan heterocycle attached was also incorporated, providing 271 in a good yield (Table 11, 
entry 5). Unfortunately attempts to incorporate an ester substituted ynamide were unsuccessful 
(Table 11, entry 6).  
With ester substituted alkynes an alternative reaction mechanism can be envisaged without the 
requirement for a π-acid. The nucleophilic sulfur oxide could undergo a conjugate addition to 
the alkyne. This pathway was ruled out as no reaction was observed on omission of the gold 




Table 11. Thioacetal preparation using aryl based alkynes as the limiting reagent. 
 
Entry Alkyne Time h Product Yielda 
1 
 
22  269 70 
2 
 
20 263 83 
3 
 
20 259 52 
4 
 
20 270 67 
5 
 
14 271 75 
6 
 
20 272 0 
7b 
 
20 263 0 
Reactions performed on a 0.1 mmol scale. a Isolated yield after purification by silica gel chromatography. b No 




3.9 Crystal structure comparisons of the insertion products 
A crystal structure was successfully obtained for the insertion products 227 and 257 using single 
crystal X-ray diffractometry (Fig 7). Naphthalene based 227 (Fig 6) comprised of two 
crystallographically independent molecules of which the right hand structure was used for 
analysis.  
In 227 the 1,3 dithiane ring sits in a sofa conformation.83,114 Ring strain is observed with the 
C1-C9-C8 bond angle of 124.5o compared to the expected 120o. The naphthalene ring is almost 
planar with the C1C9-C10C5 dihedral angle at 178.69(10)o. One of the sulfur atoms is out of 
the plane with a S1C1C9C8 bond angle of 5.7o. 
The bond lengths of the carbon sulfur bonds in compounds 227 and 257 are virtually identical. 
The S1C11 and S2C11 of 227 and the S1C14 and S2C14 of 257 are 1.81 which is significantly 
longer than the C1-S1 and the C8-S2 t 1.7669(15) and 1.7690(11) lengths for 227 and 257. 
Other interesting features are the S1C14S2 bond angle of 114.52(0)o which is in between 
tetrahedral and planar. With the fluorene derivative the S1C1C2 and S1C1C13 bond angles are 
shifted significantly from the expected 120o at 112.491(13)
o and 128.55o compared to the 
S1C1C2 and S1C1C9 angles of 114.84(11)o and 124.14(11)o in the naphthalene derivative 
124.5o. Clearly ring strain is present in both molecules but the data is not sufficient enough or 





Figure 6. Crystal structure of 227 
 
 




Several disulfide oxides have been investigated in this study exploring the chemistry of these 
species with alkynes. Two, naphthalene dithiole monoxide 212 and 9,9-dibutyl-9H-
fluoreno[4,5-cde][1,2]dithiine 4-oxide 254, have undergone insertion chemistry with alkynes. 
These results resemble the reactivity of cyclic disulfides with rhodium carbenes in Oshima’s 
study.101 Naphthalene disulfide oxide 212, on the one hand displayed good reactivity however 
the competing oxyarylation pathway adversely affected the yield. Selectivity could not be 
achieved upon screening a range of reaction conditions. 9,9-Dibutyl-9H-fluoreno[4,5-
cde][1,2]dithiine 4-oxide 254 proved less reactive but the reaction outcome could be tuned with 
the appropriate catalyst. Using this disulfide oxide a range of novel dithioacetals were prepared 
and terminal and ester substituted alkynes could be efficiently oxidised and functionalised in a 
single step. In all cases regioselectivity in the initial attack of the sulfur oxide was good with 
only trace amounts of the aldehyde observed. A limitation of this approach is the lack of 































4.1.1 Preparation and reactions of α-diazo sulfoxides 
Reactions at metal carbene centres offer substantial variety in formation of stereogenic centres. 
Ligand choice offers a good method to form stereogenic centres however this is still a 
considerable challenge.115,116 An alternative method is to employ a chiral auxiliary within the 
substrate to control the stereochemistry. Taber utilised this method by employing a chiral ester 
group near to the reaction centre in 273, in order to obtain high diastereoselectivity in a synthesis 
of cyclopentanones 274 (Scheme 58).117 
 
Scheme 58 Diastereocontrol in a C-H insertion from a diazo compound. 
α-Diazo sulfoxides may be expected to be excellent candidates for asymmetric synthesis due to 
the fact that sulfoxides can be prepared in enantiopure form relatively easily.118 Furthermore 
the proximity of the sulfoxide functionality to the reaction centre could facilitate good 
stereocontrol.119 In reality α-diazo sulfoxides are difficult to prepare, and their reactivity is hard 
to control and mostly follows undesirable pathways. This is in complete contrast to α-diazo 
sulfones which can be prepared easily and display the normal reactivity modes for diazo 
species.115,116 An illustrative example from Maguire used α-diazo sulfones 275 in a highly 
enantioselective copper catalysed synthesis of thiopyrans 276.116 A combination of copper 




Scheme 59. Enantioselective C-H insertion reactions with α-diazo sulfones. 
In 1968 Hodgson and Holt reported that under diazo transfer conditions β-keto sulfoxides 
exhibit unusual reactivity patterns compared to β-keto sulfones.120,121 Upon treatment of 
(benzylsulfinyl)acetophenone 277 with a well-used diazo transfer reagent p-toluenesulfonyl 
azide and triethylamine, no α-diazosulfoxide 284 was isolated. Instead dibenzyl disulfide 281, 
benzoylformic acid 282 and p-toluenesulfonamide 283, were obtained as the products 
(Scheme 60). The isolation of these products can be explained through initial formation of the 
α-diazo sulfoxide 284, which undergoes decomposition via an intermediate carbene 278. It was 
postulated that the first step involved an oxygen transfer from the sulfur to the carbene centre 
278 providing the corresponding thiol ester 280. The keto-acid 282 and disulfide 281 were 




Scheme 60. Attempted diazo transfer to an acyclic sulfoxide. 
Rosati was the first to demonstrate the preparation a stable cyclic α-diazo sulfoxide 286, 
achieved while synthesising cephalosporin derivatives.122 Treatment of 286 with a rhodium 
catalyst resulted in a low yield of an oxygen transfer product 287 (Scheme 61). Maguire also 
demonstrated the preparation of a stable cyclic α-diazo sulfoxide 289.  
 
Scheme 61. First successful isolation of diazo sulfoxides. 
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Constrainment of the sulfoxide within a ring was revealed to be essential in order for the α-
diazo sulfoxide to be stable. A broad range of acyclic sulfoxides 290 were prepared and 
subjected to diazo transfer conditions with no α-diazo sulfoxides 291 isolated (Scheme 62).127  
 
Scheme 62. Unsuccessful isolation of diazo sulfoxides. 
Maguire then reacted 289 with Rh2(OAc)4 in order to evaluate its reactivity (Scheme 63).
123 It 
was found that a Wolff rearrangement was proceeding, delivering a dimerization product, but 
which could be trapped by a diene affording a Diels-Alder adduct 293 (Scheme 63). 
Microwave irradiation was found to promote the Wolff rearrangement without the requirement 
for a transition metal catalyst (Scheme 63).124 A single stereoisomer of the Diels-Alder adduct 
293 could be prepared by thermodynamic equilibration of the Z sulfine to the E sulfine prior to 
diene addition (not shown).  
 
Scheme 63. Successful diazo transfer and subsequent reactivity. 
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Maguire and co-workers undertook photochemical studies with α-diazo sulfoxide 289 (Scheme 
64), in order to understand more about the reactions of these species.125 The sulfoxide was 
stabilised in an argon matrix at an extremely low temperature (10 K) and product formation 
was analysed using infra-red spectroscopy. Irradiation with light at 248 nm resulted in a good 
yield of E sulfine 295, whereas irradiation of light at 308 nm resulted in the direct formation of 
an oxithiirane 296, with the configuration shown (Scheme 64), calculated to be the most stable. 
The E sulfine 295 was converted into the oxithiirane 296 with irradiation at 308 nm and further 
irradiation led to rearrangement product 297 or decomposition. The group were unable to isolate 
the carbene intermediate, yet the results strongly support the experimental evidence, that upon 
nitrogen loss a sulfine intermediate is formed by Wolff rearrangement.  
 
Scheme 64. Reactions of a diazo sulfoxide upon irradiation with light. 
Maguire’s earlier studies on cyclic α-diazo sulfoxides were inhibited by the inefficiency of the 
sulfide precursor synthesis, where Baker’s yeast was employed in a low yielding carbonyl 
reduction.126 An efficient sulfide preparation was developed, which permitted synthesis of a 
library of chiral cyclic sulfoxides 299 from sulfides 298.127 Upon screening to establish the best 
diazo transfer agent, a wide variety of monocyclic and bicyclic α-diazo sulfoxides 300 were 
prepared (Scheme 65). Maguire rationalised that the diazo sulfoxide stability is dependant upon 
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the overlap of the sulfinyl lone pair of electrons with the unsaturated diazo moiety. This helped 
to explain why “axial” α-diazo sulfoxides showed greater stability than the “equatorial” α-diazo 
sulfoxides.127 
 
Scheme 65. Synthesis of a library of α-diazo sulfoxides. 
4.1.2 Synthesis and applications of alkynyl sulfoxides 
Many methods have been successfully employed to allow the facile preparation of 
enantioenriched sulfoxides in high yields, as mentioned earlier.118 An important example which 
allows a variety of enantiopure sulfoxides to be easily prepared is discussed below. 
An efficient asymmetric preparation of sulfoxides was demonstrated in Evans’ synthesis of 
chiral organosulfur compounds, utilising oxazolidinones derived from norepherdrin and L-
phenylalanine (Scheme 66).128 This method promoted a facile entry into enantiopure sulfoxides 
for use in asymmetric synthesis, due to readily available starting materials and no requirement 
for multiple recrystallizations. Oxazolidinone 301 was alkylated at nitrogen using n-BuLi 
affording 303. mCPBA oxidation afforded separable diastereomers 304a and 304b and these 
could be transformed to asymmetric sulfoxides 305 using Grignard reagents (Scheme 66). 
Yields and enantioselectivities were high and the nucleophilic displacement occurred with 
inversion at the sulfur centre. These transfer reagents were shown to react over 100 times faster 
than the commonly used menthol derived reagents.128 
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Scheme 66. Synthesis of sulfinyl transfer reagents from Evans’ auxiliary. 
An example showcasing the preparation of an enantiopure sulfoxide and its subsequent use in 
synthesis is Marino’s enantiospecific synthesis of an aspidosperma alkaloid.129 The key step 
introduces a chiral alkynyl sulfoxide 307 using Evans’ sulfinyl transfer reagent, which directs 
the selectivity in later stages of the synthesis (Scheme 67). Preparation of the sulfoxide 307 was 
achieved with initial deprotonation of the alkyne 306 CH followed by transmetalation and 
introduction of the auxiliary A.  
 
Scheme 67. Preparation of an enantiopure alkynyl sulfoxide. 
The only previous example of using an alkynyl sulfoxide as a substrate in gold catalysis was in 
the preparation of [3 + 2] cycloaddition products 314 from ketal esters 308 (Scheme 68).130 
Zhang designed substrates which favoured the 1,3 all-carbon dipole resonance form, on 
coordination of the gold species, allowing a chemoselective cycloaddition with aldehydes and 
ketones. 2,6-dichlorophenyl-substituted sulfoxide was an efficient electron withdrawing group 
promoting the reaction in an excellent yield. Initial attack of the ethoxy substituent onto the 
activated alkyne giving 309. Rearrangement to 310 occurs and loss of acetone which is favoured 
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over a 5-endo trig cyclisation gives the 1,3 dipolar compound 311. Cyclohexanone attack 
followed by a favourable 5-exo trig cyclisation via resonance form 312 and 313 furnishes 314. 
The substrate design allows the reaction to proceed without any competing reactivity from the 
gold carbene. 
 
Scheme 68. Effective use of an alkynyl sulfoxide in gold catalysis. 
4.2 Aims and objectives 
The aim is to employ alkynyl sulfoxides, an external oxidant and a gold species in order to 
access the α-sulfoxy metal carbene reactivity patterns that can not be accessed in a controlled 
fashion when using α-diazo sulfoxides. Reactions in which an intramolecular or intermolecular 
nucleophile trap a vinyl gold carbenoid would provide an alternative reaction pathway to avoid 
the unwanted Wolff rearrangement pathway which would be expected to occur if the gold 
carbene dominated.  
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Initially an alkynyl sulfoxide 315 was conceived with the potential to undergo cyclopropanation 
upon addition of a nucleophilic oxidant to the gold activated alkyne 316 (Scheme 69) to afford 
318.  
 
Scheme 69. Substrate design for gold catalysed cyclopropanation of alkynyl sulfoxides. 
4.3 Preliminary studies 
Synthesis of the required alkynyl sulfoxide 322 was achieved by adapting a literature 
procedure.132 Allyl magnesium bromide was treated with propargyl chloride forming the 
deprotonated 1,6 enyne in situ and quenching with the sulfinic ester 320, itself prepared in high 
yield from disulfide 319 (Scheme 70).131 
 
Scheme 70. Preparation of an alkene substituted alkynyl sulfoxide. 
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4.4 Formation of cyclopentanones 
Alkynyl sulfoxide 322 was next subjected to a number of reaction conditions with a gold 
catalyst and an oxidant in an attempt to prepare products 318. Throughout the chapter sulfoxides 
are drawn as one enantiomer to help show the diastereoselectivity. 
Cyclopropanation products 323 and 323’ were observed upon treatment of the alkynyl sulfoxide 
322 with pyridine-N-oxide and a gold catalyst in DCE (Table 12, entries 1-3) with a 1:1 
diastereomeric ratio. With the promising reactivity seen, a change in solvent and increase in 
reaction temperature was tried and this led to improved reactivity (Table 12, entry 4 vs entry 
5). A small solvent screen at this juncture revealed nitromethane to be the most suitable solvent 
(Table 12, entries 5-7). A reduction in temperature to 80 oC resulted in no change (Table 12, 
entry 8). Various oxidants were trialled. The use of diphenyl sulfoxide resulted mostly in 
degradation (Table 12, entry 9), whereas halogen substituted pyridine-N-oxides resulted in 
improved conversion and yields (Table 12, entries 10 to 13). The diastereomeric ratio improved 
with ortho and meta substituted N-oxides suggesting its involvement in the diastereoselectivity 
determining step (Table 12, entries 10, 11 and 13). The improvement was very modest, 
however, and the bulky 2,6-dichloro pyridine-N-oxide did not give any improvement and 
conversion was reduced (Table 12, entry 17). A preformed catalyst system was selected with 
SPhosAuNTf2 superior to XPhosAuNTf2 (Table 12, entries 14 and 15). 1,4-Dioxane provided 
similar yields to nitromethane but afforded increased diastereoselectivity (Table 12, entry 16). 
Further modest advances in the diastereomeric ratio of the products were achieved by reducing 
the temperature (Table 12, entry 18), however this resulted in poor conversion. 
MorDalPhosAuCl which was found to be an excellent catalyst by Zhang for an intermolecular 
prearation of methanesulfonyloxymethyl ketones was ineffective for this transformation (Table 
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12, entry 19).61 Unfortunately the diastereoselectivity achieved was quite low, and synthesis of 




















1 DTBPAuCl AgNTf2 DCE 60 A 9 16 1:1 
2 PPh3AuCl AgNTf2 DCE 60 A 30 14 1:1 
3 IPrAuCl AgNTf2 DCE 60 A 30 16 1:1 
4 XPhosAuCl AgNTf2 DCE 60 A 77 20 1:1 
5 XPhosAuCl AgNTf2 MeNO2 100 A 30 36 1:1 
6 XPhosAuCl AgNTf2 Toluene 100 A 30 24 1:1 
7 XPhosAuCl AgNTf2 C6H5Cl 100 A 30 24 1:1 
8 XPhosAuCl AgNTf2 MeNO2 80 A 30 38 1:1 
9 XPhosAuCl AgNTf2 MeNO2 80 
Ph2S
O 
30 15 - 
10 XPhosAuCl AgSbF6 MeNO2 80 B 40 49 1.4:1 
11 XPhosAuCl AgSbF6 MeNO2 80 C 42 45 1.3:1 
12 XPhosAuCl AgSbF6 MeNO2 80 D 83 20 1:1 








- MeNO2 80 E 30 59 1.2:1 












AgSbF6 MeNO2 80 A 66 7 1:1 
  a Reactions performed on a 0.1 mmol scale and yields determined by crude 1H NMR analysis using 1,2,4,5 




Substituted alkynyl sulfoxides 330-335 were synthesised over 3 steps (Scheme 71). The 
relevant thiol was oxidised to the disulfide quantitatively using sodium perborate.133 NBS was 
employed to convert the disulfide into the sulfinate ester 324-329 which proceeded in high 
yields.131 Finally the sulfinate ester was added to the deprotonated 1,6-enyne in situ to afford 
the alkynyl sulfoxide in variable but generally poor yield (Scheme 71).132 Aryl 330-333 and 
alkyl groups 334 and 335 were tolerated, including the sterically bulky 2,6-dichlorophenyl 
substituent 333.  
 
Scheme 71. Preparation of sulfinyl substituted 1,5 enynes. 
A variety of substituents were positioned next to the sulfoxide to probe the effect of varying the 
electronic and steric nature of the substrate on the diastereoselectivity. On testing the alkynyl 
sulfoxides in the cyclopropanation, the substitution on the aryl group was found to moderately 
influence the diastereoselectivity (Table 13). With weakly electron-withdrawing and -donating 
bromo and methyl substituents on the aryl alkynyl sulfoxides 330 and 331 respectively, the 
crude yield of products 336 and 337 was almost unchanged compared to the phenyl derivative 
323 (Table 13, entry 1 vs entries 2 and 3), and the diastereomeric ratio remianed roughly the 
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same. With alkynyl sulfoxide 332 containing steric bulk in the ortho-position (Table 13, entry 
4) the diastereoselectivity was further enhanced but at the price of a reduction in yield of product 
338. The best diastereoselectivity was achieved with the 2,6-dichloro-substituted alkynyl 
sulfoxide 333 (Table 13, entry 5) however the yield of product 339 was significantly lower than 
for the other examples. These results show that the diastereoselectivity cannot be easily 
controlled by varying the reaction conditions and is more dependent on the sulfoxide 
substituent. Replacing aryl with alkyl groups led to poorer results. The cyclohexane-substituted 
alkynyl sulfoxide 335 was inactive under the reaction conditions employed (Table 13, entry 6) 
and the methyl-substituted derivative 334 gave a low yield of product 340 (Table 13, entry 7) 
as a 1:1 mix of diastereomers. These substrates were reacted under conditions previously found 
to be the most effective for cyclopropanation (Table 12). NMR yields were moderate at best, 
















1 Ph 322 323 35 38 24 1.6:1 
2 p-Tol 330 336 36 43 22 2.0:1 
3 4-BrC6H4 331 337 39 45 21 2.1:1 




333 339 60 28 7 4.0:1 
6b Cy 335 341 90 0 0 - 
7b Me 334 340 60 15 15 1:1 
a Yields calculated by 1H NMR against a known quantity of internal reference standard 1,2,4,5 tetramethylbenzene. 
Other conditions used b MeNO2, SPhosAuCl/ AgSbF6 
 
4.5 Reaction screening to afford sulfur heterocycles 
An alternative alkynyl sulfoxide substrate for cyclopropanation was devised, with the alkene 
tether directly attached to the sulfoxide functionality. In work undertaken by Fatima Khan, a 
postgraduate masters student working in the Davies and Grainger research groups this new 
alkynyl sulfoxide was subjected to gold catalysis. 
Using the hex-1-yne-derived alkynyl sulfoxide 342, the diastereomeric ratio of the 
cyclopropanation products (343 and 343’) in the crude 1H NMR spectrum could not be 
successfully determined, due to the highly crowded alkyl region. Isolation of 342 provided a 
6:1 ratio of inseparable diastereomers 343 and 343’. A characteristic peak of the major 
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diastereomeric product 343 from the SOCHH hydrogen at 3.54 ppm enabled NMR yields to be 
accurately calculated (Table 13). 
The starting point for the reaction optimisation was based on the best results obtained in the 
cyclopentanone synthesis (Table 12, entry 16). A good yield (69%) of the major diastereomer 
was observed (Table 14, entry 1). Solvents were screened initially, with toluene, DCE and THF 
being significantly inferior to 1,4-dioxane (Table 14, entries 2 to 5). DCM at rt was also tested, 
with only low conversion observed (Table 14, entry 4). Variation of the gold species was 
performed, testing a range of catalysts with very different steric and electronic properties (Table 
14, entries 7-10). An acceptable yield was observed in all cases, with only L2 providing a 
similar result to the best (Table 14, entry 10). There were negligible differences in reaction 
outcome on varying the temperature between 50 and 80 degrees (Table 14, entries 1, 6 and 24), 
and lower yields were obtained with varied reaction concentrations (Table 14, entries 12-14). 
Increasing the amount of oxidant or employing other nitrogen based oxidants provided inferior 
results (Table 14, entries 15-21) and finally lowing the catalyst gave poorer yields (Table 14, 




Table 14. Reaction screening to afford fused cyclic sulfoxides from a gold catalysed cyclopropanation 




a Reactions performed on a 0.1 mmol scale and yields of the major diastereomer determined by crude NMR analysis 
using 1, 2, 4, 5 Tetramethylbenzene as an internal reference standard.
 
Entry Ligand Cat mol 
% 




C (M) Yield %a 
1 SPhos 5 Dioxane 80 N1 1.2 0.05 69 
2 SPhos 5 1,2 DCE 60 N1 1.2 0.05 45 
3 SPhos 5 THF 60 N1 1.2 0.05 37 
4 SPhos 5 CH2Cl2 rt N1 1.2 0.05 26 
5 SPhos 5 Toluene 60 N1 1.2 0.05 39 
6 SPhos 5 Dioxane 65 N1 1.2 0.05 66 
7 L3 5 Dioxane 65 N1 1.2 0.05 42 
8 L4 5 Dioxane 65 N1 1.2 0.05 45 
9 L1 5 Dioxane 65 N1 1.2 0.05 47 
10 L2 5 Dioxane 65 N1 1.2 0.05 59 
11 SPhos 5 Dioxane 80 N1 1.2 0.05 69 
12 SPhos 5 Dioxane 80 N1 1.2 0.10 52 
13 SPhos 5 Dioxane 80 N1 1.2 0.20 42 
14 SPhos 5 Dioxane 80 N1 1.2 0.025 65 
15 SPhos 5 Dioxane 80 N1 2.0 0.05 54 
18 SPhos 5 Dioxane 80 N1 1.2 0.05 66 
19 SPhos 5 Dioxane 80 N2 1.2 0.05 63 
20 SPhos 5 Dioxane 80 N3 1.2 0.05 59 
21 SPhos 5 Dioxane 80 N4 1.2 0.05 70 
22 SPhos 2.5 Dioxane 80 N1 1.2 0.05 62 
23 SPhos 1 Dioxane 80 N1 1.2 0.05 27 
24 SPhos 5 Dioxane 50 N1 1.2 0.05 69 
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4.6 Starting material preparation 
4.6.1 Precursor preparation 
Synthesis of a range of alkynyl sulfoxides was required in order to examine the substrate scope 
of the reaction. The first synthetic step involved the preparation of dibromoolefins or alkynes. 
A variety of dibromoolefins 344-349 were easily and conveniently prepared using the method 
of Shastin (Table 15, entries 1-6).108  
Table 15. Preparation of dibromoolefins 
 




















Alkynes 350-354 were synthesised using the Sonagashira reaction with TMS acetylene 
followed by desilylation (Scheme 72).134-137 Amide formation to afford 350 from the aniline 
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proceeded well and 3-bromothiophene was readily iodinated in the dark prior to alkyne 
formation affording 351.138,139  
Scheme 72. Preparation of alkynes. 
4.6.2 Sulfide preparation 
Alkynyl sulfides 355-357 were initially prepared using the method of Hu in moderate yields 
(Scheme 73).140 
 
Scheme 73. Preparation of alkynyl sulfides using Hu’s procedure. 
98 
 
As this procedure afforded moderate yields and was time-consuming, an improved procedure 
was required to ensure the starting material synthesis was attractive. An electrophilic sulfur 
compound 359 was targeted to simplify the synthesis. Thiosulfonate 359 was prepared easily, 
on a large scale and in a high yield over 2 steps (Scheme 74).141,142 
 
Scheme 74. Preparation of a thiosulfonate. 
In the modified sulfide preparation, thiosulfonate 359 was added directly to the deprotonated 
alkyne, resulting in a more convenient reaction to prepare alkynyl sulfides 360 and 361 (Table 
16, entries 1 and 2). 
Thiosulfonate 359 was then found to be compatible for use with dibromoolefins as reaction 
partners. This procedure offered an alternative route to alkynyl sulfides 362-367 (Table 16, 
entries 3-8), especially useful when the alkynes were volatile (Table 16, entries 3-5) and 
resulted in much better yields for the synthetic sequence. Alkynyl sulfides 363 and 365 were 
not obtained as pure compounds (Table 16, entries 4 and 5), but after subjection to mCPBA the 
pure alkynyl sulfoxides were obtained.  
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Table 16. Preparation of alkynyl sulfides from dibromoolefins and alkynes. 
 
Entry R Product Yield% 










363 65 (~90%)b 
5 
 










a Sulfide prepared from the terminal alkyne and n-BuLi (1.2 eq.) was used. b Sulfides isolated with a purity of 
approximately 90% from 1H NMR analysis 
The use of n-BuLi limited the functionality which could be tolerated and led to messy reactions 
(Table 15, entries 4 and 5). A test using LiHMDS to deprotonate the alkyne followed by 
trapping with 359 afforded a substantially improved yield in the synthesis of sulfide 355 
compared to the original protocol using n-BuLi (Scheme 75). This new procedure was 
employed in the preparation of sulfides 368-375 (Scheme 75). In addition, the sulfide 
purification was generally straightforward compared to that with n-BuLi due to the lack of side 




Scheme 75. Preparation of alkynyl sulfides using LiHMDS. 
4.6.3 Sulfoxide preparation 
Oxidation of the alkynyl sulfides 355-357 and 368-375 to their corresponding alkynyl 
sulfoxides was achieved using a general mCPBA oxidation method. Addition of 1 equivalent 
of mCPBA to the sulfide in CH2Cl2 at 0 
oC resulted in good to excellent yields of the sulfoxides 
376-394, after aqueous workup and purification by column chromatography (Table 17, entries 
1-18). When aryl groups were positioned next to the alkyne, the sulfoxides were unstable at 
room temperature and careful handling was required. Heteroaryl alkynyl sulfoxides 389 and 




Table 17. Preparation of alkynyl sulfoxides from alkynyl sulfides. 
 
Entry R Product 
Yield 
% 
Entry R Product Yield  % 




377 75 11 2-iPrC6H4 386 89 
3 4-MeC6H4 378 74 12 4-CO2MeC6H4 387 77 




5 4-CF3C6H4 380 50 14 2-furyl 389 70* 










383 72 17 
 
392 66 
9 tBu 384 72 18 
 
393 71 
    19 2-Napthyl 394 79 
*Used directly and not characterised 
Other functionalization at sulfur was of interest to potentially generate more structurally varied 
catalysis products, and in order to gain a wider understanding of the catalysis. Firstly 
preparation of a sulfilimine 395 from alkynyl sulfide 355 was attempted with a commonly used 
literature method.143 Unfortunately no product formation was observed by TLC (Scheme 76). 
An alkynyl sulfone 396 was also targeted, to compare its reactivity to that of an alkynyl 
sulfoxide under gold catalysis. Sulfone 396 was prepared readily from sulfide 355 using excess 




Scheme 76. Preparation of a sulfone and attempted preparation of a sulfilimine. 
4.7 Substrate Scope for the cyclopropanation reaction 
Phenyl substituted alkynyl sulfoxide 376 was subjected to gold catalysis. The reaction was 
faster and more efficient than for hex-1-yne substituted alkynyl sulfoxide 342, permitting 
reduced catalyst loading and a lower reaction temperature for the transformation (Scheme 77).  
 




A crystal structure was successfully determined for major diastereomer 397 using single crystal 
X-ray diffraction analysis (Fig 8).  
 
Fig 8. Crystal structure of 397. 
The 1H NMR spectrum for the major diastereomer of the catalysis product 397 is distinctive 
and remains consistent with modifications on the sulfoxide substituent. In each case a 
distinctive proton α to the sulfoxide resonates between 3.52 and 3.58 ppm. This constitutes a 
shift of 0.4 ppm downfield compared to the same proton in the NMR spectrum of the minor 
diastereomer. Figure 9 shows a 3D representation of the major and minor diastereomer for 
catalysis products 397 and 397’. By comparing these results to literature values the deshielded 
proton can be identified.145 The large deshielding effect is derived from the strong overlap 
between the C-H σ and the sulfoxide lone pair. In the minor diastereomer neither C-H overlaps 
with the lone pair of electrons and hence the peak is found upfield experiencing significant 
through space deshielding from the sulfoxide oxygen. The cyclopropyl hydrogens are shifted 
downfield significantly as they are in closer proximity to the sulfoxide bond (Fig 9). The minor 
diastereomer has markedly different chemical shifts. The more shielded SOCHH hydrogen is 





Fig 9. Key 1H NMR shifts in catalysis product 397 
The two identified sets of reaction conditions, A 2.5 mol% SPhosAuNTf2 at rt and
 B 5 mol% 
SPhosAuNTf2 at 50 
oC (Table 14, entry 24) were employed with the alkynyl sulfoxide to help 
decipher how the electronic nature of the substituents affected the reactivity of the system but 
in two cases .the temperature was altered. 
A study on the effect of the electronic nature of the substituent was undertaken by varying the 
group at the para position on the phenyl ring. Electron-rich substrates 398-400 with methyl, 
methoxy and acetamido substituents performed well in the catalysis (Table 18, entries 1 to 3). 
Good yields could be obtained under the milder conditions, with the more forcing conditions 
giving slightly better yields. With no substituent on the phenyl ring the yield of catalysis product 
397 was reduced slightly on employing the mild conditions (Table 18, entry 4). Reactions with 
the more electron-poor alkynyl sulfoxides were generally slower giving reduced yields. The 
employment of conditions A resulted in moderate yields for the 4-bromo 401 and the ester 402 
as well as the 4-fluoro-substituted derivative 403 (Table 18, entries 5, 6 and 7). Employing the 
strongly electron-withdrawing 4-(trifluoromethyl)phenyl substituted alkynyl sulfoxide under 
the milder conditions resulted in a poor yield of the catalysis product 404. The electronic nature 
of the substituents is important in determining the reaction outcome with electron-withdrawing 
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groups slowing the reaction considerably with incomplete conversion and some degradation 
observed. Employing the more forcing conditions B promotes moderate to good yields in all 
cases (Table 18, entries 5, 6 and 8). Notably the ratio of diastereomers formed in the catalysis 
reaction was approximately 8:1 in all cases, suggesting the nature of the aryl group is 
inconsequential to the diastereomeric outcome. In all of the cases below, only the major 
diastereomer was isolated which eluted first on the column because of co-elution with the major 




Table 18. An electronic study of 4-substituted aromatics in the gold catalysis 



















54b 74 (3 h) 
6 402 
 
54b 64 (20 h) 
7 403 
 
54b 68 (17 h) 
8 404 
 
30b 63 (17 h) 
Conditions A: rt, 2.5 mol% SPhosAuNTf2, 1.2 eq. 3,5 Cl2-Py-N-Oxide, 1,4-dioxane 0.05 M. Conditions B: 50 oC, 
5 mol% SPhosAuNTf2, 2 eq. 3,5 Cl2-Py-N-Oxide, 1,4-dioxane 0.05 M. a  Isolated yields. b reaction time 28 hours. 
c 40 oC, 2.5 mol% SPhosAuNTf2, 1 h d 65 oC, 5 mol% SPhosAuNTf2, 0.75 h 
 
Further structural variations were investigated in the catalysis (Scheme 78). A sterically bulky 
o-bromo substituent led to a moderate yield of catalysis product 405. A naphthyl derivative was 
well tolerated 406 and placing a methoxy substituent meta resulted in a significantly reduced 
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yield compared to the para derivative, however, a good yield of 407 was achieved with 
conditions B. Replacing the phenyl ring with a heterocycle successfully resulted in good yields 
of the fused sulfoxides 408 and 409. With an ortho isopropyl group the yield of the desired 
product of cyclopropanation 410 was considerably lower mainly due to a side reaction. The 
diastereoselectivity for these reactions remained consistently at 8:1.  
Scheme 78. Additional aryl and heteroaryl derived catalysis products. 
Alkyl substituted alkynyl sulfoxides were employed under optimised catalysis conditions B 
(Table 14, entry 24) due to the reduced reactivity observed compared to aryl-derivatives. In 
each case, the catalysis products 343 and 411-417 were isolated as a mixture of diastereomers 
as they were not separable by column chromatography (Table 19). The hex-1-yne derived 
sulfoxide worked well, providing the cyclic sulfoxide 343 in a 72% yield (Table 19, entry 1). 
A but-3-enyl derivative 411 was formed in a slightly reduced yield (Table 19, entry 2). The 
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cyclopropyl substituted sulfoxide worked excellently in the catalysis with no loss of yield of 
product 412 on reducing the temperature (Table 19, entry 3). A cyclohexyl group 413 was 
tolerated however the yield was much lower due to poor reactivity (Table 19, entry 4) and 
significant starting material remained. An alkynyl sulfoxide with a tert-butyl group was also 
employed in the catalysis resulting in an improved diastereomeric ratio and a surprisingly high 
yield for such a sterically bulky substituent 414 (Table 19, entry 5). A 1:1 diastereomeric ratio 
of citronellal derived sulfoxide 393 was successfully transformed providing 415 (Table 19, 
entry 9). Two alkynyl sulfoxides incorporating a tethered 1,6-enyne with an oxygen linker were 
employed under the catalysis conditions (Table 19, entries 7 and 8). The alkene could 
potentially compete in an alternative cyclopropanation pathway providing a fused 
dihydropyranone, however this was not observed and products 416 and 417 were furnished in 




Table 19. Preparation of alkyl substituted fused sulfur heterocycles. 
Entry Product Heterocycle 




1M, F 343 
 
17 72 6:1 
2F 411 
 
17 65 10:1 
3F 412 
 
17 85(85)a 10:1 
4M 413 
 
24 45 7:1 
5M 414 
 
25 70 12:1 
6M 415 
 
21 70 10:10:1:1 
7M 416 
 
21 65 10:1 
8M 417 
 
21 68 10:1 
M Reactions performed by Matthew Barrett. F Reactions performed by Ghulam Fatima Khan. 
Conditions B: 50 oC, 5 mol% SPhosAuNTf2, 2 eq. 3,5 Cl2-Py-N-Oxide, 1,4-dioxane 0.05 M. 
a rt, 5 mol% SPhosAuNTf2 1.2 eq., 3,5 Cl2-Py-N-Oxide, 1,4-dioxane 0.05 M, 17 h. 
The reactivity of sulfoxide 376 was compared with that of the corresponding sulfide 355 and 
sulfone 396 under the milder optimised catalysis conditions (Scheme 79). Both the sulfoxide 
and sulfone were transformed efficiently into products 397 and 419. The sulfide however did 
not undergo any reaction. The sulfoxide and sulfone are very electron-withdrawing, facilitating 
external nucleophilic attack on coordination of the gold species. The electron donating nature 
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of the sulfide renders the alkyne too weakly electrophilic to allow the initial intermolecular 
oxidant attack. Finally a 1,6-enyne substituted alkynyl sulfoxide 392 was prepared by Fatima 
and employed under the standard conditions, unfortunately no cyclopropanation product 393 
was isolated with lots of degradation observed. 
 
Scheme 79. Comparison of oxidation states at sulfur and failed formation of the 6 membered ring 
containing fused heterocycle. 
4.8 Origin of the diastereoselectivity 
An additional control experiment was performed to see whether epimerisation was taking place 
under the reaction conditions. If this was proceeding the ratio of products would be partially 
determined by thermodynamic control rendering the kinetic model redundant. Two catalysis 
reactions were set up as usual with sulfoxide 378. Upon some conversion of the sulfoxide to 
product 399 one was doped with 40 mol% of minor d.r 397’ and to the other was added 40 
mol% of major d.r 397. After 2 hours the reaction was complete by TLC and the crude residue 
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was analysed. In both cases the dopant sulfoxides were present without any epimerisation 
demonstrating that no interconversion occurs under the reaction conditions (Scheme 80). 
Scheme 80. Control experiment to monitor epimerisation under the reaction conditions. 
Scheme 81 depicts a stepwise mechanism for the intramolecular cyclopropanation of alkynyl 
sulfoxides. Formation of the α-oxo gold carbene 424 is unlikely to be productive considering 
the reactivity of similar α-oxo rhodium carbenes, and would be expected to lead to degradation 
products potentially via a Wolff rearrangement.123,126,127  
Scheme 81 also suggests a reasonable model for the diastereoselectivity observed. The reaction 
step in which the diastereoselectivity is determined is the nucleophilic attack of the alkene onto 
the β-gold vinyloxypyridium intermediate 423. Anti addition of the pyridine-N-oxide onto the 
activated alkyne is widely proposed to proceed.32 Coordination of the sulfoxide oxygen to the 
gold is unlikely as no vacant coordination sites are present on gold.33  
Minimisation of dipole-dipole interactions explained the stereocontrol in Soladie’s study into 
the reduction of β-keto sulfoxides without the addition of a Lewis acid for chelation and this 
may help to explain the observed stereoselectivity.146 The reaction can be represented using two 
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transition state models. 426 shows the transition state leading to the minor diastereomer product 
397’ via a concerted mechanism. Reaction leading to the minor diastereomer may be expected 
to proceed through a high energy boat transition state where there is good overlap of the C-Au 
σ-bond with the π* of the alkene. A lower energy chair conformation transition state 427 leads 
via a concerted pathway to major diastereomer 397. Unfavourable dipole-dipole interactions 
are avoided and there is the potential for a stabilising Au-O interaction  
 
Scheme 81. Mechanism and diastereochemical model for the intramolecular cyclopropanation. 
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4.9 Variation of the alkene 
Three variations of the alkene component of the alkynyl sulfoxide were considered in order to 
expand the reaction scope for the cyclopropanation and to perceive any change in reactivity. 
Firstly, an E-phenyl substituted alkene 428 was prepared following the method reported by 
Procter.147 Cyclopropylmagnesium bromide was treated with cinnamyl bromide and acetyl 
chloride to furnish the reported (3:1) mixture of halides 428 (Scheme 82). The thiosulfonate 
429 was then synthesised in a 76% yield using the method of Sharma (Scheme 82, eq. 1).148 A 
dimethyl group was introduced on the terminal alkene position, commencing from 
cyclopropylmethyl ketone. This was treated with MeMgBr before addition of sulfuric acid 
providing the crude bromide 430, which was transformed to the thiosulfonate 431 in a 39% 
yield over 2 steps (Scheme 82, eq. 2).142 Finally the internal methyl derivative 433 was obtained 
utilising an Appel reaction on the corresponding alcohol (Scheme 82, eq. 3).149 The yield over 
the two steps to the thiosulfonate 433 was 39%.  
Scheme 82. Preparation of a range of thiosulfonates. 
Aryl and alkyl derived alkynyl sulfoxides 435, 437, 439, 441, 443 and 445 were prepared to 
provide a series of substrates encompassing each alkene modification to test in the catalysis 
reaction. Yields were moderate to high over the two step sequence.  
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Scheme 83. Preparation of alkynyl sulfoxides containing substituted alkenes. 
Using 4-methoxyphenyl substituted sulfoxide 435 under the standard catalysis conditions 
resulted in a messy reaction and pure products could not be isolated. Conversely with the less 
sterically cumbersome cyclopropyl substituent 437 two novel products were isolated, in a 
moderate combined yield (Scheme 84). Cyclopropanation product 439 was identified by the 
characteristic peak at 3.58 observed in the other cyclopropanation products, the 4 separate CH 
peaks of the non-identical cyclopropyl substituent protons was also observed. Hydration 
product 447 was identified by the downfield OH peak at 4.86 ppm which was not attached to 
any carbons from the HSQC. The CHOH doublet at 3.77 ppm was also characteristic. 
Other products were present from NMR analysis of the crude reaction mixture, however, 
isolation was unsuccessful. 6-exo trig cyclisation would be expected to lead through to the 
expected cyclopropanation product whereas upon a 5-exo trig cyclisation, trapping of the 
carbocation by adventitious water is perhaps more favourable (Scheme 84).150 The 
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stereochemistry of the products was not identified but only one set of peaks were present in the 
proton and carbon NMR of compound 446 and 447. 
Scheme 84. Phenyl substituted alkene derived alkynyl sulfoxides. 
Treatment of the aryl substituted sulfoxide 439 under the catalysis conditions led to many spots 
being observed on the TLC plate and no products could be isolated. When the cyclopropyl 
derived sulfoxide 441 was employed, the product 453 was isolated in a modest 38% yield 
(Scheme 85). The product is derived from quenching of the cation with adventitious water and 
provides an increase in molecular complexity.150 Furthermore only a single set of peaks were 
observed in the 13C NMR spectrum which may suggest the product was isolated as a single 
diastereomer. Crude NMR analysis suggested cyclopropanation products were also formed and 
conversion was high, however these could not be isolated in a pure form. Repeating the 
experiment with the addition of ten equivalents of MeOH to the reaction mixture in an attempt 





Scheme 85. Catalysis reaction of a prenyl-derived alkynyl sulfoxide. 
Finally the alkynyl sulfoxides 443 and 445 incorporating an internal methyl substituent on the 
alkene were tested. Reaction of 443 and 445 proceeded well by TLC under the reaction 
conditions, but the products could not be successfully purified. 
4.10 Exploring other reactivity modes of gold carbenoids with alkynyl 
sulfoxides 
In work undertaken by Fatima Khan the alkene component for the cyclopropanation reaction 
was replaced with a benzyl group. Trapping of the gold carbenoid, formed upon addition of the 
oxidant to the activated alkyne, in a Friedel-Crafts type reaction would allow synthesis of a 
range of novel products (Scheme 86). To enhance the likelihood of reaction success, the phenyl 
ring was activated with methoxy groups in the 2 position, increasing the nucleophilicity of the 
phenyl ring. Unfortunately, competing reactivity rendered the reaction unsuccessful with only 
degradation products visible in the crude NMR spectrum. 
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Scheme 86. Attempted C-H insertion trapping from alkynyl sulfoxides. 
During investigations into finding the substrate scope for the intramolecular cyclopropanation 
reaction a side product was identified when employing ortho isopropyl substituted alkynyl 
sulfoxide 386 (Scheme 87). The side product co-eluted with the oxidant prompting the testing 
of 459, a modified sulfoxide with a methyl substituent, prepared from the sulfide 458. 
Subjection of sulfoxide 459 to catalysis conditions A for 20 hours resulted in starting material 
remaining (40%) and significant degradation (30%). Product 462 was isolated in a 22% yield, 
similar to the NMR yield observed with alkynyl sulfoxide 386 (Scheme 77). The product is 
proposed to form via the gold carbenoid 460 and a 1,5-hydride shift results in the formation of 
a stabilised carbocation 461 which is quenched by elimination (Scheme 87).  
 
Scheme 87. Unoptimised synthesis of alkene 462. 
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Two ortho acetal substituted alkynyl sulfoxides 468 and 470 were prepared from 2-bromo 
benzaldehyde 463 (Scheme 88).151,152 These substrates were prepared to explore further 
oxidative reactions of alkynyl sulfoxides. Acetal formation proceeded well and formation of 
the sulfoxides was satisfactory, with the sulfides 467 and 469 transformed into the sulfoxides 
without purification.  
 
Scheme 88. Preparation of acetal substituted alkynyl sulfoxides. 
Treatment of sulfoxide 467 and 469 under optimised reaction conditions B for the 
cyclopropanation resulted in complete conversion after 16 hours although significant 
consumption was observed after 15 minutes (Scheme 89). Upon product isolation and 
subsequent data collection it became clear that the products were derived from a dominant 
carboalkoxylation pathway proceeding through intermediate 470. No products were observed 
from oxidative pathways suggesting intramolecular oxygen attack from the acetal onto the gold 
activated alkyne is a much faster process than formation of the gold carbenoid. The novel 
sulfoxides 471 and 472 were afforded, under mild conditions and in excellent yield. Compound 




Scheme 89. Carboalkoxylation reactions of alkynyl sulfoxides. 
Tang and co-workers developed an efficient synthesis of complex dihydrofuranones 475 from 
easily prepared starting materials 473 (Scheme 90).52 Addition of a Lewis acid catalyst greatly 
speeds up the rearrangement after cyclisation. The reaction showed excellent chemoselectivity 
although the exact mechanism was debated. 
Scheme 90. Rearrangement of oxonium ylides generated under oxidative gold conditions. 
Tang’s system was selected to explore whether alkynyl sulfoxides would be suitable for this 
type of oxidative transformation to form dihydrofuranones 479. An analogous substrate 478 
was synthesised, replacing the alkynyl ester Tang employed for an alkynyl sulfoxide. A Lewis 
acid with good activity in Tang’s work was selected. In the catalysis reaction the alkynyl 
sulfoxide was consumed with a new spot formed which faded over time. Multiple isolation 
attempts proved fruitless (Scheme 91). 
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Scheme 91. Attempted dihydrofuranone preparation via an oxonium ylide. 
An alkynyl sulfoxide lacking the functionality to undergo intramolecular reactions was 
prepared as a test substrate for attempts to achieve intermolecular reactivity. Methyl substituted 
alkynyl sulfoxide 481 was prepared successfully (Scheme 92), however, with a phenyl 
substituent the sulfoxide degraded too rapidly to use.  
 
Scheme 92. Preparation of a sulfoxide to test for intermolecular reactions. 
Sulfoxide 481 was treated under the standard catalysis conditions for intramolecular 
cyclopropanation with 10 equivalents of styrene and cyclohexene (Scheme 93). The pyridine-
N-oxide was consumed within 10 minutes and a new spot formed on the baseline of the TLC 
plate. Attempts to isolate the spot were unsuccessful. In the absence of a good competing 




Scheme 93. Attempted intermolecular reactions of alkynyl sulfoxides with various nucleophiles. 
4.11 Preparation of an enantiopure alkynyl sulfoxide and its application 
It was desirable to prepare enantiopure sulfoxides as this would showcase a novel route to 
achieve assymetric products in gold catalysis. A route to synthesise an enantiopure alkynyl 
sulfoxide was envisaged, commencing from Evans’ phenylalanine derived oxazolidinone 
auxiliary. Auxiliary 484 was prepared in two steps from cheap L-phenylalanine 482 (Scheme 
94). Firstly L-phenylalanine was reduced to an amino alcohol 483 in 64% yield.153 Reaction of 
the amino alcohol 484 with diethyl carbonate at high temperature provided oxazolidinone 484 
in 78% yield.154 
 
Scheme 94. Preparation of an Evans auxiliary. 
Auxiliary 484 was deprotonated at nitrogen with n-BuLi, before the addition of the 
thiosulfonate electrophile 359, which provided the adduct 485 in a 75% yield (Scheme 95). 
mCPBA oxidation of 485 proceeded well at low temperature to afford a separable mixture of 
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diastereomers of the two sulfinyl carbamate products 486a and 486b which were assigned on 
the basis of Evans’ report.150 
 
Scheme 95. Preparation of the sulfinyl transfer reagent. 
Different conditions were employed in order to find an efficient preparation of the desired 
enantiopure sulfoxide. Hex-1-yne was treated with MeMgBr in THF. Upon addition of 
auxillary 486a a modest yield could be achieved keeping the temperature at -20 oC (Table 20, 
entry 1). Refluxing was required to ensure complete deprotonation (Table 20, compare entries 
2 and 3 vs 4). Addition of the auxiliary derived sulfinyl compound 486b at low temperature 
facilitated a moderate yield of the target alkynyl sulfoxide 487a. The reaction was proposed to 
proceed with complete inversion at sulfur which was seen by Evans.128 Alternative conditions 







Table 20. Optimisation of reaction conditions in forming an enantiomerically pure alkynyl sulfoxide. 
 





1 2.0 486b 1.0 reflux, 1 h, B -
20 oC, 4 h 
- 33 487a 
2 2.0 486a 1.0 rt, 2 h B -20 oC 
to 0 oC, 4 h 
- 16 487b 
3 1.3 486b 1.2 rt,1 h, B -20 oC 






4 1.5 486a 1.1 1 h reflux, 4 h, 
-20 oC to 0 oC 
 67 487b 
 
HPLC analysis of the chiral sulfoxides was performed showing 487a had a 69% e.e. and 487b 
97% e.e. from the chiral transfer reagent 486a. The two enantiomers could be separated using 
an amylose 1 chiral column and eluting with 25%MeCN/H2O (see appendix). 
The enantioenriched sulfoxides were then tested under the optimal catalysis conditions and 
delivered the catalysis products in comparable yields to the racemic sulfoxide (Scheme 94). 
The two enantiomers of the catalysis product were inseparable using a number of HPLC chiral 
columns and conditions. Chiral gas chromatography ensured the clean separation of the 
enantiomers but demonstrated that both diastereomers of the two catalysis products derived 




Scheme 94. Treatment of alkynyl sulfoxides derived from Evans’ auxiliary under catalysis conditions. 
Racemisation of the sulfoxide clearly proceeds rapidly, however the mechanism for this 
racemisation and at which point it occurs remains undetermined.  
Sulfoxide racemisation is known to proceed in the presence of strong acid155, or thermally often 
at high temperatures where a bipyrimidal inversion mechanism is accountable.156 Benzyl 
substituted sulfoxides are known to racemise at lower temperatures (130-150 oC) via a 
homolytic scission and cage recombination mechanism.157 Racemisation of allyl substituted 
sulfoxides is much more facile undergoing a reversible rearrangement mechanism via allyl 
sulfenates.158 Prior to this study no homoallyl substituted sulfoxides have been reported and 
they may undergo facile racemisation, however this is only speculation.  
Alkynyl sulfoxides have been used as precursors to vinyl sulfoxides159 and in Diels-Alder 
reactions.160 In the reactions transforming chiral alkynyl sulfoxides to chiral vinyl sulfoxides 
metals complexes including rhodium complexes, copper species and zinc have been 
employed.161,162 These observations and the fact no racemisation has been reported for alkynyl 
sulfoxides suggest that the unique reactivity of gold could be the cause of the racemisation. 
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The sulfoxides 487a and 487b are stable to racemisation at rt neat for several days, and no 
degradation products can be seen by TLC upon heating at 50 oC in 1,4-dioxane or after the 
addition of the gold catalyst. Inconclusive HPLC results suggest the racemisation may occur 
upon addition of the gold. The utility of chiral sulfoxides is that they do not racemise over most 
common reaction conditions, as already described. Diazo chemistry performed by Maguire 
showed no racemisation on reaction via the metal carbene.  
Another possibility is that the racemisation occurs upon formation of the gold carbenoid. The 
behaviour of the chiral sulfur centre when adjacent to the gold carbenoid is completely 
unknown, yet this is only speculation. 
Finally racemisation could potentially occur upon formation of the sulfur heterocycle product 
488a and 488b. The experiment (p.110) shows that epimerization does not occur under the 
reaction conditions. This would suggest that these products are stable to racemisation. 
4.12 Conclusions and future work 
The work presented within this chapter showcases the successful use of gold catalysis to access 
an intramolecular cyclopropanation reaction from an α-diazo sulfoxide equivalent. Two related 
alkynyl sulfoxide systems have been shown to undergo cyclopropanation. In the first case, 
forming fused cyclopentanone derived structures, yields were moderate diastereoselectivity 
was modest and heavily influenced by the substituent. A second system was much more 
successful where high yields of single diastereomers could be obtained in many cases, substrate 
scope was good and an efficient preparation of precursors was designed and realised. A model 
for the observed diastereoselectivity was given. Limited success was observed on changing the 
alkene component in the cyclopropanation, mostly due to competing reactivity however further 
reaction optimisation would be expected to solve this problem. Attempts to access other 
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‘carbene’ reactivity modes were mostly unproductive but some promising reactivity suggest 
this should be explored further. Finally an alkynyl sulfoxide was prepared asymmetrically but 
racemic products were obtained in the gold catalysed reaction.  
The basis for this is yet to be determined and is in itself interesting given the other uses of 
alkynylsulfoxides. A systematic approach to determine the cause and reasons for the 
racemisation between enantioenriched sulfoxides and racemic products should be performed. 
This would determine whether any practical solutions could be implemented. Further reaction 
screening may be expected to produce improved results from the substituted alkenes. Trapping 
of the gold carbenoid by an intramolecular nucleophile could be explored further. An alternative 




















Commercially available chemicals/reagents were purchased from Sigma Aldrich, Acros, Strem, 
Alfa Aesar and used without further purification, unless reported. All catalysis reactions were 
carried out under argon in heat gun-dried glassware unless otherwise stated. Solvents were 
purified using a Pure Solv-MD solvent purification system except for CHCl3, 1,4-dioxane 
which was dried over activated 4Å molecular sieves, and were transferred under argon. Asynt 
DrySyn heating blocks on stirrer hotplates were employed for reactions with temperature 
controlled via external probe. The following cooling baths were used: 0 oC (ice/water), -10 oC 
(NaCl/ice) and -78 oC (dry ice/acetone). Flash column chromatography: Fluorochem silica gel 
60 (0.043-0.063 mm). Thin layer chromatography (TLC): Macherey Nagel silica gel 60F254 
analytical plates which were developed using standard visualizing agents: UV fluorescence 
(254 and 366 nm), phosphomolybdic acid /Δ, potassium permanganate /Δ and vanillin /Δ. IR 
was recorded using a Perkin–Elmer Spectrum 100 FTIR spectrometer. Only selected 
absorbencies (υmax) are reported in cm
-1. MS and HRMS (EI): VG ProSpec or VG-ZabSpec at 
70 eV. High resolution EI spectra were measured using perfluorokerosene (PFK) as an internal 
calibrant. MS and HRMS (ES): Waters LCT, Time of Flight. HRMS was obtained using 
leucineenkephalin as lock-mass. 
NMR: Spectra were recorded on Bruker AVIII300 (1H = 300 MHz, 13C = 75.5 MHz) and Bruker 
AVIII400 (1H = 400 MHz, 13C = 101 MHz) in the solvents indicated; CDCl3 purchased from 
Sigma Aldrich and DMSO-d6 from Goss Scientific. 
13C NMR spectra were recorded using the 
UDEFT or PENDANT pulse sequences from the Bruker standard pulse program library. HSQC 
and HMBC spectra were recorded using the Bruker standard pulse program library. Chemical 
shifts (δ) are given in ppm relative to TMS. The solvent signals were used as references and the 
chemical shifts converted to the TMS scale (CDCl3: δc = 77.16 ppm; residual CHCl3 in CDCl3: 
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δc = 7.26 ppm). Coupling constants (J) are reported in Hz. Multiplicity is denoted in 
1H NMR 
by: s (singlet), d (doublet), t (triplet), q (quadruplet), m (multiplet). 1D  
Various alkynes and other precursors were kindly donated by members of the Davies group for 
use in this research. 
m-CPBA was purified by washing with a pH 7 phosphate buffer unless otherwise stated: A 
buffer solution was prepared from 0.1 M NaOH (154 mL) and 0.2 M KH2PO4 (94 mL) and 
made up to 376 mL with distilled water. m-CPBA (77% w/w, 10 g) was dissolved in diethyl 
ether (100 mL) and washed four times with the buffer solution. The organic extract was dried 
over MgSO4 and carefully evaporated under reduced pressure to yield pure m-CPBA (7.3 g).
83 
5.1 General experimental procedures 
General Procedure 1 (GP1) Preparation of dibromoolefins 
The general procedure follows a literature procedure.108 
PPh3 (4 eq.) was added to a solution of CBr4 (2 eq.) in dry CH2Cl2 (0.05 M based on the 
aldehyde) at 0 oC. After stirring for 10 minutes the aldehyde (1 eq.) was added and the reaction 
was stirred for 1 hour. Water was added and the mixture was extracted with Et2O, dried over 
Na2SO4, filtered and concentrated under reduced pressure. The residue was purified by column 
chromatography to afford the corresponding dibromoolefin.  
General Procedure 2 (GP2) 
Dibenzothiophene-S-oxide (1 eq.) and alkyne (2 eq.) were stirred in toluene (0.1 M) until 
dissolved in a heat gun dried schlenk tube. The mixture was then cooled in an ice bath at 0 oC 
and Au-I (1-5 mol%) was added. The reaction mixture was stirred until TLC showed 
consumption of dibenzothiophene-S-oxide, filtered through a pad of silica, washing with 
CH2Cl2 before being concentrated and the residue purified by column chromatography. 
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General Procedure 3 (GP3) 
Dibenzothiophene-S-oxide (1 eq.) and alkyne (2 eq.) were stirred in toluene (0.01 M) until 
dissolved in a heat gun dried schlenk tube. The mixture was then cooled in a (NaCl/ice) bath to 
-10 oC and Au-I (5 mol%) was added. The reaction mixture was stirred until TLC showed 
consumption of dibenzothiophene-S-oxide, filtered through a pad of silica washing with CH2Cl2 
before being concentrated and the residue purified by column chromatography. 
General Procedure 4 (GP4) 
To a flame dried Radleys tube under argon was added Naphtho dithiole monoxide 212 (1.0 eq.), 
alkyne (2.0 eq.) and toluene (0.1 M). Au-I (5 mol%) was added and the mixture was transferred 
to a hot plate at 40 oC and the reaction mixture was stirred at this temperature until completion 
was observed  by TLC or no further reaction occurred. On completion the mixture was filtered 
through a pad of silica and purified by column chromatography. 
General Procedure 5 (GP5) 
To a Radleys tube under argon was added sulfur oxide 254 (1.0 eq.) and alkyne (2.0 eq.). 
Toluene (0.2 M) was added followed by Au-II (5 mol%) a further (0.2 M) toluene was added 
and the tube was transferred to a heating block at 70 oC. The reaction was stirred until 
completion or no further reaction was observed by TLC analysis. The mixture was filtered 
through a pad of silica, washing with EtOAc, concentrated and purified by column 
chromatography. 
General Procedure 6 (GP6) 
To a Radleys tube under argon was added alkyne (1.0 eq.) and disulfide oxide 254 (1.2 eq.) 
Toluene (0.2 M) was added followed by Au-II (5 mol%). A further (0.2 M) toluene was added 
and the tube was transferred to a heating block at 90 oC. The reaction was stirred until 
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completion or no further reaction was observed by TLC analysis. The mixture was filtered 
through a pad of silica, washing with EtOAc, concentrated and purified by column 
chromatography. 
General Procedure 7 (GP7) 
To a Radleys tube under argon was added alkyne (1.0 eq.) and sulfur oxide 254 (1.2 eq.) 
Toluene (0.2 M) was added followed by Au-I (5 mol%) a further (0.2 M) toluene was added 
and the tube was transferred to a heating block at 60 oC. The reaction was stirred until 
completion or no further reaction was observed by TLC analysis. The mixture was filtered 
through a pad of silica, washing with EtOAc, concentrated and purified by column 
chromatography 
General Procedure 8 (GP 8) Preparation of Sulfinic esters 
The disulfides were prepared according to a literature procedure.133 To a RBF was added thiol 
(20 mmol), water (20 mL) and MeOH (50 mL). Sodium perborate was added and the mixture 
was stirred at rt for 2 hours. The mixture was added to a separating funnel and extracted with 
CH2Cl2 (3 × 50 mL). The organic layers were dried Na2SO4, filtered, concentrated under 
reduced pressure affording a solid which was used directly. 
The sulfinic esters were prepared according to a literature procedure.131 To a RBF containing 
disulfide (18.0 mmol) was added anhydrous MeOH (80 mL) and the mixture was cooled to 0 
oC. N-bromosuccinimide (54.0 mmol, 3.0 eq) was added in one portion. The ice bath was 
removed and the mixture stirred for 1 hour. After this time the mixture was diluted with CH2Cl2 
(100 mL) and washed with NaHCO3 (2 × 50 mL) and water (50 mL). The organic layer was 
dried Na2SO4, filtered, concentrated under reduced pressure and purified by column 
chromatography (1:1 CH2Cl2:hexane) to (CH2Cl2) to afford the sulfinic ester. 
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General Procedure 9 (GP 9) Preparation of Alkynyl Sulfoxides 
The general procedure is adapted from a literature procedure.132 
To a 2 neck RBF under argon fitted with a condenser was added Mg turnings (2.3 eq.) and a 
pellet of iodine and the mixtue was purged with argon. Et2O (1 M) was added followed by slow 
addition of allyl bromide (2.3 eq.). The grignard was stirred for 2 hours at rt.  
The reaction mixture was cooled to -10 oC, propargyl chloride (1.0 eq.) was added slowly and 
the solution was stirred for 5 hours allowing to warm to rt. After cooling to 0 oC, sulfinate (2.0 
eq.) was added dropwise and the solution was stirred at rt for 14 hours. The reaction was 
quenched by the addition of sat. NH4Cl solution at 0 
oC and the aqueous layer was extracted 
with Et2O (5 × 0.2 M with respect to propargyl chloride), washed with brine (0.2M) and the 
organic layers were dried over Na2SO4, filtered, concentrated under reduced pressure and 
purified by column chromatography to afford the alkynyl sulfoxide. 
General Procedure 10 (GP10) Preparation of alkynyl sulfides 
To a flame dried 2 neck RBF under argon was added dibromoolefin (1.1 eq.) and anhydrous 
THF (0.2 M). The flask was cooled to -78 oC using a dry ice/ acetone cool bath. n-BuLi (2.5 M 
in hexane) (2.3 eq.) was added dropwise and on complete addition the mixture was stirred at -
78 oC for an hour before S-(but-3-en-1-yl) benzenesulfonothioate (1.0 eq.) was added dropwise. 
The reaction was allowed to warm to rt o/n. The reaction was quenched with NH4Cl (sat) (0.2 
M with respect to alkyne added) and the mixture was extracted Et2O (3 × 0.2 M), the organics 
were washed with brine (0.2 M), dried Na2SO4, filtered, concentrated under reduced pressure 
and the residue was purified by column chromatography. 
General Procedure 11 (GP11) Preparation of alkynyl sulfides 
Alkyne (1.1 eq.) and anhydrous THF (0.2 M) were added to a flame dried two neck RBF under 
argon. The flask was cooled to -78 oC using a dry ice/ acetone bath. LiHMDS (1 M in 
133 
 
ethylbenzene) (1.1 eq.) was added dropwise and on complete addition the mixture was stirred 
at -78 oC for an hour before S-(but-3-en-1-yl) benzenesulfonothioate (1.0 eq.) was added 
dropwise. The reaction was allowed to warm to rt o/n. The reaction was quenched with NH4Cl 
(sat) (0.2 M with respect to alkyne added) and the mixture was extracted Et2O (3 × 0.2 M), the 
organics were washed with brine (0.2 M), dried over Na2SO4, filtered, concentrated under 
reduced pressure and the residue was purified by column chromatography. 
General Procedure 12 (GP 12) Preparation of alkynyl sulfoxides 
To a RBF equipped with a stirrer bar under argon was added alkynyl sulfide (1.0 eq.) and 
CH2Cl2 (0.1 M). The mixture was cooled to 0 
oC and mCPBA (1.0 eq.) was added in 5 portions 
over 10 mins. The reaction was allowed to warm to rt. On reaction completion the mixture was 
washed with NaHCO3 (3 × 10 mL) and the aqueous phase was extracted with CH2Cl2 (3 × 10 
mL). The combined organic layers were dried over Na2SO4, filtered, concentrated and purified 
by column chromatography (using 3-5 inches of silica) to provide the alkynyl sulfoxide. 
General procedure 13 (GP13) 
To a Radleys tube under argon was added 3,5-dichloropyridine-N-oxide (1.2 eq.) and alkynyl 
sulfoxide (1.0 eq.) as a 0.2 M solution in 1,4-dioxane. SPhosAuNTf2 (2.5 mol%) was added 
followed by 1,4-dioxane (0.067 M) and the reaction was stirred until completion or no further 
reaction was observed by TLC analysis. The mixture was filtered through a pad of silica, 
washing with EtOAc, concentrated and purified by column chromatography.  
General procedure 14 (GP14) 
To a Radleys tube under argon was added 3,5-dichloropyridine-N-oxide (1.2 eq.) and alkynyl 
sulfoxide (1 eq.) as a 0.2 M solution in 1,4-dioxane. The flask was placed in an oil bath at 50 
oC and SPhosAuNTf2 (5 mol%) was added followed by 1,4-dioxane (0.067 M) and the reaction 
was stirred until completion or no further reaction was observed by TLC analysis. The mixture 
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was filtered through a pad of silica, washing with EtOAc, concentrated and purified by column 
chromatography. 
Preparation of gold catalysts and a pyridine-N-oxide 
Chloro[tris(2,4-di-tert-butylphenyl)phosphite]gold  
Prepared according to a literature procedure.163 Thiodiethanol (114.9 mg, 1.11 mmol) was 
added dropwise to a solution of KAuCl4 (150 mg, 0.397 mmol) in H2O (3.5 mL) cooled to 0 
oC. Upon stirring for a further 30 mins, 2,4 di-tertbutylphenyl phosphite (205.5 mg, 0.318 
mmol) was added dropwise at 0 oC. Upon complete addition the mixture was stirred for a further 
30 mins, filtered and washed with pentane to afford the catalyst (250 mg); 1H-NMR (300 MHz, 
CDCl3): δ = 7.40 (dd, J = 8.5 and 1.4, 2H), 7.12 (dd, J = 8.6 and 2.5, 1H), 1.44 (s, 9H), 1.28 (s, 





Prepared according to a literature procedure.164 Chloro[tris(2,4-di-tert-
butylphenyl)phosphite]gold (87.8 mg, 0.10 mmol) was added to a 25 ml 2 neck RBF. The 
flask was covered in foil, CH3CN (7 mL) was added followed by AgSbF6 (41.2 mg, 0.12 
mmol) and the reaction was stirred at rt for 16 hours. MeCN was removed under reduced 
pressure, CH2Cl2 (5 mL) was added and the mixture was filtered under argon through celite. 
Evaporation of the solvent afforded the gold catalyst (100.8 mg, 90%) as a white solid. Sata 
matches the literature.164 1H-NMR (300 MHz, CDCl3): δ = 7.49 – 7.44 (m, 1H), 7.35 (dd, J 
8.5 and 1.4, 1H), 7.23 (dd, J 8.6 and 2.4, 1H), 2.47 (s, 1H), 1.44 (s, 9H), 1.30 (s, 9H); 31P-
NMR (122 MHz, CDCl3): δ = 87.8; IR (neat): ν = 2961, 2870, 1489, 1399, 1363, 1175, 1073, 
947, 890, 656;  
XPhosAuCl 
Prepared according to a literature procedure.165 KAuCl4 (200 mg, 0.53 mmol) was dissolved 
in MeOH (3.2 mL), before the dropwise addition of dimethylsulfide (115 µL, 1.57 mmol, 2.9 
eq.) as a solution in MeOH (0.8 mL) minimising exposure to light. After stirring for 30 
minutes the white solid was filtered under vacuum washing with MeOH, Et2O and pentane 
affording a white solid (quant) which was used directly.  
Me2SAuCl (88.4 mg, 0.30 mmol) was combined with XPhos (143 mg, 0.30 mmol, 1 eq.). 
CH2Cl2 (5 mL) was added and the solution stirred for 2 hours at rt. The solvent was mostly 
removed under reduced pressure before the addition of hexane and the product crashed out as 




1H NMR (300 MHz, CDCl3): δ = 7.67 – 7.58 (m, 1H), 7.56 – 7.46 (m, 2H), 7.32 – 7.26 (m, 
1H), 7.10 (s, 2 H), 3.00 (dt, J = 13.8, 6.9 Hz, 1H), 2.25 (dt, J = 13.5, 6.8 Hz, 2H), 2.17 – 2.02 
(m, 4H), 1.91 – 1.75 (m, 6H), 1.73 – 1.64 (m, 2H), 1.56 – 1.45 (m, 2H), 1.39 (d, J = 6.9 Hz, 
6H), 1.32 (d, J = 6.9 Hz, 6H), 1.40 – 1.15 (m, 8H), 0.96 (d, J = 6.7 Hz, 6H); 31P-NMR (122 
MHz, CDCl3): δ = 35.6; Data matches that reported in the literature.
165 
XPhosAu(NCCH3)SbF6 
Prepared according to a literature procedure.166 XPhosAuCl (70.9 mg, 0.10 mmol) was added 
to a 25 ml 2 neck RBF. The flask was covered in foil, CH3CN (7 mL) was added followed by 
AgSbF6 (41.2 mg, 0.12 mmol) and the reaction was stirred at rt for 16 hours. MeCN was 
removed under reduced pressure, CH2Cl2 (5 mL) was added and the mixture was filtered 
under argon through celite. Evaporation of the solvent afforded the gold catalyst (71.5 mg, 
75%) as a white solid. 1H-NMR (300 MHz, CDCl3): δ = 7.49 – 7.44 (m, 1H), 7.35 (dd, J 8.5 
and 1.4, 1H), 7.23 (dd, J 8.6 and 2.4, 1H), 2.47 (s, 1H), 1.44 (s, 9H), 1.30 (s, 9H); IR (neat): ν 
= 2961, 2870, 1489, 1399, 1363, 1175, 1073, 947, 890, 656; 31P-NMR (121 MHz, CDCl3): δ 
= 87.8; 1H NMR (300 MHz, CDCl3): δ = 7.71 (t, J = 8.8 Hz, 1H), 7.57 (dt, J = 14.8, 5.7 Hz, 
2H), 7.21 (s, 1H), 7.00 (s, 2H), 2.94 (dt, J = 13.7, 6.9 Hz, 1H), 2.20 (dt, J = 13.4, 6.8 Hz, 4H), 
2.10 – 1.98 (m, 2H), 1.90 – 1.67 (m, 5H), 1.35 (d, J = 6.8 Hz, 6H), 1.43-1.11 (m, 13H), 1.21 
(d, J = 6.7 Hz, 6H), 0.93 (d, J = 6.8 Hz, 6H); 31P-NMR (122 MHz, CDCl3): δ = 36.4; IR 
(neat): ν = 2929, 2856, 1448, 1428, 1383, 1270, 1178, 1124, 920, 883, 876, 854, 770, 743. 
Data matches that reported in the literature.166 
SPhosAuCl 
Prepared according to a literature procedure.167 KAuCl4 (200 mg, 0.53 mmol) was dissolved 
in MeOH (3.2 mL), before the dropwise addition of dimethylsulfide (115 µL, 1.57 mmol, 2.9 
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eq.) as a solution in MeOH (0.8 mL) minimising exposure to light. After stirring for 30 
minutes the white solid was filtered under vacuum washing with MeOH, Et2O and pentane 
affording a white solid (quant) which was used directly.  
Me2SAuCl (0.204 mmol, 60 mg) was combined with SPhos (83.7 mg, 0.204 mmol, 1 eq.). 
CH2Cl2 (5 mL) was added and the solution stirred for 2 hours at rt. The solvent was mostly 
removed under reduced pressure before the addition of hexane and the product crashed out as 
white crystals (99.6 mg, 80%) which were collectd by vacuum filtration washing with hexane. 
 1H NMR (300 MHz, CDCl3): δ = 7.60 – 7.41 (m, 4H), 7.24 – 7.17 (m, 1H), 6.66 (d, J = 8.4 
Hz, 2H), 3.69 (s, 6H), 2.21 – 2.07 (m, 2H), 2.01 – 1.89 (m, 2H), 1.86 – 1.55 (m, 8H), 1.53 – 
1.38 (m, 2H), 1.37 – 1.11 (m, 8H); 31P NMR (122 MHz, CDCl3): δ = 38.5; IR (neat): ν = 2924, 
2851, 1589, 1472, 1428, 1249, 1110, 1000, 759, 723. Data matches that reported in the 
literature.167 
SPhosAuNTf2 
Prepared according to a literature procedure.168 To SPhosAuCl (53.6 mg, 0.083 mmol) in 
CH2Cl2 (4 mL) in a RBF wrapped in foil was added AgNTf2 (32.3 mg, 0.083 mmol) and the 
mixture was stirred at rt for 1 hour. The mixture was filtered through a pad of celite, washing 
with CH2Cl2, and concentrated under reduced pressure to afford SPhosAuNTf2 (62.6 mg, 85%) 
as white crystals. Data matches that reported in the literature.168 
1H NMR (300 MHz, CDCl3): δ = 7.64 – 7.54 (m, 2H), 7.53 – 7.46 (m, 1H), 7.43 (t, J = 8.4 Hz, 
1H), 7.21 (ddd, J = 8.3, 4.6, 1.5 Hz, 1H), 6.71 (d, J = 8.4 Hz, 2H), 3.69 (s, 6H), 2.25 – 1.93 (m, 
4H), 1.92 – 1.60 (m, 8H), 1.46 – 1.00 (m, 10H); 31P NMR (122 MHz, CDCl3): δ = 37.9; IR 
(neat): ν = 2930, 2863, 1600, 1590, 1474, 1389, 1371, 1213, 1186, 1128, 1112, 962, 811, 658. 




3,5-Dichloropyridine 1-oxide  
74 was prepared according to a literature procedure.1 To a RBF was added 3,5-
dichloropyridine (740 mg, 5.00 mmol) and CH2Cl2 (50 mL). The mixtue was 
cooled to 0 oC, mCPBA (1.06 g, 6.15 mmol, 1.23 eq.) was added and the reaction was allowed 
to warm to rt over 16 hours. The mixture was quenched with NaHCO3 (5 mL of a saturated 
aqueous solution) and extracted with CH2Cl2 (4 × 10 mL). The organics were combined, dried 
over MgSO4, concentrated under reduced pressure and purified by column chromatography 
(EtOAc) to afford the title compound (686 mg, 84%) as a white solid; mp: 108-110 oC; 1H NMR 
(300 MHz, CDCl3): δ = 8.14 (d, J = 1.6 Hz, 2H), 7.31 (t, J = 1.6 Hz, 1H); IR (neat): ν = 3290, 





5.2 Experimental section:Chapter 2  
Dibenzothiophene-5-oxide (103) 
Sulfoxide 103 was prepared from a literature procedure.83 Dibenzothiophene 
102 (2.00 g, 10.9 mmol) in CH2Cl2 (46 mL) was cooled to 0 
oC. mCPBA 
(2.06 g, 11.9 mmol) in CH2Cl2 (80 mL) was added over 20 minutes. The 
reaction was left to warm to rt and stirred for 16 hours. The reaction mixture was washed with 
NaHCO3 (3 × 30 mL of a 0.1 M aqueous solution) and extracted with CH2Cl2 (3 × 30 mL), 
dried over MgSO4, filtered, concentrated under reduced pressure and purified by column 
chromatography (petroleum ether:EtOAc 9:1) to yield 103 (1.70 g, 78%) as a white solid; Rf 
0.36 (1:1 petroleum ether:EtOAc); mp: 184-186 oC; 1H NMR (300 MHz, CDCl3): δ = 8.00 (d, 
J = 7.2 Hz, 2H), 7.82 (d, J = 8.0 Hz, 2H), 7.61 (td, J = 7.5, 1.1 Hz, 2H), 7.51 (td, J = 7.5, 1.1 
Hz, 2H); m/z (ES) 223 (M + Na)+ (100), 224 (8), 255 (15). Data matches that reported in the 
literature.170  
Phenoxathiin-10-oxide (106) 
Sulfoxide 106 was prepared from a literature procedure.83 Phenoxathiin 104 
(500 mg, 2.50 mmol) in CH2Cl2 (18 mL) was cooled to 0 
oC. mCPBA (475 
mg, 2.75 mmol) in CH2Cl2 (24 mL) was added by syringe over 20 minutes,  
the reaction was left to warm to rt and stirred for 16 hours. The reaction mixture was washed 
with NaHCO3 (3 × 10 mL of a 0.1 M aqueous solution), extracted with CH2Cl2 (3 × 10 mL), 
dried over MgSO4, filtered, concentrated under reduced pressure and purified by column 
chromatography (hexane:EtOAc 1:1) to yield 106 (433 mg, 78%) as a white solid; Rf 0.38 
(hexane:EtOAc 1:1); mp: 138-139 oC; 1H NMR (300 MHz, CDCl3): δ = 7.92 (dd, J = 7.8, 1.6 
Hz, 2H), 7.61 (ddd, J = 8.7, 7.3, 1.6 Hz, 2H), 7.42 (dd, J = 8.4, 1.0 Hz, 2H), 7.37 (t, J = 7.5 
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Hz, 2H); IR (neat): ν = 3074, 1586, 1452, 1435, 1223, 1023, 1032, 770, 755. Data matches 
that reported in the literature.172 
Thianthrene-5-oxide (107) 
Sulfoxide 107 was prepared from a literature procedure.83 Thianthrene 105 
(604 mg, 2.79 mmol) in CH2Cl2 (18 mL) was cooled to 0 
oC. mCPBA (530 
mg, 3.07 mmol) in CH2Cl2 (24 mL) was added by syringe over 20 minutes,  
the reaction was left to warm to rt and stirred for 16 hours. The reaction mixture was washed 
with NaHCO3 (3 × 10 mL of a 0.1 M aqueous solution) and extracted with CH2Cl2 (3 × 10 
mL), dried over MgSO4, filtered, concentrated under reduced pressure and purified by column 
chromatography (hexane:EtOAc 85:15) to yield 107 (530 mg, 81%) as a white solid; Rf  0.21 
(1:10 EtOAc:hexane); mp: 138-139 oC; 1H NMR (300 MHz, CDCl3): δ = 7.86 (d, J = 7.8 Hz, 
2H), 7.57 (d, J = 8.5 Hz, 2H), 7.50 (t, J = 8.2 Hz, 2H), 7.37 (t, J = 7.5 Hz, 2H); IR (neat): ν = 
1569, 1434, 1248, 1117, 1075 (S=O), 1033, 747. Data matches that reported in the 
literature.172,173 
Thianthrene 5,10-dioxide (108) 
Sulfoxide 108 was prepared from a literature procedure.83 Thianthrene 105 
(100 mg, 0.46 mmol) in CH2Cl2 (3 mL) was cooled to 0 
oC. mCPBA (160 
mg, 0.92 mmol) in CH2Cl2 (4 mL) was added by syringe over 20 minutes, 
the reaction was left to warm to rt and stirred for 16 hours. The reaction mixture was washed 
with NaHCO3 (3 × 5 mL of a 0.1 M aqueous solution) and extracted with CH2Cl2 (3 × 5 mL), 
dried over Na2SO4, filtered, concentrated under reduced pressure and purified by column 
chromatography (hexane:EtOAc 1:3) to yield 108 (70 mg, 61%) as a white solid as a 1:1 
mixture of diastereomers; Rf  0.39 (1:3 hexane:EtOAc); mp: 253-255 
oC; 1H NMR (300MHz, 
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CDCl3): δ = 8.04 (dd, J = 5.6, 3.3Hz, 4H), 7.60 (dd, J = 5.6, 3.3 Hz, 4H); IR (neat): ν = 3056, 
1571, 1436, 1072, 1037, 1023, 779, 763. Data matches that reported in the literature.172,173 
1-(Cyclopropylethynyl)-4-methoxybenzene (109) 
Alkyne 109 was prepared according to the literature procedure.19 To a 
stirring solution of of CuI (38 mg, 0.46 mmol) and Pd(PPh3)2Cl2 (69 
mg, 0.98 mmol) in diethylamine (25 ml) was added 4-methoxy iodobenzene (1.15 g, 4.9 mmol). 
After stirring for 10 min, cyclopropylacetylene (389 mg, 5.88 mmol) was added. The reaction 
mixture was stirred for 16 hours, concentrated under reduced pressure and purified by column 
chromatography (hexane) to give 109 (0.513 g, 64%) as a colourless oil; Rf  0.19 (hexane);
 1H 
NMR (300MHz, CDCl3): δ = 7.31 (d, J = 8.9 Hz, 2H), 6.80 (d, J = 8.9 Hz, 2H), 3.79 (s, 3H), 
1.42 (m, 1H), 0.81 (m, 4H); 13C NMR (100 MHz, CDCl3): δ = 159.0 (C), 133.0 (2CH), 116.0 
(C), 113.8 (2CH), 91.7 (C), 75.5 (C), 55.2 (CH3), 8.5 (2CH2), 0.1 (CH). IR (neat): ν = 3009, 
2957, 2837, 2234, 1605. Data matches the literature.19 
3-(Hex-1-yn-1-yl)oxazalidin-2-one (112) 
Ynamide 112 was prepared according to the literature procedure.35 To 
a 500 ml 3 neck RBF flame dried under argon was added CuCl2 (81 
mg, 0.6 mmol), oxazalidin-2-one (1.37 g, 15.7 mmol) and Na2CO3 (636 mg, 6.0 mmol). The 
flask was purged with oxygen for 15 minutes and a balloon of oxygen was attached. The 
reaction mixture was heated to 70 oC and toluene (10 ml) and pyridine (475 mg, 6.0 mmol) 
were added. 1-Hexyne (0.35 ml, 3.0 mmol) in toluene (10 ml) was added by syringe pump over 
4 hours stirring at 70 oC. On complete addition the reaction was left stirring at 70 oC for 14 h. 
The reaction mixture was allowed to cool to rt and the inorganics were removed by filtration. 
The filtrate was concentrated under reduced pressure and purified by column chromatography 
(Hexanes:EtOAc 7:3) to yield 112 (293 mg, 59%) as a clear oil. 1H NMR (300 MHz, CDCl3): 
142 
 
δ = 4.41 (t, J = 10.9 Hz, 2H), 3.87 (t, J = 8.2 Hz, 2H), 2.30 (t, J = 7.0 Hz, 2H), 1.54-1.31 (m, 
4H), 0.91 (t, J = 7.0 Hz, 3H); IR (neat): ν = 2959, 2932, 2873, 2274, 1759, 1480, 1413, 1298, 
1201, 1113, 1033, 973, 750, 730, 614. Data matches the literature.35 
4-Methyl-N-phenylbenzenesulfonamide (114a) 
Sulfonamide was prepared according to a literature procedure.35 To a 100 ml RBF 
stirring at rt under argon was added aniline (3.00 g, 32.2 mmol) and CH2Cl2 (70 
ml). Pyridine (15.3 ml, 193 mmol) was added and TsCl (6.20 g, 38.7 mmol) was added in 
portions over 1 hour. The reaction was stirred at rt for 16 hours. The reaction mixture was 
concentrated to half its volume, washed with 5% HCl (3 × 25 ml) and purified by column 
chromatography (Hexanes:EtOAc 2:1) to give the title compound (7.50 g, 95%) as a white 
solid; Rf 0.68 (Hexanes:EtOAc 2:1);
 1H NMR (300MHz, CDCl3): δ = 7.64 (d, J = 8.3 Hz, 2H), 
7.25-7.19 (m, 4H), 7.12-7.01 (m, 3H), 2.38 (s, 3H); IR (neat): ν = 2962, 2930, 2875, 1770, 
1682, 1631, 1479, 1386, 1362, 1286, 1262, 1204, 1120, 1038, 984, 759, 706, 649, 637, 620, 
611. Data matches the literature.35 
4-Methyl-N-phenyl-N-(phenylethynyl)benzenesulfonamide (114) 
Ynamide 114 was prepared according to the literature procedure.35 To 
a 500 ml 3 neck RBF flame dried under argon was added CuCl2 (53.8 
mg, 0.4 mmol), sulfonamide 114a (2.47 g, 10 mmol) and Na2CO3 (424 
mg, 4 mmol). The flask was purged with oxygen for 15 minutes and a balloon of oxygen was 
attached. The reaction mixture was heated to 70 oC and toluene (10 ml) and pyridine (316 mg, 
4 mmol) were added. Phenylacetylene (0.22 ml, 2 mmol) in toluene (10 ml) was added by 
syringe pump over 4 hours stirring at 70 oC. On complete addition the reaction was left stirring 
at 70 oC for 14 h. The reaction mixture was allowed to cool to rt and the inorganics were 
removed by filtration. The filtrate was concentrated under reduced pressure and purified by 
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column chromatography (Hexanes:EtOAc 20:1) to yield 114 (500 mg, 68%) as a pale yellow 
solid; Rf 0.36 (Hexanes:EtOAc 20:1); 
1H NMR (300MHz, CDCl3): δ = 7.62 (d, J = 8.3 Hz, 4H), 
7.43-7.35 (m, 3H), 7.34-7.28 (m, 9H), 2.44 (s, 3H); IR (neat): ν = 3235, 1597, 1482, 1415, 
1336, 1155, 1090, 909, 818, 753, 694, 656, 622. Data matches the literature.35 
Tert-butyl(hex-5-yn-1-yloxy)diphenylsilane (120) 
Alkyne 120 was prepared according to a literature procedure.85 
To a RBF under argon containing CH2Cl2 (5 mL) was added 5-hexyn-
1-ol 119 (0.14 mL, 1.27 mmol) followed by imidazole (0.14 g, 2.05 mmol) and TBDPSCl (0.33 
mL, 1.27 mmol) at 0 oC. The reaction was allowed to warm to rt stirring for 16 hours. CH2Cl2 
(12 mL) was added followed by NH4Cl (20 mL of a saturated solution). The organic layer was 
collected and the aqueous extracted with CH2Cl2 (15 mL), dried over Na2SO4, filtered, 
concentrated under reduced pressure and purified by column chromatography (98:2 
hexanes:EtOAc) to afford 120 (330 mg, 79%) as a clear oil; Rf  0.33 (98:2 hexane:EtOAc); 
1H-
NMR (300 MHz, CDCl3): δ = 7.72 – 7.62 (m, 4H), 7.47 – 7.34 (m, 6H), 3.67 (t, J  = 5.5 Hz, 
2H), 2.20 (dt, J = 5.6, 2.8 Hz, 2H), 1.97– 1.91 (m, 1H), 1.74 – 1.59 (m, 4H), 1.04 (s, 9H); IR 
(neat): v = 3308, 3072, 2932, 2858, 1590, 1428, 1106, 700. Data matches that reported in the 
literature.85 
Dec-1-yn-3-ol (122) 
Alkyne 122 was prepared according to a literature procedure.27 
A flame dried RBF containing a stirrer bar, TMS acetylene (1.11 ml, 
8.00 mmol, 1.5 eq.) and THF (20 mL) was placed in a dry ice/ acetone 
bath at -78 oC. n-BuLi (1.6 M) (5.3 mL, 8.5 mmol, 1.6 eq.) was added dropwise over 30 minutes. 
After stirring for an additional 15 minutes, octanal (828 µL, 5.3 mmol, 1.0 eq.) in THF (20 mL) 
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was added dropwise over 30 minutes and the reaction was stirred at -78 oC for an additional 3 
hours. The reaction mixture was quenched with NH4Cl (20 mL of a saturated solution), 
extracted with Et2O (4 × 20 mL), dried over Na2SO4, filtered and concentrated under reduced 
pressure affording the TMS protected propargylic alcohol (1.10 g) which was used crude. 
To a flame dried RBF equipped with a stirrer bar, was added THF (35 mL) and crude TMS 
protected alcohol (1.10 g, 4.0 mmol). The solution was cooled to 0 oC and TBAF (1.0 M) (4.0 
ml, 4.0 mmol, 1.0 eq.) was added dropwise over a period of 15 minutes and the reaction was 
stirred for a further 90 minutes. NH4Cl (50 mL of a saturated solution) was added and the 
mixture was extracted with Et2O (3 × 25 mL), dried over Na2SO4, filtered, concentrated under 
reduced pressure and purified by column chromatography (10-20% EtOAc:hexanes) affording 
122 (540 mg, 66%) as a pale yellow oil; Rf 0.38 (9:1 hexane:EtOAc); 
1H-NMR (300 MHz, 
CDCl3): δ = 4.39-4.35 (m, 1H), 2.46 (d, J 2.1, 1H), 1.76-1.68 (m, 4H), 1.62 (s, 2H), 1.50-1.41 
(m,  2H), 1.34–1.23 (m, 8H), 0.88 (t, J 6.8, 3H); IR (neat): v = 3312, 2925, 2857, 1465, 1379, 
1302, 1118, 1045, 1021, 722, 652, 624. Data matches that reported in the literature.174 
1-Bromo-2-(2,2-dibromovinyl)benzene (123) 
Prepared according to GP1, using 2-bromo benzaldehyde (0.48 mL, 5.0 
mmol), CBr4 (3.30 g, 10.0 mmol), PPh3 (5.25 g, 20.0 mmol) and CH2Cl2 (15 
mL). The reaction time was 16 hours. Aqueous workup and purification by column 
chromatography afforded 123 (750 mg, 56%) as a pale yellow oil. 1H NMR (300 MHz, CDCl3): 
δ = 7.59 (d, J = 8.0 Hz, 2H), 7.51 (s, 1H), 7.34 (td, J = 7.6, 1.2 Hz, 1H), 7.21 (td, J = 7.6, 1.6 
Hz, 1H); 3064, 3019, 2922, 2855, 1606, 1589, 1463, 1428, 1317, 1277, 1161, 1118, 1046, 1025, 




Prepared according to GP1, using p-methoxybenzaldehyde (0.61 mL, 
5.0 mmol), CBr4 (3.30 g, 10.0 mmol), PPh3 (5.25 g, 20.0 mmol) and 
CH2Cl2 (15 mL). The reaction time was 16 hours. Aqueous workup and purification by column 
chromatography afforded 124 (1.20 g, 88%) as a pale orange solid. mp: 34-36 oC; 1H NMR (300 
MHz, CDCl3): δ = 7.51 (d, J = 8.6 Hz, 2H), 7.41 (s, 1H), 6.89 (d, J = 8.9 Hz, 2H), 3.82 (s, 3H); 
IR (neat): ν = 3006, 2965, 2934, 2840, 1898, 1603, 1507, 1254, 1177, 1026, 864. Data matches 
that reported in the literature.86 
2-(2,2-Dibromovinyl)thiophene (125) 
Prepared according to GP1, using thiophene carboxaldehyde (0.47 mL, 5.0 
mmol), CBr4 (3.30 g, 10.0 mmol), PPh3 (5.25 g, 20.0 mmol) and CH2Cl2 (15 
mL). The reaction time was 1 hour. Aqueous workup and purification by column 
chromatography afforded 125 (1.26 g, 94%) as a light brown solid. mp: 53-55 oC; 1H NMR 
(300 MHz, CDCl3): δ = 7.66 (s, 1H), 7.39 (d, J = 4.8 Hz, 1H), 7.25 (s, 1H), 7.08 – 7.00 (m, 1H); 
IR (neat): ν = 3101, 3007, 2162, 1634, 1605, 1420, 1209, 1076, 1051, 856, 817, 741, 703; Data 
matches that reported in the literature.175 
1-Bromo-2-ethynylbenzene (126) 
Prepared according to a literature method.86 To a RBF was added dibromalkene 123 
(800 mg, 2.35 mmol) and Et2O (10 mL). The mixture was cooled to -78 
oC. n-BuLi 
(2.5 M in hexanes) (2.36 mL, 5.89 mmol, 2.3 eq.) was added dropwise over 1 hour, 
the reaction was stirred at -78 oC for 1 hour before the addition of NH4Cl (10 mL). The mixture 
was warmed to rt, the organic layer separated, the aqueous layer extracted Et2O (3 × 10 mL). 
The combined organics were dried over Na2SO4, filtered, concentrated under reduced pressure 
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and purified by column chromatography (hexane) affording the title compound 126 as a light 
brown oil; 1H NMR (300 MHz, CDCl3): δ = 7.59 (dd, J = 7.8, 1.5 Hz, 1H), 7.53 (dd, J = 7.6, 
1.8 Hz, 1H), 7.28 (td, J = 7.5, 1.4 Hz, 1H), 7.21 (td, J = 7.7, 1.9 Hz, 1H), 3.38 (s, 1H); IR (neat): 
v = 3291, 1465, 1026. Data matches that reported in the literature.175 
1-Ethynyl-4-methoxybenzene (127) 
Prepared according to a literature method.86 To a RBF was added dibromalkene 124 
(730 mg, 2.50 mmol) and Et2O (10 mL). The mixture was cooled to -78 
oC. n-BuLi 
(2.5 M in hexanes) (2.40 mL, 6.0 mmol, 2.4 eq.) was added dropwise over 1 hour, the 
reaction was stirred at -78 oC for 1 hour before the addition of NH4Cl (10 mL). The mixture 
was warmed to rt, the organic layer separated, the aqueous layer extracted Et2O (3 × 10 mL). 
The combined organics were dried over Na2SO4, filtered, concentrated under reduced pressure 
and purified by column chromatography (hexane) affording the title compound 127 (261 mg, 
79%) as a colourless oil; 1H-NMR (300 MHz, CDCl3): δ = 7.47 – 7.40 (m, 2H), 6.87 – 6.81 (m, 
2H), 3.81 (s, 3H), 3.00 (s, 1H); IR (neat): v = 3286, 2960, 2540, 2106, 1606, 1505, 1290, 1245, 
1169, 1029, 830. Data matches that reported in the literature.86 
2-Ethynylthiophene (128) 
Prepared according to a literature method.86 To a RBF was added dibromalkene 125 
(669 mg, 2.50 mmol) and Et2O (10 mL). The mixture was cooled to -78 
oC. n-BuLi 
(2.5 M in hexanes) (2.40 mL, 6.0 mmol, 2.4 eq.) was added dropwise over 1 hour, the reaction 
was stirred at -78 oC for 1 hour before the addition of NH4Cl (10 mL). The mixture was warmed 
to rt, the organic layer separated, the aqueous layer extracted Et2O (3 × 10 mL). The combined 
organics were dried over Na2SO4, filtered, concentrated under reduced pressure and purified by 
column chromatography (hexane) affording 128 as a light brown oil; 1H-NMR (300 MHz, 
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CDCl3): δ =7.28 (dd, J = 3.5, 1.1 Hz, 2H), 6.98 (dd, J = 5.1, 3.6 Hz, 1H), 3.34 (s, 1H); IR (neat): 
v = 3294, 2928, 1240, 928, 852. Data matches that reported in the literature.175 
1-(Dibenzo[b,d]thiophen-4-yl)hexan-2-one (116) 
116 was prepared according to GP2 using dibenzothiophene-S-oxide (40.0 
mg, 0.20 mmol), 1-hexyne (23 µl, 0.40 mmol), toluene (2 mL) and Au-I (11.2 
mg, 0.02 mmol, 5 mol%). The reaction was stirred for 45 minutes at 0 oC. 
Column chromatography (1:19 EtOAc:hexane) afforded 116 (49 mg, 87%) as a white solid; Rf 
0.28 (1:19 EtOAc:hexane) mp: 43-45 oC; 1H-NMR (300 MHz, CDCl3): δ = 8.20–8.13 (m, 1H), 
8.10 (d, J = 7.2 Hz, 1H), 7.92–7.82 (m, 1H), 7.51-7.43 (m, 3H), 7.32 (d, J = 7.2 Hz, 1H), 3.96 
(s, 2H), 2.51 (t, J = 7.4 Hz, 2H), 1.63–1.50 (m, 2H), 1.33-1.19 (m, 2H), 0.85 (t, J = 7.3 Hz, 3H); 
13C-NMR (101 MHz, CDCl3): δ = 207.5 (C), 140.0 (C), 139.1 (C), 136.1 (C), 136.0 (C), 129.2 
(C), 128.0 (CH), 127.0 (CH), 125.2 (CH), 124.7 (CH), 123.0 (CH), 122.0 (CH), 120.6 (CH), 
49.4 (CH2), 42.0 (CH2), 26.0 (CH2), 22.3 (CH2), 14.0 (CH3); IR (neat): ν = 3057, 2957, 2930, 
2872, 1708, 1584, 1404, 749; HR-MS (ES-TOF): m/z: calcd for C18H18ONaS: 305.0976, found 
305.0978 [M + Na]+. 
6-Chloro-1-(dibenzo[b,d]thiophen-4-yl)hexan-2-one (129) 
129 was prepared according to GP2 using dibenzothiophene-S-oxide 
(40.0 mg, 0.20 mmol), 6-chloro-1-hexyne (48.5 µL, 0.40 mmol), toluene 
(2 mL) and Au-I (11.2 mg, 0.02 mmol, 5 mol%). The reaction was stirred 
for 40 minutes at 0 oC. Column chromatography (9:11 CH2Cl2: hexane) afforded 129 as a 
yellow oil (50 mg, 79%); Rf  0.44 (9:11 CH2Cl2:hexane); 
1H-NMR (300 MHz, CDCl3): δ = 
8.18–8.12 (m, 1H), 8.09 (dd, J = 7.9, 0.9 Hz, 1H), 7.91–7.83 (m, 1H), 7.54–7.42 (m, 3H), 7.32 
(d, J = 7.2 Hz, 1H), 3.95 (s, 2H), 3.50–3.42 (m, 2H), 2.59–2.50 (m, 2H), 1.76–1.66 (m, 4H); 
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13C-NMR (101 MHz, CDCl3): δ = 206.6 (C), 139.9 (C), 139.0 (C), 136.2 (C), 136.1 (C), 129.0 
(C), 128.0 (CH), 127.0 (CH), 125.2 (CH), 124.8 (CH), 123.0 (CH), 122.0 (CH), 120.7 (CH), 
49.4 (CH2), 44.7 (CH2), 41.1 (CH2), 31.8 (CH2), 21.1 (CH2); IR (neat): ν = 3060, 2953, 1711, 
1584, 1443, 1401, 749; HR-MS (ES-TOF): m/z: calcd for C18H17ONaS
35Cl3: 339.0586, found 
339.0574 [M + Na]+.  
1-(Dibenzo[b,d]thiophen-4-yl)-4-phenylbutan-2-one (130) 
130 was prepared according to GP2 using dibenzothiophene-S-oxide (40.0 
mg, 0.20 mmol), 4-phenyl-1-butyne (56 µl, 0.40 mmol), toluene (2 mL) and 
Au-I (11.2 mg, 0.02 mmol, 5 mol%). The reaction was stirred for 45 minutes 
at 0 oC. Column chromatography (1:1 hexane: CH2Cl2) afforded 130 (43 mg, 65%) as a white 
solid; Rf  0.78 (3:7 EtOAc: hexane); mp: 102-104 
oC; 1H-NMR (300 MHz, CDCl3): δ = 8.04-
7.96 (m, 1H), 7.93 (d, J = 7.8 Hz, 1H), 7.74-7.66 (m, 1H), 7.38–7.26 (m, 3H), 7.15–6.93 (m, 
6H), 3.78 (s, 2H), 2.79–2.63 (m, 4H); 13C-NMR (101 MHz, CDCl3): δ = 206.3 (C), 140.9 (C), 
140.0 (C), 139.0 (C), 136.2 (C), 136.1 (C), 128.9 (C), 128.6 (2CH), 128.5 (2CH), 128.0 (CH), 
127.0 (CH), 126.2 (CH), 125.2 (CH), 124.7 (CH), 123.0 (CH), 122.0 (CH), 120.7 (CH), 49.6 
(CH2), 43.7 (CH2), 29.9 (CH); IR (neat): ν = 3058, 3027, 2877, 1706, 1601, 1583, 1403, 1046, 




131 was prepared according to GP2 using dibenzothiophene-S-oxide (40.0 mg, 0.20 mmol), 
monomethyl propargyl ether (33.8 µl, 0.40 mmol), toluene (2 mL) and Au-I (11.2 mg, 
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0.02 mmol, 5 mol%). The reaction was stirred for 45 minutes at 0 oC. Column chromatography 
(CH2Cl2) afforded 131 (47 mg, 87%) as a yellow solid; mp: 51–53 
oC; Rf 0.31 (3:7 EtOAc: 
hexane); 1H-NMR (300 MHz, CDCl3): δ = 8.19–8.13 (m, 1H), 8.10 (d, J  = 7.7 Hz, 1H), 7.91–
7.83 (m, 1H), 7.52–7.43 (m, 3H), 7.34 (d, J = 7.2 Hz, 1H), 4.13 (s, 2H), 4.03 (s, 2H), 3.41 (s, 
3H); 13C-NMR (101 MHz, CDCl3): δ = 204.7 (C), 140.0 (C), 138.9 (C), 136.2 (C), 136.1 (C), 
128.2 (C), 128.1 (CH), 127.1 (CH), 125.2 (CH), 124.7 (CH), 123.0 (CH), 122.0 (CH), 122.0 
(CH), 77.3 (CH2), 59.5 (CH3), 45.5 (CH2); IR (neat): ν = 2903, 1712, 1590, 1427, 1394, 1316, 
1102, 759; HR-MS (ES-TOF): m/z: calcd for C16H14O2NaS: 293.0612, found 293.0610 [M + 
Na]+. 
Open flask protocol 
To a 25 mL RBF under an atmosphere of air was added dibenzothiophene-S-oxide (401 mg, 2 
mmol), monomethyl propargyl ether (338 µl, 4 mmol) and toluene (technical grade) (20 mL). 
The flask was placed in an ice bath and Au-I (22.4 mg, 0.002 mmol, 1 mol%) was added. The 
reaction was stirred at this temperature for 2 hours until TLC indicated reaction completion. 
Column chromatography (CH2Cl2) afforded 131 (456 mg, 84%). 
6-((tert-Butyldiphenylsilyl)oxy)-1-(dibenzo[b,d]thiophen-4-yl)hexan-2-one (132) 
132 was prepared according to GP2 using dibenzothiophene-S-oxide 
(100 mg, 0.50 mmol), alkyne 120 (336 mg, 1.0 mmol), toluene (5 
mL) and Au-I (11.2 mg, 2 mol%). The reaction was stirred for 2 
hours at 0 oC. Column chromatography (3:2 hexane:CH2Cl2) afforded 132 (222 mg, 83%) as a 
viscous oil; Rf 0.31 (3:2 hexane:CH2Cl2); 
1H-NMR (300 MHz, CDCl3): δ = 8.20–8.13 (m, 1H), 
8.09 (dd, J  = 7.9, 0.9 Hz, 1H), 7.88-7.82 (m, 1H), 7.67–7.59 (m, 4H), 7.51–7.32 (m, 9H), 7.30 
(d, J = 7.3 Hz, 1H), 3.93 (s, 2H), 3.60 (t, J = 6.2 Hz, 2H), 2.51 (t, J = 7.3 Hz, 2H), 1.77–1.60 
(m, 2H), 1.53–1.40 (m, 2H), 1.01 (s, 9H); 13C-NMR (101 MHz, CDCl3): δ = 207.2 (C), 140.0 
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(C), 139.1 (C), 136.2 (C), 136.1 (C), 135.7 (4CH), 134.1 (2C), 129.7 (2CH) 129.2 (C), 128.0 
(CH), 127.7 (4CH), 127.0 (CH), 125.2 (CH), 124.7 (CH), 123.0 (CH), 122.0 (CH), 120.6 (CH), 
63.6 (CH2), 49.4 (CH2), 42.0 (CH2), 32.0 (CH2), 27.0 (3CH3), 20.4 (CH2), 19.4 (C); IR (neat): 
ν = 2930, 2856, 1713, 1588, 1427, 1105; HR-MS (ES-TOF): m/z: calcd for C34H36O2NaSiS: 
559.2103, found 559.2102 [M + Na]+. 
2-(3-(Dibenzo[b,d]thiophen-4-yl)-2-oxopropyl)isoindoline-1,3-dione (134) 
134 was prepared according to GP2 using dibenzothiophene-S-oxide (200 
mg, 1.0 mmol), N-propargylphthalimide (370 mg, 2.0 mmol) and Au-I (22.4 
mg, 0.04 mmol, 2 mol%) for 4 hours at 0 oC and stirring for a further 16 
hours. The precipitate formed was washed with toluene and then 
recrystallized from hot EtOH affording 134 as yellow crystals (201 mg, 52%); Rf 0.65 (3:7 
EtOAc:hexane); mp: 190-192 oC (EtOH); 1H-NMR (300 MHz, CDCl3): δ = 8.20-8.15 (m, 1H), 
8.13 (dd, J = 7.9, 1.0 Hz, 1H), 7.90–7.85 (m, 1H), 7.85–7.78 (m, 2H), 7.75–7.67 (m, 2H), 7.54–
7.44 (m, 3H), 7.40 (d, J = 7.3 Hz, 1H), 4.56 (s, 2H), 4.11 (s, 2H); 13C-NMR (101 MHz, CDCl3): 
δ = 199.0 (C), 167.7 (C), 140.0 (C), 139.0 (C), 136.5 (C), 136.1 (C), 134.2 (2CH), 132.1 (2C), 
128.0 (CH), 127.5 (C), 127.2 (CH), 125.4 (CH), 124.8 (CH), 123.6 (2CH), 123.1 (CH), 122.0 
(CH), 121.1 (CH) 46.7 (CH2), 46.3 (CH2); IR (neat): ν = 2970, 1769, 1735, 1698, 1470, 1409, 
1067; HR-MS (ES-TOF): m/z: calcd for C23H15NO3NaS: 408.0670, found 408.0667 [M + Na]
+. 
1-(Dibenzo[b,d]thiophen-4-yl)-3-hydroxydecan-2-one (135) 
135 was prepared following GP2 using dibenzothiophene-S-oxide (40 
mg, 0.20 mmol), alkyne 122 (64 µl, 0.40 mmol), toluene (2 mL) and 
Au-I (11.2 mg, 5 mol%). Purification of the reaction mixture with 
column chromatography (9:1 hexane:EtOAc), followed by 
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recrystallization from hot MeOH afforded 135 (54 mg, 76%); Rf  0.25 (9:1 hexane:EtOAc); mp: 
52-54 oC; 1H-NMR (300 MHz, CDCl3): δ  = 8.21– 8.14 (m, 1H), 8.11 (d, J = 7.9 Hz, 1H), 7.91–
7.82 (m, 1H), 7.54–7.43 (m, 3H), 7.33 (d, J = 7.2 Hz, 1H), 4.38 (dd, J = 7.4, 3.6 Hz, 1H), 4.07 
(s, 2H), 3.33 (s, 1H), 2.02–1.88 (m, 1H), 1.75–1.62 (m, 1H), 1.59–1.16 (m, 10H), 0.88 (t, J = 
6.6 Hz, 3H); 13C-NMR (101 MHz, CDCl3): δ = 208.9 (C), 139.9 (C), 138.9 (C), 136.3 (C), 
136.1 (C), 128.1 (CH), 127.9 (C), 127.1 (CH), 125.2 (CH), 124.8 (CH), 123.0 (CH), 122.0 
(CH), 121.0 (CH), 76.4 (CH), 44.3 (CH2), 34.0 (CH2), 31.9 (CH2), 29.5 (CH2), 29.2 (CH2), 24.9 
(CH2), 22.8 (CH2), 14.2 (CH2);
 IR (neat): ν = 3446, 2924, 2854, 1714, 1585, 1443, 1402, 1047, 
749; HR-MS (ES-TOF): m/z: calcd for C22H26O2NaS: 377.1551, found 377.1565 [M + Na]
+. 
2-(Dibenzo[b,d]thiophen-4-yl)-1-phenylethanone (136) 
136 was prepared following GP3 using dibenzothiophene-S-oxide 
(60.0 mg, 0.30 mmol), phenylacetylene (65 µl, 0.60 mmol), toluene 
(0.01 M, 30 mL) and Au-I (16.8 mg, 0.03 mmol, 5 mol%). Column 
chromatography (19:1 hexane:EtOAc), followed by recrystallization 
from hot EtOAc afforded 136 (53 mg, 58%) as a white solid; Rf 0.33 (19:1 hexane:EtOAc); mp: 
127-129 oC; 1H-NMR (300 MHz, CDCl3): δ = 8.19–8.12 (m, 1H), 8.12–8.05 (m, 3H), 7.89–
7.82 (m, 1H), 7.63– 7.54 (m, 1H), 7.52–7.40 (m, 5H), 7.34 (d, J = 6.9 Hz, 1H), 4.55 (s, 2H); 
13C-NMR (101 MHz, CDCl3): δ = 196.4 (C), 139.9 (C), 139.1 (C), 136.7 (C), 136.2 (2C), 133.5 
(CH), 129.5 (C), 128.9 (2CH), 128.7 (2CH), 127.9 (CH), 127.0 (CH), 125.1 (CH), 124.7 (CH), 
123.0 (CH), 122.0 (CH), 120.6 (CH), 44.7 (CH2); IR (neat): ν = 3056, 2924, 2856, 1685, 1580, 
1440, 1206, 908; HR-MS (ES-TOF): m/z: calcd for C20H14ONaS: 325.0663, found 325.0660 




137 was prepared following GP3 using dibenzothiophene-S-oxide 
(40.0 mg, 0.20 mmol), alkyne 126 (50 µL, 0.40 mmol), toluene (20 mL, 
0.01 mmol) and Au-I (11.2 mg, 0.02 mmol, 5 mol%). Column 
chromatography (19:1 hexane:EtOAc) followed by recrystallization 
with EtOH afforded 137 (30.5 mg, 40%) as white needles; Rf  0.20 (19:1 hexane:EtOAc);  mp: 
93-95 oC; 1H-NMR (300 MHz, CDCl3): δ = 8.18–8.12 (m, 1H), 8.09 (dd, J = 7.7, 1.1 Hz, 1H), 
7.89–7.82 (m, 1H), 7.64–7.59 (m, 1H), 7.51–7.42 (m, 3H), 7.41–7.35 (m, 2H), 7.35–7.24 (m, 
2H), 4.53 (s, 2H); 13C-NMR (101 MHz, CDCl3): δ = 200.2 (C), 141.4 (C), 140.2 (C), 139.1 (C), 
136.2 (C), 136.1 (2C), 133.7 (CH), 131.8 (CH), 128.8 (CH), 128.3 (CH), 127.6 (CH), 127.0 
(CH), 125.1 (CH), 124.7 (CH), 123.0 (CH), 122.0 (CH), 120.8 (CH), 118.8(C), 48.7 (CH2); IR 
(neat): ν = 3054, 2940, 1703, 1591, 1441, 1332, 989, 742; HR-MS (ES-TOF): m/z: calcd for 
C20H14OS
79Br: 380.9949, found 380.9948 [M + H]+.  
2-(Dibenzo[b,d]thiophen-4-yl)-1-(4-methoxyphenyl)ethanone (138) 
138 was prepared following GP3 using dibenzothiophene-S-oxide 
(40.0 mg, 0.20 mmol), alkyne 127 (52 µl, 0.40 mmol), toluene (20 
mL) and Au-I (11.2 mg, 0.02 mmol, 5 mol%). Column 
chromatography (19:1 hexane:EtOAc) afforded 138 (28 mg, 42%) 
as a white solid; Rf  0.18 (19:1 hexane:EtOAc); mp: 113-115 
oC; 1H-NMR (300 MHz, CDCl3): 
δ = 8.19–8.12 (m, 1H), 8.11–8.01 (m, 3H), 7.90–7.82 (m, 1H), 7.51–7.39 (m, 3H), 7.34 (d, J = 
7.2 Hz, 1H), 6.98–6.89 (m, 2H), 4.49 (s, 2H), 3.86 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ = 
195.0 (C), 163.8 (C), 139.8 (C), 139.1 (C), 136.3 (C), 136.2 (C), 131.0 (2CH), 129.9 (C), 129.7 
(C), 127.8 (CH), 126.9 (CH), 125.1 (CH), 124.7 (CH), 123.0 (CH), 122.0 (CH), 120.4 (CH), 
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114.0 (2CH), 55.6 (CH3), 44.4 (CH2); IR (neat): ν = 2910, 1717, 1593, 1508, 1400, 1167, 751; 
HR-MS (ES-TOF): m/z: calcd for C21H17O2NS: 333.0949, found 333.0950 [M
 + H]+. 
2-(Dibenzo[b,d]thiophen-4-yl)-1-(thiophen-2-yl)ethanone (139) 
139 was prepared following GP3 using dibenzothiophene-S-oxide (40 
mg, 0.20 mmol), alkyne 128 (44 µl, 0.40 mmol), toluene (20 mL, 0.01 
mmol) and Au-I (11.2 mg, 0.02 mmol, 5 mol%). Purification of the 
reaction mixture with column chromatography (9:1 hexane:EtOAc) 
afforded 139 (38 mg, 62%) as an orange oil; Rf  0.65 (9:1 hexane:EtOAc); 
1H-NMR (300 MHz, 
CDCl3): δ = 8.19–8.11 (m, 1H), 8.09 (dd, J = 7.5, 1.2 Hz, 1H), 7.90–7.82 (m, 2H), 7.65 (dd, J 
= 4.9, 0.7 Hz, 1H), 7.51–7.38 (m, 4H), 7.11 (dd, J = 4.9, 4.0 Hz, 1H), 4.46 (s, 2H); 13C-NMR 
(101 MHz, CDCl3): δ = 189.2 (C), 143.9 (C), 139.9 (C), 138.9 (C), 136.2 (C), 136.2 (C), 134.4 
(CH), 132.9 (CH), 129.2 (C), 128.4 (CH), 127.8 (CH), 127.0 (CH), 125.1 (CH), 124.7 (CH), 
123.0 (CH), 122.0 (CH), 120.7 (CH), 45.5 (CH2); IR (neat): ν = 3092, 3074, 1641, 1410, 1276, 
1057, 750; HR-MS (EI-TOF): m/z: calcd for C18H12OS2: 308.0330, found 308.0329 [M
 + H]+. 
2,8-Dibromodibenzothiophene (140) 
140 was prepared according to the literature procedure.87 To 
dibenzothiophene (2.16 g, 10.8 mmol) in a RBF was added CHCl3 (60 
mL). The mixture was stirred and cooled to 0 oC. Bromine (1.56 mL, 61 mmol) was added over 
15 minutes and the reaction was stirred for 72 hours. The white precipitate formed was filtered 
off under vacuum and washed with ethanol affording 140 (1.60 g, 43%) as a white solid; mp: 
218-221 oC; 1H NMR (300 MHz, CDCl3): δ = 8.24 (m, 2H), 7.71 (m, 2H), 7.57 (m, 2H); Data 
matches that reported in the literature.87 
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2,8-Dibromodibenzo[b,d]thiophene 5-oxide (141) 
141 was prepared according to a modified literature procedure.88 2,8 
dibromodibenzothiophene 140 (3.65 mmol, 1.25 g) was added to a 250 
mL RBF under argon, followed by CH2Cl2 (75 mL). The reaction was 
cooled to 0 oC and mCPBA (630 mg, 3.65 mmol), in CH2Cl2 (75 mL) was added over 25 
minutes. The reaction was allowed to warm to rt and was worked up after 7 hours. The reaction 
mixture was washed with NaHCO3 (3 × 50 mL), extracted with CH2Cl2 (3 × 50 mL), dried over 
Na2SO4, filtered, concentrated and purified by column chromatography (1:1 EtOAc: hexane) to 
afford the title compound as a white solid (170 mg, 13%); mp: >350 oC; 1H NMR (300 MHz, 
CDCl3): δ = 7.94 (d, J = 1.7 Hz, 2H), 7.86 (d, J = 8.1 Hz, 2H), 7.67 (dd, J = 8.1, 1.7 Hz, 2H); 
13C NMR (101 MHz, CDCl3): δ = 144.5, 138.0, 133.3, 129.1, 127.8, 125.7; IR (neat): ν = 3073, 
3047, 3012, 1575, 1557, 1455, 1404, 1382, 1056, 1025, 811. Data matches that reported in the 
literature.88 
1-(2,8-Dibromodibenzo[b,d]thiophen-4-yl)-3-methoxypropan-2-one (142) 
Sulfoxide 141 (71.6 mg, 0.20 mmol) was added to a 50 mL RBF with 
monomethyl propargyl ether (33.8 µl, 0.40 mmol) and CHCl3 (30 mL). 
Au-I (11.2 mg, 0.01 mmol, 5 mol%) was added and the mixture was 
stirred at rt for 17 hours. Purification by column chromatography 
(CH2Cl2) afforded 142 (58 mg, 70%) as a white solid; Rf  0.07 (1:19 EtOAc:Hexane); mp: 139-
141 oC; 1H-NMR (300 MHz, CDCl3): δ = 8.18 (s, 1H), 8.12 (s, 1H), 7.68 (d, J  = 8.5 Hz, 1H), 
7.56 (dd, J  = 8.5 Hz, 1H), 7.46 (s, 1H), 4.12 (s, 2H), 4.00 (s, 2H), 3.45 (s, 3H); 13C-NMR (101 
MHz, CDCl3): δ = 204.1 (C), 139.4 (C), 138.0 (C), 136.6 (C), 136.4 (C), 131.5 (CH), 130.6 
(CH), 130.0 (C), 125.0 (CH), 124.3 (CH), 123.8 (CH), 119.1 (C), 119.0 (C), 77.6 (CH2), 59.6 
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(CH3), 44.8 (CH2); IR (neat): ν = 3067, 2901, 1723, 1567, 1410, 1319, 1072, 1042, 746; HR-
MS (ES-TOF): m/z: calcd for C16H12O2NaS
79Br81Br: 450.8802, found 450.8801 [M + Na]+. 
3-(Prop-2-yn-1-yloxy)prop-1-ene (152) 
Terminal alkyne 152 was prepared according to a literature procedure.90 
Propargyl alcohol (1.75 g, 31.0 mmol, 1.0 eq.) and allyl bromide (3.10 g, 38.8 
mmol, 1.25 eq.) were added to a 25 mL RBF and the mixture was cooled to 0 oC. KOH (4 M) 
(8 mL) was added dropwise over 10 minutes. The mixture was refluxed at 70 oC for 6 hours. 
On cooling the mixture was extracted with Et2O (20 mL), washed with water (3 × 10 mL), dried 
over Na2SO4, filtered and concentrated affording the title compound (2.00 g, 36%, (54% in 
Et2O)) as a colourless oil;
 1H-NMR (300 MHz, CDCl3): δ = 5.91 (ddt, J =17.2, 10.3, 5.8 Hz, 
1H), 5.31 (dd, J = 17.2, 1.4 Hz, 2H), 5.24 (dd, J = 10.3, 1.4 Hz, 2H), 4.16 (d, J  = 2.4 Hz, 2H), 
4.08 (dt, J = 5.8, 1.3 Hz, 2H), 2.43 (t, J = 2.4 Hz, 1H); 13C NMR (101 MHz, CDCl3): δ = 133.9 
(CH), 118.2 (CH2), 79.8 (C), 74.6 (CH), 70.7 (CH2), 57.2 (CH2);
 IR (neat): v = 2920, 1076, 631. 
Data matches that reported in the literature.90 
4-(Prop-2-yn-1-yloxy)but-1-ene (153) 
Terminal alkyne 153 was prepared according to a literature procedure.91 To 
a suspension of KOH in DMSO (25 mL), was added 3-buten-1-ol (1.08 mL, 
12.5 mmol, 1.0 eq.) at 0 oC. After 10 minutes propargyl bromide (1.39 mL, 12.5 mmol, 1.0 eq.) 
was added. The reaction mixture was stirred at rt for 3 hours, diluted with water (50 mL) and 
extracted with Et2O (3 × 30 mL). The organics were washed with water (4 × 20 mL), brine, 
dried Na2SO4, filtered, concentrated under reduced pressure and purified by column 
chromatography (2% Et2O/Petroleum ether) affording 153 (430 mg, 17% (77% in Et2O)) as a 
colourless oil; 1H-NMR (300 MHz, CDCl3): δ = 5.83 (ddt, J = 17.0, 10.2, 6.7 Hz, 1H), 5.12 (dd,  
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J = 17.0, 1.5 Hz),  5.06 (dd,  J = 10.2, 1.5 Hz), 4.16 (d, J = 2.4 Hz, 2H), 3.59 (t, J = 6.7 Hz, 2H), 
2.43 (t, J = 2.4 Hz, 1H), 2.41 – 2.32 (m, 2H); IR (neat): v = 3289, 2923, 1722, 1679, 1434, 
1359, 1047, 918, 789, 637. Data matches that reported in the literature.91 
E)-(3-(prop-2-yn-1-yloxy)prop-1-en-1-yl)benzene (154) 
154 was prepared according to a literature procedure.92 To a 50 mL RBF 
was added propargyl alcohol (2.02 g, 36.0 mmol, 1.2 eq.), acetone (15 
mL) and K2CO3 (4.98 g, 36.0 mmol). Cinnamyl bromide (5.92 g, 30.0 
mmol, 1.0 eq.) was added and the mixture was heated to reflux for 12 hours. The mixture was 
cooled to rt, water was added and the mixture was extracted with EtOAc (3 × 20 mL), dried 
over Na2SO4, filtered and concentrated under reduced pressure. Purification by column 
chromatography (9:1 hexane:EtOAc) yielded the title compound (2.70 g, 49%) as a pale yellow 
oil; Rf  0.83 (7:3 hexane:EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 7.46 – 7.19 (m, 6H), 6.65 
(d, J = 15.9 Hz, 1H), 6.28 (dt, J = 15.9, 6.2 Hz, 1H), 4.25 (dd, J = 6.2, 1.4 Hz, 2H), 4.21 (d, J = 
2.4 Hz, 2H), 2.47 (t, J = 2.4 Hz, 1H); IR (neat): ν = 2852, 2117, 1735, 1495, 1449, 1356, 1242, 
1116, 1073, 966, 743. 691. Data matches that reported in the literature.92 
N-allyl-4-methylbenzenesulfonamide (155) 
155 was prepared according to a literature procedure.93 To a RBF under argon 
containing CH2Cl2 (32 mL) was added p-toluenesulfonyl chloride (2.17 g, 1.40 
mmol, 1.14 eq.) followed by triethylamine (1.56 mL, 11.2 mmol) at 0 oC. Allyl amine (0.75 
mL, 10.0 mmol) was added dropwise and the reaction was stirred ar rt for 21 hours. To the 
reaction mixture was added NH4Cl (60 mL of a saturated solution), the organic layer was 
separated, dried over Na2SO4, filtered, concentrated under reduced pressure and purified by 
column chromatography (9:1 hexane:EtOAc) to afford the title compound (1.95 g, 92%) as a 
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white solid; mp: 61-63 oC; 1H NMR (300 MHz, CDCl3): δ = 7.75 (d, J = 8.2 Hz, 2H), 7.32 (d, 
J = 8.2 Hz, 2H), 5.72 (ddt, J = 17.1, 10.2, 5.8 Hz, 1H), 5.16 (dd, J = 17.1, 1.4 Hz, 1H), 5.10 
(dd, J = 10.2, 1.4 Hz, 1H), 4.38 (t, J = 6.0 Hz, 1H), 3.59 (tt, J = 6.2, 1.4 Hz, 2H), 2.43 (s, 3H); 
IR (neat): ν = 3246, 3046, 2926, 2854, 1649, 1596, 1494, 1423, 1318, 1157, 1092, 936, 811, 
665. Data matches that reported in the literature.93 
N-allyl-4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide (156) 
156 was prepared according to a literature procedure.93 To a flame dried 2 
neck flask containing a stirrer bar was added amine 155 (1.91 g, 9.04 mmol, 
1.00 eq.). Anhydrous DMF (17 mL) was added, followed by the careful portionwise addition 
of NaH (60% in mineral oil) (470 mg, 11.8 mmol, 1.30 eq.). The mixture was stirred at rt for 1 
hour, before the dropwise addition of propargyl bromide (80% in toluene) (1.66 mL, 14.9 mmol, 
1.65 eq.) The reaction was then stirred for a further 80 minutes. The reaction mixture was then 
quenched with water (30 mL) and the product was extracted with diethyl ether (4 × 20 mL). 
The organic layer was dried over Na2SO4, filtered and concentrated under reduced pressure. 
Column chromatography (8:2 hexane:Et2O) provided the title compound as a white solid; Rf  
0.33 (8:2 hexane:Et2O); mp: 61-62 
oC; 1H NMR (300 MHz, CDCl3): δ = 7.76 (d, J = 8.3 Hz, 
2H), 7.32 (d, J = 8.0 Hz, 2H), 5.75 (ddt, J = 16.5, 10.0, 6.5 Hz, 1H), 5.31 (dd, J = 16.5, 1.4 Hz, 
1H), 5.26 (d, J = 10.0, 1.4 Hz, 1H), 4.11 (d, J = 2.4 Hz, 2H), 3.84 (d, J = 6.5 Hz, 2H), 2.45 (s, 
3H), 2.02 (t, J = 2.5 Hz, 1H); IR (neat): ν = 3268, 2907, 2119, 1644, 1599, 1340, 1324, 1157, 




158 was prepared according to GP2 using dibenzothiophene-S-oxide (100 
mg, 0.50 mmol), 3-(prop-2-yn-1-yloxy)prop-1-ene 152 (54% wt% in Et2O 
177 mg, 1.0 mmol), and Au-I (11.2 mg, 0.02 mmol, 2 mol%). The reaction 
mixture was stirred for 2 hours at 0 oC and left to warm to rt for a further 14 
hours. Column chromatography (CH2Cl2) afforded 158 (119 mg, 80%) as a yellow oil; Rf 0.34 
(CH2Cl2); 
1H-NMR (300 MHz, CDCl3): δ = 8.19–8.14 (m, 1H), 8.10 (dd, J = 7.9, 1.0 Hz, 1H), 
7.90–7.83 (m, 1H), 7.52–7.43 (m, 3H), 7.35 (d, J = 7.2 Hz, 1H), 5.89 (ddt, J = 17.2, 10.4, 5.8 
Hz, 1H), 5.27 (dd, J = 17.2, 1.5 Hz, 1H), 5.21 (dd, J = 10.4, 1.5 Hz 1H), 4.18 (s, 2H), 4.06 (s, 
2H), 4.06–4.02 (m, 2H); 13C-NMR (101 MHz, CDCl3): δ = 205.0 (C), 140.0 (C), 139.0 (C), 
136.2 (C), 136.1 (C), 133.8 (CH), 128.3 (C), 128.1 (CH), 127.0 (CH), 125.2 (CH), 124.7 (CH), 
123.0 (CH), 122.0 (CH), 120.8 (CH), 118.3 (CH2), 74.8 (CH2), 72.6 (CH2), 45.6 (CH2); IR 
(neat): ν = 2901, 1726, 1554, 1443, 1402, 1096, 912; HR-MS (ES-TOF): m/z: calcd for 
C18H16O2SNa: 319.0769, found 319.0775 [M + Na]
+.  
N-allyl-N-(3-(dibenzo[b,d]thiophen-4-yl)-2-oxopropyl)-4-methylbenzenesulfonamide (160) 
160 was prepared according to GP2 using dibenzothiophene-S-oxide (40 mg, 
0.20 mmol), N-allyl-4-methyl-N-(prop-2-yn-1-yl)benzenesulfonamide 156 
(96  mg, 0.40 mmol), and Au-I (11.2 mg, 0.02 mmol, 5 mol%). The reaction 
mixture was stirred for 2 hours 30 mins at 0 oC. Column chromatography (9:1 
hexane:EtOAc) followed by recrystallization from hot MeOH afforded 160 (66 mg, 74%) as a 
white solid; Rf  0.31 (9:1 hexane:EtOAc); mp: 104-106 
oC; 1H NMR (300 MHz, CDCl3): δ = 
8.21 – 8.14 (m, 1H), 8.11 (dd, J = 8.1, 0.9 Hz, 1H), 7.91 – 7.82 (m, 1H), 7.65 (d, J = 8.3 Hz, 
2H), 7.53 – 7.43 (m, 3H), 7.32 (d, J = 7.2 Hz, 1H), 7.21 (d, J = 8.1 Hz, 2H), 5.58 (ddt, J = 16.9, 
10.1, 6.8 Hz, 1H), 5.03 (dd, J  = 10.1, 1.1 Hz, 1H), 4.96 (dd, J  = 16.9, 1.1 Hz, 1H), 4.10 (s, 
159 
 
2H), 4.01 (s, 2H), 3.78 (d, J = 6.7 Hz, 2H), 2.36 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ = 
201.9 (C), 143.7 (C), 140.0 (C), 139.0 (C), 136.3 (C), 136.2 (C), 136.0 (C), 132.1 (CH), 129.8 
(2CH), 128.2 (CH), 128.0 (C), 127.6 (2CH), 127.1 (CH), 125.3 (CH), 124.8 (CH), 123.0 (CH), 
122.0 (CH), 120.9 (CH), 120.5 (CH2) 54.4 (CH2), 51.4 (CH2), 46.4 (CH2), 21.6 (CH3); IR (neat): 
ν = 1731, 1443, 1397, 1153, 1045, 924, 752; HR-MS (ES-TOF): m/z: calcd for C25H24NO3S2: 
450.1198, found 450.1180 [M + H]+.  
1-Methoxy-3-(5-oxidodibenzo[b,d]thiophen-4-yl)propan-2-one (166) 
 mCPBA (129 mg, 0.75 mmol, 1.1 equiv.) was added in 5 portions 
over 10 minutes to a solution of 131 (184 mg, 0.68 mmol) in CH2Cl2 
(15 mL) at 0 oC. The reaction was allowed to warm to rt over 2 hours, 
worked up, washed with NaHCO3 (4 × 10 mL), extracted with CH2Cl2  (4 × 10 mL), dried over 
Na2SO4, filtered and concentrated under reduced pressure. Purification by column 
chromatography (8:2 hexane:EtOAc to EtOAc) afforded firstly 131 (37 mg, 20%) and then 166 
(120 mg, 61%) as a white solid; Rf  0.25 (EtOAc); mp: 110-112 
oC ; 1H-NMR (300 MHz, 
CDCl3): δ = 7.95 (d, J  = 7.5 Hz, 1H), 7.79 (d, J = 7.6 Hz, 1H), 7.73 (d, J = 7.2 Hz, 1H), 7.59 
(td, J = 7.6, 1.1 Hz, 1H), 7.56 (t, J  = 7.6 Hz, 1H), 7.49 (td, J = 7.6, 1.1 Hz, 1H), 7.29 (d, J = 
7.6 Hz, 1H), 4.34–4.15 (m, 4H), 3.46 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ = 204.4 (C), 
144.6 (C), 143.9 (C), 137.7 (C), 137.2 (C), 134.9 (C), 133.1 (CH), 132.8 (CH), 131.6 (CH), 
129.7 (CH), 127.5 (CH), 122.2 (CH), 121.1 (CH), 77.6 (CH2), 59.6 (CH3), 42.4 (CH2); IR 
(neat): ν = 3047, 2925, 2827, 1725, 1448, 1049, 1012; HR-MS (ES-TOF): m/z: calcd for 





Sulfoxide 167 (85.9 mg, 0.30 mmol) and monomethyl propargyl 
ether (51 μl, 0.6 mmol) were dissolved in toluene (3 mL). Au-I (16.8 
mg, 0.015 mmol) was added and the reaction was stirred at rt for 16 
hours. The reaction mixture was filtered through a plug of silica and 
washed with CH2Cl2 (10 mL). The reaction mixture was concentrated under reduced pressure 
and purified by column chromatography (1:1 hexane:EtOAc) to afford 167 (60.5 mg, 58%) as 
a yellow crystalline solid; Rf  0.25 (1:1 hexane:EtOAc); mp: 70–72 
oC; 1H-NMR (300 MHz, 
CDCl3): δ = 8.10 (dd, J = 7.9, 0.9 Hz, 2H), 7.48 (appt, J = 7.6 Hz, 2H), 7.35 (d, J = 7.2 Hz, 
2H), 4.13 (s, 4H), 4.05 (s, 4H), 3.42 (s, 6H); 13C-NMR (101 MHz, CDCl3): δ = 204.7 (C), 139.5 
(C), 136.7 (C), 128.3 (CH), 128.2 (C), 125.4 (CH), 121.1 (CH), 77.3 (CH2), 59.5 (CH3), 45.5 
(CH2); IR (neat): ν = 2927, 1721, 1572, 1049, 912, 778, 727; HR-MS (ES-TOF): m/z: calcd for 
C20H20O4NaS: 379.0980, found 379.0999 [M + Na]
+. 
1-(Allyloxy)-3-(5-oxidodibenzo[b,d]thiophen-4-yl)propan-2-one (168) 
mCPBA (72.3 mg, 0.42 mmol, 1.1 equiv) was added 
portionwise to a solution of 158 (113 mg, 0.38 mmol)  in 
CH2Cl2 (10 mL)  at 0 
oC. The reaction was allowed to warm to 
rt over 2 hours, worked up, washed with NaHCO3 (4 × 10 mL), extracted with CH2Cl2 (4 × 10 
mL), dried over Na2SO4, filtered and concentrated under reduced pressure. Purification by 
column chromatography (1:4 EtOAc:hexane) to (EtOAc) afforded firstly 158 (25 mg, 22%) and 
168 (74 mg, 62%) as a white solid; Rf 0.37 (7:3 EtOAc:hexane);  mp: 98-100 
oC; 1H-NMR (300 
MHz, CDCl3): δ = 7.96 (d, J = 7.5 Hz, 1H), 7.80 (d, J = 7.6 Hz, 1H), 7.74 (d, J = 7.5 Hz, 1H), 
7.64–7.53 (m, 2H), 7.50 (td, J = 7.5, 0.9 Hz, 1H), 7.29 (d, J = 7.6 Hz, 1H), 5.94 (ddt, J = 17.2, 
10.5, 5.7 Hz, 1H), 5.32 (dd, J = 17.2, 1.5 Hz, 1H), 5.24 (dd, J = 10.5, 1.2 Hz, 1H), 4.38–4.17 
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(m, 4H), 4.11 (d, J = 5.8 Hz, 2H); 13C-NMR (101 MHz, CDCl3): δ = 204.6 (C), 144.7 (C), 144.0 
(C), 137.7 (C), 137.3 (C), 135.0 (C), 133.9 (CH), 132.7 (CH), 132.7 (CH), 131.7 (CH), 129.7 
(CH), 127.5 (CH), 122.2 (CH), 121.0 (CH), 118.3 (CH2), 75.1 (CH2), 72.7 (CH2), 42.5 (CH2); 
IR (neat): ν = 3050, 2857, 1725, 1551, 1485, 1424, 1321, 1161, 1145, 1070, 1045, 1012, 762; 
HR-MS (ES-TOF): m/z: calcd for C18H17O3S: 313.0898, found 313.0906 [M + H]
+. 
3,3'-(Dibenzo[b,d]thiophene-4,6-diyl)bis(1-(allyloxy)propan-2-one) (169) 
 Sulfoxide 168 (68 mg, 0.22 mmol) and enyne 152 (54 wt% in Et2O, 
78.3 mg, 0.44 mmol) were dissolved in toluene (8.8 mL, 0.025 M). 
After stirring for 20 minutes the reaction mixture was transferred to 
an ice bath at 0 oC. Au-I (12.3 mg, 0.011 mmol, 5 mol%) was added 
and after 3 hours Au-I (6.1 mg, 0.0055 mmol, 2.5 mol%) was added  
and the reaction mixture was stirred for a further 1 hour at 0 oC. The reaction mixture was 
filtered through a plug of silica and washed with CH2Cl2 (10 mL). The reaction mixture was 
concentrated under reduced pressure and purified by column chromatography (4:1 
hexane:EtOAc) providing 169 (65 mg, 73%) as a white solid; Rf 0.58 (1:1 EtOAc: hexane); mp: 
77-80 oC; 1H-NMR (300 MHz, CDCl3): δ = 8.08 (d, J = 7.7 Hz, 2H), 7.47 (appt, J = 7.6 Hz, 
2H), 7.34 (d, J = 7.2 Hz, 2H), 5.90 (ddt, J = 17.2, 10.4, 5.7 Hz, 1H), 5.27 (app d, J = 17.2 Hz, 
1H), 5.21 (app d, J = 10.4 Hz, 1H) 4.17 (s, 4H), 4.11-4.01 (m, 8H); 13C-NMR (101 MHz, 
CDCl3): δ = 204.8 (2C), 139.5 (2C), 136.6 (2C), 133.8 (2CH), 128.3 (2CH), 128.3 (2C), 125.4 
(2CH), 121.0 (2CH), 118.3 (2CH2), 74.8 (CH2), 72.6 (CH2), 45.6 (2CH2); IR (neat): ν = 2855, 
1722, 1574, 1426, 1390, 1331, 1164, 1060, 1045; HR-MS (ES-TOF): m/z: calcd for 






Sulfoxide 168 (60 mg, 0.192 mmol) and ene-yne 153 (77% wt% in 
Et2O, 50 mg, 0.348 mmol) were dissolved in toluene (0.025 M, 10 
mL). After stirring for 20 minutes at rt the reaction was transferred 
to an ice bath at 0 oC and Au-I (7.5 mol%) was added. The reaction 
was stirred for 4 hours filtered through a pad of silica washing with 
CH2Cl2, concentrated and purified by column chromatography (1:4 EtOAc:hexane) to afford 
170 (68 mg, 83%) as an off white solid; Rf 0.81 (1:1 EtOAc:hexane); mp: 57-59 
oC; 1H-NMR 
(300 MHz, CDCl3): δ = 8.02 (dd, J = 7.9, 0.8 Hz, 2H), 7.40 (app t, J = 7.6, 2H), 7.28 (d, J = 7.3 
Hz, 2H), 5.91–5.68 (m, 2H), 5.21 (dd, J = 17.2, 1.6 Hz, 1H), 5.15 (dd, J = 10.2, 1.6 Hz, 1H), 
5.04 (dd, J = 17.2, 1.6 Hz, 1H), 4.97 (dd, J = 10.2, 1.6 Hz, 1H), 4.10 (s, 4H), 4.02–3.96 (m, 
6H), 3.48 (t, J = 6.7 Hz, 2H), 2.37–2.27 (m, 2H); 13C-NMR (101 MHz, CDCl3): δ = 205.1 (C), 
204.9 (C), 139.6 (2C), 136.7 (2C), 134.9 (CH), 133.8 (CH), 128.3 (2CH), 128.2 (2C), 125.4 
(2CH), 121.0 (2CH), 118.3 (CH2), 117.0 (CH2), 75.9 (CH2), 74.8 (CH2), 72.6 (CH2), 71.3 
(CH2), 45.6 (2CH2), 34.2 (CH2); IR (neat): ν = 2860, 1721, 1644, 1575, 1476, 143, 1061, 913, 
776; HR-MS (ES-TOF): m/z: calcd for C25H26O4NaS: 445.1450, found 445.1429 [M + Na]
+. 
Macrocycle 1 (171) 
To a solution of 169 (100 mg, 0.245 mmol) in CH2Cl2 (25 mL) 
was added Grubbs 2nd generation catalyst (10.4 mg, 0.012 mmol). 
The reaction mixture was heated to reflux for 1 hour, allowed to 
cool, concentrated and purified by column chromatography (3:7 
EtOAc:hexane) to afford 171 (80 mg, 86%) as a white solid; Rf 0.58 (1:1 EtOAc:hexane); mp: 
165-167 oC; 1H-NMR (300 MHz, CDCl3): δ = 8.08 (d, J = 7.2 Hz, 2H), 7.48 (app t, J = 7.6 Hz, 
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2H), 7.39 (d, J = 7.0 Hz, 2H), 5.74–5.60 (m, 2H), 4.19 (s, 4H), 4.02 (s, 4H), 3.96 (dd, J = 3.0, 
1.3 Hz, 4H); 13C-NMR (101 MHz, CDCl3): δ = 205.0 (2C), 139.2 (2C), 136.7 (2C), 130.2 
(2CH), 128.1 (2CH), 128.1 (2C), 125.7 (2CH), 121.1 (2CH), 74.3 (2CH2), 71.1 (CH2), 45.6 
(CH2); IR (neat): ν = 2855, 1722, 1574, 1426, 1390, 1331, 1144, 1060, 1045, 919, 776, 731; 
HR-MS (ES-TOF): m/z: calcd for C22H20O4NaS: 403.0980, found 403.0996 [M + Na]
+. 
Macrocycle 2 (172) 
To a solution of 170 (50 mg, 0.118 mmol) in CH2Cl2 (25 mL) was 
added Grubbs 2nd generation catalyst (5.0 mg, 0.006 mmol). The 
reaction mixture was heated to reflux for 2 hours, concentrated and 
purified by column chromatography (7:3 EtOAc:hexane) to afford 
172 (35 mg, 70%) as a white solid; Rf 0.48 (1:1 EtOAc:hexane); mp: 138-139 
oC ; 1H-NMR 
(300 MHz, CDCl3): δ = 8.07 (d, J = 7.8 Hz, 2H), 7.48 (td, J = 7.6, 3.1 Hz, 2H), 7.37 (d, J = 5.1 
Hz, 2H), 6.11–5.95 (m, 1H), 5.69 (dt, J = 15.0, 5.6 Hz, 1H), 4.18 (s, 4H), 4.15-4.05 (m, 6H), 
3.64 (t, J = 5.8 Hz, 2H), 2.42 (dd, J = 11.6, 5.6 Hz, 2H); 13C-NMR (101 MHz, CDCl3): δ = 
206.6 (C), 205.8 (C), 139.2 (C), 139.1 (C), 136.7 (C), 136.6 (C), 132.0 (CH), 128.7 (CH), 128.7 
(CH), 128.4 (C), 127.4 (CH), 125.4 (2CH), 121.0 (CH), 120.9 (CH), 76.3 (CH2), 74.4 (CH2), 
71.7 (CH2), 71.2 (CH2), 44.7 (CH2), 44.2 (CH2), 32.8 (CH2); IR (neat): ν = 2861, 1720, 1644, 
1575, 1426, 1143, 1062, 914, 775; HR-MS (ES-TOF): m/z: calcd for C23H22O4NaS: 417.1137, 
found 417.1136 [M + Na]+. 
4-Methyl-N,N-di(prop-2-yn-1-yl)benzenesulfonamide (173) 
173 was prepared according to a literature procedure.94 A RBF under argon was 
charged with p-toluenesulfonamide (399 mg, 2.33 mmol, 1.0 eq.) and acetone (10 mL). 
Upon dissolving, cesium carbonate (2.28 g, 7.00 mmol, 3.0 eq.) was added. Propargyl bromide 
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(0.92 mL, 7.00 mmol, 3.0 eq.) was added and the mixture was stirred at rt for 16 hours. The 
solvent was removed under reduced pressure, the residual solid was dissolved in water (10 mL) 
and CH2Cl2 (10 mL) was added. The layers were separated and the aqueous layer was extracted 
with CH2Cl2 (10 mL). The combined organic layers were dried over Na2SO4, filtered, 
concentrated under reduced pressure and purified by column chromatography (5:1 petroleum 
ether:EtOAc) to afford the title compound (508 mg, 88%) as a pale yellow solid; Rf 0.18 (5:1 
petroleum ether:EtOAc); mp: 57-59 oC; 1H NMR (300 MHz, CDCl3): δ = 7.72 (d, J = 8.1 Hz, 
2H), 7.30 (d, J = 8.1 Hz, 2H), 4.16 (d, J = 2.2 Hz, 4H), 2.43 (s, 3H), 2.15 (t, J = 2.2 Hz, 2H); 
13C NMR (101 MHz, CDCl3): δ = 144.1 (C), 135.3 (C), 129.7 (2CH), 128.0 (2CH), 76.3 (2C), 
74.2 (2CH), 36.3 (CH2), 21.7 (CH3); IR (neat): ν = 3278, 3065, 1699, 1410, 1341, 1305, 1093, 
957, 751. Data matches that reported in the literature.94 
Diethyl 2,2-di(prop-2-yn-1-yl)malonate (174) 
174 was prepared according to a literature procedure.94 A RBF 
containing dry Et2O (10 mL) in ice was charged with NaH (304 mg, 
9.08 mmol, 2.0 eq.) in small portions. Diethyl malonate (727 mg, 4.54 
mmol, 1.0 eq.) was added dropwise. Propargyl bromide (1.18 g, 9.08 mmol, 2.0 eq.) was added 
dropwise and the reaction mixture was stirred for 16 hours at rt. Water (20 mL) was added 
slowly, the organic layer was separated, the aqueous layer was washed with EtOAc (15 mL × 
3), dried over Na2SO4, evaporated under reduced pressure and purified by column 
chromatography (5:1 petroleum ether:EtOAc) to afford the title compound (538 mg, 50%) as a 
white solid; 1H NMR (300 MHz, CDCl3): δ = 4.23 (q, J = 7.1 Hz, 2H), 2.99 (d, J = 2.6 Hz, 2H), 
2.03 (t, J = 2.6 Hz, 1H), 1.26 (t, J = 7.1 Hz, 3H); IR (neat): ν = 3289, 2984, 1734, 1447, 1368, 






178 was prepared according to GP2 using dibenzothiophene-S-
oxide (40 mg, 0.20 mmol), diyne 174 (48.6 mg, 0.40 mmol), 
toluene (2 mL) and Au-I (11.2 mg, 5 mol%). The reaction was 
stirred for 2 hours at 0 oC before allowing to warm to rt for 16 hours. 
Column chromatography (3:7 hexane:CH2Cl2 to CH2Cl2) afforded 178 (49 mg, 57%) as a clear 
oil; Rf 0.48 (3:7 EtOAc:hexane); 
1H NMR (300 MHz, CDCl3): δ = 8.13 (ddd, J  = 12.9, 5.7, 2.4 
Hz, 2H), 7.83 – 7.75 (m, 1H), 7.55–7.37 (m, 3H), 7.11 (dd, J  = 7.2, 1.0 Hz, 1H), 4.44–4.21 (m, 
4H), 3.32-2.94 (m, 2H), 1.85 (s, 3H), 1.32 (t, J = 7.1 Hz, 3H), 1.31 (t, J  = 7.1 Hz, 3H); 13C 
NMR (101 MHz, CDCl3): δ = 192.4 (C), 169.9 (C), 156.3 (C), 140.1 (C), 139.4 (C), 136.1 (C), 
135.8 (C), 128.2 (CH), 126.8 (CH), 124.7 (CH), 124.5 (CH), 122.8 (CH), 121.8 (CH), 121.0 
(CH), 62.6 (CH2), 62.4 (CH2), 55.0 (C), 42.6 (CH2), 37.5 (CH2), 22.7 (CH3), 14.2 (2CH3); IR 
(neat): ν = 2982, 1729, 1673, 1302, 1250, 1167, 752; HR-MS (ES-TOF): m/z: calcd for 
C25H24O5
23NaS: 459.1242, found 459.1229 [M + Na]+. 
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Diethyl 2-(3-(dibenzo[b,d]thiophen-4-yl)-2-oxopropyl)-2-(2-oxopropyl)malonate (177) 
177 (15 mg, 17%) eluted second (CH2Cl2 ) in the above reaction as 
a clear oil; Rf 0.42 (3:7 EtOAc:hexane); 
1H NMR (300 MHz, 
CDCl3): δ = 8.18–8.12 (m, 1H), 8.09 (dd, J = 7.9, 0.9 Hz, 1H), 
7.87–7.81 (m, 1H), 7.50–7.42 (m, 3H), 7.31 (d, J = 7.0 Hz, 1H), 
4.13 (q, J = 7.1 Hz, 2H), 4.12 (q, J = 7.1 Hz, 2H), 3.97 (s, 2H), 3.50 (s, 2H), 3.31 (s, 2H), 1.99 
(s, 3H), 1.17 (t, J = 7.0 Hz, 6H); 13C NMR (101 MHz, CDCl3): δ = 206.0 (C), 204.6 (C), 169.5 
(2C), 139.9 (C), 139.1 (C), 136.3 (C), 136.0 (C), 128.4 (CH), 128.2 (C), 127.1 (CH), 125.3 
(CH), 124.8 (C), 122.9 (C), 122.0 (CH), 120.8 (CH), 62.1 (2CH2), 53.2 (C), 49.4 (CH2), 45.8 
(CH2), 44.9 (CH2), 30.2 (CH3), 14.0 (2CH3); IR (neat): ν = 2982, 2930, 1719, 1444, 1403, 1364, 
1201, 1096, 754; HR-MS (ES-TOF): m/z: calcd for C25H26O6SNa: 477.1348, found 477.1339 
[M + Na]+.  
3-(Dibenzo[b,d]thiophen-4-yl)-2-phenyl-1H-indole (179) 
To substituted dibenzothiophene 136 (55 mg, 0.183 mmol, 1.0 eq.) was 
added AcOH (0.80 ml), TFA (0.28 ml) and phenylhydrazine (45 µL, 
0.46 mmol, 2.5 eq.) in a sealed (ace) tube. The reaction was stirred at 
100 oC for 28 hours at which point reaction completion was observed 
by TLC. The mixture was added to 10 mL ice/water, the mixture was extracted with with 
CH2Cl2 (10 mL × 3) and the organic portions were washed with HCl (1M, 5 mL), water (5 mL), 
dried over Na2SO4, concentrated and purified by column chromatography (1:9 EtOAc:hexane) 
to afford 179 (45.6 mg, 66%) as a viscous orange oil; Rf 0.31 (1:9 EtOAc:hexane); 
1H-NMR 
(300 MHz, CDCl3): δ = 8.46 (s, 1H), 8.21 (ddd, J  = 7.6, 5.6, 1.4 Hz, 2H), 7.77–7.70 (m, 1H), 
7.59–7.48 (m, 3H), 7.48–7.41 (m, 3H), 7.40–7.34 (m, 2H), 7.33–7.20 (m, 4H), 7.13 (td, J = 7.6, 
0.9 Hz, 1H); 13C-NMR (101 MHz, CDCl3): δ = 141.4 (C), 140.1 (C), 136.1 (C), 136.0 (2C), 
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134.8 (C), 132.5 (C), 130.5 (C), 129.3 (CH), 128.9 (2CH), 128.8 (C), 127.9 (CH), 127.3 (2CH), 
126.7 (CH), 125.0 (CH), 124.3 (CH), 123.0 (CH), 122.9 (CH), 121.8 (CH), 120.4 (CH), 120.4 
(CH), 120.3 (CH), 113.5 (C), 111.1 (CH); IR (neat): ν = 3408, 3057, 1578, 1487, 1442, 1384, 
1253, 905, 742, 693; HR-MS (ES-TOF): m/z: calcd for C26H18NS: 376.1160, found 376.1170 




5.3 Experimental section:Chapter 3  
Naphtho [1,8-cd][1,2]dithiole (205) 
Disulfide 205 was prepared according to the literature procedure.83 A 500 mL 3 
neck RBF was fitted with a reflux condenser, a thermometer and a septa. The flask 
was purged with argon, n-BuLi in hexanes (73.6 mL, 120 mmol, 1.2 eq.) was added and was 
diluted with dry Et2O (80 mL). The mixture was cooled to 0 
oC and 1-bromo naphthalene (20.0 
g, 100 mmol, 1.0 eq.) was added over 20 min preventing the temperature from rising above 10 
oC. After stirring for an additional 15 min the reaction was cooled to -10 oC and stirring was 
stopped. On standing for 10 min the supernatant was removed by cannula. Hexane (250 mL) 
was added and stirring continued at -20 oC for 10 min. On standing for a further 10 min the 
supernatant was removed by cannula. This was repeated twice.  
n-BuLi in hexanes (79.8 mL, 130 mmol, 1.3 eq.) followed by TMEDA (16.3 g, 140 mmol, 1.4 
eq.) was added to the suspension. The mixture was heated at reflux for 3 h and left to cool to 
room temperature. The reaction was cooled to -78 oC and THF (80 mL) was added to dissolve 
the solid. The mixture was stirred for 20 minutes at -78 oC before addition of sulfur (202 mmol 
6.54 g, 2.02 eq.) and the reaction mixture was stirred for 16 hours. The reaction was quenched 
with HCl (30 mL of a 1 M solution) followed by filtration through a pad of celite. The organic 
phase was separated and the aqueous phase acidified to pH 1. The aqueous layer was then 
extracted with diethyl ether (3 × 30 mL). The organic fractions were combined, dried over 
MgSO4 and the solvent was concentrated under reduced pressure giving a red-brown oil. The 
product was purified by column chromatography (petroleum ether), and recrystallised in EtOH 
to give 205 (4.00 g, 21.0%) as bright red crystals; Rf 0.65 (petroleum  ether): mp: 108-110 
oC; 
1H NMR (300 MHz, CDCl3): δ = 7.36 (d,  J = 8.1, 0.7 Hz, 2H), 7.27 (t, J = 7.3 Hz, 2H), 7.15 
(dd, J = 7.3, 0.7 Hz, 2H); 13C NMR (100 MHz, CDCl3): δ = 144.0 (2C), 135.6 (C), 134.7 (C), 
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127.8 (2CH), 121.6 (2CH), 115.9 (2CH); m/z  (EI) 190 (M+, 100). Data matches that reported 
in the literature.83,177 
Naphtho [1,8-cd][1,2]dithiole-1-oxide (212) 
Disulfide monoxide 212 was prepared according to the literature procedure.83 A 
solution of mCPBA (998 mg, 5.78 mmol) dissolved in CH2Cl2 (42 mL) was added 
dropwise over 30 minutes to a stirred solution of 205 (1.00 g, 5.26 mmol) in CH2Cl2 
(21 mL) at 0 
oC. The reaction mixture was allowed to warm to rt over 2 h. The mixture was 
quenched with NaHCO3 (5 mL of a saturated aqueous solution) and extracted with CH2Cl2 (4 
× 10 mL). The organics were combined, dried over MgSO4, concentrated under reduced 
pressure, purified by column chromatography (6:4 hexane:Et2O) and  recrystallised (ethanol) 
to give 212 (850 mg, 79%); Rf 0.25 (6:4 hexanes:EtOAc); mp: 84-86 
oC (ethanol); 1H NMR 
(300 MHz, CDCl3): δ = 8.21 (dd, J = 7.3, 0.9 Hz, 1H), 8.16 (d, J = 8.1, 0.9 Hz, 1H), 7.82 (app 
t, J = 8.1 Hz, 1H), 7.84 (dd, J = 8.1, 0.9 Hz, 1H), 7.67 (t, J = 7.6 Hz, 1H), 7.61 (dd, J = 8.1, 0.9 
Hz, 1H); m/z (EI) 190 [M - O]+(100), 192 (9), 114 (8). Data matches that reported in the 
literature.178,179 
3,8-Di-tert-butylnaphtho[1,8-c,d][1,2]dithole (224)  
Disulfide 224 was prepared according to the literature procedure.83 t-
BuBr (2.89 g, 21.0 mmol) was added to a solution of 205 (2.00 g, 10.50 
mmol) in CH2Cl2 (4 mL). FeCl3 (341 mg, 2.102 mmol. 0.2 eq.) was added and the reaction 
mixture was heated at reflux for 16 hours. The reaction mixture was allowed to cool to rt and 
filtered through a silica plug (petroleum ether). The solution was concentrated under reduced 
pressure and recrystallized from hot acetone yielding 224 (2.32 g, 73%) as orange crystals; Rf 
0.96 (95:5 petroleum ether:Et2O); mp: 153-155 
oC (acetone);  1H NMR (300 MHz, CDCl3): δ 
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= 7.40 (d, J = 8.6 Hz, 2H), 7.35 (d, J = 8.6 Hz, 2H), 1.50 (s, 18H); 13C NMR (100 MHz, CDCl3): 
δ = 139.4 (2C), 138.9 (2C), 133.1 (2C), 125.7 (2CH), 121.9 (2CH), 35.6 (2C), 28.4 (2CH3); m/z 
(EI) 287  [M - CH3]
+ (100), 288 (18), 289 (10), 302 (70), 303 (13). Data matches that reported 
in the literature.180 
3,8-Di-tert-butylnaphtho[1,8-c,d][1,2]dithole 1-oxide (213) 
Disulfide monoxide 213 was prepared according to the literature 
procedure.83 224 (230 mg, 0.761 mmol) in CH2Cl2 (8 mL) was cooled 
to 0oC. mCPBA (144 mg, 0.836 mmol) in CH2Cl2 (16 mL) was added 
by syringe over 20 min. The reaction was left to warm to rt and stirred for 16 hours. The reaction 
mixture was washed with NaOH (3 × 5 mL of a 0.1 M aqueous solution) and extracted with 
CH2Cl2 (3 × 5 mL), dried MgSO4, filtered, concentrated under reduced pressure and purified by 
column chromatography (9:1 hexanes:EtOAc) giving 213 (171 mg, 71%) as a light yellow 
solid. Rf  0.32 (9:1 hexanes:EtOAc); mp: 153-155 
oC; 1H NMR (300MHz, CDCl3): δ = 8.03 (d, 
J = 8.7 Hz, 1H), 7.83 (d, J = 8.7 Hz, 1H), 7.76 (app q, J = 8.7 Hz, 2H), 1.75 (s, 9H,), 1.59 (s, 
9H); 13C NMR (100 MHz, CDCl3): δ = 151.7 (C), 146.2 (C), 145.5 (C), 131.7 (CH), 131.5 (C), 
131.3 (C), 131.0 (C), 127.1 (CH), 126.8 (CH), 125.4 (CH), 38.2 (C), 36.4 (C), 33.3 (CH3), 30.5 
(CH)3;  m/z (ES)
 341 (M + Na)+ (100), 319.1 (8), 357.1 (14), 373.2 (13), 425.2 (6). Data matches 
that reported in the literature.83 
3,8-Di-tert-butylnaphtho[1,8-c,d][1,2]dithole 1,2-dioxide (214) 
Vic-disulfoxide 214 was prepared according to the literature 
procedure.83 224 (500 mg, 1.65 mmol) in CH2Cl2 (15 mL) was cooled 
0 oC. mCPBA (598 mg, 3.47 mmol) in CH2Cl2 (70 mL) was added by 
syringe over 20 minutes, the reaction was left to warm to rt and stirred for 16 hours. The reaction 
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mixture was washed with NaOH (3 × 10 mL of a 0.1 M aqueous solution) and extracted with 
CH2Cl2 (3 × 10 mL), dried over MgSO4, filtered, concentrated under reduced pressure and 
purified by column chromatography (8:2 hexanes:EtOAc) to give 214 (353 mg, 64%) as a 
yellow solid; Rf 0.29 (8:2 hexanes:EtOAc); mp: 172-174 
oC; 1H NMR (300 MHz, CDCl3): δ = 
8.06 (d, J = 8.7 Hz, 2H), 7.85 (d, J = 8.7 Hz, 2H), 1.71 (s, 18H); 13C NMR (100 MHz, CDCl3): 
δ = 155.2 (2C), 139.5 (2C), 138.8 (C), 132.7 (C), 132.3 (2CH), 127.4 (2CH), 38.0 (2C), 33.2 
(2CH3); m/z (ES) 357 [M + Na]
+ (100), 389 (25), 358 (18), 355 (7), 341 (7). Data matches that 
reported in the literature.83 
S-tert-butyl 2-methylpropane-2-sulfinothioate (215) 
Monoxide 215 was prepared according to the literature procedure.83 To a RBF 
was added di-tert butyl disulfide (966 µL, 5.0 mmol, 1.0 eq.) and CH2Cl2 (20 
mL). mCPBA (949 mg, 5.5 mmol, 1.1 eq.) in CH2Cl2 (30 mL) was added by syringe over 20 
minutes and the reaction was left to warm to rt and stirred for 3 hours. The reaction mixture 
was washed with NaOH (3 × 10 mL of a 0.1 M aqueous solution) and extracted with CH2Cl2 (3 
× 10 mL), dried over MgSO4, filtered, concentrated under reduced pressure and purified by 
column chromatography (5:1 hexanes:EtOAc) to give 215 (567 mg, 58%) as a colourless oil; 
Rf 0.48 (8:2 hexanes:EtOAc); 
1H  NMR (300 MHz, CDCl3): δ = 1.55 (s, 9H), 1.38 (s, 9H); 
13C 
NMR (101 MHz, CDCl3): δ = 59.5 (C), 48.8 (C), 32.5 (3CH3), 24.4 (3CH3); IR (neat): ν = 2962, 
2925, 2900, 2866, 1471, 1456, 1393, 1365, 1163, 1070. Data matches that reported in the 
literature.181 
2-(2,2-Dibromovinyl)furan (229) 
Prepared using GP1, with furfural (331 µl, 4.00 mmol), CBr4 (2.63 g, 8.00 mmol), 
and PPh3 (4.63g, 16.0 mmol) in dry CH2Cl2 (12 mL). The reaction time was 1 hour. 
Aqueous work-up and purification by column chromatography (hexane), yielded 
172 
 
dibromoalkene 229 (750 mg, 64%); 1H NMR (300 MHz, CDCl3): δ = 7.44 (dd, J = 1.7, 0.5 Hz, 
1H), 7.40 (s, 1H), 6.95 (d, J = 3.4 Hz, 1H), 6.46 (dd, J = 3.4, 1.7 Hz, 1H); 13C NMR (101 MHz, 
CDCl3): δ = 150.1 (C), 142.7 (CH), 126.6 (CH), 111.7 (CH), 111.6 (CH), 87.2 (C); IR (neat): ν 
= 3147, 3031, 1705, 1561, 1481, 1142, 1019, 834, 737. Data matches that reported in the 
literature.182 
Ethyl 3-(furan-2-yl)propiolate (230) 
230 was prepared according to a literature procedure.109 Dibromoolefin 
229 (470 mg, 1.74 mmol) was added to a flame dried RBF. THF (10 mL) 
was added and the mixture was cooled to -78 oC. n-BuLi (2.19 mL, 3.48 mmol, 2.0 eq.) was 
added dropwise and the reaction was stirred at -78 oC for 1 hour. Ethyl chloroformate (239 µL, 
2.61 mmol, 1.5 eq.) was dropwise and the mixture was stirred for a further hour. The mixture 
was quenched with NH4Cl (20 mL), the organic layer separeated and the aqueous layer washed 
with Et2O (3 × 10 mL), the combined organics washed with brine (10 mL), dried over Na2SO4, 
filtered, concentrated under reduced pressure and purified by column chromatohgraphy (95:5 
hexane:EtOAc) to afford the title compound (126 mg, 44%) as a colourless oil. 
Rf 0.33 (9:1 hexane:EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 7.51 (m, 1H), 6.93 (d, = 3.5 Hz, 
1H), 6.47 (dd, J = 3.5 Hz, J = 1.8 Hz, 1H), 4.30 (q, J = 7.1 Hz, 2H), 1.35 (t, J = 7.1 Hz, 3H); IR 
(neat): ν =3135, 3106, 2996, 2970, 2210. 1702, 1475, 1281, 1200, 1024, 767, 740; Data matches 
that reported in the literature.109 
Naphtho[1,8-de][1,3]dithiin-2-yl(phenyl)methanone (227) 
To a Radleys tube under argon was added sulfur oxide 212 (82.4 mg, 0.40 
mmol), phenylacetylene (87.0 µl, 0.80 mmol) and toluene 3.2 ml. The 
mixture was heated to 50 oC and after 20 minutes XPhosAuCl (7.0 mg, 2.5 
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mol%) was added followed by AgSbF6 (3.4 mg, 2.5 mol%). Toluene (0.8 ml) was added and 
the reaction was kept at this temperature for 20 hours before being filtered through a plug of 
silica, concentrated and purified by column chromatography (3:7 hexane:CH2Cl2) to afford 212 
(56.0 mg, 46%) as a pale yellow solid; Rf 0.42 (1:9 hexane:EtOAc); mp: 126-127 
oC (EtOH); 
1H NMR (400 MHz, CDCl3): δ = 8.02 (d, J = 7.8 Hz, 2H), 7.73 (d, J = 8.2 Hz, 2H), 7.62 (app 
t, J = 7.5 Hz, 1H), 7.50 (app t, J = 7.5 Hz, 4H), 7.40 (t, J = 7.8 Hz, 2H), 5.83 (s, 1H); 13C NMR 
(101 MHz, CDCl3): δ = 190.0 (C), 134.6 (C), 134.0 (C), 133.9 (CH), 129.1 (2CH), 128.8 (2CH), 
128.2 (2CH), 127.9 (2C), 126.6 (2CH), 125.6 (2CH), 125.5 (C), 44.7 (CH); IR (neat): ν =  2922, 
2853, 1689, 1593, 1578, 1551, 1447, 1262, 1209, 1193, 986, 812, 759, 728, 681, 654; HR-MS 
(ES-TOF): m/z: calcd for C18H12ONaS2: 331.0227, found 331.0230 [M + Na]
+.  
2-(Naphtho[1,8-cd][1,2]dithiol-3-yl)-1-phenylethan-1-one (228) 
228 was also isolated from the reaction above eluting second with 
(3:7 hexane:CH2Cl2) providing (11.0 mg, 9%) as a red solid; Rf  0.53 
(4:6 hexanes:CH2Cl2); mp: 87-89 
oC; 1H NMR (300 MHz, CDCl3): δ = 8.09 – 8.03 (m, 2H), 
7.65 – 7.57 (m, 1H), 7.55 – 7.47 (m, 2H), 7.41 – 7.36 (m, 2H), 7.29 (t, J = 7.7 Hz, 1H), 7.24 – 
7.17 (m, 2H), 4.26 (s, 2H); 13C NMR (101 MHz, CDCl3): δ = 195.5 (C), 144.0 (C), 143.7 (C), 
136.5 (C), 135.0 (C), 134.9 (C), 133.7 (CH), 129.9 (CH), 128.9 (2CH), 128.7 (2CH), 127.6 
(CH), 123.3 (C), 122.8 (CH), 121.7 (CH), 116.4 (CH), 44.5 (CH); IR (neat): ν = 3039, 2926, 
1679, 1544, 1447, 1320, 1205, 986, 806, 747,683, 667; HR-MS (ES-TOF): m/z: calcd for 





225 was prepared according to GP4 using 212 (61.8 mg, 0.30 mmol), hex-
1-yne (68.9 µl, 0.60 mmol), Au-I (11.2 mg, 5 mol%) and toluene (3.0 ml). 
The reaction time was 18 hours. Purification by column chromatography 
(6:4 hexane:CH2Cl2) afforded 225 (30.0 mg, 36%) as a colourless oil; Rf  0.25 (6:4 
hexane:CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ = 7.69 (dd, J = 8.2, 1.2 Hz, 2H), 7.49 (dd, J = 
7.3, 1.2 Hz, 2H), 7.42 – 7.35 (m, 2H), 4.87 (s, 1H), 2.66 (t, J = 7.2 Hz, 2H), 1.59 – 1.49 (m, 
2H), 1.31 – 1.18 (m, 2H), 0.83 (t, J = 7.3 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 200.6 (C), 
134.7 (C), 128.3 (2CH), 127.3 (2C), 126.6 (2CH), 125.8 (2CH), 125.6 (C), 47.9 (CH), 39.3 
(CH2), 26.1 (CH2), 22.2 (CH2), 13.9 (CH3); IR (neat): ν = 3054, 2955, 2929, 2870, 1713, 1554, 
1209, 1039, 900, 812, 757; HR-MS (ES-TOF): m/z: calcd for C12H16OS2: 288.0659, found 
288.0668 [M + H]+.  
1-(Naphtho[1,8-cd][1,2]dithiol-3-yl)hexan-2-one (226) 
226 was also isolated from the reaction above eluting second with 
(6:4 hexane:CH2Cl2) to afford the title compound (28.4 mg, 33%) 
as a colourless oil; Rf  0.21 (6:4 hexane:CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 7.37 (dd, J 
= 8.1, 3.9 Hz, 2H), 7.27 (t, J = 7.7 Hz, 1H), 7.19 – 7.15 (m, 1H), 7.14 (d, J = 8.3 Hz, 1H), 3.64 
(s, 2H), 2.49 (t, J = 7.4 Hz, 2H), 1.62 – 1.53 (m, 2H), 1.34 – 1.23 (m, 2H), 0.87 (t, J = 7.3 Hz, 
3H); 13C NMR (101 MHz, CDCl3): δ = 206.7 (C), 144.0 (C), 143.7 (C), 135.0 (C), 134.9 (C), 
130.1 (CH), 127.6 (CH), 123.0 (C), 122.9 (CH), 121.7 (CH), 116.4 (CH), 49.1 (CH2), 42.2 
(CH2), 23.0 (CH2), 22.4 (CH2), 14.0 (CH3); IR (neat): ν = 2956, 2927, 2871, 1708, 1607, 1543, 
1493, 1331, 1048, 810, 751; HR-MS (ES-TOF): m/z: calcd for C12H16OS2: 288.0643 found 




 249 was prepared according to GP4 using 212 (41.2 mg, 0.20 mmol), 3,3-
dimethyl-1-butyne (49.2 µl, 0.40 mmol), Au-I (11.2 mg, 5 mol%) and toluene 
(2.0 ml). The reaction time was 23 hours. Purification by column 
chromatography (2:1 hexane:CH2Cl2) afforded 249 (26.3 mg, 46%) as a colourless oil; Rf  0.51 
(6:4 hexane:CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ = 7.71 (dd, J = 8.2, 1.2 Hz, 2H), 7.48 (dd, 
J = 7.3, 1.2 Hz, 2H), 7.43 – 7.34 (m, 2H), 5.23 (s, 1H), 1.29 (s, 9H); 13C NMR (101 MHz, 
CDCl3): δ = 205.7 (C), 134.5 (C), 128.3 (2CH), 127.7 (2C), 126.7 (2CH), 125.7 (2CH), 125.4 
(C), 45.0 (C), 41.2 (CH), 27.1 (3CH3); IR (neat): ν = 3054, 2966, 2868, 1704, 1554, 1475, 1365, 
1209, 1053, 995, 813, 757; HR-MS (ES-TOF): m/z: calcd for C16H16ONaS2: 311.0540 found 
311.0539 [M + Na]+.  
3,3-Dimethyl-1-(naphtho[1,8-cd][1,2]dithiol-3-yl)butan-2-one (250) 
250 was also isolated from the reaction above eluting second with (2:1 
hexane:CH2Cl2) affording the title compound (14.8 mg, 26%) as an 
orange solid; Rf  0.46 (6:4 hexane:CH2Cl2);
 mp 73-74 oC; 1H NMR (300 
MHz, CDCl3): δ = 7.36 (dd, J = 8.1, 1.2 Hz, 2H), 7.26 (t, J = 7.7 Hz, 1H), 7.18 – 7.08 (m, 2H), 
3.79 (s, 2H), 1.26 (s, 9H); 13C NMR (101 MHz, CDCl3): δ = 211.5 (C), 143.9 (C), 143.4 (C), 
134.9 (C), 134.8 (C), 130.4 (CH), 127.4 (CH), 123.9 (C), 122.5 (CH), 121.7 (CH), 116.2 (CH), 
44.8 (C), 42.4 (CH2), 26.6 (3CH3); IR (neat): ν = 2964, 2930, 2868, 1708, 1544, 1315, 1209, 
1060, 1002, 902, 750; HR-MS (ES-TOF): m/z: calcd for C16H16ONaS2: 311.0540 found 




241 was prepared according to GP4 using 212 (41.2 mg, 0.20 mmol), 
cyclopropylacetylene (33.9 µl, 0.40 mmol), Au-I (11.2 mg, 5 mol%) and 
toluene (2.0 ml). The reaction time was 23 hours. Purification by column 
chromatography (6:4 hexane:CH2Cl2) afforded 241 (20.8 mg, 38%) as a pale orange oil; Rf  0.24 
(6:4 hexane:CH2Cl2): 
1H NMR (300 MHz, CDCl3): δ = 7.69 (dd, J = 8.2, 1.1 Hz, 2H), 7.51 (dd, 
J = 7.3, 1.1 Hz, 2H), 7.43 – 7.34 (m, 2H), 5.10 (s, 1H), 2.21 (tt, J = 7.8, 4.6 Hz, 1H), 1.09 – 
1.00 (m, 2H,), 0.98 – 0.90 (m, 2H); 13C NMR (101 MHz, CDCl3): δ = 200.8 (C), 134.8 (C), 
128.2 (2CH), 127.7 (2C), 126.6 (2CH), 125.8 (2CH), 125.7 (C), 49.3 (CH), 19.0 (CH), 12.4 
(2CH2); IR (neat): ν = 3054, 2926, 1698, 1554, 1496, 1375, 1209, 1193, 1059, 903, 812, 757, 
727; HR-MS (ES-TOF): m/z: calcd for C15H12ONaS2: 295.0227 found 295.0232 [M + Na]
+.  
1-Cyclopropyl-2-(naphtho[1,8-cd][1,2]dithiol-3-yl)ethan-1-one (242) 
242 was also isolated from the above reaction eluting second with (6:4 
hexane:CH2Cl2) affording the title compound (11.1 mg, 20%) as a red 
solid; Rf  0.19 (6:4 hexane:CH2Cl2); mp: 83-85 
oC; 1H NMR (300 MHz, CDCl3): δ = 7.43 – 7.33 
(m, 2H), 7.28 (app t, J = 7.7 Hz, 1H), 7.17 (d, J = 8.2 Hz, 2H), 3.79 (s, 2H), 2.01 (tt, J = 7.8, 
4.5 Hz, 1H), 1.12 – 1.05 (m, 2H), 0.88 (dq, J = 11.1, 3.6 Hz, 2H); 13C NMR (101 MHz, CDCl3): 
δ = 206.3 (C), 144.1 (C), 143.9 (C), 135.0 (C), 134.9 (C), 130.1 (CH), 127.6 (CH), 123.1 (C), 
122.9 (CH), 121.7 (CH), 116.5 (CH), 49.7 (CH2), 20.4 (CH), 11.8 (2CH2); IR (neat): ν = 3050, 
3006, 2924, 1691, 1543, 1492, 1378, 1207, 1067, 900, 813, 750, 671; HR-MS (ES-TOF): m/z: 





252 was prepared according to an adapted literature procedure.110 To 
fluorene 251 (4.00 g, 24.4 mmol) in a RBF under argon was added 
anhydrous THF (160 mL). Potassium tert-butoxide (10.8 g, 96.0 mmol) 
was added in one portion. 1-Butyl iodide (8.19 mL, 72.0 mmol) was added over 10 mins and 
the reaction was stirred at rt for 16 hours. NH4Cl was added and the organic layer was separated. 
The aqueous layer was extracted CH2Cl2 (3 × 30 mL). The combined organics were washed 
with brine (30 mL), dried over Na2SO4, filtered and purified by column chromatography 
(hexane) to give the title compound (5.83 g, 86%) as a white solid; mp: 48–50 oC; 1H NMR 
(300 MHz, CDCl3): δ = 7.74 – 7.68 (m, 1H), 7.39 – 7.27 (m, 3H), 1.97 (dd, J = 10.1, 6.6 Hz, 
2H), 1.19 – 0.99 (m, 2H), 0.67 (t, J = 7.3 Hz, 3H), 0.64 – 0.52 (m, 2H); IR (neat): ν = 3065, 
2957, 2927, 2856, 1447, 771, 734. Data matches that reported in the literature.111 
9,9-dibutyl-9H-fluoreno[4,5-cde][1,2]dithiine (253) 
Disulfide 253 was prepared according to the literature procedure.110,111 A 
250 mL flask was equipped with a reflux condenser and flame dried. 252 
(3.90 g, 14.0 mmol, 1.0 eq.) was added followed by n-BuLi (1.6 M in 
hexanes) (35 mL, 56 mmol, 4.0 eq.) and TMEDA (9.1 mL, 56 mmol, 4.0 eq.) The reaction was 
then heated to 60 oC and stirred at this temperature for 3 hours. The mixture was cooled to -78 
oC and diluted with THF (80 mL). S8 (3.61 g, 1.75 mmol, 1.0 eq.) was added and the mixture 
was allowed to warm to rt over 16 hours. The reaction was quenched with water (20 mL) and 
NaOH (20 mL of a 5% solution). The aqueous layer was extracted with Et2O (3 × 100 mL), the 
combined organic layers washed with brine (100 mL), dried over Na2SO4, filtered and 
concentrated under reduced pressure. Purification by column chromatography (hexane) 
afforded the title compound 253 (2.10 g, 41%) as a light orange solid; mp: 76-77 oC; 1H NMR 
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(300 MHz, CDCl3): δ = 7.21 (t, J = 7.5 Hz, 3H), 7.12 (dd, J = 7.5, 0.8 Hz, 2H), 7.05 (dd, J = 
7.6, 0.8 Hz, 2H), 1.96-1.87 (m, 4H), 1.17-1.04 (m, 4H), 0.71 (t, J = 7.3 Hz, 6H), 0.68-0.63 (m, 
4H); IR (neat): ν = 3046, 2955, 2927, 2855, 1567, 1463, 1464, 1406, 1376, 1187, 1164, 1120, 
787; Data matches that reported in the literature.111 
9,9-Dibutyl-9H-fluoreno[4,5-cde][1,2]dithiine 4-oxide (254) 
A flask under argon was charged with 253 (900 mg, 2.65 mmol) and 
CH2Cl2 (27 mL). The mixture was cooled to -20 
oC, mCPBA (458 mg, 2.65 
mmol) was added portionwise over 10 minutes. The reaction was stirred at 
this temperature for 2 hours then quenched with NaHCO3 (5 mL of a 
saturated aqueous solution) and extracted with CH2Cl2 (4 × 10 mL). The organics were 
combined, dried over Na2SO4, concentrated under reduced pressure, purified by column 
chromatography (8:2 hexane:Et2O) to give 254 (495 mg, 52% ) as a yellow solid; Rf 0.45 (6:4 
hexane:Et2O); mp: 145-146 
oC; 1H NMR (300 MHz, CDCl3): δ = 7.75 (dd, J = 6.5, 2.1 Hz, 1H), 
7.67 – 7.59 (m, 2H), 7.55 – 7.48 (m, 1H), 7.40 (dd, J = 9.7, 0.8 Hz, 2H), 2.15 – 1.96 (m, 4H), 
1.19 – 1.02 (m, 4H), 0.91 – 0.44 (m, 4H), 0.69 (q, J = 7.4 Hz, 6H); 13C NMR (101 MHz, CDCl3): 
δ = 152.6 (C), 151.5 (C), 132.9 (C), 132.2 (C), 131.8 (C), 130.1 (CH), 129.0 (CH), 126.5 (CH), 
124.7 (CH), 124.4 (CH), 121.5 (CH), 120.2 (C), 57.0 (C), 39.5 (CH2), 39.2 (CH2), 26.3 (CH2), 
26.3 (CH2), 23.1 (CH2), 23.1 (CH2), 13.9 (2CH3); IR (neat): ν = 2956, 2929, 2858, 1573, 1464, 
1412, 1087, 790, 734; HR-MS (ES-TOF): m/z: calcd for C21H24OS2: 356.1269 found 356.1269 




257 was prepared according to GP5 using 254 (71.2 mg, 0.20 mmol), 
phenylacetylene (43 µl, 0.40 mmol) and Au-II (9.8 mg, 5 mol%). The 
reaction time was 20 hours. Purification by column chromatography 
(95:5 hexane:Et2O) afforded the title compound (70.3 mg, 77%) as a 
white solid; Rf  0.66 (8:2 hexane:Et2O); mp: 155-156 
oC; 1H NMR (300 
MHz, CDCl3): δ = 7.99 (dd, J = 5.2, 3.3 Hz, 2H), 7.62 – 7.55 (m, 1H), 7.50 – 7.42 (m, 2H), 
7.29 (dd, J = 7.0, 2.0 Hz, 2H), 7.26 – 7.18 (m, 4H), 5.73 (s, 1H), 2.04 – 1.90 (m, 4H), 1.16 – 
0.97 (m, 4H), 0.73 – 0.58 (m, 8H), 0.55 – 0.37 (m, 2H); 13C NMR (101 MHz, CDCl3): δ = 191.9 
(C), 154.0 (2C), 139.3 (2C), 134.2 (CH), 134.1 (C), 131.6 (2C), 129.4 (2CH), 129.0 (2CH), 
128.3 (2CH), 127.0 (2CH), 121.0 (2CH), 56.6 (CH), 54.4 (C), 41.3 (CH2), 41.0 (CH2), 25.9 
(CH2), 25.7 (CH2), 23.1 (2CH2), 13.9 (2CH3); IR (neat): ν = 2951, 2925, 2857, 1678, 1580, 
1450, 1401, 1274, 1174, 987, 792, 738, 686; HR-MS (ES-TOF): m/z: calcd for C29H30ONaS2: 
481.1636 found 481.1634 [M + Na]+.  
Methyl 4-(4,4-dibutyl-4H-fluoreno[4,5-def][1,3]dithiepine-9-carbonyl)benzoate (259) 
259 was prepared according to GP5 using 254 (72.8 mg, 0.20 
mmol), methyl 4-ethynylbenzoate (64.7 mg, 0.40 mmol) and Au-
II (9.8 mg, 5 mol%). The reaction time was 26 hours. Purification 
by column chromatography (95:5 hexane:Et2O) afforded the title 
compound (58.1 mg, 56%) as a bright yellow solid. 259 was also prepared according to GP6  
using methyl 4-ethynylbenzoate (16.2 mg, 0.10 mmol), 254 (42.7 mg, 0.12 mmol) and Au-II 
(9.8 mg, 5 mol%). The reaction time was 20 hours. Purification by column chromatography 
(95:5 hexane:Et2O) afforded the title compound (26.9 mg, 52%) as a bright yellow solid; Rf 
0.40 (8:2 hexane:Et2O); mp: 158-160 
oC; 1H NMR (300 MHz, CDCl3): δ = 8.16 (d, J = 8.7 Hz, 
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2H), 8.07 (d, J = 8.7 Hz, 2H), 7.35 – 7.23 (m, 6H), 5.79 (s, 1H), 3.97 (s, 3H), 2.08 – 1.94 (m, 
4H), 1.18 – 1.02 (m, 4H), 0.78 – 0.64 (m, 8H), 0.55 – 0.45 (m, 2H); 13C NMR (101 MHz, 
CDCl3): δ = 191.1 (C), 166.1 (C), 154.0 (2C), 139.3 (2C), 137.6 (C), 134.7 (C), 131.2 (2C), 
130.1 (2CH), 129.3 (2CH), 128.3 (2CH), 127.1 (2CH), 121.2 (2CH), 56.4 (CH), 54.5 (C), 52.7 
(CH3), 41.2 (CH2), 41.0 (CH2), 25.9 (CH2), 25.7 (CH2), 23.3 (2CH2), 13.9 (2CH3); IR (neat): ν 
= 2929, 2858, 1718, 1681, 1401, 1268, 1105, 995, 872, 797, 737; HR-MS (ES-TOF): m/z: calcd 
for C31H32O3NaS2: 539.1961 found 539.1989 [M + Na]
+. 
(4,4-Dibutyl-4H-fluoreno[4,5-def][1,3]dithiepin-9-yl)(3-methoxyphenyl)methanone (260) 
260 was prepared according to GP5 using 254 (71.2 mg, 0.20 mmol), 
3-methylphenylacetylene (46.5 mg, 0.40 mmol) and Au-II (11.2 mg, 5 
mol%). The reaction time was 20 hours. Purification by column 
chromatography (95:5 hexane:Et2O)  afforded the title compound (70.3 
mg, 70%) as a white solid; mp: 79-81 oC; Rf  0.79 (8:2 hexane:Et2O); 
1H 
NMR (300 MHz, CDCl3): δ = 7.64 (s, 1H), 7.60 (d, J = 7.8 Hz, 1H), 7.31 – 6.92 (m, 8H), 5.52 
(s, 1H), 2.21 (s, 3H), 1.89 – 1.68 (m, 4H), 1.01 – 0.79 (m, 4H), 0.59 – 0.39 (m, 8H), 0.41 – 0.22 
(m, 2H); 13C NMR (101 MHz, CDCl3): δ = 192.1 (C), 154.0 (2C), 139.3 (2C), 138.9 (C), 135.1 
(CH), 134.1 (C), 131.7 (2C), 129.8 (CH), 128.8 (CH), 128.3 (2CH), 126.9 (2CH), 126.7 (CH), 
121.0 (2CH), 56.7 (CH), 54.4 (C), 41.4 (CH2), 41.0 (CH2)   26.0 (CH2), 25.7 (CH2), 23.1 (2CH2), 
21.5 (CH3), 14.0 (2CH3); IR (neat): ν = 2954, 2929, 2859, 1677, 1602, 1451, 1400, 1278, 1173, 
791, 737, 685; HR-MS (ES-TOF): m/z: calcd for C30H32ONaS2: 495.1792 found 495.1790 [M 




261 was prepared according to GP5 using 254 (72.8 mg, 0.20 mmol), 2-
ethynylthiophene (43.3 mg, 0.40 mmol) and Au-II (11.2 mg, 5 mol%). The 
reaction time was 24 hours. Purification by column chromatography (95:5 
hexane:Et2O) and recrystallisation from Et2O afforded the title compound 
(45.8 mg, 49%) as a bright yellow solid; Rf  0.68 (8:2 hexane:Et2O); mp: 
138-139 oC; 1H NMR (300 MHz, CDCl3): δ = 7.88 (dd, J = 4.0, 1.0 Hz, 1H), 7.76 (dd, J = 4.9, 
1.0 Hz, 1H), 7.38 – 7.22 (m, 6H), 7.18 (dd, J = 4.9, 4.0 Hz, 1H), 5.58 (s, 1H), 2.11 – 1.92 (m, 
4H), 1.23 – 1.00 (m, 4H), 0.78 – 0.59 (m, 8H), 0.58 – 0.43 (m, 2H); 13C NMR (101 MHz, 
CDCl3): δ = 184.5 (C), 154.0 (2C), 140.6 (C), 139.1 (2C), 135.8 (CH), 134.5 (CH), 131.5 (2C), 
128.6 (CH), 128.2 (2CH), 127.0 (2CH), 121.1 (2CH), 57.6 (CH), 54.4 (C), 41.3 (CH2), 41.0 
(CH2), 25.9 (CH2), 25.7 (CH2), 23.1 (2CH2), 13.9 (CH3), 13.9 (CH3); IR (neat): ν = 2953, 2928, 
2857, 1678, 1584, 1451, 1400, 1280, 1174, 989, 851, 791, 731; HR-MS (ES-TOF): m/z: calcd 
for C27H28ONaS3: 487.1200 found 487.1188 [M + Na]
+. 
Allyl 9-benzoyl-4,4-dibutyl-4H-fluoreno[4,5-def][1,3]dithiepine-9-carboxylate (263) 
263 was prepared according to GP5 using 254 (35.6 mg, 0.10 mmol), 
allyl 3-phenylpropiolate (37.2 mg, 0.20 mmol) and Au-I (5 mol%) 
but at 90 oC. The reaction time was 20 hours. Purification by column 
chromatography afforded the title compound (41.3 mg, 74%) as a 
white solid. 263 was also prepared according to GP6 using allyl 3-phenylpropiolate (18.6 mg, 
0.10 mmol), 254 (42.7 mg, 0.12 mmol), and Au-II (4.8 mg, 5 mol%). The reaction time was 20 
hours. Purification by column chromatography (95:5 hexane:Et2O) afforded the title compound 
263 (46.5 mg, 83%) as a yellow solid; Rf  0.46 (8:2 hexane:Et2O); mp: 114-115 
oC; 1H NMR 
(300 MHz, CDCl3): δ = 8.11 (d, J = 7.6 Hz, 2H), 7.57 (app t, J = 7.4 Hz, 1H), 7.42 (t, J = 7.7 
182 
 
Hz, 2H), 7.35 – 7.13 (m, 6H), 5.49 (ddt, J = 16.4, 10.5, 5.9 Hz, 1H) 5.21 – 4.94 (m, 2H), 4.40 
(d, J = 5.9 Hz, 2H), 2.22 – 1.86 (m, 4H), 1.21 – 1.00 (m, 4H), 0.77 – 0.63 (m, 6H), 0.60 – 0.42 
(m, 4H); 13C NMR (101 MHz, CDCl3): δ = 187.1 (C), 165.3 (C), 153.1 (2C), 140.5 (2C), 133.9 
(C), 133.8 (CH), 130.6 (CH), 130.1 (2CH), 129.0 (2C), 128.5 (2CH), 128.4 (2CH), 127.2 
(2CH), 121.1 (2CH), 119.7 (CH2), 72.2 (C), 67.8 (CH2), 54.6 (C), 41.2 (CH2), 41.0 (CH2), 25.7 
(CH2), 25.6 (CH2), 23.1 (CH2), 23.1 (CH2), 14.0 (CH3), 13.9 (CH3); IR (neat): ν = 2956, 2930, 
2859, 1742, 1686, 1596, 1448, 1402, 1231, 1199, 988, 792, 737, 688; HR-MS (ES-TOF): m/z: 
calcd for C33H34O3NaS2: 565.1847 found 565.1835 [M + Na]
+. 
(4-Bromophenyl)(4,4-dibutyl-4H-fluoreno[4,5-def][1,3]dithiepin-9-yl)methanone (269) 
269 was prepared according to GP6 using 1-bromo-4-
ethynylbenzene (18.1 mg, 0.10 mmol), 254 (42.7 mg, 0.12 mmol), 
and Au-II (4.8 mg, 5 mol%). The reaction time was 24 hours. 
Purification by column chromatography (95:5 hexane:Et2O) and 
recrystallisation from hot Et2O afforded the title compound (42.6 
mg, 70%) as a pale yellow solid; Rf  0.68 (8:2 hexane:Et2O); mp: 82-83 
oC;  1H NMR (300 MHz, 
CDCl3): δ = 7.89 (d, J = 8.5 Hz, 2H), 7.64 (d, J = 8.5 Hz, 2H), 7.35 – 7.23 (m, 6H), 5.71 (s, 
1H), 2.15 – 1.89 (m, 4H), 1.18 – 1.02 (m, 4H), 0.71 (dt, J = 11.8, 7.4 Hz, 8H), 0.57 – 0.45 (m, 
2H); 13C NMR (101 MHz, CDCl3): δ = 190.8 (C), 154.0 (2C), 139.3 (2C), 132.9 (C), 132.3 
(2CH), 131.3 (2C), 130.9 (2CH), 129.5 (C), 128.3 (2CH), 127.1 (2CH), 121.1 (2CH), 56.4 
(CH), 54.4 (C), 41.2 (CH2), 41.0 (CH2), 25.9 (CH2), 25.7 (CH2), 23.1 (2CH2), 13.9 (2CH3); IR 
(neat): ν = 2954, 2928, 2857, 1678, 1584, 1399, 1280, 1174, 1070, 990, 851, 791, 731; HR-MS 
(ES-TOF): m/z: calcd for C29H29 ONaS2




270 was prepared according to GP6 using 3-methoxybenzene (13.2 
mg, 0.10 mmol), 254 (42.7 mg, 0.12 mmol), and Au-II (4.8 mg, 5 
mol%). The reaction time was 20 hours. Purification by column 
chromatography (97:3 hexane:Et2O) and recrystallization from Et2O 
afforded the title compound (32.7 mg, 67%) as yellow crystals; Rf 
0.75 (8:2 hexane:Et2O); mp: 145-147 
oC; 1H NMR (400 MHz, CDCl3): δ = 7.59 (d, J = 7.8 Hz, 
1H), 7.56 – 7.53 (m, 1H), 7.38 (app t, J = 8.0 Hz, 1H), 7.31 (dd, J = 7.2, 1.7 Hz, 2H), 7.29 – 
7.21 (m, 4H), 7.18 – 7.13 (m, 1H), 5.71 (s, 1H), 3.83 (s, 3H), 2.05 – 1.91 (m, 4H), 1.17 – 1.00 
(m, 4H), 0.69 (dt, J = 14.9, 7.4 Hz, 6H), 0.69 – 0.59 (m, 2H), 0.55 – 0.42 (m, 2H); 13C NMR 
(101 MHz, CDCl3): δ = 191.7 (C), 160.1 (C), 154.0 (2C), 139.2 (2C), 135.4 (C), 131.6 (2C), 
129.9 (CH), 128.3 (2CH), 127.0 (2CH), 122.0 (CH), 121.0 (2CH), 121.0 (CH), 113.4 (CH), 
56.7 (CH), 55.6 (CH3), 54.4 (C), 41.3 (CH2), 41.0 (CH2), 25.9 (CH2), 25.7 (CH2), 23.1 (2CH2), 
13.9 (2CH3); IR (neat): ν = 2955, 2927, 2857, 1678, 1596, 1582, 1486, 1451, 1273, 1172, 1119, 
1044, 873, 767, 791, 735, 682; HR-MS (ES-TOF): m/z: calcd for C30H32O2NaS2 : 511.1735, 
found 511.1741 [M + Na]+. 
Ethyl 4,4-dibutyl-9-(furan-2-carbonyl)-4H-fluoreno[4,5-def][1,3]dithiepine-9-carboxylate 
(271) 
271 was prepared according to GP6 using 254 (16.0 mg, 0.10 mmol), 
230 (42.7 mg, 0.12 mmol), and Au-II (4.8 mg, 5 mol%). The reaction 
time was 14 hours. Purification by column chromatography (15:1 
hexane:Et2O) afforded the title compound (38.6 mg, 75%) as a pale 
yellow solid; Rf  0.28 (8:2 hexane:Et2O); mp: 128-130 
oC; 1H NMR (300 MHz, CDCl3): δ = 
7.66 (dd, J = 1.6, 0.6 Hz, 1H), 7.45 (dd, J = 3.7, 0.6 Hz, 1H), 7.34 – 7.28 (m, 2H), 7.27 – 7.22 
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(m, 4H), 6.56 (dd, J = 3.7, 1.6 Hz, 1H), 4.04 (q, J = 7.1 Hz, 2H), 2.04 – 1.93 (m, 4H), 1.12 – 
1.01 (m, 4H), 0.97 (t, J = 7.1 Hz, 3H), 0.68 (q, J = 7.4 Hz, 6H), 0.58 – 0.42 (m, 4H); 13C NMR 
(101 MHz, CDCl3): δ = 175.3 (C), 164.8 (C), 153.2 (2C), 149.1 (C), 147.7 (CH), 140.5 (2C), 
129.0 (2C), 128.3 (2CH), 127.2 (2CH), 121.7 (CH), 121.0 (2CH), 112.7 (CH), 71.4 (C), 63.5 
(CH2), 54.6 (C), 41.1 (CH2), 41.0 (CH2), 25.7 (2CH2), 23.1 (2CH2), 13.9 (CH3), 13.9 (2CH3); 
IR (neat): ν = 2955, 2928, 2857, 1745, 1670, 1562, 1456, 1270, 1200, 1031, 791, 764, 735; HR-
MS (ES-TOF): m/z: calcd for C30H32O4NaS2: 543.1640, found 543.1646 [M + Na]
+.  
1-(4,4-Dibutyl-4H-fluoreno[4,5-def][1,3]dithiepin-9-yl)pentan-1-one (255) 
255 was prepared according to GP7 using 1-hexyne (8.4 mg, 0.10 
mmol), 254 (42.7 mg, 0.12 mmol) and Au-I (5.6 mg, 5 mol%). The 
reaction time was 20 hours. Purification by column chromatography 
(95:5 hexane:Et2O) afforded the title compound (25.1 mg, 57%) as a 
colourless oil; Rf 0.71 (8:2 hexane:Et2O); 
1H NMR (400 MHz, CDCl3): δ = 7.32 (p, J = 3.7 Hz, 
2H), 7.25 – 7.19 (m, 4H), 5.02 (s, 1H), 2.83 (t, J = 7.3 Hz, 2H), 2.00 – 1.92 (m, 4H), 1.66 – 
1.55 (m, 2H), 1.37 – 1.23 (m, 2H), 1.13 – 0.97 (m, 4H), 0.89 (t, J = 7.3 Hz, 3H), 0.73 – 0.62 
(m, 6H), 0.61 – 0.52 (m, 2H), 0.48 – 0.38 (m, 2H); 13C NMR (101 MHz, CDCl3): δ = 201.2 (C), 
153.8 (2C), 139.3 (2C), 131.3 (2C), 128.3 (2CH), 127.0 (2CH), 120.9 (2CH), 59.1 (CH), 54.4 
(C), 41.2 (2CH2), 40.6 (CH2), 26.0 (2CH2), 25.9 (CH2), 25.6 (CH2), 23.1 (CH2), 22.3 (CH2), 
13.9 (CH3), 13.9 (2CH3); IR (neat): ν = 2956, 2928, 2854, 1715, 1455, 1400, 1172, 1054, 791; 






268 was prepared according to GP7 using alkyne 120 (33.6 
mg, 0.10 mmol), 254 (42.7 mg, 0.12 mmol) and Au-I (5.6 
mg, 5 mol%). The reaction time was 20 hours. Purification 
by column chromatography (95:5 hexane:Et2O) afforded the 
title compound (30.0 mg, 44%) as a viscous oil; Rf  0.74 (8:2 
hexane:Et2O); 
1H NMR (300 MHz, CDCl3): δ = 7.68 – 7.61 (m, 4H), 7.41 – 7.32 (m, 6H), 7.32 
– 7.28 (m, 2H), 7.25 – 7.19 (m, 4H), 4.97 (s, 1H), 3.64 (t, J = 6.1 Hz, 2H), 2.80 (t, J = 7.2 Hz, 
2H), 2.03 – 1.90 (m, 4H), 1.78 – 1.65 (m, 2H), 1.59 – 1.49 (m, 4H), 1.15 – 0.95 (m, 4H), 1.03 
(s, 9H), 0.69 (t, J = 6.3 Hz, 3H), 0.64 (t, J = 6.3 Hz, 3H), 0.61 – 0.51 (m, 2H), 0.49 – 0.37 (m, 
2H); 13C NMR (101 MHz, CDCl3): δ = 201.1 (C), 153.9 (2C), 139.4 (2C), 135.8 (2CH), 134.1 
(2C), 131.3 (2C), 129.8 (2CH), 128.4 (2CH), 127.8 (4CH), 127.0 (2CH), 121.0 (2CH), 63.5 
(CH2), 59.1 (CH), 54.4 (C), 41.3 (CH2), 40.6 (CH2), 31.8 (CH2), 27.1 (3CH3), 25.9 (CH2), 25.7 
(CH2), 23.1 (CH2), 20.5 (CH2), 19.4 (CH2), 14.0 (2CH3); IR (neat): ν = 3053, 2956, 2929, 2857, 
1716, 1590, 1562, 1454, 1428, 1400, 1108, 908, 734, 700, 613; HR-MS (ES-TOF): m/z: calcd 
for C43H52O2Na
28SiS2: 715.3068, found 715.3076 [M + Na]
+. 
4-Chloro-1-(4,4-dibutyl-4H-fluoreno[4,5-def][1,3]dithiepin-9-yl)butan-1-one (262) 
262 was prepared according to GP7 using 5-chloro-1-pentyne (10.3 
mg, 0.10 mmol), 254 (42.7 mg, 0.12 mmol) and Au-I (5.6 mg, 5 
mol%). The reaction time was 20 hours. Purification by column 
chromatography (95:5 hexane:Et2O) afforded the title compound 
(30.5 mg, 66%) as a colourless viscous oil; Rf 0.55 (8:2 hexane:Et2O); 
1H NMR (300 MHz, 
CDCl3): δ = 7.38 – 7.32 (m, 2H),  7.28 – 7.23 (m, 4H), 5.08 (s, 1H), 3.53 (t, J = 6.3 Hz, 2H), 
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3.07 (t, J = 6.8 Hz, 2H), 2.08 (dq, J = 13.2, 6.6 Hz, 2H), 2.02 – 1.93 (m, 4H), 1.20 – 0.97 (m, 
4H), 0.71 (t, J = 5.2 Hz, 3H), 0.66 (t, J = 5.2 Hz, 3H), 0.63 – 0.52 (m, 2H), 0.50 – 0.37 (m, 2H); 
13C NMR (101 MHz, CDCl3): δ = 199.8 (C), 153.8 (2C), 139.4 (2C), 130.9 (2C), 128.3 (2CH), 
127.1 (2CH), 121.0 (2CH), 58.6 (CH), 54.4 (C), 44.1 (CH2), 41.3 (2CH2), 41.1 (CH2), 37.5 
(CH2), 26.7 (CH2), 25.8 (CH2), 25.6 (CH2), 23.1 (CH2), 13.9 (2CH3); IR (neat): ν = 2957, 2929, 
2858, 1718, 1563; HR-MS (ES-TOF): m/z: calcd for C26H31ONaS2Cl: 481.1403 found 




5.4 Experimental section: Chapter 4  
Methyl benzenesulfinate (320) 
 320 was prepared according to GP8 using diphenyl disulfide (1.31 g, 6.00 
mmol), N-bromosuccinimide (3.24 g, 18.0 mmol) and MeOH (30.0 mL). The 
reaction time was 2 hours. Column chromatography (CH2Cl2) provided the title compound 
(1.56 g, 83%) as a colourless oil; Rf 0.33 (CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ = 7.71 (dt, 
J = 5.5, 2.1 Hz, 2H), 7.60 – 7.50 (m, 3H), 3.48 (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 144.0 
(C), 132.4 (CH), 129.2 (2CH), 125.5 (2CH), 49.8 (CH3); IR (neat): ν = 3060, 2942, 1478, 1445, 
1307, 1124, 1082, 1067, 958, 755, 672, 689. Data matches that reported in the literature.131 
 (Hex-5-en-1-yn-1-ylsulfinyl)benzene (322) 
322 was prepared according to GP9 with magnesium (1.73 g, 72.0 
mmol), allyl bromide (6.14 mL, 72.0 mmol), propargyl chloride (3.45 
mL, 30 mmol) and 320 (9.37 g, 60 mmol). The reaction time was 16 
hours. Subsequent workup and purification by column chromatography (9:1 hexane:EtOAc) 
afforded 322 as a yellow oil (1.23 g, 26%); Rf  0.27
 (9:1 hexane:EtOAc); 1H NMR (300 MHz, 
CDCl3): δ = 7.85 – 7.75 (m, 2H), 7.59 – 7.50 (m, 3H), 5.79 (ddt, J = 17.0, 10.2, 6.6 Hz, 1H,), 
5.06 (dd, J = 17.0, 1.4 Hz, 1H), 5.06 (dd, J = 10.2, 1.4 Hz, 1H), 2.52 (t, J = 7.2 Hz, 2H), 2.31 
(dt, J = 7.2, 6.6 Hz, 2H); 13C NMR (101 MHz, CDCl3): δ = 144.4 (C), 135.7 (CH), 131.7 (CH), 
129.6 (2CH), 125.1 (2CH), 116.8 (CH2), 106.2 (C), 78.2 (C), 31.7 (CH2), 19.7 (CH2); IR (neat): 
ν = 3078, 2981, 2913, 2180, 1643, 1581, 1476, 1444, 1188, 1086, 1052, 985, 917, 885, 788, 




1-(Phenylsulfinyl)bicyclo[3.1.0]hexan-2-one (323 and 323’) 
323 was isolated from the combination of crude NMR’s from 3 (0.1 M) scale 
screening reactions. Column chromatography (2:1 hexane:EtOAc ) afforded 
firstly one diastereomer (5.0 mg) as an oily solid; Rf  0.22 (2:1 
hexane:EtOAc); 1H NMR (300 MHz, CDCl3): δ = 7.82 – 7.74 (m, 2H), 7.50 (dd, J = 5.0, 1.9 
Hz, 3H), 2.80 – 2.70 (m, 2H), 2.38 – 2.23 (m, 6H), 2.13 – 2.01 (m, 2H), 1.75 (dd, J = 8.6, 5.3 
Hz, 2H), 1.24 (t, J = 5.3 Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 208.5 (C), 143.2 (C), 131.3 
(CH), 129.1 (2CH), 124.8 (2CH), 54.6 (C), 34.4 (CH2), 30.3 (CH), 21.6 (CH2), 15.5 (CH2); IR 
(neat): ν = 3059, 2946, 2879, 1718, 1582, 1477, 1443, 1276, 1083, 1041, 1022, 749, 689; HR-
MS (ES-TOF): m/z: calcd for C12H13O2S: 221.0636, found 221.0638 [M+ H]
+. 
The other diastereomer (5.0 mg) was next eluted (2:1 hexane:EtOAc ) as a colorless oil; 1H 
NMR (300 MHz, CDCl3): δ = 7.68 – 7.58 (m, 2H), 7.52 – 7.46 (m, 3H), 2.44 (dt, J = 8.7, 5.0 
Hz, 1H), 2.29 – 1.91 (m, 4H), 1.90 – 1.74 (m, 1H), 1.48 (t, J = 5.3 Hz, 1H); 13C NMR (101 
MHz, CDCl3): δ = 208.5 (C), 143.2 (C), 131.5 (CH), 129.2 (2CH), 124.6 (2CH), 55.4 (C), 33.6 
(CH2), 26.5 (CH), 21.1 (CH2), 19.0 (CH2); IR (neat): ν = 3060, 2944, 2880, 1721, 1582, 1476, 
1443, 1274, 1084, 1030, 956, 748, 690; HR-MS (ES-TOF): m/z: calcd for C12H13O2S: 221.0636, 
found 221.0631 [M + H]+. 
Methyl 4-methylbenzenesulfinate (324) 
324 was prepared according to GP8 with 1,2-di-p-tolyldisulfane (2.09 g, 8.40 
mmol), N-bromosuccinimide (4.49 g, 25.2 mmol) and MeOH (50 mL). The 
reaction time was 2 hours. Aqueous workup and purification by column 
chromatography (1:1 CH2Cl2:hexane) afforded the title compound (2.48 g, 87%) as a colourless 
oil; Rf 0.60
 (CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ = 7.59 (d, J = 8.1 Hz, 2H), 7.34 (d, J = 
8.1 Hz, 2H), 3.46 (s, 3H), 2.43 (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 143.1 (C), 140.8 (C), 
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129.9 (2CH), 125.5 (2CH), 49.7 (CH2), 21.7 (CH2); IR (neat): ν = 3082, 2994, 2941, 2827, 
1572, 1472, 1386, 1128, 1062, 1009, 954, 818, 676. Data matches that reported in the 
literature.128 
Methyl 4-bromobenzenesulfinate (325) 
325 was prepared according to GP8 with 1,2-bis(4-bromophenyl)disulfane 
(3.17 g, 8.40 mmol), N-bromosuccinimide (4.49 g, 25.2 mmol) and MeOH 
(50 mL). The reaction time was 2 hours. Aqueous workup and purification 
by column chromatography (CH2Cl2) afforded the title compound (3.42 g, 86%) as a colourless 
oil; Rf 0.60
 (CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ = 7.73 – 7.66 (m, 2H), 7.62 – 7.55 (m, 
2H), 3.48 (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 143.1 (C), 132.5 (2CH), 127.2 (2CH), 49.9 
(CH3); IR (neat): ν = 3082, 2994, 2941, 2826, 1572, 1472, 1386, 1128, 1062, 954, 818, 676; 
HR-MS (ES-TOF): m/z: calcd for C7H18O2S
79Br: 234.9428, found 234.9425 [M + H]+.  
Methyl 2-methylbenzenesulfinate (326) 
326 was prepared according to GP8 with 1,2-di-o-tolyldisulfane (2.46 g, 10.0 
mmol), N-bromosuccinimide (2.49 g, 30.0 mmol) and MeOH (60 mL). The 
reaction time was 2 hours. Aqueous workup and purification by column chromatography 
(CH2Cl2) afforded the title compound (2.49 g, 73%) as a colourless oil; Rf 0.24
 (CH2Cl2); 
1H 
NMR (300 MHz, CDCl3): δ = 7.90 (dd, J = 7.4, 1.8 Hz, 1H), 7.42 (pd, J = 7.3, 1.4 Hz, 2H), 
7.25 (d, J = 7.3 Hz, 1H), 3.47 (s, 3H), 2.48 (s, 3H); IR (neat): ν = 2931, 2855, 1727, 1450, 1298, 
1130, 987, 690. Data matches that reported in the literature.185  
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Methyl 2,6-dichlorobenzenesulfinate (327) 
327 was prepared adapting GP8. Disulfide (6.1 mmol) was dissolved in CH2Cl2 
(200 mL) and MeOH (200 mL). N-bromosuccinimide (3.26 g, 18.3 mmol) was 
added in one portion at 0 oC. The mixture was allowed to warm to rt and was 
then heated to reflux for 2 hours, cooled to rt and stirred for a further 12 hours. It was then 
washed with NaHCO3 (2 × 50 mL) and water (50 mL). The organic layer was dried Na2SO4, 
filtered, concentrated under reduced pressure and purified by column chromatography (1:1 
CH2Cl2:hexane to CH2Cl2) to afford sulfinic ester 327 (1.91 g, 69%) over 2 steps, as a colourless 
oil. Rf 0.58
 (CH2Cl2); 
1H NMR (300 MHz, CDCl3): δ = 7.35 (app q, J = 3.3 Hz, 3H), 3.89 (s, 
1H); 13C NMR (101 MHz, CDCl3): δ = 134.9 (C), 132.9 (CH), 130.4 (2CH), 55.0 (CH3); IR 
(neat): ν = 3073, 2942, 1559, 1425, 964, 778, 717, 691; HR-MS (ES-TOF): m/z: calcd for 
C7H7O2SCl2: 224.9544, found 224.9543 [M + H]
+. 
Methyl cyclohexanesulfinate (329) 
329 was prepared according to GP8 with disulfide (2.30 g, 10.0 mmol), N-
bromosuccinimide (5.34 g, 30 mmol) and MeOH (60 mL). The reaction time 
was 2 hours. Aqueous workup and purification by column chromatography 
(CH2Cl2) afforded the title compound (1.60 g, 49%) as a colourless oil; Rf 0.24
 (CH2Cl2); 
1H 
NMR (300 MHz, CDCl3): δ = 3.78 (s, 3H), 2.61 – 2.47 (m, 1H), 2.05 – 1.94 (m, 2H), 1.92 – 
1.78 (m, 3H), 1.73 – 1.65 (m, 1H), 1.41 – 1.22 (m, 4H); IR (neat): ν = 3056, 2942, 2547, 1705, 
1473, 1458, 1278, 1141, 1087, 1006, 805, 755, 702. Data matches that reported in the 
literature.186 




328 Prepared according to GP8 and used directly with no data collected. 
1-(Hex-5-en-1-yn-1-ylsulfinyl)-4-methylbenzene (330) 
330 was prepared according to GP9 with magnesium (437 mg, 
18.0 mmol), allyl bromide (1.57 mL, 18.0 mmol), propargyl 
chloride (829 µl, 7.50 mmol) and sulfinate 324 (15.0 mmol). The 
reaction time was 16 hours. Aqueous workup and purification by column chromatography (9:1 
hexane:EtOAc) afforded 330 as a yellow oil (195 mg, 12%); Rf 0.24 (9:1 hexane:EtOAc); 
1H 
NMR (400 MHz, CDCl3): δ = 7.69 (d, J = 8.1 Hz, 2H), 7.34 (d, J = 8.1 Hz, 2H), 5.79 (ddt, J = 
17.0, 10.2, 6.6 Hz, 1H), 5.07 (dd, J = 17.0, 1.5 Hz, 1H), 5.04 (dd, J = 10.2, 1.5 Hz, 1H), 2.51 
(t, J = 7.2 Hz, 2H), 2.43 (s, 3H), 2.31 (dt, J = 7.2, 6.6 Hz, 2H); 13C NMR (101 MHz, CDCl3): δ 
= 142.4 (C), 141.4 (C), 135.8 (CH), 130.3 (2CH), 125.3 (2CH), 116.7 (CH2), 104.9 (C), 78.9 
(C), 31.7 (CH2), 21.6 (CH3), 19.7 (CH2); IR (neat): ν = 3079, 2980, 2922, 2180, 1643, 1595, 
1492, 1085, 1055, 808; HR-MS (ES-TOF): m/z: calcd for C13H15OS: 219.0844, found 219.0847 
[M + Na]+.  
1-Bromo-4-(hex-5-en-1-yn-1-ylsulfinyl)benzene (331) 
331 was prepared according to GP9 above with magnesium (437 
mg, 18.0 mmol), allyl bromide (1.57 mL, 18.0 mmol), propargyl 
chloride (829 µl, 7.50 mmol) and sulfinate 325 (15.0 mmol). The 
reaction time was 16 hours. Aqueous workup and purification by column chromatography (9:1 
hexane:EtOAc) afforded 331 as a yellow oil (215 mg, 10%); Rf
  0.16 (9:1 hexane:EtOAc); 1H 
NMR (300 MHz, CDCl3): δ = 7.71 – 7.63 (m, 4H), 5.78 (ddt, J = 17.0, 10.2, 6.5 Hz, 1H), 5.07 
(dd, J = 17.0, 1.5 Hz, 1H), 5.05 (dd, J = 10.2, 1.5 Hz, 1H), 2.52 (t, J = 7.2 Hz, 2H), 2.32 (dd, J 
= 7.2, 6.5 Hz, 2H); 13C NMR (101 MHz, CDCl3): δ = 143.5 (C), 135.6 (CH), 132.8 (2CH), 
126.6 (2CH), 126.3 (C), 116.8 (CH2), 105.7 (C), 78.5 (C), 31.6 (CH2), 19.7 (CH2); IR (neat): ν 
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= 3079, 2980, 2916, 2180, 1642, 1569, 1470, 1386, 1085, 1055, 1006, 815, 721; HR-MS (ES-
TOF): m/z: calcd for C12H12OS
79Br: 282.9792, found 282.9786 [M + H]+. 
1-(Hex-5-en-1-yn-1-ylsulfinyl)-2-methylbenzene (332) 
332 was prepared according to GP9 above using magnesium (437 
mg, 18.0 mmol), allyl bromide (1.57 mL, 18.0 mmol), propargyl 
chloride (829 µl, 7.50 mmol) and sulfinate 326 (15.0 mmol). The 
reaction time was 16 hours. Subsequent workup and purification by column chromatography 
(8:2 hexane:EtOAc) afforded 332 (649 mg, 40%) as a yellow oil; Rf 0.10 (8:2 hexane:EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 8.01 – 7.93 (m, 1H), 7.46 – 7.38 (m, 2H), 7.26 – 7.22 (m, 
1H), 5.76 (ddt, J = 17.0, 10.2, 6.6 Hz, 1H), 5.03 (dd, J = 17.0, 1.5 Hz, 1H), 5.02 (dd, J = 10.2, 
1.5 Hz, 1H), 2.49 (t, J = 7.2 Hz, 2H), 2.48 (s, 3H), 2.28 (dt, J = 7.2, 6.6 Hz, 2H); 13C NMR (101 
MHz, CDCl3): δ = 142.1 (C), 135.7 (CH), 135.4 (C), 131.4 (CH), 131.3 (CH), 127.3 (CH), 
124.4 (CH), 116.7 (CH2), 104.5 (C), 77.7 (C), 31.7 (CH2), 19.7 (CH2), 18.4 (CH3); IR (neat): ν 
= 3067, 2980, 2919, 2180, 1643, 1594, 1471, 1454, 1074, 1036, 916, 755, 708; HR-MS (ES-
TOF): m/z: calcd for C13H15OS: 219.0844, found 219.0848 [M + H]
+. 
1,3-Dichloro-2-(hex-5-en-1-yn-1-ylsulfinyl)benzene (333) 
333 was prepared according to GP9 with magnesium (243 mg, 10.0 
mmol), allyl bromide (869 µl, 10.0 mmol), propargyl chloride (3.45 
mL, 4.0 mmol) and 327 (9.37 g, 4.0 mmol). The reaction time was 
16 hours. Subsequent workup and purification by column chromatography (9:1 hexane:EtOAc) 
afforded 333 as a yellow oil (273 mg, 15%); 1H NMR (300 MHz, CDCl3): δ = 7.44 – 7.31 (m, 
3H), 5.78 (ddt, J = 17.1, 10.2, 1.6 Hz, 1H), 5.07 (dd, J = 17.1, 1.6 Hz, 1H), 5.03 (dd, J = 10.2, 
1.6 Hz, 1H), 2.54 (t, J = 6.9 Hz, 2H), 2.39 – 2.28 (m, 2H); 13C NMR (101 MHz, CDCl3): δ = 
139.3 (C), 135.7 (2C), 135.7 (2CH), 133.0 (CH), 130.2 (CH), 116.7 (CH2), 107.0 (C), 76.5 (C), 
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31.6 (CH2), 19.9 (CH2); IR (neat): ν = 3066, 2902, 21670, 1758, 1559, 1428, 1374, 1186, 1071, 
783, 769, 661; HR-MS (ES-TOF): m/z: calcd for C12H11OSCl2: 272.9908, found 272.9908 [M 
+ H]+. 
 
 (Hex-5-en-1-yn-1-ylsulfinyl)cyclohexane (335)  
335 was prepared according to GP9 with magnesium (267 mg, 14.0 
mmol), allyl bromide (1.21 mL, 14.0 mmol), propargyl chloride (608 
µl, 30.0 mmol) and 329 (1.60 g, 11.0 mmol). The reaction time was 
16 hours. Subsequent workup and purification by column chromatography (8:2 hexane:EtOAc) 
afforded 335 (269 mg, 23%) as a yellow oil; Rf  0.21
 (8:2 hexane:EtOAc); 1H NMR (300 MHz, 
CDCl3): δ = 5.82 (ddt, J = 16.8, 10.2, 6.5 Hz, 1H), 5.16 – 5.04 (m, 2H), 2.88 (tt, J = 11.6, 3.6 
Hz, 1H), 2.55 (dd, J = 10.8, 3.8 Hz, 2H), 2.39 – 2.28 (m, 2H), 2.23 – 2.06 (m, 2H), 2.01 – 1.85 
(m, 2H), 1.80 – 1.66 (m, 1H), 1.59 – 1.16 (m, 5H); 13C NMR (101 MHz, CDCl3): δ = 135.9 
(CH), 116.7 (CH2), 105.1 (C), 76.4 (C), 63.4 (CH), 31.9 (CH2), 25.7 (CH2), 25.6 (CH2), 25.5 
(CH2), 25.4 (CH2), 19.6 (2CH2); IR (neat): ν = 3079, 2930, 2855, 2182, 1677, 1643, 1449, 1058, 
995, 915; HR-MS (ES-TOF): m/z: calcd for C12H18ONaS: 233.0976, found 233.0981 [M + 
Na]+. 
6-(Methylsulfinyl)hex-1-en-5-yne (334) 
334 was prepared according to GP9 with magnesium (437 mg, 18 mmol), 
allyl bromide (1.57 mL, 18 mmol), propargyl chloride (829 µl, 7.5 mmol) 
and sulfinate 328 (1.63 g, 15 mmol). The reaction time was 16 hours. Aqueous workup and 
purification by column chromatography (9:1 hexane:EtOAc) afforded 334 (185 mg, 17%) as a 
yellow oil; Rf
  0.12 (7:3 hexane:EtOAc); 1H NMR (300 MHz, CDCl3): δ = 5.82 (ddt, J = 16.8, 
10.2, 6.5 Hz, 1H), 5.16 – 5.04 (m, 2H), 2.94 (s, 3H), 2.57-2.49 (m, 2H), 2.33 (dt, J = 7.0, 3.8 
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Hz, 2H); 13C NMR (101 MHz, CDCl3): δ = 135.7 (CH), 116.7 (CH2), 103.9 (C), 79.1 (C), 43.9 
(CH3), 31.7 (CH2), 19.5 (CH2); IR (neat): ν = 3079, 3303, 2981, 2917, 2183, 1643, 1417, 1061, 
917, 675; HR-MS (ES-TOF): m/z: calcd for C7H10ONaS: 165.0350, found 165.0345 [M + Na]
+. 
2-(2,2-Dibromovinyl)naphthalene (344) 
Prepared using GP1, with 2-naphthaldehyde (546 µL, 4.00 mmol), CBr4 (2.63 g, 
8.00 mmol) and PPh3 (4.20 g, 16.0 mmol) in dry CH2Cl2 (12 mL). The reaction 
time was 1 hour. Purification by column chromatography, eluting with n-hexane, 
afforded the dibromoalkene 344 as a white solid (1.05 g, 84%); mp: 93-94 oC; 1H 
NMR (300 MHz, CDCl3): δ = 8.02 (s, 1H), 7.88 – 7.81 (m, 3H), 7.68 – 7.62 (m, 2H), 7.53 – 
7.48 (m, 2H); 13C NMR (101 MHz, CDCl3): δ = 137.1 (CH), 133.1 (2C), 132.9 (C), 128.4 (CH), 
128.3 (CH), 128.2 (CH), 127.9 (CH), 126.9 (CH), 126.7 (CH), 125.8 (CH), 90.0 (C); IR (neat): 
ν = 3060, 3014, 1588, 1505, 1372, 1081, 1013, 945, 830, 789, 771, 709. Data matches that 
reported in the literature.187 
1-(2,2-Dibromovinyl)-4-fluorobenzene (345) 
Prepared using GP1, with para-fluorobenzaldehyde (422 µl, 4.00 mmol), CBr4 
(2.63 g, 8.00 mmol) and PPh3 (4.63 g, 16.00 mmol) in dry CH2Cl2 (12 mL). The 
reaction time was 1 hour. Aqueous work-up and purification by column 
chromatography (hexane), provided the dibromoalkene 345 (880 mg, 79%) as a 
colourless oil; 1H NMR (300 MHz, CDCl3): δ = 7.52 (dd, J = 8.7, 5.5 Hz, 2H), 7.44 (s, 1H), 
7.12 – 7.00 (m, 2H); 13C NMR (CDCl3): δ = 163.2 (J = 248.7 Hz, C) 130.9 (J = 7.6 Hz, C), 
136.4 (CH), 132.0 (C), 115.1 (J = 21.6 Hz, C),  90.0 (C); IR (neat): ν = 2981, 1602, 1506, 1411, 




Prepared using GP1, with 4-(Trifluoromethyl)benzaldehyde (546 µL, 4.00 mmol), 
CBr4 (2.63 g, 8.00 mmol), and PPh3 (4.20 g, 16.0 mmol) in dry CH2Cl2 (12 mL). 
The reaction time was 1 hour. Aqueous work-up and purification by column 
chromatography, eluting with n-hexane, afforded the dibromoalkene 346 (977 mg, 
74%) as a colourless oil; 1H NMR (300 MHz, CDCl3): δ = 7.63 (s, 4H), 7.52 (s, 1H); 
13C NMR 
(101 MHz, CDCl3): δ = 138.9 (C), 135.7 (CH), 130.3 (C), 128.8 (2CH), 125.6 (CH), 125.5 
(CH), 123.8 (C), 92.4 (C); IR (neat): ν = 1617, 1409, 1320, 1165, 1122, 1067, 1017, 877, 746. 
Data matches that reported in the literature.108 
(2,2-Dibromovinyl)cyclohexane (347) 
Prepared using GP1, with 2-cyclohexylcarbaldehyde (606 µl, 5.00 mmol), 
CBr4 (3.18 g, 10.0 mmol), and PPh3 (5.79 g, 20.0 mmol) in dry CH2Cl2 (15 
mL). The reaction time was 10 minutes. The mixture was precipitated with pentane, filtering 
through celite, repeating (× 4), the residue was dry loaded and filtered through a short silica 
column affording dibromooalkene 347 (640 mg, 48%) as a colourless oil; Rf 0.90 (hexane); 1H 
NMR (300 MHz, CDCl3): δ = 6.23 (d, J = 9.1 Hz, 1H), 2.35 – 2.20 (m, 1H), 1.80 – 1.59 (m, 
5H), 1.38 – 1.04 (m, 5H); 13C NMR (101 MHz, CDCl3): δ = 143.9 (CH), 87.1 (C), 42.6 (CH), 
31.4 (2CH2), 25.9 (CH2), 25.6 (2CH2); IR (neat): ν = 2924, 2851, 1610, 1448, 1350, 1311, 1257, 
1218, 1140, 965, 893, 833, 813, 764. Data matches that reported in the literature.188 
1,1-Dibromo-8-methylnona-1,7-diene (348) 
Prepared using GP1, with citronellal (722 µl, 4.00 mmol), CBr4 (2.63 
g, 8.00 mmol), and PPh3 (4.63 g, 16.0 mmol) in dry CH2Cl2 (12 mL). 
The reaction time was 2 hours. Aqueous work-up and purification by column chromatography 
(hexane), yielded 320 (882 mg, 71%) as a colourless oil; 1H NMR (300 MHz, CDCl3): δ = 6.40 
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(t, J = 7.3 Hz, 1H), 5.08 (dddt, J = 8.4, 4.1, 2.7, 1.3 Hz, 1H), 2.10 (ddd, J = 14.7, 7.1, 5.9 Hz, 
1H), 2.05 – 1.90 (m, 3H), 1.72 – 1.56 (m, 7H), 1.41 – 1.27 (m, 1H), 1.26 – 1.11 (m, 1H), 0.92 
(d, J = 6.7 Hz, 3H); IR (neat): ν = 2959, 1705, 1458, 1381, 1127, 779. Data matches that reported 
in the literature.189 
N-(4-Ethynylphenyl)acetamide (350) 
350 was prepared according to a literature procedure.135, 143 4-iodoaniline 
(2.00 g, 9.12 mmol, 1.0 eq.), Pd(PPh3)2Cl2 (166 mg, 2.7 mol%) and CuI 
(44 mg, 2.7 mol%) were added to a RBF under argon. Degassed triethylamine (30 mL) was 
added and the mixture was stirred at rt over 30 minutes. TMS acetylene (1.56 mL 11.4 mmol, 
1.25 eq.) was added dropwise and the reaction mixture was stirred at rt for 24 hours, The organic 
phase was extracted with water/ethyl acetate (3 ×), washed with brine, dried over Na2SO4, 
filtered and the solvent was removed under reduced pressure. The crude product was purified 
by column chromatography to afford 4-(trimethylsilylethynyl)aniline as a yellow solid. The 
alkyne was dissolved in MeOH (20 mL) and K2CO3 (189 mg, 1.37 mmol, 0.15 eq.) Water (20 
mL) was added and the mixture was extracted with CH2Cl2 (3 × 20 mL), dried over Na2SO4, 
filtered and concentrated under reduced pressure to afford 4-ethynylaniline (1.01 g, 86%). 4-
Ethynylaniline (995 mg, 8.50 mmol, 1.0 eq.) was dissolved in CH2Cl2 (20 mL) and acetic 
anhydride (892 µL, 9.5 mmol, 1.12 eq.) was added. The mixture was stirred at rt for 16 hours, 
CH2Cl2 removed under reduced pressure and the residue was purified by column 
chromatography (6:4 hexane:EtOAc) yielding the title compound (694 mg, 44%) as a yellow 
solid); mp: 114-117 oC; 1H NMR (300 MHz, CDCl3): δ = 7.53 – 7.42 (m, 4H), 7.31 (s, 1H), 
3.04 (s, 1H), 2.18 (s, 3H); IR (neat): ν = 3317, 3301, 3185, 3115, 3055, 2107, 1666, 1596, 1529, 




351 was prepared in two steps from 3-bromothiophene according to a literature 
procedure.137,138 To a mixture of 3-bromothiophene (1.63 g, 10.0 mmol, 1.0 eq.), 
CHCl3 (20 mL) and acetic acid (10 mL) in the dark was added N-iodosuccinimide (2.70 g, 12.0 
mmol, 1.2 eq.) in one portion and the reaction was stirred at rt for 48 hours. The solution was 
concentrated under reduced pressure, NaHCO3 (sat) (20 mL) was added to neutralise the 
solution and the mixture was extracted with hexane (2 × 10 mL). The combined organics layers 
were dried over Na2SO4, filtered and concentrated under reduced pressure to afford a pink oil 
which was directly used in the sonagashira coupling. 
A flame dried 100 mL RBF was charged with 3-bromo-2-iodothiophene (1.80 g, 5.6 mmol), 
Pd(PPh3)2Cl2 (36 mg, 1 mol%) and CuI (90 mg, 5 mol%). Degassed diisopropyl amine (56 mL) 
and degassed anhydrous toluene (15 mL) were added before the dropwise addition of TMS 
acetylene (1.01 ml, 7.3 mmol, 1.3 eq.). The reaction mixture was heated to 70 oC and stirred at 
this temperature for 16 hours. On cooling to rt, HCl (50 mL of a 2M solution) was added, the 
organic layer was separated and washed with brine (20 mL), dried over Na2SO4, filtered, 
concentrated under reduced pressure and purified by column chromatography (hexane) to 
afford the TMS protected alkyne. The alkyne was dissolved in MeOH (20 mL) and K2CO3 (189 
mg, 1.37 mmol, 0.15 eq.) and stirred at rt for 1 hour. Water (20 mL) was added and the mixture 
was extracted with CH2Cl2 (3 × 20 mL), dried over Na2SO4, filtered and concentrated under 
reduced pressure to afford the title compound (443 mg, 24%) over 3 steps; 1H NMR (300 MHz, 
CDCl3): δ = 7.22 (d, J = 5.4 Hz, 1H), 6.97 (d, J = 5.4 Hz, 1H), 3.58 (s, 1H); IR (neat): ν = 3290, 





352 was prepared according to a literature procedure.10 To a RBF under 
argon was added 4-iodoanisole (1.17 g, 5.00 mmol) and Et3N (10 mL). 
The vessel was degassed for 10 minutes before the addition of Pd(PPh3)2Cl2 (35.0 mg, 1 mol%) 
and CuI (10.0 mg, 1 mol%), TMS acetylene (1.38 mL, 10.0 mmol) was added dropwise and the 
reaction mixture was stirred for 1 hour at rt. The mixture was concentrated under reduced 
pressure, CH2Cl2 (20 mL) added, washed with NaHCO3 (sat) (20 mL), water (20 mL), dried 
over Na2SO4, filtered and concentrated under reduced pressure. The residue was purified by 
column chromatography (hexane) to afford the TMS protected alkyne. The alkyne in a RBF 
was evacuated and MeOH (5 mL) and CH2Cl2 (5 mL) were added followed by K2CO3 (1.38 g, 
10.0 mmol, 2.0 eq.). The reaction was stirred at rt for 1 hour before the addition of water (10 
mL). The organic layer was collected and the aqueous layer was extracted with CH2Cl2 (3 × 10 
mL), dried over Na2SO4, filtered and concentrated under reduced pressure to afford the title 
compound (562 mg, 85% over 2 steps) as a yellow oil; 1H NMR (300 MHz, CDCl3): δ = 7.46 
– 7.39 (m, 2H), 6.88 – 6.80 (m, 2H), 3.82 (s, 3H), 3.00 (s, 1H). IR (neat): ν = 3286, 2961, 2839, 
2106, 1606, 1571, 1505, 1290, 1245, 1169, 1029, 830, 811, 685. Data matches that reported in 
the literature.134 
1-Ethynyl-4-methylbenzene (353) 
353 was prepared according to a literature procedure.134 To a RBF under 
argon was added 4-iodotoluene (1.09 g, 5.00 mmol) and Et3N (10 mL). The 
vessel was degassed for 10 minutes before the addition of Pd(PPh3)2Cl2 (35.0 mg, 1 mol%) and 
CuI (10.0 mg, 1 mol%), TMS acetylene (1.38 mL, 10.0 mmol) was added dropwise and the 
reaction mixture was stirred for 1 hour at rt. The mixture was concentrated under reduced 
pressure, extracted with CH2Cl2 (20 mL), washed with NaHCO3 (sat) (20 mL), water (20 mL), 
199 
 
dried over Na2SO4, filtered and concentrated under reduced pressure. The residue was purified 
by column chromatography (hexane) to afford the TMS protected alkyne. The alkyne in a RBF 
was evacuated and MeOH (5 mL) and CH2Cl2 (5 mL) were added followed by K2CO3 (1.38 g, 
10.0 mmol, 2.0 eq.). The reaction was stirred at rt for 1 hour before the addition of water (10 
mL). The organic layer was collected and the aqueous was extracted CH2Cl2 (3 × 10 mL), dried 
Na2SO4, filtered and concentrated under reduced pressure to afford the title compound (562 mg, 
43% over 2 steps) as a yellow oil; 1H NMR (300 MHz, CDCl3): δ = 7.39 (d, J = 8.0 Hz, 2H), 
7.13 (d, J = 8.0 Hz, 2H), 3.03 (s, 1H), 2.36 (s, 3H); IR (neat): ν = 3312, 2955, 2924, 2855, 1693, 
1608, 1508, 1249, 838, 755. Data matches that reported in the literature.190 
1-Ethynyl-2-isopropylbenzene (354) 
354 was prepared according to a literature procedure.136 To a mixture of 1-iodo-
2-isopropyl benzene (1.23 g, 5.00 mmol), Pd(PPh3)2Cl2 (166 mg, 5 mol%) and 
CuI (88 mg, 10 mol%) under argon was added degassed Et3N (10 mL). The 
mixture was cooled to 0 oC and TMS acetylene (0.78 mL, 5.5 mmol, 1.1 eq.) was added 
dropwise. The mixture was stirred at rt for 20 hours, filtered through celite and concentrated 
under reduced pressure. The residue was purified by column chromatography (hexane) 
affording the TMS protected alkyne. The alkyne was dissolved in MeOH (10 mL) and K2CO3 
(104 mg, 0.15 eq.) was added and the reaction was stirred at rt for 1 hour. Water (10 mL) was 
added and the mixture was extracted with CH2Cl2 (3 × 10 mL), dried over Na2SO4, filtered and 
concentrated under reduced pressure to afford the title compound (655 mg, 91%) as a pale 
orange oil; 1H NMR (300 MHz, CDCl3): δ = 7.50 – 7.45 (m, 1H), 7.36 – 7.27 (m, 2H), 7.18 – 
7.10 (m, 1H), 3.50 (dt, J = 13.8, 6.9 Hz, 1H), 3.25 (s, 1H), 1.27 (d, J = 6.9 Hz, 6H); IR (neat): 




Sodium benzenesulfonothioate (358) 
358 was prepared according to a literature procedure.141 To a RBF under argon 
was added pyridine (31 mL) and benzene sulfinate (5.00 g, 30.0 mmol). Sulfur 
(975 mg, 30.0 mmol) was added and the suspension was stirred at rt for 75 minutes. The mixture 
was filtered, washing with anhydrous Et2O (30 mL) and the crude product collected. 
Recrystallisation from boiling (EtOH) affording the title compound (4.91 g, 83%) as white 
crystals; mp: 286-288 oC; 1H NMR (300 MHz, DMSO): δ = 7.76 – 7.70 (m, 2H), 7.39 – 7.29 
(m, 3H); IR (neat): ν = 3467, 3405, 3063, 1608, 1444, 1222, 1118, 1064, 760, 718, 688. Data 
is in agreement with literature values.141 
S-(But-3-en-1-yl) benzenesulfonothioate (359) 
359 was prepared following a literature procedure.142 To a RBF was 
added sodium benzenesulfonothioate 358 (7.60 g, 38.7 mmol, 1.0 eq) 
and the flask was evacuated and refilled with argon (× 3). Anhydrous DMF (60 mL) was added 
and the mixture was stirred at rt. 4-bromo-1-butene (4.03 mL, 40 mmol, 1.03 eq.) was added 
over 5 minutes by syringe and the mixture was stirred for 4 days. The mixture was poured into 
ice/ water (200 mL) and was extracted with Et2O (6 × 50 mL). The combined organic fractions 
were washed with NaHCO3 (sat) solution (50 mL), brine (3 × 50 mL), dried over Na2SO4, 
filtered, concentrated under reduced pressure and purified by column chromatography (9:1 
hexane:EtOAc) to afford 359 (8.90 g, 86%) as a pale orange oil; Rf 0.29 (9:1 hexane: EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 8.01 – 7.87 (m, 2H), 7.75 – 7.49 (m, 3H), 5.67 (ddt, J = 17.0, 
10.4, 6.7 Hz, 1H), 5.08 – 4.96 (m, 2H), 3.07 (t, J = 7.3 Hz, 2H), 2.41 – 2.28 (m, 2H); 13C NMR 
(101 MHz, CDCl3): δ = 145.0 (C), 134.8 (CH), 133.8 (CH), 129.4 (2CH), 127.1 (2CH), 117.7 
(CH2), 35.3 (CH2), 32.9 (CH2); IR (neat): ν =  3068, 2981, 1641, 1582, 1447, 1322, 1308, 1293, 
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1139, 1076, 714; HR-MS (ES-TOF): m/z: calcd for C10H12O2S2Na: 251.0179, found 251.0176 
[M + Na]+. 
But-3-en-1-yl(phenylethynyl)sulfane (355) 
355 was prepared according to GP11 using phenylacetylene (563 
mg, 5.5 mmol), LiHMDS (1 M, 5.5 mL, 5.5 mmol), 359 (1.14 g, 5.0 
mmol) and THF (25 mL). The reaction time was 19 hours. Aqueous 
workup and purification by column chromatography (hexane) provided 355 (804 mg, 94%) as 
a colourless oil; Rf 0.26 (hexane); 
1H NMR (300 MHz, CDCl3): δ = 7.46 – 7.37 (m, 2H), 7.34 
– 7.27 (m, 3H), 5.88 (ddt, J = 17.0, 10.2, 6.6 Hz, 1H), 5.16 (dd, J = 17.0, 1.6 Hz, 1H), 5.10 (dd, 
J = 10.2, 1.6 Hz, 1H), 2.86 (t, J = 7.4 Hz, 2H), 2.57 (dt, J = 7.4, 6.6 Hz, 2H); 13C NMR (101 
MHz, CDCl3): δ =135.8 (CH), 131.7 (2CH), 128.5 (2CH), 128.3 (C), 117.1 (CH2), 93.5 (C), 
35.1 (CH2), 33.7 (CH2); IR (neat): ν = 3079, 2979, 2927, 2166, 1640, 1595, 1487, 1442, 915, 
752, 688; HR-MS (ES-TOF): m/z: calcd for C12H12S: 188.0660, found 188.0663 [M + H]
+.  
But-3-en-1-yl(p-tolylethynyl)sulfane (356) 
356 was prepared according to a literature procedure.140 To a 50 
mL 3 neck RBF was added alkyne 353 (190 mg, 1.64 mmol, 1.0 
eq.) and THF (8 mL). The mixture was cooled to -78 oC in a dry ice/ acetone bath and n-BuLi 
(2.5 M in hexanes) (0.72 mL, 1.80 mmol, 1.0 eq.) was added dropwise. On complete addition 
the mixture was stirred for 1 hour at -78 oC before addition of sulfur (52.6 mg, 1.64 mmol, 1.0 
eq.). The resulting red solution was stirred for a further hour at -78 oC before warming to 0 oC 
over 1 hour. 4 Bromo-1-butene (167 µL, 1.64 mmol, 1.0 eq.) was added and the mixture was 
stirred for 2 hours at 0 oC and left to warm to rt for 16 hours. The mixture was quenched with 
NH4Cl (10 mL of a saturated solution), extracted with Et2O (3 × 10 mL), washed with brine (10 
mL), dried over Na2SO4, concentrated under reduced pressure and purified by column 
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chromatography (hexane) to afford 356 (222 mg, 67%) as a colourless oil; Rf 0.43 (hexane); 
1H 
NMR (300 MHz, CDCl3): δ = 7.32 (d, J = 8.0 Hz, 2H), 7.11 (d, J = 8.0 Hz, 2H), 5.88 (ddt, J = 
17.0, 10.2, 6.4 Hz, 1H), 5.15 (dd, J = 17.0, 1.6 Hz, 1H), 5.20 – 5.07 (dd, 10.2, 1.6 Hz, 2H), 2.85 
(t, J = 7.5 Hz, 2H), 2.56 (dt, J = 7.5, 6.4 Hz, 2H), 2.34 (s, 3H); 13C NMR (101 MHz, CDCl3): δ 
= 138.4 (C), 135.8 (CH), 131.7 (2CH), 129.2 (2CH), 120.5 (C), 116.9 (CH2), 93.5 (C), 78.2 
(C), 35.1 (CH2), 33.6 (CH2), 21.6 (CH3); IR (neat): ν = 3079, 3028, 2979, 2921, 2166, 1641, 
1506, 1434, 1417, 916, 813; HR-MS (ES-TOF): m/z: calcd for C13H15S: 203.0894, found 
203.0893 [M + H]+.  
But-3-en-1-yl((4-methoxyphenyl)ethynyl)sulfane (357) 
357 was prepared according to a literature procedure.140 To a 50 
mL 3 neck RBF was added alkyne 352 (170 mg, 1.29 mmol, 1.0 
eq.) and THF (7 mL). The mixture was cooled to -78 oC in a dry 
ice/ acetone bath and n-BuLi (2.5 M in hexanes) (0.57 mL, 1.42 mmol, 1.0 eq.) was added 
dropwise. After complete addition the mixture was stirred for 1 h at -78 oC before addition of 
sulfur (41.3 mg, 1.29 mmol, 1.0 eq.) the resulting red solution was stirred for a further 1 h at -
78 oC before warming to 0 oC slowly. 4 Bromo-1-butene (131 µL, 1.29 mmol, 1.0 eq.) was 
added and the mixture was stirred for 2 h at 0 oC and left to warm to rt for 16 h. The mixture 
was quenched with NH4Cl (10 ml of a saturated solution), extracted with Et2O (3 × 10 mL), 
washed with brine (10 mL), dried over Na2SO4, concentrated under reduced pressure and 
purified by column chromatography (hexane) to afford 356 (222 mg, 67%) as a colourless oil; 
Rf 0.34 (19:1 hexane:EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 7.41 – 7.35 (m, 2H), 6.85 – 
6.81 (m, 2H), 5.87 (ddt, J = 17.0, 10.2, 6.6 Hz, 1H), 5.15 (dd, J = 17.0, 1.6 Hz, 1H), 5.10 (dd, 
J = 10.2, 1.6 Hz, 1H), 3.81 (s, 3H), 2.83 (t, J = 7.4 Hz, 2H), 2.55 (dt, J = 7.4, 6.6 Hz, 2H); 13C 
NMR (101 MHz, CDCl3): δ = 159.8 (C), 135.9 (CH), 133.5 (2CH), 116.9 (CH2), 115.7 (C), 
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114.1 (2CH), 93.2 (C), 55.4 (CH3), 35.1 (CH2), 33.6 (CH2); IR (neat): ν = 2933, 2837, 1604, 
1505, 1289, 1245, 1171, 1030, 917, 829, 810, 777; HR-MS (ES-TOF): m/z: calcd for C13H15OS: 
219.0844, found 219.0836 [M + H]+.  
(3-(Allyloxy)prop-1-yn-1-yl)(but-3-en-1-yl)sulfane (360) 
To a flame dried (50 mL) 3 neck RBF was added alkyne 152 
(60% in Et2O (760 µl, 4.00 mmol) and THF (20 mL). The 
mixture was cooled to -78 oC in a dry ice/ acetone bath and n-BuLi (2.4 M in hexane) (1.82 mL, 
1.2 equiv, 4.4 mmol) was added dropwise. On complete addition the mixture was stirred for an 
hour at -78 oC before the dropwise addition of  359 (827 mg, 3.63 mmol). The reaction mixture 
was allowed to warm to rt over 16 hours. The mixture was quenched NH4Cl (20 mL), the 
organic layer was removed and the aqueous layer extracted with Et2O (3 × 10 mL). The 
combined organic portions were washed with brine (20 mL), dried over Na2SO4, filtered, 
concentrated under reduced pressure and purified by column chromatography (hexane) 
providing 360 (376 mg, 57%) as a pale yellow oil; Rf 0.50 (19:1 hexane:EtOAc); 
1H NMR (300 
MHz, CDCl3): δ = 5.99 – 5.74 (m, 2H), 5.38 – 5.03 (m, 4H), 4.26 (s, 2H), 4.06 (dt, J = 5.8, 1.3 
Hz, 2H), 2.81 – 2.72 (m, 2H), 2.55 – 2.43 (m, 2H); 13C NMR (101 MHz, CDCl3): δ = 135.7 
(CH), 134.2 (CH), 118.0 (CH2), 117.0 (CH2), 90.7 (C), 90.7 (C), 70.5 (CH2), 58.4 (CH2), 34.7 
(CH2), 33.5 (CH2); IR (neat): ν = 3080, 2980, 2847, 2179, 1641, 1420, 1279, 1124, 1074, 991, 
917; HR-MS (AP-TOF): m/z: calcd for C10H15OS: 183.0844, found 183.0852 [M + H]
+.  
But-3-en-1-yl(3-(cinnamyloxy)prop-1-yn-1-yl)sulfane (361) 
To a flame dried (50 mL) 3 neck RBF was added alkyne 
153 (692 mg, 1.1 equiv, 4.00 mmol) and THF (20 mL). 
The mixture was cooled to -78 oC in a dry ice/ acetone bath and n-BuLi (2.35 M in hexane) 
(1.87 mL, 1.2 equiv, 4.4 mmol) was added dropwise. On complete addition the mixture was 
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stirred for an hour at -78 oC before the dropwise addition of 359 (820 mg, 1.0 equiv, 3.6 mmol). 
The reaction mixture was allowed to warm to rt over 16 hours. The mixture was quenched 
NH4Cl (20 mL), the organic layer was removed and the aqueous layer extracted with Et2O (3 × 
10 mL). The combined organics were washed with brine (20 mL), dried over Na2SO4, filtered, 
concentrated under reduced pressure and purified by column chromatography (hexane) 
providing 361 (683 mg, 66%) as a pale yellow oil; Rf 0.41 (hexane); 
1H NMR (300 MHz, 
CDCl3): δ = 7.29 (m, 5H), 6.67 (d, J = 15.9 Hz, 1H), 6.32 (dt, J = 15.9, 6.2 Hz, 1H), 5.87 (ddt, 
J = 16.9, 10.2, 6.6 Hz, 1H), 5.23 – 5.07 (m, 2H), 4.34 (s, 2H), 4.27 (d, J = 6.2 Hz, 2H), 2.80 (t, 
J = 7.4 Hz, 2H), 2.55 –  2.45 (m, 2H); 13C NMR (101 MHz, CDCl3): δ = 136.7 (C), 135.7 (CH), 
133.4 (CH), 128.7 (2CH), 127.9 (CH), 126.7 (2CH), 125.3 (CH), 117.0 (CH2), 90.7 (C), 70.1 
(C), 58.3 (CH2), 34.7 (CH2), 33.5 (CH2); IR (neat): ν = 3027, 2845, 2179, 1640, 1495, 1448, 
1350, 1073, 966, 916, 744, 692; HR-MS (ES-TOF): m/z: calcd for C16H19OS: 259.1157, found 
259.1159 [M + H]+.  
2-((But-3-en-1-ylthio)ethynyl)furan (362) 
362 was prepared according to GP10 using dibromoolefin 229 (670 
mg, 2.66 mmol), n-BuLi (2.4 M in hexanes) (2.32 mL, 5.57 mmol), 
331 (552 mg, 2.42 mmol). The reaction time was 18 hours. Aqueous workup and purification 
by column chromatography (pentane) provided 362 (191 mg, 44%) as a colourless oil; Rf 0.50 
(hexane); 1H NMR (300 MHz, CDCl3): δ = 7.39 (dd, J = 1.9, 0.7 Hz, 1H), 6.64 (dd, J = 3.4, 0.7 
Hz, 1H), 6.39 (dd, J = 3.4, 1.9 Hz, 1H), 5.85 (ddt, J = 17.0, 10.2, 6.6 Hz, 1H), 5.15 (dd, J = 
17.0, 1.6 Hz, 1H), 5.09 (dd, J = 10.2, 1.6 Hz, 1H), 2.84 (t, J = 7.5 Hz, 2H), 2.53 (dt, J = 7.5, 6.6 
Hz, 2H); 13C NMR (101 MHz, CDCl3): δ = 144.1 (CH), 137.4 (C), 135.6 (CH), 117.1 (CH2), 
117.1 (CH), 111.2 (CH), 85.3 (C), 83.4 (C), 35.3 (CH2), 33.5 (CH2); IR (neat): ν = 3079, 2979, 
205 
 
2925, 2154, 1640, 1565, 1461, 1015, 917, 745; HR-MS (EI-TOF): m/z: calcd for C10H10OS: 
178.0452, found 178.0454 [M + H]+. 
But-3-en-1-yl(naphthalen-2-ylethynyl)sulfane (365) 
365 was prepared according to GP10 using dibromoolefin 344 
(550 mg, 1.76 mmol), n-BuLi (1.54 mL, 3.69 mmol) and 359 
(365 mg, 1.60 mmol). The reaction time was 18 hours. Aqueous 
work-up and purification by column chromatography (hexane) provided 365 (248 mg, 65%) as 
a colourless oil; Rf 0.26 (hexane); 
1H NMR (300 MHz, CDCl3): δ = 7.94 (s, 1H), 7.86 – 7.73 
(m, 3H), 7.51-7.45 (m, 3H), 5.91 (ddt, J = 17.0, 10.2, 6.6 Hz, 1H), 5.19 (dd, J = 17.0, 1.6 Hz, 
1H), 5.10 (dd, J = 10.2, 1.6 Hz, 1H), 2.91 (t, J = 7.5 Hz, 2H), 2.61 (dt, J = 7.5, 6.6 Hz, 2H); 13C 
NMR (101 MHz, CDCl3): δ = 135.7 (CH), 133.1 (C), 132.8 (C), 131.3 (CH), 128.4 (CH), 128.1 
(CH), 127.9 (CH), 127.8 (CH), 126.7 (2CH), 120.9 (C), 117.0 (CH2), 93.9 (C), 79.7 (C), 35.1 
(CH2), 33.7 (CH2); IR (neat): ν = 3057, 2979, 2928, 2156, 1640, 1626, 1596, 1501, 1272, 918, 
857, 816, 746; HR-MS (ES-TOF): m/z: calcd for C16H15S: 239.0894, found 239.0899 [M + H]
+. 
(R)-But-3-en-1-yl(4,8-dimethylnon-7-en-1-yn-1-yl)sulfane (366) 
366 was prepared according to GP10 using dibromoolefin 
348 (828 mg, 2.67 mmol), n-BuLi (2.4 M in hexanes) 
(2.21 mL, 5.52 mmol), 359 (547 mg, 2.40 mmol) and THF (20 mL). The reaction time was 16 
hours. Aqueous workup and purification by column chromatography (hexane) provided 338 
(346 mg, 62%) as a colourless oil; Rf 0.33 (hexane); [α]D 
21 11.60 (c 0.010 in CHCl3); 
1H NMR 
(300 MHz, CDCl3): δ = 5.84 (ddt, J = 16.9, 10.2, 6.6 Hz, 1H), 5.17 – 5.03 (m, 3H), 2.76 – 2.68 
(m, 2H), 2.53 – 2.43 (m, 2H), 2.24 (qd, J = 16.8, 6.2 Hz, 2H), 1.98 (dd, J = 15.1, 7.5 Hz, 2H), 
1.75 – 1.58 (m, 7H), 1.52 – 1.37 (m, 1H), 1.32 – 1.16 (m, 1H), 0.98 (d, J = 6.7 Hz, 3H); 13C 
NMR (101 MHz, CDCl3): δ = 136.1 (CH), 131.6 (C), 124.6 (CH), 116.7 (CH2), 93.7 (C), 68.8 
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(C), 36.2 (CH2), 34.8 (CH2), 33.6 (CH2), 32.5 (CH), 27.5 (CH2), 25.9 (CH3), 25.7 (CH2), 19.6 
(CH3), 17.8 (CH3); IR (neat): ν = 2964, 2914, 1641, 1445, 1377, 1277, 1222, 993, 916, 825; 
HR-MS (EI-TOF): m/z: calcd for C15H24S: 236.1599, found 236.1604 [M + H]
+. 
But-3-en-1-yl(cyclohexylethynyl)sulfane (367) 
367 was prepared according to GP10 using dibromoolefin 347 (630 
mg, 2.35 mmol), n-BuLi (2.5M in hexanes) (1.97 mL, 4.91 mmol), 
359 (448 mg, 2.14 mmol) and THF (10 mL). The reaction time was 
17 hours. Aqueous work-up and purification by column chromatography (hexane) provided 367 
(260 mg, 63%) as a colourless oil; Rf 0.34 (hexane); 
1H NMR (300 MHz, CDCl3): δ = 5.85 (ddt, 
J = 17.0, 10.2, 6.6 Hz, 1H), 5.12 (dd, J = 17.0. 1.6 Hz, 1H), 5.07 (dd, J = 10.2, 1.6 Hz, 1H), 
2.71 (t, J = 7.2 Hz, 2H), 2.55 – 2.41 (m, 3H), 1.73 (ddt, J = 14.7, 12.0, 6.0 Hz, 4H), 1.55 – 1.37 
(m, 3H), 1.37 – 1.20 (m, 3H); 13C NMR (101 MHz, CDCl3): δ = 136.1 (CH), 116.7 (CH2), 99.0 
(C), 67.9 (C), 34.8 (CH2), 33.5 (2CH2), 32.8 (CH2), 30.5 (CH), 26.0 (2CH2), 25.0 (CH2); IR 
(neat): ν = 2928, 2853, 1641, 1496, 1447, 993, 910, 730; HR-MS (ES-TOF): m/z: calcd for 
C12H18S: 194.1129, found 194.1134 [M + H]
+. 
Methyl-4-((but-3-en-1-ylthio)ethynyl)benzoate (368) 
368 was prepared according to GP11 using terminal alkyne 
(333 mg, 2.08 mmol), LiHMDS 1 M (2.08 mL, 2.08 mmol), 
359 (432 mg, 1.89 mmol) and THF (10 mL). The reaction 
time was 16 hours. Aqueous work-up and purification by column chromatography (hexane) 
provided 368 (428 mg, 92%) as a colourless oil; Rf 0.15 (hexane); 
1H NMR (300 MHz, CDCl3): 
δ = 7.96 (d, J = 8.2 Hz, 2H), 7.43 (d, J = 8.2 Hz, 2H), 5.87 (ddt, J = 17.0, 10.2, 6.6 Hz, 1H), 
5.16 (dd, J = 17.0, 1.6 Hz, 1H), 5.11 (d, J = 10.2, 1,6 Hz, 1H), 3.91 (s, 3H), 2.88 (t, J = 7.3 Hz, 
2H), 2.63 – 2.51 (m, 2H); 13C NMR (101 MHz, CDCl3): δ = 166.7 (C), 135.5 (CH), 131.0 
207 
 
(2CH), 129.6 (2CH), 129.1 (C), 128.3 (C), 117.2 (CH2), 93.1 (C), 83.5 (C), 52.3 (CH3), 35.1 
(CH2), 33.6 (CH2); IR (neat): ν = 2951, 2162, 1717, 1603, 1434, 1270, 1174, 1270, 1174, 1105, 
1017, 855, 766; HR-MS (ES-TOF): m/z: calcd for C14H15O2S: 247.0793, found 247.0789 [M + 
H]+. 
But-3-en-1-yl((2-isopropylphenyl)ethynyl)sulfane (369) 
369 was prepared according to GP11 using alkyne 354 (300 mg, 2.08 
mmol), LiHMDS (1 M, 2.08 mL, 2.08 mmol), 359 (431 mg, 1.89 
mmol) and THF (10 mL). The reaction time was 20 hours. Aqueous 
workup and purification by column chromatography (hexane) provided 369 (350 mg, 80%) as 
a colourless oil; Rf 0.64 (hexane); 
1H NMR (300 MHz, CDCl3): δ = 7.39 (dd, J = 4.6, 3.6 Hz, 
1H), 7.29 – 7.24 (m, 2H), 7.12 (ddd, J = 7.7, 5.2, 3.6 Hz, 1H), 5.89 (ddt, J = 17.0, 10.2, 6.6 Hz, 
1H), 5.16 (dd, J = 17.0, 1.6 Hz, 1H), 5.11 (dd, J = 10.2, 1.6 Hz, 1H), 3.51 – 3.35 (m, 1H), 2.87 
(t, J = 7.4 Hz, 2H), 2.58 (dt, J = 7.4, 6.6 Hz, 2H), 1.28 (s, 3H), 1.25 (s, 3H); 13C NMR (101 
MHz, CDCl3): δ = 150.5 (C), 135.8 (CH), 132.3 (CH), 128.5 (CH), 125.6 (CH), 125.0 (CH), 
122.4 (C), 117.0 (CH2), 92.3 (C), 82.4 (C), 35.2 (CH2), 33.8 (CH2), 31.7 (CH), 23.3 (2CH3); IR 
(neat): ν = 3048, 2961, 2927, 2868, 2163, 1641, 916, 754. No success was found in obtaining a 
HRMS for this compound, however the HRMS for the corresponding sulfoxide was obtained. 
((2-Bromophenyl)ethynyl)(but-3-en-1-yl)sulfane (370) 
370 was prepared according to GP11 using 2-bromophenylacetylene 
(195 mg, 1.08 mmol), LiHMDS 1 M (1.08 mL, 1.08 mmol), 359 (223 
mg, 0.98 mmol) and THF (5 mL). The reaction time was 16 hours. 
Aqueous work-up and purification by column chromatography (hexane) provided 370 (183 mg, 
70%) as a colourless oil; Rf 0.30 (hexane); 
1H NMR (300 MHz, CDCl3): δ = 7.56 (dd, J = 8.0, 
1.1 Hz, 1H), 7.42 (dd, J = 7.7, 1.7 Hz, 1H), 7.24 (app dt, J = 7.7, 1.4 Hz, 1H), 7.17 – 7.08 (m, 
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1H), 5.88 (ddt, J = 17.0, 10.2, 6.6 Hz, 1H), 5.18 (dd, J = 17.0, 1.6 Hz, 1H), 5.11 (dd, J = 10.2, 
1.6 Hz, 1H), 2.90 (t, J = 7.4 Hz, 2H), 2.63 (dt, J = 7.4, 6.6 Hz, 2H); 13C NMR (101 MHz, 
CDCl3): δ = 135.7 (CH), 132.8 (CH), 132.5 (CH), 129.0 (CH), 126.9 (CH), 125.7 (C), 125.0 
(C), 117.1 (CH2), 92.2 (C), 84.9 (C), 35.2 (CH2), 33.7 (CH2); IR (neat): ν = 3075, 2978, 2926, 
2170, 1640, 1585, 1465, 1432, 1025, 918, 750; HR-MS (ES-TOF): m/z: calcd for C12H12S
79Br: 
266.9843, found 266.9841 [M + H]+. 
((4-Bromophenyl)ethynyl)(but-3-en-1-yl)sulfane (371) 
371 was prepared according to GP11 using 
4- bromophenylacetylene (240 mg, 1.32 mmol), LiHMDS 1 M 
(1.32 mL, 1.32 mmol), 359 (275 mg, 1.21 mmol) and THF (7 
mL). The reaction time was 16 hours. Aqueous work-up and purification by column 
chromatography (hexane) provided 371 (190 mg, 59%) as a colourless oil; Rf 0.59 (hexane); 
1H 
NMR (300 MHz, CDCl3): δ = 7.25 (d, J = 8.6 Hz, 2H) 7.08 (d, J = 8.6 Hz, 2H), 5.68 (ddt, J = 
17.0, 10.2, 6.6 Hz, 1H), 4.97 (dd, J = 17.0, 1.6 Hz, 1H), 4.92 (dd, J = 10.2, 1.6 Hz, 1H), 2.68 
(t, J = 7.4 Hz, 2H), 2.39 (dt, J = 7.4, 6.6 Hz, 2H); 13C NMR (101 MHz, CDCl3): δ = 135.6 (CH), 
132.9 (2CH), 131.7 (2CH), 122.5 (C), 122.3 (C), 117.1 (CH2), 92.4 (C), 80.8 (C), 35.0 (CH2), 
33.6 (CH2); IR (neat): ν = 3078, 2978, 2925, 2164, 1640, 1583, 1483, 1393, 1069, 1009, 819; 
HR-MS (ES-TOF): m/z: calcd for C12H12S
79Br: 266.9843, found 266.9837 [M + H]+. 
But-3-en-1-yl((3-methoxyphenyl)ethynyl)sulfane (373) 
373 was prepared according to GP11 using 3-
methoxyphenylacetylene (265 mg, 2.00 mmol), LiHMDS (1 M, 2.00 
mL, 2.00 mmol), 359 (415 mg, 1.82 mmol) and THF (10 mL). The 
reaction time was 16 hours. Aqueous workup and purification by column chromatography 
(hexane) provided 373 (346 mg, 91%) as a colourless oil; Rf 0.18 (hexane); 
1H NMR (300 MHz, 
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CDCl3): δ = 7.21 (t, J = 8.1 Hz, 1H), 7.04 – 6.98 (m, 1H), 6.94 (dd, J = 2.6, 1.4 Hz, 1H), 6.85 
(ddd, J = 8.1, 2.6, 1.0 Hz, 1H), 5.88 (ddt, J = 17.1, 10.2, 6.6 Hz, 1H), 5.16 (dd, J = 17.1, 1.6 
Hz, 1H), 5.10 (dd, J = 10.2, 1.6 Hz, 1H), 3.80 (s, 3H), 2.86 (t, J = 7.5 Hz, 2H), 2.57 (dt J = 7.5, 
6.6 Hz, 2H); 13C NMR (101 MHz, CDCl3): δ = 159.4 (C), 135.8 (CH), 129.5 (CH), 124.3 (C), 
124.1 (CH), 117.0 (CH2), 116.3 (CH), 114.8 (CH), 93.4 (C), 79.2 (C), 55.4 (CH3), 35.0 (CH2), 
33.6 (CH2); IR (neat): ν = 3076, 2962, 2935, 2835, 2162, 1640, 1593, 1573, 1283, 1157, 1041, 
775, 684; HR-MS (ES-TOF): m/z: calcd for C13H15OS: 219.0844, found 219.0838 [M + H]
+. 
3-Bromo-2-((but-3-en-1-ylthio)ethynyl)thiophene (374) 
374 was prepared according to GP1 using 351 (335 mg, 1.78 mmol), 
LiHMDS (1 M, 1.78 mL, 1.78 mmol), 359 (369 mg, 1.62 mmol) and 
THF (9 mL). The reaction time was 16 hours. Aqueous work-up and purification by column 
chromatography (hexane) provided 374 (238 mg, 55%) as a yellow oil; Rf 0.47 (hexane); 
1H 
NMR (300 MHz, CDCl3): δ = 7.19 (d, J = 5.4 Hz, 1H), 6.95 (d, J = 5.4 Hz, 1H), 5.87 (ddt, J = 
17.0, 10.2, 6.6 Hz, 1H), 5.18 (dd, J = 17.1, 1.6 Hz, 1H), 5.11 (dd, J = 10.2, 1.6 Hz, 1H), 2.87 
(t, J = 7.4 Hz, 2H), 2.60 (dt, J = 7.4, 6.6 Hz, 2H); 13C NMR (101 MHz, CDCl3): δ = 135.6 (CH), 
130.1 (CH), 127.4 (CH), 121.3 (C), 117.2 (CH2), 117.1 (C), 88.4 (C), 84.5 (C), 35.4 (CH2), 33.5 
(CH2); IR (neat): ν = 3105, 3081, 2978, 2925, 2153, 1640, 1499, 1416, 917, 862, 708; HR-MS 
(ES-TOF): m/z: calcd for C10H9S2
79Br: 271.9329, found 271.9335 [M + H]+. 
But-3-en-1-yl(3,3-dimethylbut-1-yn-1-yl)sulfane (375) 
375 was prepared according to GP11 using 3,3-dimethyl-1-butyne (400 
µL, 3.30 mmol), LiHMDS (1 M, 3.30 mL, 3.30 mmol), 359 (678 mg, 
3.00 mmol) and THF (10 mL). The reaction time was 20 hours. Aqueous workup and 
purification by column chromatography (hexane) provided 374 (336 mg, 67%) as a colourless 
oil; Rf 0.33 (hexane); 
1H NMR (300 MHz CDCl3): δ = 5.85 (ddt, J = 17.2, 10.2, 6.6, 1H), 5.12 
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(dd, J = 17.2, 1.7, 1H), 5.07 (dd, J = 10.2, 1.7, 1H), 2.71 (t, J = 7.2, 2H), 2.48 (td, J = 7.2, 6.6, 
2H), 1.23 (s, 9H); 13C NMR (101 MHz CDCl3): δ = 136.2 (CH), 116.7 (CH2), 103.0 (C), 66.7 
(C), 34.8 (CH2), 33.5 (CH2), 31.2 (3CH3), 29.0 (C); IR (neat): ν = 2963, 2865, 1706, 1640, 
1467, 1393, 1362, 1218, 991, 914, 744. HR-MS (ES-TOF): m/z calculated for C10H16S 
168.0973, found 168.0976 [M + H]+. 
((But-3-en-1-ylsulfinyl)ethynyl)benzene (376) 
376 was prepared according to GP12 using sulfide 355 (266 mg, 
1.41 mmol), mCPBA (243 mg, 1.41 mmol) and CH2Cl2 (14 mL). 
The reaction time was 2 hours. Aqueous work-up and column 
chromatography (9:1 hexane: EtOAc) provided 376 (220 mg, 77%) as a colourless oil; Rf 0.67 
(1:1 hexane:EtOAc); 1H NMR (300 MHz, CDCl3): δ = 7.58 – 7.50 (m, 2H), 7.50 – 7.34 (m, 
3H), 5.90 (ddt, J = 17.0, 10.2, 6.6 Hz, 1H), 5.21 (dd, J = 17.0, 1.5 Hz, 1H), 5.15 (dd, J = 10.2, 
1.5 Hz, 1H), 3.23 (ddd, J = 8.0, 7.2, 1.0 Hz, 2H), 2.82 – 2.60 (m, 2H); 13C NMR (101 MHz, 
CDCl3): δ = 134.6 (CH), 132.4 (2CH), 130.8 (CH), 128.8 (2CH), 119.9 (C), 117.7 (CH2), 102.7 
(C), 85.1 (C), 55.4 (CH2), 26.7 (CH2); IR (neat): ν = 3068, 2920, 2164, 1719, 1574, 1282, 1244, 
1057, 1023, 917, 832, 753, 688; HRMS (ES) m/z calculated for C12H12OSNa 227.0507, found 
227.0504 [M + Na]+. 
1-((But-3-en-1-ylsulfinyl)ethynyl)-4-methoxybenzene (377) 
377 was prepared according to GP3 using 357 (151 mg, 0.69 
mmol), mCPBA (120 mg, 0.69 mmol) and CH2Cl2 (7 mL). The 
reaction time was 2 hours. Aqueous work-up followed by 
column chromatography (4:1 hexane: EtOAc) provided 377 (124 mg, 75%) as a colourless oil; 
Rf 0.11 (4:1 hexane: EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 7.48 (d, J = 8.9 Hz, 2H), 6.89 
(d, J = 8.9 Hz, 2H,), 5.90 (ddt, J = 16.9, 10.1, 6.6 Hz, 1H), 5.21 (dd, J = 16.9, 1.5 Hz, 1H), 5.15 
211 
 
(dd, J = 10.1, 1.5 Hz, 1H), 3.84 (s, 3H), 3.21 (t, J = 7.2 Hz, 2H), 2.79 – 2.61 (m, 2H); 13C NMR 
(101 MHz, CDCl3): δ = 161.6 (C), 139.3 (C), 134.7 (CH), 134.3 (2CH), 117.6 (CH2), 114.5 
(2CH), 103.4 (C), 84.1 (C), 55.6 (CH3), 55.4 (CH2), 26.8 (CH2); IR (neat): ν = 3077, 2918, 
2840, 2156, 1641, 1602, 1507, 1295, 1251, 1172, 1024, 832, 762; HR-MS (ES-TOF): m/z: calcd 
for C13H15O2S: 235.0793, found 235.0799 [M + H]
+. 
1-((But-3-en-1-ylsulfinyl)ethynyl)-4-methylbenzene (378) 
378 was prepared according to GP12 using 356 (180 mg, 0.89 
mmol), mCPBA (154 mg, 0.89 mmol) and CH2Cl2 (9 mL). The 
reaction time was 2 hours. Aqueous work-up and  purification by 
column chromatography (9:1 hexane: EtOAc) provided 378 (143 mg, 74%) as a pale yellow 
oil; Rf 0.24 (4:1 hexane: EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 7.43 (d, J = 8.0 Hz, 2H), 
7.19 (d, J = 8.0 Hz, 2H), 5.89 (ddt, J = 17.0, 10.1, 6.6 Hz, 1H), 5.21 (dd, J = 17.0, 1.5 Hz, 1H), 
5.14 (dd, J = 10.2, 1.5 Hz, 1H), 3.29 – 3.14 (m, 2H), 2.84 – 2.57 (m, 2H), 2.39 (s, 3H); 13C 
NMR (101 MHz, CDCl3): δ = 141.4 (C), 134.6 (CH), 132.4 (2CH), 129.5 (2CH), 117.6 (CH2), 
116.8 (C), 103.2 (C), 84.5 (C), 55.4 (CH2), 26.7 (CH2), 21.9 (CH3); IR (neat): ν = 2923, 2243, 
2162, 1605, 1508, 1055, 908, 817, 730; HR-MS (ES-TOF): m/z: calcd for C13H14OSNa: 
241.0663, found 241.0670 [M + Na]+. 
1-((But-3-en-1-ylsulfinyl)ethynyl)-4-fluorobenzene (379) 
379 was prepared in 2 steps starting from dibromoolefin 345. 
Prepared according to GP10 using dibromoolefin 345 (840 mg, 
3.0 mmol), n-BuLi (2.7 mL, 6.2 mmol), THF (15 mL) and 359 
(616 mg, 2.7 mmol). The reaction time was 16 hours. Purification by column chromatography 
(hexane) afforded 363 (90% pure) 65%. 379 was prepared according to GP3 using 363 (97 mg, 
0.47 mmol), mCPBA (81 mg, 0.47 mmol) and CH2Cl2 (5 mL). The reaction time was 2 hours. 
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Aqueous workup and purification by column chromatography (9:1 hexane: EtOAc) provided 
379 (76 mg, 73%) as a colourless oil; Rf 0.19 (9:1 hexane:EtOAc); 
1H NMR (300 MHz, CDCl3): 
δ = 7.65 – 7.46 (m, 2H), 7.17 – 7.00 (m, 2H), 5.89 (ddt, J = 17.0, 10.2, 6.6 Hz, 1H), 5.21 (dd, J 
= 17.0, 1.5 Hz, 1H), 5.15 (dd, J = 10.2, 1.5 Hz, 1H), 3.31 – 3.13 (m, 2H), 2.82 – 2.59 (m, 2H); 
13C NMR (101 MHz, CDCl3): δ = 164.0 (d, J = 253.6 Hz, C), 134.6 (d, J = 8.8 Hz, 2CH), 134.4 
(CH), 117.7 (CH2), 116.3 (d, J = 22.4 Hz, 2CH), 116.0 (d, J = 2.8 Hz, C) 101.6 (C), 85.0 (C), 
55.3 (CH2), 26.7 (CH2); IR (neat): ν = 3077, 2981, 2919, 2165, 1641, 1598, 1505, 1233, 1216, 
1157, 1054, 918, 837, 775; HR-MS (ES-TOF): m/z: calcd for C12H12OSF: 223.0593, found 
223.0601 [M + H]+. 
1-((But-3-en-1-ylsulfinyl)ethynyl)-4-(trifluoromethyl)benzene (380) 
380 was prepared in 2 steps according to GP10 and GP12 
starting from dibromoolefin 346 (825 mg, 2.50 mmol), n-BuLi 
(2.18 mL, 5.23 mmol), 359 (517 mg, 2.27 mmol) and THF (12 
mL). The reaction time was 16 hours. Aqueous work-up and 
removal of most impurities by column chromatography (hexane) provided the crude sulfide 364 
(537 mg). Sulfide 364 (195 mg) was dissolved in CH2Cl2 (7 mL), the mixture was cooled to 0 
oC and mCPBA (118 mg, 0.68 mmol) was added in 5 portions over 10 minutes. The reaction 
time was 2 hours. The mixture was washed with NaHCO3 (10 mL) and the aqueous phase was 
extracted with CH2Cl2 (3 × 10 mL). The combined organic layers were dried over Na2SO4, 
filtered, concentrated and purified by column chromatography (9:1 hexane:EtOAc) to yield 380 
(130 mg, 59% over 2 steps); 1H NMR (300 MHz, CDCl3): δ = 7.65 (s, 4H), 5.89 (ddt, J = 16.9, 
10.1, 6.6 Hz, 1H), 5.26 – 5.13 (m, 2H), 3.31 – 3.18 (m, 2H), 2.84 – 2.60 (m, 2H); 13C NMR 
(101 MHz, CDCl3): δ = 134.3 (CH), 134.7 (q, J = 32.6 Hz, C) 132.6 (2CH), 125.8 (d, J = 3.2 
Hz, 2CH), 123.6 (q, J = 271.4 Hz, C), 123.6 (C), 117.9 (CH2), 100.6 (C), 87.4 (C), 55.3 (CH2), 
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26.7 (CH2); IR (neat): ν = 2981, 2170, 1643, 1615, 1321, 1241, 1128, 1065, 842, 655; HR-MS 
(ES-TOF): m/z: calcd for C13H11OF3NaS : 295.0380, found 295.0371 [M + Na]
+.  
1-Bromo-4-((but-3-en-1-ylsulfinyl)ethynyl)benzene (381) 
381 was prepared according to GP12 using 371 (180 mg, 0.67 
mmol), mCPBA (117 mg, 0.67 mmol) and CH2Cl2 (7 mL). The 
reaction time was 2 hours. Aqueous work-up and purification by 
column chromatography (9:1 hexane: EtOAc) provided 381 (153 mg, 80%) as a yellow oil; Rf 
0.15 (9:1 hexane: EtOAc); 1H NMR (300 MHz, CDCl3): δ = 7.53 (d, J = 8.4 Hz, 2H), 7.39 (d, 
J = 8.4 Hz, 2H), 5.89 (ddt, J = 17.0, 10.2, 6.6 Hz, 1H), 5.21 (dd, J = 17.0, 1.4 Hz, 1H), 5.15 
(dd, J = 10.2, 1.4 Hz, 1H), 3.34 – 3.12 (m, 2H), 2.85 – 2.55 (m, 2H); 13C NMR (101 MHz, 
CDCl3): δ = 134.4 (CH), 133.7 (2CH), 132.2 (2CH), 125.6 (C), 118.7 (C), 117.8 (CH2), 101.5 
(C), 86.2 (C), 55.3 (CH2), 26.7 (CH2); IR (neat): ν = 3080, 2978, 2914, 2163, 1640, 1583, 1483, 
1394, 1056, 762; HR-MS (ES-TOF): m/z: calcd for C12H11ONaS
79Br: 304.9612, found 
304.9620 [M + Na]+ 
1-Bromo-2-((but-3-en-1-ylsulfinyl)ethynyl)benzene (382) 
382 was prepared according to GP12 using 370 (175 mg, 0.65 
mmol), mCPBA (114 mg, 0.65 mmol) and CH2Cl2 (7 mL). The 
reaction time was 2 hours. Aqueous work-up and purification by 
column chromatography (9:1 hexane: EtOAc) provided 382 (157 mg, 85%) as a yellow oil; Rf  
0.15 (9:1 hexane: EtOAc); 1H NMR (300 MHz, CDCl3): δ = 7.68 – 7.54 (m, 2H), 7.40 – 7.26 
(m, 2H), 5.90 (ddt, J = 17.0, 10.1, 6.6 Hz, 1H), 5.22 (dd, J = 17.0, 1.5 Hz, 1H), 5.15 (dd, J = 
10.1, 1.5 Hz, 1H), 3.35 – 3.20 (m, 2H), 2.87 – 2.63 (m, 2H); 13C NMR (101 MHz, CDCl3): δ = 
134.5 (CH), 134.4 (CH), 132.9 (CH), 131.8 (CH), 127.5 (CH), 126.1 (C), 122.3 (C), 117.7 
(CH2), 100.0 (C), 89.2 (C), 55.4 (CH2), 26.7 (CH2); IR (neat): ν = 3077, 2979, 2917, 2167, 
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1675, 1640, 1584, 1057, 1045, 754; HR-MS (ES-TOF): m/z: calcd for C12H12OS
79Br: 282.9808, 
found 282.9792 [M + H]+.  
1-((But-3-en-1-ylsulfinyl)ethynyl)-3-methoxybenzene (383) 
383 was prepared according to GP12 using 373 (218 mg, 1.00 
mmol), mCPBA (173 mg, 1.00 mmol) and CH2Cl2 (10 ml). The 
reaction time was 2 hours. Aqueous work-up and purification by 
column chromatography (8:2 hexane: EtOAc) afforded 383 (170 mg 
72%) as a yellow oil; 1H NMR (300 MHz, CDCl3): δ = 7.32 – 7.25 (m, 1H), 7.16 – 7.09 (m, 
1H), 7.08 – 6.96 (m, 2H), 5.89 (ddt, J = 16.8, 10.2, 6.6 Hz, 1H), 5.26 – 5.11 (m, 2H), 3.81 (s, 
3H), 3.23 (ddd, J = 8.1, 7.1, 1.2 Hz, 2H), 2.85 – 2.58 (m, 2H); 13C NMR (101 MHz, CDCl3): δ 
= 159.5 (C), 134.5 (CH), 129.9 (CH), 124.8 (CH), 120.7 (C), 117.7 (CH2), 117.3 (CH), 117.0 
(CH), 102.6 (C), 84.8 (C), 55.5 (CH3), 55.3 (CH2), 26.7 (CH2); IR (neat): ν = 3076, 2939, 2837, 
2159, 1641, 1594, 1574, 1487, 1287, 1156, 1042, 683; HR-MS (ES-TOF): m/z: calcd for 
C13H15O2S: 235.0793, found 235.0796 [M + H]
+. 
4-((3,3-Dimethylbut-1-yn-1-yl)sulfinyl)but-1-ene (384) 
384 was prepared according to GP12 using 375 (336 mg, 2.00 mmol), 
mCPBA (345 mg, 2.00 mmol) and CH2Cl2 (20 mL). The reaction time 
was 16 hours. Aqueous workup and purification by column chromatography (hexane to 4:1 
hexane: EtOAc) provided 384 (190 mg, 52%) as a colourless oil; Rf 0.21 (4:1 hexane: EtOAc); 
1H NMR (300 MHz CDCl3): δ = 5.81 (ddt, J = 17.1, 10.2, 6.6 Hz, 1H), 5.14 (dd, J = 17.1, 1.4 
Hz, 1H), 5.08 (dd, J = 10.2, 1.4 Hz, 1H), 3.08 (td, J = 7.7, 2.1 Hz, 2H), 2.67 – 2.51 (m, 2H), 
1.25 (s, 9H); 13C NMR (101 MHz CDCl3): δ = 134.7 (CH), 117.5 (CH2), 112.9 (C), 73.2 (C), 
55.5 (CH2), 30.2 (3CH3), 29.9 (C), 26.7 (CH2); IR (neat): ν = 2973, 2928, 2870, 2162, 1720, 
215 
 
1642, 1575, 1456, 1365, 1252, 1141, 1060, 918, 838, 768, 752, 701; HRMS (ES-TOF) m/z 
calculated for C10H17OS [M+H]
+ 185.1000 found 185.1001. 
((But-3-en-1-ylsulfinyl)ethynyl)cyclohexane (385) 
385 was prepared according to GP12 using 367 (225 mg, 1.16 
mmol), mCPBA (200 mg, 1.16 mmol) and CH2Cl2 (12 mL). The 
reaction time was 2 hours. Aqueous workup and purification by 
column chromatography (hexane to 4:1 hexane:EtOAc) provided 385 (140 mg, 57%) as a 
colourless oil; Rf 0.25 (4:1 hexane:EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 5.86 (ddt, J = 
16.8, 10.1, 6.6 Hz, 1H), 5.17 (dd, J = 17.1, 1.5 Hz, 1H), 5.12 (dd, J = 10.2, 1.5 Hz, 1H), 3.09 
(t, J = 7.7 Hz, 2H), 2.74 – 2.50 (m, 3H), 1.91 – 1.77 (m, 2H), 1.76 – 1.66 (m, 2H), 1.60 – 1.45 
(m, 3H), 1.43 – 1.23 (m, 3H); 13C NMR (101 MHz, CDCl3): δ = 134.7 (CH), 117.4 (CH2), 109.4 
(C), 76.8 (C), 55.5 (CH2), 31.6 (CH2), 29.9 (CH), 26.7 (2CH2), 25.7 (2CH2), 24.7 (CH2); IR 
(neat): ν = 2930, 2855, 2177, 1641, 1448, 1057, 915, 650; HR-MS (ES-TOF): m/z: calcd for 
C12H18ONaS: 233.0973, found 233.0976 [M + Na]
+. 
1-((But-3-en-1-ylsulfinyl)ethynyl)-2-isopropylbenzene (386) 
386 was prepared according to GP12 using 369 (230 mg, 1.00 
mmol), mCPBA (173 mg, 1.00 mmol) and CH2Cl2 (10 mL). The 
reaction time was 2 hours. Aqueous work-up and purification by 
column chromatography (17:3 hexane: EtOAc) provided 386 (218 
mg, 89%) as a yellow oil; Rf 0.16 (17:3 hexane: EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 7.50 
(dd, J = 7.7, 1.1 Hz, 1H), 7.41 (td, J = 7.7, 1.4 Hz, 1H), 7.32 (d, J = 6.7 Hz, 1H), 7.19 (td, J = 
7.7, 1.4 Hz, 1H), 5.90 (ddt, J = 17.0, 10.2, 6.6 Hz, 1H), 5.21 (dd, J = 17.0, 1.5 Hz, 1H), 5.15 
(dd, J = 10.2, 1.5 Hz, 1H), 3.39 (dt, J = 13.8, 6.9 Hz, 1H), 3.24 (t, J = 7.7 Hz, 2H), 2.87 – 2.58 
(m, 2H), 1.27 (d, J = 6.9 Hz, 6H); 13C NMR (101 MHz, CDCl3): δ = 152.0 (C), 134.6 (CH), 
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133.4 (CH), 131.2 (CH), 126.0 (CH), 125.5 (CH), 118.6 (C), 117.6 (CH2), 101.7 (C), 88.4 (C), 
55.4 (CH2), 32.0 (CH), 26.8 (CH2), 23.3 (CH3), 23.3 (CH3); IR (neat): ν = 3067, 2963, 2870, 
2157, 1641, 1482, 1444, 1056, 758; HR-MS (ES-TOF): m/z: calcd for C15H19OS: 247.1157, 
found 247.1155 [M + H]+. 
Methyl 4-((but-3-en-1-ylsulfinyl)ethynyl)benzoate (387) 
387 was prepared according to GP12 using 368 (246 mg, 
1.00 mmol), mCPBA (173 mg, 1.00 mmol) and CH2Cl2 (10 
mL). The reaction time was 2 hours. Aqueous work-up and 
purification by column chromatography (17:3 hexane: 
EtOAc) provided 387 (206 mg, 77%) as a pale orange oil; Rf 0.19 (17:3 hexane: EtOAc); 
1H 
NMR (300 MHz, CDCl3): δ = 8.05 (d, J = 8.6 Hz, 2H), 7.60 (d, J = 8.6 Hz, 2H), 5.89 (ddt, J = 
17.0, 10.2, 6.6 Hz, 1H), 5.22 (dd, J = 17.0, 1.5 Hz, 1H), 5.16 (dd, J = 10.2, 1.5 Hz, 1H), 3.93 
(s, 3H), 3.30 – 3.19 (m, 2H), 2.83 – 2.59 (m, 2H); 13C NMR (101 MHz, CDCl3): δ = 166.1 (C), 
134.4 (CH), 132.3 (2CH), 131.8 (C), 129.8 (2CH), 124.2 (C), 117.8 (CH2), 101.3 (C), 87.6 (C), 
55.3 (CH2), 52.6 (CH3), 26.7 (CH2); IR (neat): ν = 2952, 2166, 1436, 1275, 1107, 1060, 769; 
HR-MS (ES-TOF): m/z: calcd for C14H14O3NaS: 285.0561, found 285.0567 [M + Na]
+. 
N-(4-((but-3-en-1-ylsulfinyl)ethynyl)phenyl)acetamide (388) 
To a flame dried 2 neck RBF under argon was added 350 (320 
mg, 1.01 mmol, 1.1 eq.) and anhydrous THF (10 mL). The 
flask was cooled to -78 oC using a dry ice/ acetone bath. 
LiHMDS (1 M in ethylbenzene) (4.02 mL, 4.02 mmol, 2.2 eq.) was added dropwise and on 
complete addition the mixture was stirred at -78 oC for an hour before 359 (417 mg, 1.83 mmol, 
1.0 eq.) was added dropwise. The reaction was allowed to warm to rt for 16 hours. The reaction 
was quenched with NH4Cl (10 mL of a saturated solution) and the mixture was extracted with 
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Et2O (3 × 10 mL), the organics were washed with brine (10 mL), dried over Na2SO4, filtered, 
concentrated under reduced pressure and most impurities were removed by column 
chromatography (7:3 hexane: EtOAc) to provide (370 mg) of a 1.8:1 ratio of sulfide 372 to 
alkyne. (372 was used as a 1.8:1 mixture of alkynyl sulfide to alkyne) 388 was prepared 
according to GP12 using 372 (225 mg, 0.92 mmol), mCPBA (158 mg, 0.92 mmol) and CH2Cl2 
(9 mL). The reaction time was 2 hours. Aqueous workup and purification by column 
chromatography (1:1 hexane: EtOAc) to (EtOAc) provided 388 (176 mg, 74%) as a yellow 
solid; Rf 0.20 (1:1 hexane: EtOAc); mp: 73-74 
oC; 1H NMR (300 MHz, CDCl3): δ = 8.17 (s, 
1H), 7.57 (d, J = 8.6 Hz, 2H), 7.37 (d, J = 7.0 Hz, 2H), 5.89 (ddt, J = 16.8, 10.1, 6.6 Hz, 1H), 
5.27 – 5.10 (m, 2H), 3.32 – 3.15 (m, 2H), 2.81 – 2.56 (m, 2H), 2.19 (s, 3H); 13C NMR (101 
MHz, CDCl3): δ = 169.0 (C), 140.7 (C), 134.4 (CH), 133.5 (2CH), 119.6 (2CH), 117.8 (CH2), 
114.4 (C), 103.7 (C), 84.3 (C), 55.3 (CH2), 26.8 (CH2), 24.8 (CH3); IR (neat): ν = 3307, 3257, 
3096, 2980, 2163, 1688, 1592, 1525, 1509, 1313, 1022, 839; HR-MS (ES-TOF): m/z: calcd for 
C14H16NO2S: 262.0902, found 262.0900 [M + H]
+.  
2-((But-3-en-1-ylsulfinyl)ethynyl)furan (389) 
389 was prepared according to GP12 from 362 (54.3 mg, 0.30 mmol), 
mCPBA (52.0 mg, 0.30 mmol) and CH2Cl2 (3 mL). The reaction time 
was 16 hours. Aqueous workup and purification by column 
chromatography (4:1 hexane: EtOAc) provided 389 (41.4 mg, 70%) as a colourless oil; Rf 0.83 





390 was prepared according to GP12 from 374 (82.0 mg, 0.30 mmol), 
mCPBA (52.0 mg, 0.30 mmol) and CH2Cl2 (3 mL). The reaction time 
was 16 hours. Aqueous workup and purification by column 
chromatography (4:1 hexane: EtOAc) provided 390 (60.7 mg, 70%) as a colourless oil; Rf 0.81 
(1:1 hexane: EtOAc). On solvent removal the product was unstable and was used directly in the 
catalysis reaction.  
4-((3-(Allyloxy)prop-1-yn-1-yl)sulfinyl)but-1-ene (391) 
391 was prepared according to GP12 using 360 (249 mg, 1.36 
mmol), mCPBA (233 mg, 1.36 mmol) and CH2Cl2 (13 mL). The 
reaction time was 2 hours. Aqueous workup and purification by column chromatography (4:1 
hexane: EtOAc) provided 363 (217 mg, 80%) as a colourless oil; Rf 0.25 (7:3 hexane: EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 5.95 – 5.76 (m, 2H), 5.36 – 5.08 (m, 4H), 4.34 (s, 2H), 4.06 
(dt, J = 5.8, 1.3 Hz, 2H), 3.14 (dd, J = 11.6, 4.1 Hz, 2H), 2.76 – 2.51 (m, 2H); 13C NMR (101 
MHz, CDCl3): δ = 134.3 (CH), 133.3 (CH), 118.7 (CH2), 117.7 (CH2), 99.7 (C), 82.9 (C), 71.3 
(CH2), 57.3 (CH2), 55.1 (CH2), 26.5 (CH2); IR (neat): ν = 3081, 2850, 2181, 1641, 1435, 1351, 
1058, 990, 919; HR-MS (ES-TOF): m/z: calcd for C10H15O2S: 199.0793, found 199.0799 [M + 
H]+. 
(E)-(3-((3-(But-3-en-1-ylsulfinyl)prop-2-yn-1-yl)oxy)prop-1-en-1-yl)benzene (392) 
392 was prepared according to GP12 using 361 (500 
mg, 1.93 mmol), mCPBA (333 mg, 1.93 mmol) and 
CH2Cl2 (19 mL). The reaction time was 16 hours. Aqueous workup and purification by column 
chromatography (4:1 hexane: EtOAc) provided 392 (353 mg, 66%) as a colourless oil; Rf 0.20 
(4:1 hexane: EtOAc); 1H NMR (300 MHz, CDCl3): δ = 7.44 – 7.21 (m, 5H), 6.65 (d, J = 15.9 
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Hz, 1H), 6.25 (dt, J = 15.9, 6.3 Hz, 1H), 5.85 (ddt, J = 16.9, 10.1, 6.6 Hz, 1H), 5.25 – 5.09 (m, 
2H), 4.41 (s, 2H), 4.25 (dd, J = 6.3, 1.3 Hz, 2H), 3.28 – 3.06 (m, 2H), 2.79 – 2.52 (m, 2H); IR 
(neat): ν = 2850, 2180, 1641, 1599, 1495, 1448, 1352, 1057, 990, 968, 918, 744, 692; HR-MS 
(ES-TOF): m/z: calcd for C16H19O2S: 275.1106, found 275.1113 [M + H]
+. 13C NMR was not 
successfully obtained. 
R)-1-((R)-but-3-en-1-ylsulfinyl)-4,8-dimethylnon-7-en-1-yne (393) 
393 was prepared according to GP12 using 366 (156 mg, 
0.66 mmol), mCPBA (113 mg, 0.66 mmol) and CH2Cl2 (7 
mL). The reaction time was 19 hours. Aqueous workup and purification by column 
chromatography (9:1 hexane: EtOAc) afforded 393 (118 mg, 71%) as a colourless oil; Rf 0.57 
(7:3 hexane: EtOAc); [α]D 
21 16.80 (c 0.010 in CHCl3);
  1H NMR (300 MHz, CDCl3): δ = 5.86 
(ddt, J = 16.9, 10.1, 6.6 Hz, 1H), 5.23 – 4.99 (m, 3H), 3.09 (t, J = 7.7 Hz, 2H), 2.75 – 2.51 (m, 
2H), 2.38 (qd, J = 17.2, 6.3 Hz, 2H), 2.07 – 1.90 (m, 2H), 1.76 (td, J = 13.3, 6.6 Hz, 1H), 1.68 
(s, 3H), 1.60 (s, 3H), 1.43 (ddt, J = 13.3, 8.5, 6.5 Hz, 1H), 1.35 – 1.19 (m, 1H), 1.01 (d, J = 6.7 
Hz, 3H); 13C NMR (101 MHz, CDCl3): δ = 134.7 (CH), 132.0 (C), 124.1 (CH), 117.4 (CH2), 
104.9 (C), 78.0 (C), 55.5 (CH2), 36.2 (CH2), 31.8 (CH), 27.0 (CH2), 26.6 (CH2), 25.8 (CH3), 
25.5 (CH2), 19.6 (CH3), 17.8 (CH3); IR (neat): ν = 2964, 2916, 2180, 1641, 1444, 1379, 1060, 
993, 915, 617; HR-MS (ES-TOF): m/z: calcd for C15H25OS: 253.1626, found 253.1631 [M 
+H]+. 
2-((But-3-en-1-ylsulfinyl)ethynyl)naphthalene (394) 
394 was prepared according to GP12 using sulfide 365 (90 mg, 
0.38 mmol), mCPBA (65 mg, 0.38 mmol) and CH2Cl2 (4 mL). 
The reaction time was 2 hours. Aqueous work-up and 
purification by column chromatography (9:1 hexane: EtOAc) provided 394 as a clear oil (73 
220 
 
mg, 79%); Rf 0.24 (4:1 hexane: EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 8.10 (d, J = 0.9 Hz, 
1H), 7.85 (dd, J = 7.2, 3.7 Hz, 3H), 7.56 (app tdd, J = 8.7, 6.9, 1.8 Hz, 3H), 5.92 (ddt, J = 17.0, 
10.2, 6.6 Hz, 1H), 5.24 (dd, J = 17.0, 1.5 Hz, 1H), 5.17 (dd, J = 10.2, 1.5 Hz, 1H), 3.35 – 3.20 
(m, 2H), 2.89 – 2.62 (m, 2H); 13C NMR (101 MHz, CDCl3): δ = 134.6 (CH), 133.9 (C), 133.5 
(CH), 132.7 (C), 128.6 (CH), 128.3 (CH), 128.1 (CH), 128.1 (CH), 127.8 (CH), 127.2 (CH), 
117.7 (CH2), 117.0 (C), 103.2 (C), 85.3 (C), 55.4 (CH2), 26.8 (CH2); IR (neat): ν = 3057, 2924, 
2154, 1720, 1641, 1277, 1056, 916, 818, 749; HR-MS (ES-TOF): m/z: calcd for C16H15OS: 
255.0844, found 255.0841 [M + H]+. 
1-(But-3-en-1-ylsulfinyl)hex-1-yne (342) 
Following GP1 using sulfide (371 mg, 2.21 mmol) mCPBA (381.4 
mg, 2.21 mmol) and CH2Cl2 (22 mL). The reaction time was 16 
hours. Aqueous workup and purification by column chromatography (4:1 hexane: EtOAc) 
provided 342 as a pale yellow oil (308 mg, 76%); 1H NMR (300 MHz CDCl3): δ = 5.66 (ddt, J 
= 17.2, 10.3, 6.6, 1H), 5.17 (dd, J = 17.2, 1.4, 1H), 5.12 (dd, J = 10.3, 1.4, 1H), 3.09 (t, J = 7.7, 
2H), 2.63 (m, 2H), 2.44 (t, J = 7.0, 2H), 1.60 – 1.37 (m, 4H), 0.93 (t, J = 7.3, 3H); 13C NMR 
(101 MHz CDCl3): δ = 134.7 (CH), 117.4 (CH2), 106.1 (C), 56.4 (C), 55.5 (CH2), 29.8 (CH2), 
26.6 (CH2), 22.1 (CH2), 19.5 (CH2), 13.6 (CH3); IR (neat): ν = 2959, 2933, 2873, 2181, 1641, 
1466, 1056, 916; HR-MS (ES-TOF): m/z: calcd for C10H16OSNa 207.0820, found 207.0825. 
[M + Na]+. 
((But-3-en-1-ylsulfonyl)ethynyl)benzene (396) 
To a RBF under argon was added 376 (130 mg, 0.69 mmol), and 
CH2Cl2 (10 mL). The mixture was cooled to 0 
oC and mCPBA (238 
mg, 1.38 mmol, 2.0 eq.) was added in 5 portions over 10 mins. The 
mixture was stirred for 3 hours allowinging to warm to rt. The mixture was cooled to 0 oC and 
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mCPBA (59 mg, 0.35 mmol, 0.5 eq.) was added in one portion. The reaction was stirred for a 
further hour. The mixture was washed with NaHCO3 (3 × 10 mL) and the aqueous phase was 
extracted with CH2Cl2 (3 × 10 mL). The combined organic layers were dried over Na2SO4, 
filtered, concentrated and purified by column chromatography (9:1 hexane: EtOAc) providing 
396 (129 mg, 85%) as a viscous colourless oil; Rf 0.80 (7:3 hexane: EtOAc); 
1H NMR (300 
MHz, CDCl3): δ = 7.69 – 7.60 (m, 2H), 7.59 – 7.51 (m, 1H), 7.50 – 7.40 (m, 2H), 5.89 (ddt, J 
= 16.8, 10.2, 6.5 Hz, 1H), 5.30 – 5.14 (m, 2H), 3.44 – 3.34 (m, 2H), 2.83 – 2.70 (m, 2H); 13C 
NMR (101 MHz, CDCl3): δ = 133.4 (CH), 133.0 (2CH), 131.9 (CH), 129.0 (2CH), 117.8 (CH2), 
117.7 (C), 92.8 (C), 83.3 (C), 57.5 (CH2), 27.3 (CH2); IR (neat): ν = 3082, 2922, 2181, 1643, 
1490, 1444, 1319, 1232, 1136, 847, 756, 687; HR-MS (AP-TOF): m/z: calcd for C12H13O2S: 






397 was prepared according to GP13 using 376 (61.2 mg, 0.30 mmol), 3,5-dichloropyridine-
N-oxide (59.1 mg, 0.36 mmol), SPhosAuNTf2 (6.6 mg, 2.5 mol%) and 1,4-dioxane (6 mL). The 
reaction time was 28 hours. 1H NMR analysis using 1,2,4,5 tetramethyl benzene as internal 
standard showed a d.r. ratio of 8:1. Purification by column chromatography (3:7 hexane:EtOAc) 
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afforded 397 (48.2 mg, 73%) as an off white solid as a single diastereomer; 
397 prepared using an alternative method. To a Radleys tube under argon 
was added 3,5-dichloropyridine-N-oxide (59.1 mg, 0.3 mmol, 1.2 eq.) and alkynyl sulfoxide 
348 (61.2 mg, 0.30 mmol,1 eq.) as a 0.2 M solution in 1,4-dioxane. The flask was placed in an 
oil bath at 65 oC and SPhosAuNTf2 (5 mol%) was added followed by 1,4-dioxane (0.067 M) 
and the reaction was stirred for 45 minutes. The mixture was filtered through a pad of silica, 
washing with EtOAc, concentrated and purified by column chromatography providing 397 
(52.8 mg, 80%) as a single diastereomer; Rf 0.06 (1:1 hexane:EtOAc); mp: 77-78 
oC (Et2O); 
1H 
NMR (300 MHz, CDCl3): δ = 8.06 – 7.92 (m, 2H), 7.65 – 7.56 (m, 1H), 7.50 (t, J = 7.4 Hz, 
2H), 3.53 (ddd, J = 12.9, 7.7, 4.3 Hz, 1H), 2.79 – 2.64 (m, 2H), 2.56 – 2.34 (m, 2H), 2.26 (t, J 
= 5.9 Hz, 1H), 1.82 (dd, J = 8.7, 5.9 Hz, 1H); 13C NMR (101 MHz, CDCl3): δ = 196.5 (C), 
136.9 (C), 133.5 (CH), 129.5 (2CH), 128.8 (2CH), 59.7 (C), 54.4 (CH2), 34.0 (CH), 26.5 (CH2), 
19.5 (CH2); IR (neat): ν = 3078, 3006, 2989, 2934, 2860, 1661, 1600, 1449, 1442, 1060, 754, 
692, 662; HR-MS (ES-TOF): m/z: calcd for C12H12O2NaS: 243.0456, found 243.0458 [M + 
Na]+. 
(2-Oxido-2-thiabicyclo[3.1.0]hexan-1-yl)(phenyl)methanone (397’) 
The minor diastereomer 397’ was isolated from a separate reaction run; Rf 
0.07 (3:7 hexane:EtOAc); mp: 129-130 oC; 1H NMR (400 MHz, CDCl3): δ 
= 8.10 – 8.02 (m, 2H), 7.60 (t, J = 7.4 Hz, 1H), 7.49 (t, J = 7.6 Hz, 2H), 3.12 (dd, J = 14.4, 7.1 
Hz, 1H), 3.02 – 2.85 (m, 2H), 2.67 (ddd, J = 14.4, 12.4, 7.1 Hz, 1H), 2.40 (dd, J = 13.2, 7.0 Hz, 
1H), 1.43 (dd, J = 8.2, 6.6 Hz, 1H), 1.14 (app t, J = 6.2 Hz, 1H); 13C NMR (101 MHz, CDCl3): 
δ = 194.0 (C), 137.3 (C), 133.6 (CH), 129.0 (2CH), 128.8 (2CH), 58.7 (C), 50.4 (CH2), 27.5 
(CH), 25.5 (CH2), 18.4 (CH2); IR (neat): ν = 3082, 3009, 2990, 2934, 2865, 1667, 1597, 1286, 
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1022, 989, 775; HR-MS (EI-TOF): m/z: calcd for C12H12O2S: 220.0558 found 220.0556 [M + 
H]+.  
N-(4-(2-Oxido-2-thiabicyclo[3.1.0]hexane-1-carbonyl)phenyl)acetamide (398) 
398 was prepared according to GP13 using 388 (78.3 mg, 0.30 
mmol), 3,5-dichloropyridine-N-oxide (59.1 mg, 0.36 mmol), 
SPhosAuNTf2 (6.6 mg, 2.5 mol%) and 1,4-dioxane (6 mL). The reaction time was 28 hours. 
1H 
NMR analysis using 1,2,4,5 tetramethyl benzene as internal standard showed a d.r. of 8:1. 
Purification by column chromatography (3:7 hexane:EtOAc) afforded 398 (66.0 mg, 79%) as 
a white solid as a single diastereomer; 398 was also prepared according to GP14 using 388 
(52.2 mg, 0.20 mmol), 3,5-dichloropyridine-N-oxide (39.4 mg, 0.24 mmol), SPhosAuNTf2 (8.8 
mg, 5 mol%) and 1,4-dioxane (4 mL). The reaction time was 4 hours. Purification by column 
chromatography (EtOAc) afforded 398 (44.0 mg, 79%) as a white solid; Rf 0.14 (EtOAc); mp: 
170-172 oC; 1H NMR (300 MHz, CDCl3): δ = 8.48 (s, 1H), 7.99 (d, J = 8.6 Hz, 2H), 7.71 (d, J 
= 8.6 Hz, 2H), 3.58 (ddd, J = 12.9, 7.8, 4.0 Hz, 1H), 2.81 – 2.64 (m, 2H), 2.59 – 2.34 (m, 2H), 
2.22 (t, J = 6.0 Hz, 1H), 2.18 (s, 3H), 1.77 (dd, J = 8.6, 6.0 Hz, 1H); 13C NMR (101 MHz, 
CDCl3): δ = 194.3 (C), 169.1 (C), 143.6 (C), 131.8 (C), 131.1 (2CH), 119.0 (2CH), 59.1 (C), 
54.4 (CH2), 33.0 (CH3), 26.4 (CH2), 24.8 (CH), 18.9 (CH2); IR (neat): ν = 3086, 3039, 2958, 
1678, 1662, 1597, 1579, 1286, 1117, 885; HR-MS (ES-TOF): m/z: calcd for C14H15NO3NaS: 
300.0670, found 300.0658 [M + Na]+. 
(2-Oxido-2-thiabicyclo[3.1.0]hexan-1-yl)(p-tolyl)methanone (399) 
399 was prepared according to GP13 using 378 (65.4 mg, 0.30 mmol), 
3,5-dichloropyridine-N-oxide (59.1 mg, 0.36 mmol), SPhosAuNTf2 (6.6 
mg, 2.5 mol%) and 1,4-dioxane (6 mL). The reaction time was 28 hours. 1H NMR analysis 
using 1,2,4,5 tetramethyl benzene as internal standard showed a d.r. of 8:1. Purification by 
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column chromatography (3:7 hexane: EtOAc) afforded 399 (53.0 mg, 75%) as a colourless oil 
as a single diastereomer; Rf 0.29 (EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 7.87 (d, J = 8.1 
Hz, 2H), 7.27 (d, J = 8.1 Hz, 2H), 3.49 (ddd, J = 13.1, 7.7, 4.3 Hz, 1H), 2.73 – 2.62 (m, 2H), 
2.52 – 2.29 (m, 2H), 2.39 (s, 3H), 2.24 – 2.17 (t, J = 5.9 Hz, 1H), 1.75 (dd, J = 8.7, 5.9 Hz, 1H); 
13C NMR (101 MHz, CDCl3): δ = 195.8 (C), 144.4 (C), 134.2 (C), 129.6 (2CH), 129.4 (2CH), 
59.4 (C), 54.5 (CH2), 33.3 (CH), 26.4 (CH2), 21.8 (CH3), 19.1 (CH2); IR (neat): ν = 3463, 2926, 
1760, 1660, 1605, 1571, 1281, 1180, 1055, 1029, 734; HR-MS (ES-TOF): m/z: calcd for 
C13H14O2NaS: 257.0612, found 257.0605 [M + Na]
+.  
(4-Methoxyphenyl)(2-oxido-2-thiabicyclo[3.1.0]hexan-1-yl)methanone (400) 
400 was prepared according to GP13 using 377 (70.2 mg, 0.30 mmol), 
3,5-dichloropyridine-N-oxide (59.1 mg, 0.36 mmol), SPhosAuNTf2 (6.6 
mg, 2.5 mol%) and 1,4-dioxane (6 mL). The reaction time was 19 hours. 
1H NMR analysis using 1,2,4,5 tetramethyl benzene as internal standard showed a d.r. ratio of 
8:1. Purification by column chromatography (1:1 hexane:EtOAc to EtOAc) afforded 400 (53.0 
mg, 74%) as a colourless oil as a single diastereomer; 400 prepared using an alternative method. 
To a Radleys tube under argon was added 3,5-dichloropyridine-N-oxide (59.1 mg, 0.3 mmol, 
1.2 eq.) and alkynyl sulfoxide 377 (70.2 mg, 0.30 mmol, 1 eq.) as a 0.2 M solution in 1,4-
dioxane. The flask was placed in an oil bath at 40 oC and SPhosAuNTf2 (5 mol%) was added 
followed by 1,4-dioxane (0.067 M) and the reaction was stirred for 1 hour. The mixture was 
filtered through a pad of silica, washing with EtOAc, concentrated and purified by column 
chromatography providing 400 (58.5 mg, 78%) as a single diastereomer; Rf 0.25 (EtOAc); 
1H 
NMR (300 MHz, CDCl3): δ = 8.08 – 7.99 (m, 2H), 7.04 – 6.95 (m, 2H), 3.53 (ddd, J = 13.1, 
7.8, 4.3 Hz, 1H), 2.77 – 2.64 (m, 2H), 2.55 – 2.31 (m, 2H), 2.22 (t, J = 5.9 Hz, 1H), 1.71 (dd, J 
= 8.7, 5.9 Hz, 1H); 13C NMR (101 MHz, CDCl3): δ = 194.2 (C), 164.1 (C), 132.3 (2CH), 129.6 
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(C), 114.1 (2CH), 59.1 (C), 55.7 (CH3) 54.7 (CH2), 32.4 (CH) 26.4 (CH2), 18.8 (CH2); IR (neat): 
ν = 3452, 2934, 1731, 1655, 1597, 1573, 1510, 1285, 1258, 1170, 1024, 841; HR-MS (ES-
TOF): m/z: calcd for C13H14O3NaS: 273.0561, found 273.0570 [M + Na]
+.  
4-Bromophenyl)(2-oxido-2-thiabicyclo[3.1.0]hexan-1-yl)methanone (401) 
401 was prepared according to GP13 using 381 (85.0 mg, 0.30 mmol), 
3,5-dichloropyridine-N-oxide (59.1 mg, 0.36 mmol), SPhosAuNTf2 (6.6 
mg, 2.5 mol%) and 1,4-dioxane (6 mL). The reaction time was 28 hours. 1H NMR analysis 
using 1,2,4,5 tetramethyl benzene as internal standard showed a d.r. of 8:1. Purification by 
column chromatography (3:7 hexane:EtOAc) afforded 401 (49.3 mg, 54%) as a white solid as 
a single diastereomer; Rf 0.19 (1:1 hexane:EtOAc); 401 was also prepared according to GP14 
using 381 (56.6 mg, 0.20 mmol), 3,5-dichloropyridine-N-oxide (39.4 mg, 0.24 mmol), 
SPhosAuNTf2 (8.8 mg, 5 mol%) and 1,4-dioxane (4 mL). The reaction time was 3 hours. 
Purification by column chromatography (3:7 hexane:EtOAc) afforded 401 (42.0 mg, 74%) as 
a white solid; mp: 78-80 oC; 1H NMR (300 MHz, CDCl3): δ = 7.89 – 7.82 (m, 2H), 7.67 – 7.59 
(m, 2H), 3.54 (ddd, J = 13.2, 7.5, 4.1 Hz, 1H), 2.78 – 2.61 (m, 2H), 2.53 – 2.32 (m, 2H), 2.25 
(t, J = 6.0 Hz, 1H), 1.76 (dd, J = 8.7, 6.0 Hz, 1H); 13C NMR (101 MHz, CDCl3): δ = 195.5 (C), 
135.5 (C), 132.1 (2CH), 131.1 (2CH), 128.8 (C), 59.2 (C), 54.0 (CH2), 33.6 (CH), 26.2 (CH2), 
19.3 (CH2); IR (neat): ν = 3082, 3068, 2991, 1647, 1410, 1275, 1013, 874, 756; HR-MS (ES-
TOF): m/z: calcd for C12H11O2SNa
79Br: 320.9561, found 320.9550 [M + Na]+. 
 
Methyl 4-(2-oxido-2-thiabicyclo[3.1.0]hexane-1-carbonyl)benzoate (402) 
402 was prepared according to GP13 using 387 (78.6 mg, 0.30 mmol), 
3,5-dichloropyridine-N-oxide (59.1 mg, 0.36 mmol), SPhosAuNTf2 
(6.6 mg, 2.5 mol%) and 1,4-dioxane (6 mL). The reaction time was 28 hours. 1H NMR analysis 
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using 1,2,4,5 tetramethyl benzene as internal standard showed a d.r. of 8:1. Purification by 
column chromatography (3:7 hexane:EtOAc) afforded 402 (38.5 mg, 54%) as an off white solid 
as a single diastereomer; 402 was also prepared according to GP14 using 387 (52.5 mg, 0.20 
mmol), 3,5-dichloropyridine-N-oxide (39.4 mg, 0.24 mmol), SPhosAuNTf2 (8.8 mg, 5 mol%) 
and 1,4-dioxane (4 mL). The reaction time was 20 hours. Purification by column 
chromatography (3:7 hexane:EtOAc) afforded 402 (35.6 mg, 64%) as an off white solid; Rf 
0.35 (EtOAc); mp: 63-64 oC; 1H NMR (300 MHz, CDCl3): δ = 8.18 – 8.12 (m, 2H), 8.04 – 7.98 
(m, 2H), 3.94 (s, 3H), 3.55 (ddd, J = 13.2, 7.5, 4.2 Hz, 1H), 2.80 – 2.62 (m, 2H), 2.54 – 2.38 
(m, 2H), 2.33 – 2.26 (t, J = 5.9 Hz, 1H), 1.86 (dd, J = 8.7, 5.9 Hz, 1H); 13C NMR (101 MHz, 
CDCl3): δ = 196.6 (C) 166.2 (C), 140.3 (C), 134.1 (C), 129.9 (2CH), 129.3 (2CH), 59.7 (C), 
54.0 (CH2), 52.6 (CH3), 34.7 (CH), 26.3 (CH2), 19.7 (CH2); IR (neat): ν = 3493, 3094, 3022, 
2960, 2936, 1716, 1665, 1436, 1273, 1031, 763; HR-MS (ES-TOF): m/z: calcd for 
C14H14O4NaS: 301.0510, found 301.0500 [M + Na]
+. 
(4-Fluorophenyl)(2-oxido-2-thiabicyclo[3.1.0]hexan-1-yl)methanone (403) 
403 was prepared according to GP13 using 379 (66.6 mg, 0.30 mmol), 
3,5-dichloropyridine-N-oxide (59.1 mg, 0.36 mmol), SPhosAuNTf2 (6.6 
mg, 2.5 mol%) and 1,4-dioxane (6 mL). The reaction time was 28 hours. 1H NMR analysis 
using 1,2,4,5 tetramethyl benzene as internal standard showed a d.r. ratio of 8:1. Purification 
by column chromatography (3:7 hexane:EtOAc) afforded 403 (38.5 mg, 54%) as a viscous oil; 
403 was also prepared according to GP14 using 379 (66.6 mg, 0.30 mmol), 3,5-
dichloropyridine-N-oxide (59.1 mg, 0.36 mmol), SPhosAuNTf2 (13.2 mg, 5 mol%) and 1,4-
dioxane (6 mL). The reaction time was 17 hours. Purification by column chromatography (3:7 
hexane:EtOAc) afforded 375 (53.6 mg, 68%) as a colourless viscous oil, as a single 
diastereomer; Rf 0.39 (EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 8.15 – 7.99 (m, 2H), 7.23 – 
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7.10 (m, 2H), 3.56 (ddd, J = 13.2, 7.6, 4.1 Hz, 1H), 2.78 – 2.64 (m, 2H), 2.54 – 2.33 (m, 2H), 
2.25 (t, J = 5.9 Hz, 1H), 1.76 (dd, J = 8.7, 5.9 Hz, 1H); 13C NMR (101 MHz, CDCl3): δ = 194.8 
(C), 166.1 (d, J = 255.8 Hz, C), 133.1 (C), 132.5 (d, J = 9.4 Hz, 2CH), 116.0 (d, J = 22.1 Hz, 
2CH), 59.1 (C), 54.2 (CH2), 33.2 (CH), 26.3 (CH2), 19.2 (CH2); IR (neat): ν = 3070, 2937, 
1663, 1596, 1506, 1280, 1230, 1027, 844, 609; HR-MS (ES-TOF): m/z: calcd for C12H12O2FS: 
239.0542, found 239.0547 [M + H]+.  
(2-Oxido-2-thiabicyclo[3.1.0]hexan-1-yl)(4-(trifluoromethyl)phenyl)methanone (404) 
404 was prepared according to GP13 using 380 (81.6 mg, 0.30 mmol), 
3,5-dichloropyridine-N-oxide (59.1 mg, 0.36 mmol), SPhosAuNTf2 
(6.6 mg, 2.5 mol%) and 1,4-dioxane (6 mL). The reaction time was 28 
hours. 1H NMR analysis using 1,2,4,5 tetramethyl benzene as internal standard showed a d.r. 
of 8:1; Purification by column chromatography (1:1 hexane:EtOAc to EtOAc) afforded 404 
(26.0 mg, 30%) as a colourless oil, as a single diastereomer; 1H NMR analysis using 1,2,4,5 
tetramethyl benzene as internal standard showed a d.r. of 8:1; 404 was also prepared according 
to GP14 using 380 (54.4 mg, 0.20 mmol), 3,5-dichloropyridine-N-oxide (39.4 mg, 0.24 mmol), 
SPhosAuNTf2 (8.8 mg, 5 mol%) and 1,4-dioxane (4 mL). The reaction time was 17 hours. 
Purification by column chromatography (1:1 hexane:EtOAc to EtOAc) afforded 404 (35.6 mg, 
63%) as a colourless oil, as a single diastereomer; Rf 0.26 (1:1 hexane:EtOAc); 
1H NMR (300 
MHz, CDCl3): δ = 8.09 (d, J = 8.2 Hz, 2H), 7.77 (d, J = 8.2 Hz, 2H), 3.57 (ddd, J = 13.2, 7.3, 
4.2 Hz, 1H), 2.82 – 2.64 (m, 2H), 2.55 – 2.36 (m, 2H), 2.31 (t, J = 5.9 Hz, 1H), 1.85 (dd, J = 
8.7, 5.9 Hz, 1H); 13C NMR (101 MHz, CDCl3): δ = 196.2 (C), 139.8 (C), 134.7 (q, J = 32.7 Hz, 
C), 129.8 (2CH), 125.8 (d, J = 3.2 Hz, 2CH), 123.4 (q, J = 272.4 Hz, C), 59.4 (C), 53.8 (CH2), 
34.4 (CH), 26.2 (CH2), 19.8 (CH2); IR (neat): ν = 2937, 1673, 1409, 1323, 1279, 1167, 1112, 
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1063, 855; HR-MS (ES-TOF): m/z: calcd for C13H11O2NaSF3: 311.0330, found 311.0327 [M + 
Na]+. 
(2-Bromophenyl)(2-oxido-2-thiabicyclo[3.1.0]hexan-1-yl)methanone (405) 
405 was prepared according to GP13 using 383 (85.0 mg, 0.30 mmol), 3,5-
dichloropyridine-N-oxide (59.1 mg, 0.36 mmol), SPhosAuNTf2 (6.6 mg, 2.5 
mol%) and 1,4-dioxane (5 mL). The reaction time was 28 hours. 1H NMR 
analysis using 1,2,4,5 tetramethyl benzene as internal standard showed a d.r. of 8:1; Purification 
by column chromatography (3:7 hexane:EtOAc) afforded 405 (44.3 mg, 50%) as a white solid 
as a single diastereomer; Rf 0.29 (EtOAc); mp: 120-122 
oC; 1H NMR (300 MHz, CDCl3): δ = 
7.65 – 7.59 (m, 1H), 7.49 – 7.41 (m, 1H), 7.41 – 7.32 (m, 2H), 3.60 – 3.48 (m, 1H), 2.73 – 2.63 
(m, 1H), 2.59 – 2.39 (m, 3H), 2.31 – 2.16 (m, 2H); 13C NMR (101 MHz, CDCl3): δ = 199.2 (C), 
140.2 (C), 133.0 (CH), 131.9 (CH), 128.4 (CH), 128.0 (CH), 118.4 (C), 60.4 (C), 52.4 (CH2), 
40.2 (CH), 26.6 (CH2), 19.1 (CH2); IR (neat): ν = 3049, 3006, 2924, 1662, 1589, 1426, 1326, 
1054, 1026, 754; HR-MS (ES-TOF): m/z: calcd for C12H11O2SNa
79Br: 320.9561, found 
320.9551 [M + Na]+. 
Naphthalen-2-yl(2-oxido-2-thiabicyclo[3.1.0]hexan-1-yl)methanone (406) 
406 was prepared according to GP13 using 394 (48.9 mg, 0.20 mmol), 
3,5-dichloropyridine-N-oxide (39.4 mg, 0.24 mmol), SPhosAuNTf2 (4.4 
mg, 2.5 mol%) and 1,4-dioxane (4 mL). The reaction time was 28 hours. 1H NMR analysis 
using 1,2,4,5 tetramethyl benzene as internal standard showed a d.r. ratio of 8:1. Purification 
by column chromatography (3:7 hexane:EtOAc) afforded 406 (35.1 mg, 65%) as an off white 
solid as a single diastereomer; 406 was also prepared according to GP14 using 394 (50.9 mg, 
0.20 mmol), 3,5-dichloropyridine-N-oxide (39.4 mg, 0.24 mmol), SPhosAuNTf2 (8.8 mg, 0.01 
mmol) and 1,4-dioxane (4 mL). The reaction time was 28 hours. Purification by column 
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chromatography (3:7 hexane: EtOAc) afforded 406 (37.7 mg, 70%) as a white solid; Rf 0.41 
(EtOAc); mp: 108-109 oC; 1H NMR (300 MHz, CDCl3): δ = 8.65 (s, 1H), 8.09 – 7.83 (m, 4H), 
7.67 – 7.52 (m, 2H), 3.56 (ddd, J = 13.0, 7.7, 4.2 Hz, 1H), 2.85 – 2.61 (m, 2H), 2.62 – 2.38 (m, 
2H), 2.33 (t, J = 5.9 Hz, 1H), 1.86 (dd, J = 8.6, 5.9 Hz, 1H); 13C NMR (101 MHz, CDCl3): δ = 
196.3 (C), 135.8 (C), 134.1 (C), 132.4 (C), 132.1 (CH), 130.1 (CH), 128.9 (CH), 128.7 (CH), 
127.9 (CH), 127.1 (CH), 124.7 (CH), 59.6 (C), 54.4 (CH2), 33.6 (CH), 26.4 (CH2), 19.5 (CH2); 
IR (neat): ν = 3065, 3021, 2930, 1651, 1628, 1365, 1292, 1181, 1125, 1051, 1001, 813; HR-
MS (ES-TOF): m/z: calcd for C16H15O2S: 271.0793, found 271.0798 [M + H]
+. 
(3-Methoxyphenyl)(2-oxido-2-thiabicyclo[3.1.0]hexan-1-yl)methanone (407) 
407 was prepared according to GP13 using 383 (70.3 mg, 0.30 mmol), 
3,5-dichloropyridine-N-oxide (59.1 mg, 0.36 mmol), SPhosAuNTf2 (6.6 
mg, 2.5 mol%) and 1,4-dioxane (6 mL). The reaction time was 28 hours. 
1H NMR analysis using 1,2,4,5 tetramethyl benzene as internal standard showed a d.r. ratio of 
8:1; Purification by column chromatography (3:7 hexane: EtOAc) afforded 407 (40.0 mg, 54%) 
as colourless oil as a single diastereomer; Rf 0.33 (EtOAc); 407 was also prepared according to 
GP14 using 383 (46.9 mg, 0.20 mmol), 3,5-dichloropyridine-N-oxide (39.4 mg, 0.24 mmol), 
SPhosAuNTf2 (4.4 mg, 2.5 mol%) and 1,4-dioxane (4 mL). The reaction time was 18 hours. 
Purification by column chromatography (3:7 hexane:EtOAc) afforded 407 (35.0 mg, 70%); 1H 
NMR (300 MHz, CDCl3): δ = 7.61 – 7.54 (m, 1H), 7.49 (dd, J = 2.4, 1.7 Hz, 1H), 7.40 (t, J = 
7.9 Hz, 1H), 7.13 (ddd, J = 8.2, 2.6, 0.9 Hz, 1H), 3.85 (s, 3H), 3.53 (ddd, J = 13.2, 7.6, 4.1 Hz, 
1H), 2.76 – 2.61 (m, 2H), 2.52 – 2.32 (m, 2H), 2.25 (t, J = 5.9 Hz, 1H), 1.80 (dd, J = 8.7, 5.9 
Hz, 1H); 13C NMR (101 MHz, CDCl3): δ = 196.4 (C), 159.8 (C), 138.1 (C), 129.8 (CH), 122.0 
(CH), 120.4 (CH), 113.4 (CH), 59.5 (C), 55.6 (CH3), 54.2 (CH2), 34.0 (CH), 26.3 (CH2), 19.4 
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(CH2); IR (neat): ν = 2939, 1722, 1663, 1596, 1580, 1279, 1030, 787; HR-MS (ES-TOF): m/z: 
calcd for C13H14O3SNa: 273.0561, found 273.0563 [M + Na]
+. 
Furan-2-yl(2-oxido-2-thiabicyclo[3.1.0]hexan-1-yl)methanone (408) 
A Radleys tube under argon was charged with 3,5-dichloropyridine-N-oxide 
(39.4 mg, 0.24 mmol, 1.2 eq.) and 389 (38.8 mg, 0.20 mmol, 1.0 eq.) as a 0.2 
M solution in 1,4-dioxane. SPhosAuNTf2 (8.8 mg, 5 mol%) was added followed by 1,4-dioxane 
(3 mL) and the reaction mixture was stirred for 22 hours. Purification by column 
chromatography (1:4 hexane:EtOAc) afforded 408 (20.0 mg, 46%) as a colourless oil, as a 
single diastereomer; 408 was also prepared according to GP14 using 389 (41.4 mg, 0.21 mmol), 
3,5-dichloropyridine-N-oxide (41.0 mg, 0.25 mmol), SPhosAuNTf2 (9.0 mg, 5 mol%) and 1,4-
dioxane (4.2 mL). The reaction time was 28 hours. Purification by column chromatography (1:4 
hexane:EtOAc) afforded 408 (33.3 mg, 74%) as a colourless oil; Rf 0.08 (1:1 hexane: EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 7.67 – 7.58 (m, 2H), 6.58 (dd, J = 3.7, 1.7 Hz, 1H), 3.57 (dt, 
J = 13.1, 5.0 Hz, 1H), 2.88 – 2.77 (m, 1H), 2.68 – 2.53 (m, 1H), 2.44 – 2.33 (m, 2H), 2.18 (t, J 
= 6.1 Hz, 1H), 1.91 (dd, J = 8.6, 6.1 Hz, 1H); 13C NMR (101 MHz, CDCl3): δ = 182.5 (C), 151.5 
(C), 147.4 (CH), 120.9 (CH), 112.8 (CH), 58.1 (C), 52.0 (CH2), 33.8 (CH), 25.5 (CH2), 18.3 
(CH2); IR (neat): ν = 3425, 3127, 2935, 1635, 1563, 1461, 1390, 1297, 1138, 1055, 1017, 991, 
884, 768; HR-MS (AP-TOF): m/z: calcd for C10H11O3S: 211.0429, found 211.0425 [M + H]
+. 
(5-Bromothiophen-2-yl)(2-oxido-2-thiabicyclo[3.1.0]hexan-1-yl)methanone (409) 
409 was prepared according to GP14 using 390 (60.7 mg, 0.21 mmol), 
3,5-dichloropyridine-N-oxide (41.0 mg, 0.25 mmol), SPhosAuNTf2 (9.0 
mg, 5 mol%) and 1,4-dioxane (4.2 mL). The reaction time was 28 hours. Purification by column 
chromatography (1:4 hexane:EtOAc) afforded 409 (44.4 mg, 73%) as a white solid, as a single 
diastereomer; Rf 0.12 (1:1 hexane:EtOAc); mp: 116-118 
oC; 1H NMR (300 MHz, CDCl3): δ = 
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7.58 (d, J = 5.1 Hz, 1H), 7.13 (d, J = 5.1 Hz, 1H), 3.68 – 3.52 (m, 1H), 2.72 – 2.39 (m, 4H), 
2.13 (t, J = 6.2 Hz, 1H), 2.07 (dd, J = 8.3, 6.2 Hz, 1H); 13C NMR (101 MHz, CDCl3): δ = 187.2 
(C), 135.1 (C), 132.9 (CH), 132.1 (CH), 115.2 (C), 60.8 (C), 54.5 (CH2), 36.6 (CH), 27.8 (CH2), 
16.8 (CH2); IR (neat): ν = 3082, 3068, 2989, 1650, 1411, 1277, 1011, 755; HR-MS (ES-TOF): 
m/z: calcd for C10H9O2NaS2
79Br: 326.9125, found 326.9131 [M + Na]+. 
2-Isopropylphenyl)(2-oxido-2-thiabicyclo[3.1.0]hexan-1-yl)methanone (410) 
410 was prepared according to GP13 using 386 (74.0 mg, 0.30 mmol), 3,5-
dichloropyridine-N-oxide (59.1 mg, 0.36 mmol), SPhosAuNTf2 (6.6 mg, 2.5 
mol%) and 1,4-dioxane (6 mL). The reaction time was 28 hours. Purification 
by column chromatography (3:7 hexane:EtOAc) afforded 410 (39.4 mg, 50%) as a colourless 
oil; Rf 0.35 (EtOAc); 410 was also prepared according to GP14 using 386 (49.3 mg, 0.20 
mmol), 3,5-dichloropyridine-N-oxide (39.4 mg, 0.24 mmol), SPhosAuNTf2 (8.8 mg, 5 mol%) 








 hours. Purification by column chromatography (3:7 hexane:EtOAc) afforded 410 (27.5 mg, 
52%) as a colourless oil, as a 7:1 mixture of diastereomers; 1H NMR (300 MHz, CDCl3): δ = 
7.41 – 7.32 (m, 2H), 7.29 – 7.24 (m, 1H), 7.21 (dd, J = 6.0, 2.2 Hz, 1H), 3.45 – 3.35 (m, 1H), 
3.03 – 2.87 (m, 1H), 2.64 – 2.45 (m, 2H), 2.36 – 2.28 (m, 2H), 2.25 – 2.15 (m, 1H), 1.96 (dd, J 
= 8.7, 5.7 Hz, 1H), 1.19 (d, J =, 6.8 Hz, 3H), 1.14 (d, J =, 6.8 Hz, 3H); 13C NMR (101 MHz, 
CDCl3): δ = 201.7 (C), 146.4 (C), 137.2 (C), 130.9 (CH), 126.6 (CH), 126.3 (CH), 125.7 (CH), 
61.1 (C), 52.4 (CH2), 37.2 (CH), 30.5 (CH), 26.1 (CH2), 24.2 (CH3), 24.0 (CH3), 19.1 (CH2); 
IR (neat): ν = 3039, 3084, 2959, 1677, 1663, 1597, 1579, 1286, 1263, 1056, 762; HR-MS (ES-
TOF): m/z: calcd for C15H18O2NaS: 285.0925, found 285.0932 [M + Na]
+. 
Cyclohexyl(2-oxido-2-thiabicyclo[3.1.0]hexan-1-yl)methanone (413) 
413 was prepared according to GP14 using 385 (42.7 mg, 0.20 mmol), 3,5-
dichloropyridine-N-oxide (39.4 mg, 0.24 mmol), SPhosAuNTf2 (8.8 mg, 5 
mol%) and 1,4-dioxane (4 mL). The reaction time was 24 hours. Purification by column 
chromatography (1:1 hexane:EtOAc to EtOAc) afforded 413 (20.6 mg, 45%) as a white solid 
as a 7:1 mixture of diastereomers; Rf 0.20 (EtOAc); mp: 86-87 
oC; 1H NMR (300 MHz, CDCl3): 
δ = 3.60 – 3.48 (ddd, J = 10.2, 6.2, 4.8, 1H), 3.17 – 3.01 (m, 1H), 2.59 – 2.47 (m, 1H), 2.45 – 
2.36 (m, 1H), 2.34 – 2.27 (m, 2H), 2.08 – 2.02 (m, 1H), 2.02 – 1.95 (m, 1H), 1.85 (dd, J = 8.5, 
5.6 Hz, 1H), 1.80 (dd, J = 9.1, 3.2 Hz, 2H), 1.75 – 1.63 (m, 2H), 1.56 – 1.11 (m, 5H); 13C NMR 
(101 MHz, CDCl3): δ = 207.1 (C), 58.3 (C), 51.8 (CH2), 48.7 (CH), 36.2 (CH), 28.8 (CH2), 
28.5 (CH2), 25.8 (CH2), 25.7 (CH2), 25.5 (2CH2), 18.0 (CH2); IR (neat): ν = 2980, 2925, 2853, 
1667, 1442, 1382, 1332, 1267, 1259, 1057, 1041, 980, 874; HR-MS (ES-TOF): m/z: calcd for 




 2,2-Dimethyl-1-((1S,2R)-2-oxido-2-thiabicyclo[3.1.0]hexan-1-yl)propan-1-one (414) 
414 was prepared according to GP14 using 384 (36.9 mg, 0.20 mmol), 3,5-
dichloropyridine-N-oxide (39.4 mg, 0.24 mmol), SPhosAuNTf2 (8.8 mg, 5 
mol%) and 1,4-dioxane (4 mL). The reaction time was 25 hours. 1H NMR analysis using 1,2,4,5 
tetramethyl benzene as internal standard showed a d.r. ratio of 12:1. Purification by column 
chromatography (EtOAc) afforded 414 (28.0 mg, 70%) as a colourless oil as a 12:1 mixture of 
diastereomers; 1H NMR (300 MHz CDCl3): δ = 3.51 (ddd, J = 13.2, 6.8, 4.9, 1H), 2.65 (ddd, J 
= 13.2, 6.8, 4.9, 1H), 2.48 – 2.39 (m, 1H), 2.38 – 2.29 (m, 2H), 2.03 (app t, J = 5.7, 1H), 1.78 
(dd, J = 8.6, 5.7, 1H), 1.36 (s, 9H); 13C NMR (101 MHz CDCl3): δ = 207.0 (C), 58.3 (C), 53.7 
(CH2), 45.4 (C), 36.6 (CH), 26.7 (3CH3), 25.9 (CH2), 18.5 (CH2); IR (neat): ν = 3470, 2971, 
2871, 1678, 1478, 1367, 1225, 1169, 1091, 1057, 994. HR-MS (ES-TOF): m/z calculated for 
C10H16O2S 200.0871, found 200.0879 [M + H]
+. 
3S)-3,7-Dimethyl-1-(2-oxido-2-thiabicyclo[3.1.0]hexan-1-yl)oct-6-en-1-one (415) 
415 was prepared according to GP14 using 393 (50.4 mg, 0.20 
mmol), 3,5-dichloropyridine-N-oxide (39.4 mg, 0.24 mmol), 
SPhosAuNTf2 (8.8 mg, 0.010 mmol) and 1,4-dioxane (4 mL). The 
reaction time was 21 hours. Purification by column chromatography (1:1 hexane:EtOAc to 
EtOAc) afforded 415 (37.8 mg, 70%) as a colourless oil (d.r. ratio 10:10:1:1, assignment of the 
two major diastereomers is observed in the 13C NMR); Rf 0.17 (1:1 hexane:EtOAc); [α]D 
21 3.60 
(c 0.010 in CHCl3); 
1H NMR (300 MHz, CDCl3): δ = 5.08 (dtd, J = 7.0, 2.7, 1.3 Hz, 1H), 3.58 
– 3.45 (m, 1H), 2.93 – 2.62 (m, 2H), 2.59 – 2.38 (m, 2H), 2.37 – 2.25 (m, 2H), 2.19-2.05 (m, 
1H), 2.10 – 2.04 (m, 1H), 1.97 (td, J = 14.0, 7.1 Hz, 2H), 1.85 (dd, J = 7.9, 5.8 Hz, 1H), 1.67 
(s, 3H), 1.59 (s, 4H), 1.43 – 1.15 (m, 3H), 0.93 (dd, J = 6.6, 2.0 Hz, 3H); Major diastereomer 
1;13C NMR (101 MHz, CDCl3): 203.5 (C), 131.7 (C), 124.3 (CH), 59.3 (C), 51.3 (CH2), 50.1 
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(CH2), 48.6 (CH2), 37.0 (CH2), 35.5 (CH), 28.8 (CH), 25.8 (CH3), 25.6 (CH2), 19.9 (CH3), 18.1 
(CH2), 17.8 (CH3); Major diastereomer 2: δ = 203.5 (C), 131.7 (C), 124.3 (CH), 59.2 (C), 51.1 
(CH2), 50.1 (CH2), 48.6 (CH2), 36.9 (CH2), 35.4 (CH), 28.8 (CH), 25.8 (CH3), 25.6 (CH2), 19.8 
(CH3), 18.0 (CH2), 17.8 (CH3); IR (neat): ν = 3458, 2961, 2924, 1688, 1446, 1375, 1287, 1241, 
1100, 1057, 1031, 989; HR-MS (ES-TOF): m/z: calcd for C15H24O2NaS: 291.1395, found 
291.1393 [M + Na]+.  
2-(Allyloxy)-1-(2-oxido-2-thiabicyclo[3.1.0]hexan-1-yl)ethan-1-one (416) 
416 was prepared according to GP14 using 391 (39.7 mg, 0.20 mmol), 
3,5-dichloropyridine-N-oxide (39.4 mg, 0.24 mmol), SPhosAuNTf2 (8.8 
mg, 5 mol%) and 1,4-dioxane (4 mL). The reaction time was 21 hours. Purification by column 
chromatography (EtOAc to 1:9 MeOH:EtOAc) afforded 416 (27.0 mg, 63%) as a colourless oil 
as a 10:1 mixture of diastereomers; Rf 0.35 (1:9 MeOH:EtOAc); 
1H NMR (300 MHz, CDCl3): 
δ = 5.92 (ddt, J = 17.0, 10.4, 5.8 Hz, 1H), 5.37 – 5.17 (m, 2H), 4.64 (d, J = 17.0 Hz, 1H), 4.52 
(d, J = 17.0 Hz, 1H), 4.11 – 4.05 (m, 2H), 3.52 (dt, J = 13.1, 5.2 Hz, 1H), 2.63 – 2.48 (m, 2H), 
2.32 (ddd, J = 5.9, 4.4, 2.0 Hz, 2H), 2.14 – 2.06 (m, 1H), 1.94 (dd, J = 8.6, 5.7 Hz, 1H); 13C 
NMR (101 MHz, CDCl3): δ = 200.4 (C), 133.5 (CH), 118.8 (CH2), 74.4 (CH2), 72.7 (CH2), 
58.1 (C), 52.3 (CH2), 36.9 (CH), 25.9 (CH2), 18.6 (CH2); IR (neat): ν = 3451, 2935, 1703, 1423, 
1250, 1140, 1092, 992, 926, 730; HR-MS (AP-TOF): m/z: calcd for C10H15O3S: 215.0742, 
found 215.0746 [M + H]+. 
2-(Cinnamyloxy)-1-(2-oxido-2-thiabicyclo[3.1.0]hexan-1-yl)ethan-1-one (417) 
417 was prepared according to GP14 using 392 (54.8 mg, 0.20 
mmol), 3,5-dichloropyridine-N-oxide (39.4 mg, 0.24 mmol), 
SPhosAuNTf2 (8.8 mg, 5 mol%) and 1,4-dioxane (4 mL). The 
reaction time was 21 hours. Purification by column chromatography (EtOAc to 1:19 
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MeOH:EtOAc) afforded 417 (38.0 mg, 65%) as a viscous white semi solid, as a 10:1 mixture 
of diastereomers; Rf 0.40 (1:9 MeOH:EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 7.46 – 7.22 
(m, 5H), 6.64 (d, J = 16.0 Hz, 1H), 6.30 (dt, J = 16.0, 6.3 Hz, 1H), 4.71 (d, J = 17.0 Hz, 1H), 
4.60 (d, J = 17.0 Hz, 1H), 4.36 – 4.19 (m, 2H), 3.59 – 3.48 (m, 1H), 2.65 – 2.50 (m, 2H), 2.38 
– 2.26 (m, 2H), 2.16 – 2.07 (m, 1H), 1.95 (dd, J = 8.6, 5.7 Hz, 1H); 13C NMR (101 MHz, 
CDCl3): δ = 200.5 (C), 136.3 (C), 134.1 (CH), 128.7 (2CH), 128.1 (CH), 126.7 (2CH), 124.7 
(CH), 74.4 (CH2), 72.4 (CH2), 58.1 (C), 52.2 (CH2), 37.0 (CH), 25.9 (CH2) 18.8 (CH2); IR 
(neat): ν = 2934, 1704, 1495, 1449, 1248, 1137, 1093, 1058, 1031, 968, 872, 735, 693; HR-MS 
(AP-TOF): m/z: calcd for C16H19O3S: 291.1055, found 291.1059 [M + H]
+. 
 (2,2-Dioxido-2-thiabicyclo[3.1.0]hexan-1-yl)(phenyl)methanone (419) 
419 was prepared according to GP13 using 396 (66.0 mg, 0.30 mmol), 3,5-
dichloropyridine-N-oxide (59.1 mg, 0.36 mmol), SPhosAuNTf2 (6.6 mg, 2.5 
mol%) and 1,4-dioxane (6 mL). The reaction time was 28 hours. Purification by column 
chromatography (7:3 hexane:EtOAc), followed by recrystallisation from hot EtOH  afforded 
419 (56.0 mg, 79%) as a white solid; Rf 0.28 (7:3 hexane: EtOAc); mp: 118-119 
oC (EtOH); 1H 
NMR (300 MHz, CDCl3): δ = 8.18 – 8.09 (m, 2H), 7.68 – 7.58 (m, 1H), 7.56 – 7.46 (m, 2H), 
3.34 – 3.03 (m, 2H), 2.79 (dt, J = 8.6, 5.7 Hz, 1H), 2.63 – 2.46 (m, 1H), 2.32 (dd, J = 13.7, 7.7 
Hz, 1H), 1.85 (t, J = 6.6 Hz, 1H), 1.77 – 1.68 (m, 1H); 13C NMR (101 MHz, CDCl3): δ = 190.7 
(C), 136.5 (C), 134.3 (CH), 129.7 (2CH), 128.8 (2CH), 50.6 (C), 48.6 (CH2), 25.4 (CH), 19.7 
(CH2), 18.4 (CH2); IR (neat): ν = 3039, 3086, 2958, 1678, 1662, 1597, 1452, 1302, 1286, 1117, 




 Phenylhalide (428) 
428 was prepared according to a literature procedure.147 A 3 neck 
RBF was fitted with a reflux condenser. Mg turnings (550 mg, 22.5 
mmol, 1.0 eq.), and THF (22 mL) was added. Cyclopropylbromide (2.00 mL, 25 mmol, 1.1 eq.) 
was added dropwise to the stirred mixture with gentle warming. Upon reflux starting, heating 
was stopped until complete halide addition. Once reflux had stopped the reaction was heated to 
reflux for 1 hour and cooled to rt. The Grignard was added to a separate flask and cooled to 0 
oC. Benzaldehyde (2.03 mL, 22.0 mmol) was added and the solution stirred for 15 minutes 
followed by the addition of acetyl chloride (1.92 mL, 22.0 mmol, 1.0 eq.). The reaction was 
heated to 50 oC for 1 hour and then concentrated under reduced pressure. The residue was 
dissolved in a H2O/Et2O mixture and the organic layer was separated. The aqueous layer was 
extracted with Et2O (2 × 25 ml). The organic layers were combined, dried over NaSO4, filtered, 
concentrated under reduced pressure and purified by column chromatography (hexane) to 
afford the title compound (1.08 g, 39%) as a yellow oil; Rf 0.33 (hexane); 
1H NMR (300 MHz, 
CDCl3): δ = 7.42 – 7.20 (m, 5H), 6.49 (d, J = 15.8 Hz, 1H), 6.32 – 6.13 (m, 1H), 3.63 (t, J = 
7.0 Hz, 0.5H, CH2CH2Cl), 3.48 (t, J = 7.0 Hz, 1.5H, CH2CH2Br), 2.78 (dt, J = 7.0, 1.3 Hz, 3H 
CH2Br), 2.69 (dt, J = 7.0, 1.3 Hz, 0.5H CH2Cl); 
13C NMR (101 MHz, CDCl3): δ = 137.2 (C), 
132.8 (CH), 128.7 (2CH), 127.6 (C), 126.8 (C), 126.3 (CH), 36.4 (CH2), 32.4 (CH2); IR (neat): 
ν = 3028, 2966, 1701, 1598, 1495, 1311, 1262, 966, 744, 695. The data matches the literature 
data.147 
(E)-S-(4-Phenylbut-3-en-1-yl) benzenesulfonothioate (429) 
429 was prepared following a literature procedure.142 To a RBF 
was added sodium benzenesulfonothioate 358 (981 mg, 5.0 
mmol, 1.2 eq.) and the flask was evacuated and refilled with 
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argon (× 3). Anhydrous DMF (7 mL) was added and the mixture was stirred at rt for 10 minutes. 
Halide 428 (1.00 g, 4.0 mmol, 1.0 eq.) was added over 5 minutes by syringe and the mixture 
was stirred at rt for 2.5 days. The mixture was poured into ice/ water (20 mL) and was extracted 
with Et2O (6 × 15 mL). The combined organics were washed with NaHCO3 (sat) solution (15 
mL), brine (3 × 15 mL), dried over Na2SO4, filtered, concentrated under reduced pressure and 
purified by column chromatography (95:5 hexane:EtOAc) to (9:1 hexane:EtOAc) to afford 429 
(930 mg, 76%) as a viscous orange oil; Rf 0.30 (9:1 hexane:EtOAc); 
1H NMR (300 MHz, 
CDCl3): δ = 8.01 – 7.91 (m, 2H), 7.71 – 7.51 (m, 3H), 7.33 – 7.28 (m, 4H), 7.25 – 7.19 (m, 1H), 
6.34 (dt, J = 15.8, 1.3 Hz, 1H), 6.04 (dt, J = 15.8, 7.2 Hz, 1H), 3.15 (t, J = 7.2 Hz, 2H), 2.53 
(qd, J = 7.2, 1.3 Hz, 2H); 13C NMR (101 MHz, CDCl3): δ = 145.0 (C), 136.9 (C), 133.8 (CH), 
132.9 (CH), 129.5 (2CH), 128.7 (2CH), 127.7 (2CH), 127.1 (2CH), 126.3 (2CH), 35.8 (CH2), 
32.3 (CH2); IR (neat): ν = 3060, 3026, 2933, 1597, 1581, 1446, 1307, 1320, 1138, 1076, 966, 
744, 714, 684, 594; HR-MS (ES-TOF): m/z: calcd for C16H16O2NaS2: 327.0489, found 
327.0484 [M + Na]+.  
S-(4-Methylpent-3-en-1-yl) benzenesulfonothioate (431) 
The homo prenyl bromide 430 was prepared first, following a 
literature procedure.148 To a flame dried RBF under argon was 
added THF (7 mL) and MeMgBr (3M in Et2O) (6.66 mL, 20 mmol, 
1.2 eq.). A condenser was fitted and cyclopropylmethylketone (1.65 mL, 16.7 mmol, 1.0 eq.) 
in THF (3 mL) was added dropwise. On complete addition, the mixture was heated to reflux 
and stirred for 20 minutes. On cooling to rt, the solution was added slowly to an ice cooled 
conical flask containing 15 mL of a 1:2 H2SO4: H2O mixture keeping the temperature below 10 
oC. On complete addition the mixture was stirred for 30 minutes and the organic layer separated. 
The aqueous layer was extracted with Et2O (3 × 10 mL), and the combined organic layers were 
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washed with NaHCO3, brine, dried over Na2SO4, filtered and concentrated. The crude oil 430 
was taken forward in the next step (yield taken as quant). 431 was prepared following a 
literature procedure.142 To a RBF was added sodium benzenesulfonothioate 358 (3.93 g, 20.0 
mmol, 1.2 eq.) and the flask was evacuated and refilled with argon (× 3). Anhydrous DMF (30 
mL) was added and the mixture was stirred at rt for 10 minutes. Crude bromide 430 (2.71 g, 
16.7 mmol, 1.0 eq.) was added over 5 minutes by syringe and the mixture was stirred for 2.5 
days at rt. The mixture was poured into ice/ water (100 mL) and was extracted Et2O (6 × 30 
mL). The combined organic layers were washed with NaHCO3 (sat) solution (30 mL), brine (3 
× 30 mL), dried over Na2SO4, filtered, concentrated under reduced pressure and purified by 
column chromatography eluting (97:3 hexane:EtOAc) to afford 431 (1.67 g, 39%) as a 
colourless oil; Rf 0.45 (9:1 hexane:EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 7.97 – 7.91 (m, 
2H), 7.68 – 7.59 (m, 1H), 7.59 – 7.51 (m, 2H), 5.02 – 4.93 (m, 1H), 2.99 (t, J = 7.4 Hz, 2H), 
2.28 (q, J = 7.3 Hz, 2H), 1.65 (s, 3H), 1.53 (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 145.1 
(C), 135.4 (C), 133.7 (CH), 129.4 (2CH), 127.1 (2CH), 120.7 (CH), 36.3 (CH2), 27.6 (CH2), 
25.8 (CH3), 18.0 (CH3); IR (neat): ν = 3063, 2970, 2933, 2870, 1446, 1303, 1291, 1143, 1084, 
723, 688, 583; HR-MS (ES-TOF): m/z: calcd for C12H16O2S2: 256.0592, found 256.0595 [M + 
H]+ 
S-(3-Methylbut-3-en-1-yl) benzenesulfonothioate (433) 
433 was prepared according to a literature procedure.149 To a 25 mL 
RBF under argon was added 3-methyl-3-butene-1-ol (2.53 mL, 25 
mmol, 1.0 eq.), CH2Cl2 (5 mL) and triphenylphosphine (7.20 g, 27.5 mmol, 1.1 eq.). The 
mixture was cooled to 0 oC and N-bromosuccinimide (4.90 g, 27.5 mmol) was added in 5 
portions with vigorous stirring over 15 mins. On complete addition the reaction was stirred for 
a further 90 minutes. Hexane (20 mL) was added and the mixture was filtered through a pad of 
240 
 
silica, washing with hexane (20 mL). The solvent was removed under reduced pressure 
providing 432 as a colourless oil (1.76 g, 45%) which was used directly. 433 was prepared 
following a literature procedure.142 To a RBF was added sodium benzenesulfonothioate 358 
(2.67 g, 13.6 mmol, 1.2 eq) and the flask was evacuated and refilled with argon (× 3). 
Anhydrous DMF (12 mL) was added and the mixture was stirred at rt. Halide 432 (1.76 g, 11.2 
mmol, 1.0 eq.) was added over 5 minutes by syringe and the mixture was stirred for 24 hours. 
The mixture was poured into ice/ water (50 mL) and was extracted with Et2O (6 × 25 mL). The 
combined organic layers were washed with NaHCO3 (sat) solution (25 mL), brine (3 × 25 mL), 
dried Na2SO4, filtered, concentrated under reduced pressure and purified by column 
chromatography (95:5 hexane:EtOAc) to afford 433 (1.04 g, 39%) as a viscous colourless oil; 
Rf 0.50 (4:1 hexane:EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 8.02 – 7.86 (m, 2H), 7.68 – 7.53 
(m, 3H), 4.77 (s, 1H) 4.62 (s, 1H), 3.11 (t, J = 7.5 Hz, 2H), 2.30 (t, J = 7.5 Hz, 2H), 1.66 (s, 
3H); 13C NMR (101 MHz, CDCl3): δ = 144.9 (C), 142.3 (C), 133.8 (CH), 129.4 (CH), 127.1 
(2CH), 112.7 (CH2), 36.6 (CH2), 34.2 (CH2), 22.1 (CH3); IR (neat): ν = 3074, 2972, 2936, 1650, 
1447, 1321, 1307, 1138, 1077, 894, 754, 714, 685, 593, 535; HR-MS (ES-TOF): m/z: calcd for 
C11H15O2S2: 243.0513, found 243.0506 [M + H]
+. 
(E)-((4-Methoxyphenyl)ethynyl)(4-phenylbut-3-en-1-yl)sulfane (434) 
434 was prepared according to GP11 using 352 (132 
mg, 1.00 mmol), LiHMDS (1 M, 1.00 mL, 1.00 mmol), 
429 (277 mg, 0.91 mmol) and THF (5 mL). The reaction 
time was 20 hours. Aqueous workup and purification by column chromatography (hexane) 
provided 434 (216 mg, 75%) as a colourless oil; Rf 0.19 (hexane); 
1H NMR (300 MHz, CDCl3): 
δ = 7.32 – 7.08 (m, 8H), 6.77 – 6.70 (m, 2H), 6.41 (d, J = 15.8 Hz, 1H), 6.18 (dt, J = 15.8, 7.1 
Hz, 1H), 3.71 (s, 3H), 2.81 (t, J = 7.1 Hz, 2H), 2.67 – 2.56 (m, 2H); 13C NMR (101 MHz, 
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CDCl3): δ = 159.8 (C), 137.4 (C), 133.6 (2CH), 132.1 (CH), 128.7 (2CH), 127.6 (CH), 127.4 
(CH), 126.3 (2CH), 115.7 (C), 114.1 (2CH), 93.4 (C), 77.3 (C), 55.5 (CH3), 35.6 (CH2), 33.1 
(CH2); IR (neat): ν = 3025, 2959, 2836, 2156, 1603, 1505, 1246, 1171, 1030, 963, 829, 741, 
691; HR-MS (ES-TOF): m/z: calcd for C19H19OS: 295.1157, found 295.1161 [M + H]
+.  
(E)-1-Methoxy-4-(((4-phenylbut-3-en-1-yl)sulfinyl)ethynyl)benzene (435) 
435 was prepared according to GP12 using using 434 
(200 mg, 0.68 mmol), mCPBA (117 mg, 0.68 mmol) 
and CH2Cl2 (7 mL). The reaction time was 2 hours. 
Aqueous workup and purification by column chromatography (4:1 hexane:EtOAc) provided 
435 (157 mg, 74%) as a white solid; Rf 0.37 (2:1 hexane:EtOAc); mp: 50-51 
oC ; 1H NMR (300 
MHz, CDCl3): δ = 7.47 (d, J = 8.9 Hz, 2H), 7.40 – 7.19 (m, 5H), 6.89 (d, J = 8.9 Hz, 2H), 6.56 
(d, J = 15.8 Hz, 1H), 6.26 (dt, J = 15.8, 7.0 Hz, 1H), 3.84 (s, 3H), 3.28 (t, J = 7.7 Hz, 2H), 2.99 
– 2.76 (m, 2H); 13C NMR (101 MHz, CDCl3): δ = 161.6 (C), 137.0 (C), 134.3 (CH), 132.9 
(2CH), 128.7 (2CH), 127.7 (CH), 126.3 (2CH), 126.1 (CH), 114.5 (2CH), 111.7 (C), 103.7 (C), 
84.1 (C), 55.7 (CH3), 55.6 (CH2), 26.1 (CH2); IR (neat): ν = 3052, 2966, 2840, 2159, 1604, 
1508, 1264, 1250, 1028, 731, 700; HR-MS (ES-TOF): m/z: calcd for C19H18O2NaS: 333.0925, 
found 333.0929 [M + Na]+.  
(E)-(Cyclopropylethynyl)(4-phenylbut-3-en-1-yl)sulfone (436) 
436 was prepared according to GP11 using 
cyclopropylacetylene (168 µl, 2.00 mmol), LiHMDS (1 M, 
2.00 mL, 2.00 mmol), 429 (554 mg, 1.82 mmol) and THF (10 mL). The reaction time was 16 
hours. Aqueous workup and purification by column chromatography (hexane) provided 436 
(308 mg, 74%) as a pale yellow oil; Rf 0.21 (hexane); 
1H NMR (300 MHz, CDCl3): δ = 7.42 – 
7.27 (m, 4H), 7.25 – 7.18 (m, 1H), 6.48 (d, J = 15.8 Hz, 1H), 6.25 (dt, J = 15.8, 6.8 Hz, 1H), 
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2.78 (dd, J = 10.7, 4.1 Hz, 2H), 2.69 – 2.58 (m, 2H), 1.37 (tt, J = 8.3, 5.0 Hz, 1H), 0.85 – 0.70 
(m, 4H); 13C NMR (101 MHz, CDCl3): δ = 137.4 (C), 131.9 (CH), 128.7 (2CH), 127.7 (CH), 
127.4 (CH), 126.2 (2CH), 98.8 (C), 64.0 (C), 35.2 (CH2), 32.9 (CH2), 9.1 (2CH2), 0.9 (CH); IR 
(neat): ν = 3025, 2924, 2167, 1598, 1493, 1448, 1350, 1268, 1192, 1053, 1028, 987, 963, 839, 
810, 740, 691; HR-MS (EI-TOF): m/z: calcd for C15H16S: 228.0977, found 228.0973 [M + H]
+.  
(E)-(4-((Cyclopropylethynyl)sulfinyl)but-1-en-1-yl)benzene (437) 
437 was prepared according to GP12 using 436 (280 mg, 1.23 
mmol), mCPBA (212 mg, 1.23 mmol) and CH2Cl2 (12 mL).  
The reaction time was 2 hours. Aqueous workup and 
purification by column chromatography (4:1 hexane:EtOAc) provided 437 (208 mg, 69%) as a 
colourless oil; Rf 0.37 (2:1 hexane:EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 7.39 – 7.18 (m, 
5H), 6.52 (d, J = 15.8 Hz, 1H), 6.21 (dt, J = 15.8, 7.0 Hz, 1H), 3.14 (t, J = 7.6 Hz, 2H), 2.89 – 
2.66 (m, 2H), 1.51 – 1.41 (m, 1H), 1.03 – 0.85 (m, 4H); 13C NMR (101 MHz, CDCl3): δ = 137.0 
(C), 132.7 (CH), 128.7 (2CH), 127.6 (CH), 126.2 (2CH), 126.1 (CH), 109.8 (C), 72.0 (C), 55.8 
(CH2), 26.0 (CH2), 9.7 (CH), 0.3 (2CH2); IR (neat): ν = 3025, 2179, 1598, 1493, 1444, 1059, 
967, 829, 745, 694; HR-MS (ES-TOF): m/z: calcd for C15H17OS: 245.1000, found 245.1004 [M 
+ H]+.  
((3-Methoxyphenyl)ethynyl)(4-methylpent-3-en-1-yl)sulfane (438) 
438 was prepared according to GP11 using 3-methoxybenzene 
(330 mg, 2.50 mmol), LiHMDS (1 M 2.50 mL, 2.50 mmol), 431 
(581 mg, 2.27 mmol) and THF (13 mL). The reaction time was 16 
hours. Aqueous workup and purification by column 
chromatography (hexane) provided 438 (388 mg, 60%) as a colourless oil; Rf 0.23 (hexane); 
1H NMR (300 MHz, CDCl3): δ = 7.20 (t, J = 7.9 Hz, 1H), 7.03 – 6.98 (m, 1H), 6.93 (dd, J = 
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2.5, 1.4 Hz, 1H), 6.85 (ddd, J = 8.3, 2.6, 1.0 Hz, 1H), 5.23 – 5.14 (m, 1H), 3.79 (s, 3H), 2.79 (t, 
J = 7.4 Hz, 2H), 2.49 (q, J = 7.3 Hz, 2H), 1.73 (s, 3H), 1.67 (s, 3H); IR (neat): ν = 2925, 2854, 
2162, 1594, 1574, 1479, 1284, 1157, 1040, 776, 685; HR-MS (ES-TOF): m/z: calcd for 
C15H18OS: 246.1078, found 246.1075 [M + H]
+. (No 13C NMR obtained!) 
1-Methoxy-3-(((4-methylpent-3-en-1-yl)sulfinyl)ethynyl)benzene (439) 
439 was prepared according to GP12 using 438 (246 mg, 1.00 
mmol), mCPBA (173 mg, 1.00 mmol) and CH2Cl2 (10 mL). The 
reaction time was 2 hours. Aqueous workup and purification by 
column chromatography (4:1 hexane:EtOAc) provided 439 (139 
mg, 53%) as a pale yellow oil; Rf 0.15 (4:1 hexane:EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 
7.25 – 7.19 (m, 1H), 7.07 (d, J = 7.6 Hz, 1H), 7.00 – 6.97 (m, 1H), 6.97 – 6.91 (m, 1H), 5.20 – 
5.09 (m, 1H), 3.76 (s, 3H), 3.19 – 3.03 (m, 2H), 2.70 – 2.46 (m, 2H), 1.68 (s, 3H), 1.63 (s, 3H); 
13C NMR (101 MHz, CDCl3): δ = 159.6 (C), 135.5 (C), 129.9 (CH), 124.8 (CH), 120.9 (C), 
120.1 (CH), 117.4 (CH), 116.9 (CH), 102.3 (C), 85.1 (C), 56.4 (CH2), 55.5 (CH3), 25.9 (CH3), 
21.5 (CH2), 18.0 (CH3); IR (neat): ν = 2966, 2928, 2836, 2162, 1670, 1595, 1580, 1464, 1286, 
1268, 1037, 786; HR-MS (EI)+: m/z: calcd for C15H18O2S: 262.1022, found 262.1028 [M + H]
+. 
Cyclopropylethynyl)(4-methylpent-3-en-1-yl)sulfane (440) 
440 was prepared according to GP11 using cyclopropylacetylene 
(126 µl, 1.50 mmol), LiHMDS (1 M, 1.50 mL, 1.50 mmol), 431 (349 
mg, 1.36 mmol) and THF (8 mL). The reaction time was 4 hours. Aqueous workup and 
purification by column chromatography (hexane) provided 440 (166 mg, 68%) as a colourless 
oil; Rf 0.82 (4:1 hexane:EtOAc); 
1H NMR (400 MHz, CDCl3): δ = 5.17 – 5.11 (m, 1H), 2.62 (t, 
J = 7.4 Hz, 2H), 2.39 (q, J = 7.3 Hz, 2H), 1.71 (s, 3H), 1.64 (s, 3H), 1.34 (tt, J = 8.1, 5.0 Hz, 
1H), 0.82 – 0.68 (m, 4H); 13C NMR (101 MHz, CDCl3): δ = 134.2 (C), 121.8 (CH), 98.4 (C), 
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64.3 (C), 35.7 (CH2), 28.1 (CH2), 25.9 (CH3), 18.0 (CH3), 9.0 (CH2), 0.9 (CH); IR (neat): ν = 
3094, 3012, 2967, 2917, 2857, 1449, 1377, 1027, 988, 839, 811; HR-MS (EI-TOF): m/z: calcd 
for C11H16S: 180.0973 found 180.0966 [M + H]
+. 
(((4-Methylpent-3-en-1-yl)sulfinyl)ethynyl)cyclopropane (441) 
441 was prepared according to GP12 using 440 (140 mg, 0.78 
mmol), mCPBA (134 mg, 0.78 mmol) and CH2Cl2 (8 mL). The 
reaction time was 2 hours. Aqueous workup and purification by 
column chromatography (4:1 hexane:EtOAc) provided 441 (107 mg, 70%) as a colourless oil; 
Rf 0.14 (4:1 hexane:EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 5.14 (tdt, J = 7.2, 2.7, 1.3 Hz, 
1H), 3.09 – 2.91 (m, 2H), 2.66 – 2.38 (m, 2H), 1.71 (s, 3H), 1.65 (s, 3H), 1.53 – 1.37 (m, 1H), 
1.03 – 0.84 (m, 4H); 13C NMR (101 MHz, CDCl3): δ = 135.2 (C), 120.2 (CH), 109.2 (C), 72.3 
(C), 56.5 (CH2), 25.8 (CH3), 21.4 (CH2), 17.9 (CH3), 9.6 (CH2), 0.31 (CH); IR (neat): ν = 2969, 
2915, 2179, 2161, 1450, 1056, 829, 781, 579; HR-MS (ES-TOF): m/z: calcd for C19H18O2NaS: 
333.0920, found 333.0925 [M + Na]+. 
((4-Methoxyphenyl)ethynyl)(3-methylbut-3-en-1-yl)sulfane (442) 
442 was prepared according to GP11 using 353 (145 mg, 1.10 
mmol), LiHMDS 1M (1.10 mL, 1.10 mmol), 433 (238 mg, 1.00 
mmol) and THF (6 mL). The reaction time was 20 hours. 
Aqueous workup and purification by column chromatography (98:2 hexane:EtOAc) provided 
442 (187 mg, 81%) as a colourless oil; Rf 0.40 (hexane); 
1H NMR (300 MHz, CDCl3): δ = 7.41 
– 7.34 (m, 2H), 6.87 – 6.79 (m, 2H), 4.86 – 4.77 (m, 2H), 3.81 (s, 3H), 2.94 – 2.86 (m, 2H), 
2.50 (t, J = 7.6 Hz, 2H), 1.77 (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 159.7 (C), 143.3 (C), 
133.5 (2CH), 115.7 (2CH), 114.0 (C), 112.1 (CH2), 93.2 (C), 55.4 (CH3), 37.5 (CH2), 34.0 
(CH2), 22.4 (CH3); IR (neat): ν = 3075, 2966, 2933, 2836, 2167, 1650, 1604, 1569, 1505, 1441, 
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1289, 1246, 1171, 1031, 891, 829, 777; HR-MS (EI-TOF): m/z: calcd for C14H16OS: 232.0922 
found 232.0909 [M + H]+.  
1-Methoxy-4-(((3-methylbut-3-en-1-yl)sulfinyl)ethynyl)benzene (443) 
443 was prepared according to GP12 using 442 (166 mg, 0.71 
mmol), mCPBA (123 mg, 0.71 mmol) and CH2Cl2 (7 mL). The 
reaction time was 2 hours. Aqueous workup and purification by 
column chromatography (4:1 hexane:EtOAc) provided 443 (134 mg, 75%) as a colourless oil; 
Rf 0.33 (7:3 hexane:EtOAc); 
1H NMR (400 MHz, CDCl3): δ = 7.52 – 7.44 (m, 2H), 6.92 – 6.86 
(m, 2H), 4.85 (d, J = 13.9 Hz, 2H), 3.83 (s, 3H), 3.25 (t, J = 7.9 Hz, 2H), 2.76 – 2.50 (m, 2H), 
1.81 (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 161.6 (C), 142.2 (C), 134.3 (2CH), 114.4 (2CH), 
112.4 (CH2), 111.7 (C), 103.4 (C), 84.1 (C), 55.5 (CH3), 54.6 (CH2), 30.3 (CH2), 22.6 (CH3).  
(Cyclopropylethynyl)(3-methylbut-3-en-1-yl)sulfone (417) 
417 was prepared according to GP11 using cyclopropylacetylene (176 
µl, 2.00 mmol), LiHMDS 1M (2.00 mL, 2.00 mmol), 406 (433 mg, 2.00 
mmol) and THF (10 mL). The reaction time was 17 hours. Aqueous workup and purification 
by column chromatography (hexane) provided 417 (253 mg, 84%) as a colourless oil; Rf 0.32 
(hexane); 1H NMR (300 MHz, CDCl3): δ = 4.78 (d, J = 16.2 Hz, 2H), 2.85 – 2.71 (m, 2H), 2.41 
(t, J = 7.6 Hz, 2H), 1.75 (s, 3H), 1.40 – 1.29 (m, 1H), 0.87 – 0.65 (m, 4H); 13C NMR (101 MHz, 
CDCl3): δ = 142.3 (C), 112.3 (CH2), 109.4 (C), 72.1 (C), 54.6 (CH2), 30.2 (CH2), 22.6 (CH3), 
9.7 (CH), 0.32 (2CH2); IR (neat): ν = 3078, 3013, 2969, 2935, 1650, 1445, 1375, 1350, 1028, 





445 was prepared according to GP12 using 444 (151 mg, 0.91 mmol), 
mCPBA (157 mg, 0.91 mmol) and CH2Cl2 (9 mL). The reaction time 
was 2 hours. Aqueous workup and purification by column 
chromatography (4:1 hexane:EtOAc) provided 445 (125 mg, 76%) as a colourless oil; Rf 0.17 
(4:1 hexane:EtOAc); 1H NMR (400 MHz, CDCl3): δ = 4.82 (d, J = 20.4 Hz, 2H), 3.16 – 3.06 
(m, 2H), 2.66 – 2.44 (m, 2H), 1.78 (s, 3H), 1.51 - 1.42 (m, 1H), 1.04 – 0.86 (m, 4H); 13C NMR 
(101 MHz, CDCl3): δ = 142.3 (C), 112.2 (CH2), 109.4 (C), 72.1 (C), 54.6 (CH2), 30.2 (CH2), 
22.6 (CH3), 9.7 (CH), 0.3 (2CH2); IR (neat): ν = 3080, 2971, 2919, 2179, 1650, 1446, 1057, 
890, 828, 781; IR (neat): ν = 3029, 2914, 1753, 1640, 1603, 1389, 1211, 1132, 1044, 999, 915, 
701; HR-MS (ES-TOF): m/z: calcd for C10H15OS: 183.0839, found 183.0844 [M + H]
+. 
Cyclopropyl(2-oxido-6-phenyl-2-thiabicyclo[3.1.0]hexan-1-yl)methanone (446) 
Prepared according to GP14 using sulfoxide 437 (97.7 mg, 0.40 mmol), 3,5 
dichloropyridine-N-oxide (78.6 mg, 0.48 mmol), SPhosAuNTf2 (17.6 mg, 5 
mol%) and dioxane (8 mL). The reaction time was 3 hours. Purification by 
column chromatography (1:1 hexane:EtOAc) to (2:1 hexane:EtOAc) afforded 446 (41.6 mg, 
40%) as a white solid, stereochemistry is undefined; Rf 0.38 (EtOAc); mp: 107-108 
oC; 1H NMR 
(400 MHz, CDCl3): δ = 7.35 – 7.22 (m, 5H), 3.77 (d, J = 6.8 Hz, 1H), 3.58 (dt, J = 13.1, 5.8 
Hz, 1H), 3.17 (dt, J = 6.8, 3.3 Hz, 1H), 2.83 – 2.70 (m, 1H), 2.61 – 2.50 (m, 2H), 2.39 – 2.28 
(m, 1H), 1.07 – 0.94 (m, 1H), 0.92 – 0.83 (m, 1H), 0.82 – 0.71 (m, 1H), 0.67 – 0.58 (m, 1H); 
13C NMR (101 MHz, CDCl3): δ = 201.1 (C), 133.3 (C), 129.2 (2CH), 128.4 (CH), 127.7 (2CH), 
68.3 (C), 53.6 (CH2), 35.4 (CH), 33.9 (CH), 27.1 (CH2), 21.3 (CH), 12.6 (CH2), 12.2 (CH2); IR 
(neat): ν = 2983, 2941, 2871, 1659, 1601, 1497, 1447, 1396, 1249, 1218, 1058, 1032, 968, 896, 
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747, 702; HR-MS (ES-TOF): m/z: calcd for C15H16O2NaS: 283.0769, found 283.0775 [M + 
Na]+. 
Cyclopropyl(3-(hydroxy(phenyl)methyl)-1-oxidotetrahydrothiophen-2-yl)methanone (447) 
Prepared from the same reaction eluting with (EtOAc) yielding 422 (24.5 mg, 
22%); mp: 94-95 oC; 1H NMR (400 MHz, CDCl3): δ = 7.37 (dt, J = 15.1, 7.4 
Hz, 4H), 7.27 (t, J = 6.3 Hz, 1H), 4.86 (t, J = 5.1 Hz, 1H), 4.24 (dd, J = 4.7, 1.5 
Hz, 1H), 3.74 (d, J = 4.7 Hz, 1H), 3.22 – 3.05 (m, 2H), 2.78 – 2.60 (m, 2H), 
2.44 – 2.29 (m, 1H), 1.69 (ddd, J = 12.4, 7.8, 4.6 Hz, 1H), 1.00 – 0.80 (m, 4H); 13C NMR (101 
MHz, CDCl3): δ = 205.4 (C), 143.7 (C), 128.8 (2CH), 127.9 (CH), 126.0 (2CH), 80.0 (CH), 
74.8 (CH), 53.1 (CH2), 52.2 (CH), 29.6 (CH2), 21.3 (CH), 12.4 (CH2), 12.3 (CH2); IR (neat): ν 
= 3314, 3063, 3011, 2935, 1677, 1604, 1380, 1063, 1028, 1041, 998, 760, 703; HR-MS (ES-
TOF): m/z: calcd for C15H18O3SNa: 301.0874, found 301.0878 [M + Na]
+. 
Cyclopropyl(3-(2-hydroxypropan-2-yl)-1-oxidotetrahydrothiophen-2-yl)methanone (453) 
Prepared according to GP14 using sulfoxide 441 (78.5 mg, 0.40 mmol), 3,5 
dichloropyridine-N-oxide (78.6 mg, 0.48 mmol), SPhosAuNTf2 (17.6 mg, 5 
mol%) and dioxane (8 mL). The reaction time was 24 hours. Purification by 
column chromatography (EtOAc) afforded 453 (35.0 mg, 38%) as a white solid; Rf 0.17 
(EtOAc); mp: 96-98 oC; 1H NMR (400 MHz, CDCl3): δ = 4.34 (dd, J = 6.1, 1.6 Hz, 1H), 3.17 
– 3.09 (m, 1H), 2.87 (dt, J = 10.4, 6.4 Hz, 1H), 2.72 – 2.60 (m, 1H), 2.57 (t, J = 6.2 Hz, 2H), 
2.47 – 2.39 (m, 1H), 2.30 (tt, J = 7.7, 4.6 Hz, 1H), 1.30 (s, 3H), 1.25 (s, 3H), 1.18 – 1.06 (m, 
4H); 13C NMR (101 MHz, CDCl3): δ = 205.2 (C), 81.4 (CH), 70.3 (C), 53.8 (CH), 53.0 (CH2), 
30.5 (CH3), 28.3 (CH2), 27.6 (CH3), 22.2 (CH), 12.8 (CH2), 12.6 (CH2); IR (neat): ν = 3372, 
2968, 2926, 1678, 1452, 1380, 1040, 1001, 955, 909; HR-MS (ES-TOF): m/z: calcd for 




S-methyl benzenesulfonothioate (457) 
457 was prepared according to a literature procedure.191 To RBF was added 
benzenethiosulfonate 358 (4.00 g, 20.0 mmol, 1.2 eq.) and anhydrous DMF (20 
mL). After stirring at rt for 10 minutes methyl iodide (1.04 mL, 16.7 mmol, 1.0 eq.) was added 
dropwise and the reaction mixture was stirred at rt for 3 days. The mixture was then poured in 
to H2O (100 mL) and extracted with Et2O (6 × 30 mL). The combined organics were washed 
with NaHCO3 (30 mL of a saturated solution), brine (3 × 30 mL), dried over Na2SO4, filtered, 
concentrated under reduced pressure and purified by column chromatography (19:1 
hexane:EtOAc) to (9:1 hexane:EtOAc) yielding the title compound (2.62 g, 85%) as a 
colourless oil; Rf 0.25 (9:1 hexane:EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 7.97 – 7.90 (m, 
2H), 7.70 – 7.62 (m, 1H), 7.61 – 7.52 (m, 2H), 2.51 (s, 3H); IR (neat): ν = 3065, 1582, 1447, 
1328, 1305, 1138, 1076, 754, 714, 684. Data is in agreement with literature values.191 
((2-Isopropylphenyl)ethynyl)(methyl)sulfane (458) 
458 was prepared according to GP11 using sulfinate (144 mg, 1.00 mmol), 
LiHMDS (1 M, 1.00 mL, 1.00 mmol), 457 (167 mg, 0.91 mmol) and THF (5 
mL). The reaction time was 16 hours. Aqueous workup and purification by 
column chromatography (hexane) provided 458 (82 mg, 50%) as a colourless oil; Rf 0.47 
(hexane); 1H NMR (300 MHz, CDCl3): δ = 7.30 – 7.25 (m, 1H), 7.15 (dd, J = 2.6, 1.1 Hz, 1H), 
7.14 (d, J = 1.0 Hz, 1H), 7.00 (ddd, J = 7.7, 5.3, 3.4 Hz, 1H), 3.30 (dt, J = 13.8, 6.9 Hz, 1H), 
2.38 (s, 3H), 1.15 (d, J = 6.9 Hz, 6H); 13C NMR (101 MHz, CDCl3): δ = 150.4 (C), 132.2 (CH), 
128.4 (CH), 125.5 (CH), 124.9 (CH), 122.2 (C), 90.7 (C), 84.1 (C), 31.6 (CH), 23.1 (2CH3), 
19.6 (CH3); IR (neat): ν = 3062, 2961, 2927, 2868, 2164, 1596, 1481, 1444, 1312, 1082, 976, 





459 was prepared according to GP12 from 458 (74.1 mg, 0.39 mmol), 
mCPBA (67.3 mg, 0.39 mmol) and CH2Cl2 (4 mL). The reaction time was 2 
hours. Aqueous workup and purification by column chromatography (4:1 
hexane: EtOAc) provided 459 (60.3 mg, 75%) as a colourless oil; The product was used directly 
in the catalysis. 
2-(Methylsulfinyl)-1-(2-(prop-1-en-2-yl)phenyl)ethan-1-one (462) 
 462 was prepared according to GP13 using 459 (41.2 mg, 0.20 mmol), 3,5-
dichloropyridine-N-oxide (39.4 mg, 0.24 mmol), SPhosAuNTf2 (4.4 mg, 2.5 
mol%) and 1,4-dioxane (4 mL). The reaction time was 24 hours. Purification 
by column chromatography (7:3 hexane:EtOAc) afforded 462 (9.0 mg, 22%) as an off white 
solid; Rf 0.11 (1:1 hexane:EtOAc); mp: 104-106 
oC; 1H NMR (300 MHz, CDCl3): δ = 7.51 
(ddd, J = 15.2, 7.6, 1.3 Hz, 2H), 7.42 – 7.30 (m, 2H), 5.29 – 5.26 (m, 1H), 4.90 (d, J = 0.5 Hz, 
1H), 4.33 (d, J = 14.3 Hz, 1H), 4.14 (d, J = 14.4 Hz, 1H), 2.76 (s, 3H), 2.18 (dd, J = 1.3, 0.9 
Hz, 3H); 13C NMR (101 MHz, CDCl3); δ = 197.2 (C), 144.8 (C), 143.2 (C), 137.9 (C), 132.2 
(CH), 128.8 (CH), 128.7 (CH), 127.9 (CH), 118.2 (CH2), 65.4 (CH2), 40.0 (CH3), 24.0 (CH2); 
IR (neat): ν = 2916, 1679, 1594, 1288, 1039, 770; HR-MS (ES-TOF): m/z: calcd for C12H14O2S: 
222.0715, found 222.0713 [M + H]+.  
2-((Trimethylsilyl)ethynyl)benzaldehyde (464) 
464 was prepared according to a modified literature procedure.152 To an 
argon dried flask was added Et3N (17 mL) and 2-bromobenzaldehyde (1.67 
g, 9.0 mmol, 1.0 eq.). The flask was degassed for 10 minutes before the 
addition of Pd(PPh3)2Cl2 (121 mg, 0.18 mmol, 2 mol%) and CuI (55 mg, 0.36 mmol, 4 mol%). 
TMS acetylene (1.49 mL, 10.8 mmol, 1.2 eq.) was added dropwise over 40 minutes and the 
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reaction was stirred at rt for 22 hours. Additional Pd(PPh3)2Cl2 (30 mg, 0.045 mmol, 0.5 mol%) 
and CuI (14 mg, 0.09 mmol, 1 mol%) was added and the reaction was stirred for a further 2 
hours. The reaction mixture was filtered through celite, and the filtrate concentrated under 
reduced pressure. Column chromatography (hexane) to (96:4 hexane:EtOAc) afforded the title 
compound as a yellow solid (1.55 g, 85%); Rf  0.87 (9:1 hexane:EtOAc); mp: 46-48 
oC; 1H 
NMR (300 MHz, CDCl3): δ = 10.56 (d, J = 0.8 Hz, 1H), 7.93 – 7.89 (m, 1H), 7.60 – 7.51 (m, 
2H), 7.47 – 7.40 (m, 1H), 0.28 (s, 9H), IR (neat): ν = 2958, 2900, 2763, 2152, 1694, 1593, 1474, 
1246, 1217, 863, 842, 757, 653. Data matches that reported in the literature.152 
1-(Dimethoxymethyl)-2-ethynylbenzene (465) 
465 was prepared according to a literature procedure.153 To a methanol (16.4 
mL) solution of 464 (1.66 g, 8.2 mmol) and HC(OMe)3 (8.30 g, 82 mmol) was 
added p-TSA (0.14 g, 0.82 mmol). The reaction was stirred for 1 h before it was 
quenched with NaHCO3 solution (10 mL), and extracted with EtOAc (3 × 10 mL). The 
combined organic layers were washed with brine, dried over Na2SO4 and concentrated under 
reduced pressure. The crude residue was dissolved in dichloromethane (10 mL)/methanol (20 
mL), and added with potassium carbonate (1.13 g, 8.2 mmol). Upon completion, the reaction 
was quenched by water and extracted with dichloromethane. The combined organic layers were 
dried over Na2SO4 and concentrated under reduced pressure. The crude residue was then 
purified by column chromatography to afford 465 (1.20 g, 83%) as a colourless oil; 1H NMR 
(300 MHz, CDCl3): δ = 7.60 (dd, J = 7.6, 1.4 Hz, 1H), 7.52 (dd, J = 7.6, 1.4 Hz, 1H), 7.38 (td, 
J = 7.6, 1.4 Hz, 1H), 7.30 (td, J = 7.6, 1.4 Hz, 1H), 5.72 (s, 1H), 3.39 (s, 6H), 3.33 (s, 1H); 13C 
NMR (101 MHz, CDCl3): δ =140.3 (C), 133.1 (CH), 128.9 (CH), 128.5 (CH), 126.4 (CH), 
121.1 (C), 102.1 (CH), 81.9 (CH), 81.3 (C), 53.97 (2CH3); IR (neat): ν = 2992, 2906, 2830, 
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1464, 1448, 1367, 1211, 1114, 1084, 1070, 1050, 978, 909, 760, 649. Data is in agreement with 
literature values.153 
1-(Dimethoxymethyl)-2-((methylsulfinyl)ethynyl)benzene (467) 
467 was prepared according to a literature procedure over 2 steps.27 Alkyne 
465 (468 mg, 2.66 mmol 1.1 eq.) was added to a flame dried 2 neck RBF 
under argon. THF (14 mL) was added and the reaction mixture was cooled 
to -78 oC. LiHMDS (1M) (2.66 mL, 2.66 mmol, 1.1 eq.) was added dropwise 
and the mixture was stirred for a further hour at -78 oC. Methyl thionosulfonate 457 was added 
(443 mg, 2.41 mmol, 1.0 eq.) and the reaction allowed to warm to rt and stirred for 4 hours. 
NH4Cl (10 mL) was added and the mixture was extracted with Et2O (3 × 10 mL), the organics 
washed with brine (10 mL), dried over Na2SO4, filtered, concentrated under reduced pressure 
and purified by column chromatography (hexane) affording the crude sulfide 466 476 mg 
(~80% pure). The sulfide (278 mg, 1.00 mmol) was dissolved in CH2Cl2 (10 mL), the mixture 
was cooled to 0 oC and mCPBA (173 mg, 1.00 mmol) was added in 5 portions over 10 minutes. 
The mixture was allowed to warm to rt and was stirred for 2 hours. The reaction mixture was 
washed NaHCO3 (sat.) (3 × 10 mL) and the aqueous layers were extracted
 with CH2Cl2 (3 × 5 
mL). The organic layers were dried Na2SO4, filtered, concentrated under reduced pressure and 
purified by column chromatography (EtOAc) providing the title compound (195 mg, 53% over 
2 steps) as a yellow oil; Rf 0.68 (EtOAc); 
1H NMR (300 MHz, CDCl3): δ = 7.64 (dd, J = 7.8, 
0.5 Hz, 1H), 7.55 (d, J = 6.5 Hz, 1H), 7.47 (dd, J = 11.0, 4.2 Hz, 1H), 7.35 (td, J = 7.5, 1.0 Hz, 
1H), 5.59 (s, 1H), 3.38 (s, 6H), 3.08 (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 141.0 (C), 133.3 
(CH), 130.7 (CH), 128.7 (CH), 126.7 (CH), 118.5 (C), 101.9 (CH), 99.1 (C), 90.7 (C), 54.2 
(CH3), 43.6 (2CH3); IR (neat): ν = 2935, 2830, 2163, 1671, 1447, 1351, 1198, 1116, 1048, 979, 
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959, 763; HR-MS (ES-TOF): m/z: calcd for C12H14O3NaS: 261.0561, found 261.0552 [M + 
Na]+. 
1-(Dimethoxymethyl)-2-((phenylsulfinyl)ethynyl)benzene (469) 
469 was prepared over 2 steps. Alkyne 466 (468 mg, 2.66 mmol 1.1 eq.) 
was added to a flame dried 2 neck RBF under argon. THF (14 mL) was 
added and the reaction mixture was cooled to -78 oC. LiHMDS (1M) 
(2.66 mL, 2.66 mmol) was added dropwise and the mixture was stirred 
for a further hour at -78 oC. Phenyl thionosulfonate (607 mg, 2.41 mmol, 1.0 eq.) was added 
and the reaction allowed to warm to rt and stirred for 4 hours. NH4Cl (10 mL) was added and 
the mixture was extracted with Et2O (3 × 10 mL), the organics were washed with brine (10 
mL), dried Na2SO4, filtered, concentrated under reduced pressure and purified by column 
chromatography (hexane) affording the crude sulfide 468 446 mg (~75% pure). The sulfide 
(284 mg, 1.00 mmol) was dissolved in CH2Cl2 (12 mL), the mixture was cooled to 0 
oC and 
mCPBA (173 mg, 1.00 mmol) was added in 5 portions over 10 minutes. The mixture was 
allowed to warm to rt and was stirred for 2 hours. The reaction mixture was washed with 
NaHCO3 (sat.) (3 × 10 mL) and the aqueous layers were extracted with CH2Cl2 (3 × 5 mL). The 
organic layers were dried over Na2SO4, filtered, concentrated under reduced pressure and 
purified by column chromatography (4:1 hexane:EtOAc) providing the title compound (246 
mg, 36% over 2 steps) as a viscous yellow oil; Rf  0.30 (4:1 hexane:EtOAc); 
1H NMR (300 
MHz, CDCl3): δ = 7.98 – 7.86 (m, 2H), 7.65 – 7.51 (m, 5H), 7.45 (td, J = 7.7, 1.3 Hz, 1H), 7.33 
(td, J = 7.6, 1.3 Hz, 1H), 5.46 (s, 1H), 3.33 (s, 3H), 3.29 (s, 3H); 13C NMR (101 MHz, CDCl3): 
δ = 144.1 (C), 141.3 (C), 133.3 (CH), 131.9 (CH), 130.8 (CH), 129.7 (2CH), 128.7 (CH), 126.6 
(CH), 125.2 (2CH), 118.6 (C), 102.2 (CH), 99.9 (C), 90.6 (C), 54.4 (CH3), 54.3 (CH3); IR 
(neat): ν = 3061, 2934, 2829, 2162, 1724, 1678, 1578, 1476, 1444, 1196, 1084, 1070, 1049, 
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747, 686; HR-MS (ES-TOF): m/z: calcd for C17H16O3NaS: 323.0718, found 323.0706 [M + 
Na]+. 
1,3-Dimethoxy-2-(methylsulfinyl)-1H-indene (471) 
 A Radleys tube under argon was charged with 3,5-dichloropyridine-N-oxide 
(39.4 mg, 0.24 mmol, 1.2 eq.) and alkynyl sulfoxide 467 (47.6 mg, 0.20 
mmol, 1.0 eq.) as a 0.2 M solution in 1,4-dioxane. The mixture was 
transferred to an oil bath at 50 oC and SPhosAuNTf2 (8.8 mg, 5 mol%) was added followed by 
1,4-dioxane (3 mL). The reaction was stirred for 16 hours, allowed to cool and the mixture was 
filtered through a pad of silica, washing with EtOAc, concentrated and purified by column 
chromatography (1:1 hexane:EtOAc to EtOAc) yielding the title compound (45.2 mg, 95%) as 
a colourless oil as a 2.7:1 inseparable mixture of diastereomers; Rf 0.16 (EtOAc) Major 
diastereomer; 1H NMR (300 MHz, CDCl3): δ = 7.52 – 7.33 (m, 4H), 5.70 (s, 1H), 4.42 (s, 3H), 
3.16 (s, 3H), 3.05 (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 163.4 (C), 141.4 (C), 137.6 (C), 
129.8 (CH), 129.1 (CH), 123.9 (CH), 120.9 (CH), 112.2 (C), 80.8 (CH), 61.4 (CH3), 51.3 (CH3), 
37.1 (CH3); Minor diastereomer; 
1H NMR (300 MHz, CDCl3): δ = 7.53 – 7.32 (m, 4H), 5.92 
(s, 1H), 4.25 (s, 3H), 3.24 (s, 3H), 3.02 (s, 3H); 13C NMR (101 MHz, CDCl3): δ = 162.3 (C), 
142.1 (C), 137.5 (C), 129.6 (CH), 129.0 (CH), 124.1 (CH), 120.8 (CH), 112.6 (C), 78.6 (CH), 
61.5 (CH3), 53.0 (CH3), 37.9 (CH3); IR (neat): ν = 3260, 3017, 2989, 2827, 1613, 1600, 1563, 
1434, 1066, 977, 943,  739; HR-MS (ES-TOF): m/z: calcd for C12H14O3NaS: 261.0561, found 
261.0556 [M + Na]+. 
1,3-Dimethoxy-2-(phenylsulfinyl)-1H-indene (472) 
A Radleys tube under argon was charged with 3,5 dichloropyridine-N-
oxide (39.4 mg, 0.24 mmol, 1.2 equiv) and alkynyl sulfoxide 469 (60.8 
mg, 0.20 mmol, 1.0 eq.) as a 0.2 M solution in 1,4-dioxane. The mixture 
254 
 
was transferred to an oil bath at 50 oC and SPhosAuNTf2 (8.8 mg, 5 mol%) was added followed 
by 1,4-dioxane (3 mL). The reaction was stirred at  50 oC for 16 hours, allowed to cool and the 
mixture was filtered through a pad of silica, washing with EtOAc, concentrated and purified by 
column chromatography (1:9 hexane:EtOAc) to (2:8 hexane:EtOAc) yielding the title 
compound (48.5 mg, 80%) as a pale yellow oil as a 3.2:1 inseparable mixture of diastereomers; 
Rf  0.75 (EtOAc); mp: 104-106 
oC; Major diastereomer; 1H NMR (300 MHz, CDCl3): δ = 7.75 
– 7.69 (m, 2H), 7.57 – 7.42 (m, 4H), 7.39 – 7.34 (m, 3H), 4.89 (s, 1H), 4.55 (s, 3H), 3.14 (s, 
3H); 13C NMR (101 MHz, CDCl3): δ = 164.3 (C), 143.4 (C), 142.0 (C), 137.4 (C), 130.4 (CH), 
130.0 (CH), 129.1 (2CH), 129.0 (CH), 124.9 (2CH), 123.8 (CH), 120.8 (CH), 113.5 (C), 80.9 
(CH), 62.2 (CH3), 51.8 (CH3); Minor diastereomer; 
1H NMR (300 MHz, CDCl3): δ = 7.81 – 
7.75 (m, 2H), 7.57 – 7.42 (m, 4H), 7.33 – 7.29 (m, 3H), 5.80 (s, 1H), 4.45 (s, 3H), 2.37 (s, 3H); 
13C NMR (101 MHz, CDCl3): δ = 163.2 (C), 143.4 (C), 142.8 (C), 137.3 (C), 130.1 (CH), 129.7 
(CH), 129.1 (2CH), 128.9 (CH), 128.7 (CH), 124.9 (2CH), 124.2 (CH), 120.8 (CH), 113.7 (C), 
77.9 (CH), 62.2 (CH3), 51.9 (CH3); IR (neat): ν = 3064, 2987, 2931, 2830, 1611, 1598, 1560, 
1430, 1361, 1307, 1198, 1081, 1065, 1034, 927, 770, 753, 739, 688, 659; HR-MS (ES-TOF): 
m/z: calcd for C17H16O3NaS: 323.0718, found 323.0702 [M + Na]
+. 
2-(Allyloxy)benzaldehyde (476)   
Prepared according to a literature procedure.154 A RBF was charged with 
salicaldehyde (1.75 g, 14.3 mmol, 1.0 eq.) and DMF (20 mL). Allyl bromide 
(1.83 mL, 17.2 mmol, 1.2 eq.) and K2CO3 (3.95 g, 28.6 mmol) were added and the mixture was 
heated to 50 oC and stirred at this temperature for 16 hours. The mixture was cooled to rt, diluted 
with EtOAc (20 mL), washed with NH4Cl (20 mL), water (20 mL), brine (20 mL), dried over 
Na2SO4, filtered and concentrated under reduced pressure. The residue was purified by column 
chromatography (95:5 hexane:EtOAc) affording the title compound (2.31 g, 99%) as a 
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colourless oil. 1H NMR (300 MHz, CDCl3): δ = 10.54 (d, J = 0.7 Hz, 2H), 7.84 (dd, J = 7.6, 1.8 
Hz, 2H), 7.53 (ddd, J = 8.5, 7.6, 1.8 Hz, 2H), 7.03 (app t, J = 7.6 Hz, 2H), 6.98 (d, J = 8.4 Hz, 
2H), 6.08 (ddt, J = 17.2, 10.5, 5.1 Hz, 2H), 5.46 (dd, J = 17.2, 1.5 Hz, 1H), 5.34 (dd, J = 10.5, 
1.4 Hz, 1H),  4.66 (dt, J = 5.1, 1.5 Hz, 4H); IR (neat): ν = 3078, 2988, 2868, 1683, 1597, 1481, 
1455, 1396, 1285, 1238, 1161, 992, 843, 755. Data matches that reported in the literature.154 
1-(Allyloxy)-2-(2,2-dibromovinyl)benzene (349) 
Prepared using GP1, with 2-(allyloxy)benzaldehyde (2.00 g, 12.3 mmol), 
CBr4 (8.18 g, 24.7 mmol), and PPh3 (12.9 g, 49.0 mmol) in dry CH2Cl2 (40 
mL). The reaction time was 2 hours. Aqueous work-up and purification by 
column chromatography, eluting with n-hexane, afforded the dibromoalkene 349 (3.76 g, 95%) 
as a pale yellow oil; 1H NMR (300 MHz, CDCl3): δ = 7.71 (dd, J = 7.7, 1.3 Hz, 1H), 7.64 (s, 
1H), 7.38 – 7.26 (m, 4H), 6.97 (td, J = 7.6, 0.7 Hz, 1H), 6.87 (d, J = 8.3 Hz, 1H), 6.06 (ddt, J = 
17.2, 10.4, 5.1 Hz, 1H), 5.42 (dd, J = 17.3, 1.6 Hz, 1H), 5.31 (dd, J = 10.5, 1.4 Hz, 1H), 4.57 
(dt, J = 5.1, 1.5 Hz, 2H); IR (neat): ν = 3071, 2866, 1597, 1481, 1449, 1290, 1242, 1108, 995, 
875, 744, 695. Data matches that reported in the literature.154 
 ((2-(Allyloxy)phenyl)ethynyl)(methyl)sulfone (477) 
477 was prepared according to GP10 using dibromoolefin 349 (1.27 g, 4.00 
mmol), n-BuLi (2.5 M in hexanes) (3.37 mL, 8.60 mmol) and 458 (670 mg, 
3.64 mmol). The reaction time was 18 hours. Aqueous workup and purification by column 
chromatography (pentane) provided 477 (510 mg, 69%) as a colourless oil; Rf 0.22 (hexane); 
1H NMR (300 MHz, CDCl3): δ = 7.38 (dd, J = 7.6, 1.7 Hz, 1H), 7.23 (ddd, J = 8.3, 7.6, 1.7 Hz, 
1H), 6.92 – 6.80 (m, 2H), 6.07 (ddt, J = 17.3, 10.5, 4.9 Hz, 1H), 5.49 (dd, J = 17.3, 1.7 Hz, 1H), 
5.30 (dd, J = 10.5, 1.7 Hz, 1H), 4.60 (dt, J = 4.9, 1.7 Hz, 2H), 2.49 (s, 3H); 13C NMR (101 
MHz, CDCl3): δ = 159.2 (C), 133.4 (CH), 133.2 (CH), 129.4 (CH), 120.8 (CH), 117.4 (CH2), 
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112.1 (CH), 88.2 (C), 84.9 (C), 69.3 (CH2), 19.8 (CH3); IR (neat): ν = 3073, 2162, 1721, 1595, 
1488, 1287, 1255, 1067, 752; HR-MS (EI-TOF): m/z: calcd for C12H12OS: 204.0612, found 
204.0609 [M + H]+.  
1-(Allyloxy)-2-((methylsulfinyl)ethynyl)benzene (478) 
478 was prepared according to GP12 using 4771 (180 mg, 0.88 mmol), 
mCPBA (152 mg, 0.88 mmol) and CH2Cl2 (10 mL). The reaction time was 2 
hours. Aqueous work-up and purification by column chromatography (7:3 
hexane: EtOAc) provided 478 (164 mg, 85%) as a yellow oil; Rf  0.38 (1:1 hexane: EtOAc); 
1H 
NMR (300 MHz, CDCl3): δ = 7.47 (dd, J = 7.6, 1.7 Hz, 1H), 7.37 (ddd, J = 8.4, 7.5, 1.8 Hz, 
1H), 6.94 (td, J = 7.6, 0.9 Hz, 1H), 6.88 (d, J = 8.5 Hz, 1H), 6.13 – 5.94 (m, 1H), 5.46 (ddd, J 
= 17.3, 3.2, 1.7 Hz, 1H), 5.35 – 5.26 (m, 1H), 4.60 (dt, J = 4.8, 1.6 Hz, 2H), 3.06 (s, 3H); 13C 
NMR (101 MHz, CDCl3): δ = 160.1 (C), 134.3 (CH), 132.6 (CH), 132.3 (CH), 120.9 (CH), 
117.8 (CH2), 112.4 (CH), 109.5 (C), 98.6 (C), 90.2 (C), 69.3 (CH2), 43.7 (CH3); IR (neat): ν = 
2935, 2162, 1721, 1595, 1488, 1287, 1255, 1067, 752. HR-MS (EI-TOF): m/z: calcd for 
C12H12O2S: 220.0562, found 220.0558 [M + H]
+.  
1-Methoxy-4-((methylsulfinyl)ethynyl)benzene (481) 
481 was prepared over 2 steps. 4-methoxyphenylacetylene 352 (223 mg, 
1.69 mmol) was added to a flame dried 2 neck RBF under argon. THF (8 
mL) was added and the reaction mixture was cooled to -78 oC. LiHMDS 
(1M) (1.69 mL, 1.69 mmol) was added dropwise and the mixture was stirred for a further hour 
at -78 oC. Methyl thionosulfonate 457 was added (1.54 mmol, 1.0 eq.) and the reaction allowed 
to warm to rt and stirred for 4 hours. NH4Cl (10 mL) was added and was extracted Et2O (3 ×10 
mL), organics washed with brine (10 mL), dried Na2SO4, filtered, concentrated under reduced 
pressure and purified by column chromatography (hexane) affording the crude sulfide (~85% 
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pure). The sulfide (240 mg, 1.15 mmol) was dissolved in CH2Cl2 (12 mL), the mixture was 
cooled to 0 oC and mCPBA (200 mg, 1.15 mmol) was added in 5 portions over 10 minutes. The 
mixture was allowed to warm to rt and was stirred for 2 hours. The reaction mixture was washed 
with NaHCO3 (sat.) (3 × 10 mL) and the aqueous layers were extracted 
 with CH2Cl2 (3 × 5 mL). 
The organic layers were dried over Na2SO4, filtered, concentrated under reduced pressure and 
purified by column chromatography (2:1 hexane:EtOAc) providing the title compound (170 
mg, 57% over 2 steps) as a viscous yellow oil; Rf 0.25 (2:1 hexane:EtOAc); 
1H NMR (300 
MHz, CDCl3): δ = 7.44 (d, J = 8.9 Hz, 2H), 6.86 (d, J = 8.9 Hz, 2H), 3.80 (s, 3H), 3.01 (s, 3H); 
13C NMR (101 MHz, CDCl3): δ = 161.6 (C), 134.1 (2CH), 114.3 (2CH), 111.4 (CH), 102.3 (C), 
85.3 (C), 55.4 (CH3), 43.5 (CH3); IR (neat): ν = 3053, 2852, 1724, 1543, 1331, 1145, 1077, 
1544, 1331, 1077, 923, 817, 752; HR-MS (EI-TOF): m/z: calcd for C10H10O2S: 194.0403 found 
194.0402 [M + Na]+.  
(S)-2-amino-3-phenylpropan-1-ol (483) 
483 was prepared according to a literature procedure.154 A 500 mL RBF was 
equipped with a condenser and sodium borohydride (5.49 g, 145 mmol) was 
added, followed by THF (200 mL). Phenylalanine 482 (10.0 g, 60.50 mmol, 
1.0 eq.) was added and the mixture was cooled to 0 oC. Iodine (15.4 g, 60.50 mmol, 1.0 eq.) in 
THF (50 mL) was added by dropping funnel over 1 hour. The mixture was heated to reflux and 
stirred at this temperature for 18 hours, cooled to rt and MeOH was added dropwise. The 
mixture was concentrated under reduced pressure and dissolved in a 20% KOH solution (150 
mL), stirred at rt for 4 hours and extracted with CHCl3 (100 mL × 4). The organic layers were 
dried over Na2SO4, filtered and concentrated under reduced pressure affording a white solid 
which was purified by recrystallisation from hot EtOH affording the title compound (5.90 g, 
64%) as a white solid; mp: 85-87 oC (EtOH). 1H NMR (300 MHz, CDCl3): δ = 7.35 – 7.15 (m, 
258 
 
5H), 3.63 (dd, J = 10.5, 4.0 Hz, 1H), 3.37 (dd, J = 10.5, 7.2 Hz, 1H), 3.18 – 3.06 (m, 1H), 2.79 
(dd, J = 13.5, 5.2 Hz, 1H), 2.51 (dd, J = 13.5, 8.6 Hz, 1H), 1.81 – 1.48 (bs, 3H). 
IR (neat): ν = 3357, 3299, 2876, 2820, 1576, 1493, 1065, 753, 698. Data mataches that reported 
in the literature.154 
(S)-4-benzyloxazolidin-2-one (484) 
484 was prepared according to a literature procedure.155 A RBF was equipped 
with an oven dried downward distillation kit. (S)-2-amino-2-phenylethan-1-
ol 483 (5.90 g, 39 mmol, 1.0 eq.), diethyl carbonate (13.0 mL, 107 mmol, 
2.74 eq.) and K2CO3 (684 mg, 5.96 mmol, 0.127 eq.) were combined in the RBF and the mixture 
was carefully heated to 130 oC. After 3 hours no more ethanol was being collected and the 
mixture was allowed to cool, diluted with CH2CH2 (150 mL), filtered through a sintered funnel, 
concentrated and purified by column chromatography (2:8 EtOAc:hexane) to (1:1 
EtOAc:hexane) affording the title compound (5.41 g, 78%) as a white solid. mp: 87-89 oC; 1H 
NMR (300 MHz, CDCl3): δ = 7.39 – 7.27 (m, 3H), 7.22 – 7.16 (m, 2H), 5.41 (bs, 1H), 4.46 (t, 
J = 8.0 Hz, 1H), 4.20 – 4.02 (m, 2H), 2.87 (d, J = 6.8 Hz, 2H); IR (neat): ν = 3257, 2922, 1752, 
1700, 1406, 1247, 1019, 703.Data matches that reported in the literature.155 
 (S)-4-Benzyl-3-(but-3-en-1-ylthio)oxazolidin-2-one (485) 
485 was prepared according to a literature procedure128 A 2 neck flame dried 
25 mL RBF was charged with THF (5 mL) and Oxazolidin-2-one 484 (177 
mg, 1.00 mmol, 1.0 eq.) and the mixture was cooled to 0 oC. n-BuLi (2.5 M 
in hexanes) (0.44 mL, 1.00 mmol, 1.0 eq.) was added dropwise and the mixture was stirred for 
30 minutes at this temperature. Sulfonothioate 359 (228 mg, 1.0 mmol, 1.0 eq.) was then added 
as a solution in THF (2 mL) over 2 mins. The mixture was stirred for 10 mins at 0 oC and then 
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at rt for 2 hours. The reaction mixture was quenched with NH4Cl (10 mL), extracted with Et2O 
(2 × 10 mL) and the combined organics were washed with brine (10 mL), dried over Na2SO4, 
filtered, concentrated under reduced pressure and purified by column chromatography (9:1 
hexane:EtOAc to 4:1 hexane:EtOAc) to afford the title compound (190 mg, 75%) as a clear 
viscous oil; 1H NMR (300 MHz, CDCl3): δ = 7.39 – 7.26 (m, 3H), 7.21 – 7.13 (m, 2H), 5.87 
(ddt, J = 16.8, 10.2, 6.6 Hz, 1H), 5.20 – 5.05 (m, 2H), 4.26 – 3.90 (m, 3H), 3.37 (dd, J = 13.5, 
3.4 Hz, 1H), 3.07 – 2.82 (m, 2H), 2.70 (dd, J = 13.5, 9.4 Hz, 1H), 2.51 – 2.38 (m, 2H); 13C 
NMR (101 MHz, CDCl3): δ = 158.3 (C), 135.8 (CH), 135.2 (C), 129.3 (2CH), 129.1 (2CH), 
127.4 (CH) , 116.7 (CH2), 67.2 (CH2), 60.4 (CH), 39.0 (CH2), 37.5 (CH2), 32.4 (CH2); IR (neat): 
ν = 3029, 2914, 1753, 1640, 1603,1389, 1211, 1132, 1044, 999, 915, 701; HR-MS (ES-TOF): 
m/z: calcd for C14H18NO2S: 264.1058, found 264.1058 [M + H]
+.  
(4S)-4-Benzyl-3-(but-3-en-1-ylsulfinyl)oxazolidin-2-one (486a and 486b) 
486a and 486b were prepared according to a literature 
procedure.128 A flame dried RBF under argon was 
charged with 485 (2.40 g, 9.0 mmol) and CH2Cl2 (90 
mL). The reaction mixture was cooled to -20 oC and mCPBA (1.55 mg, 9.0 mmol, 1.0 eq) was 
added in 5 portions over 10 minutes. The reaction was stirred at -20 oC for 2 hours before being 
quenched with NaHCO3 (20 mL), washed with NaHCO3 (3 × 20 mL) and extracted with CH2Cl2 
(3 × 20 mL). The combined organics were then dried over Na2SO4, filtered and concentrated 
under reduced pressure. The residue was purified by column chromatography (3:1 
hexanes:EtOAc) to give 486a (1.17 g, 38%) and then 486b (795 mg, 31%);  
486a 1H NMR (300 MHz, CDCl3): δ = 7.44 – 7.13 (m, 5H), 4.51 (ddt, J = 9.8, 7.6, 4.7 Hz, 1H), 
4.29 – 4.12 (m, 2H), 3.34 (dd, J = 13.4, 4.67 Hz, 1H), 3.20 (ddd, J = 12.7, 8.5, 5.1 Hz, 2H), 
2.90 (dd, J = 13.4, 10.1 Hz, 1H), 2.63 – 2.42 (m, 2H); 13C NMR (101 MHz, CDCl3): δ =156.4 
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(C), 134.9 (C), 134.0 (CH), 129.3 (2CH), 127.7 (2CH), 117.8 (CH2), 69.0 (CH2), 54.8 (CH2), 
53.1 (CH3), 41.1 (CH2), 27.2 (CH2); IR (neat): ν = 2919, 1755, 1386, 1175, 1092, 1038, 919, 
729, 701; HR-MS (ES-TOF): m/z: calcd for C14H17NO3NaS: 302.0827, found 302.0833  [M + 
Na]+. 
486b 1H NMR (300 MHz, CDCl3): δ = 7.54 – 7.12 (m, 5H), 5.85 (ddt, J = 16.9, 10.1, 6.6 Hz, 
1H), 5.21 (dd, J = 14.3, 1.3 Hz, 1H), 5.17 (dd, J = 7.4, 1.4 Hz, 1H), 4.56 (ddt, J = 9.5, 7.9, 4.8 
Hz, 1H), 4.29 (t, J = 8.4 Hz, 1H), 4.18 (dd, J = 8.9, 4.9 Hz, 1H), 3.59 (ddd, J = 13.1, 8.4, 6.3 
Hz, 1H), 3.36 (ddd, J = 6.9, 6.5, 3.6 Hz, 2H), 3.02 – 2.83 (m, 1H), 2.64 – 2.38 (m, 2H); 13C 
NMR (101 MHz, CDCl3): δ = 154.8 (C), 134.8 (C), 134.0 (CH), 129.3 (2CH), 129.2 (2CH), 
127.7 (CH), 117.8 (CH2), 68.0 (CH2), 57.0 (CH), 52.3 (CH2), 40.6 (CH2), 27.4 (CH2); IR (neat): 
ν = 2921, 1753, 1641, 1603, 1388, 1186, 1090, 921, 702; HR-MS (ES-TOF): m/z: calcd for 
C14H17NO3NaS: 302.0827, found 302.0833 [M + Na]
+. 
1-(But-3-en-1-ylsulfinyl)hex-1-yne (487a) 
A 2 neck RBF was fitted with a reflux condenser and was flame 
dried. MeMgBr (3 M in Et2O) (0.40 mL, 1.18 mmol, 1.0 eq.) was 
added followed by the addition of 1-hexyne (204 µl, 1.78 mmol, 1.5 eq.). The mixture was 
heated to reflux for 2 hours before being cooled to -20 oC. Sulfinamide 486b (333 mg, 1.18 
mmol, 1.0 eq.) in toluene (5 mL) was added dropwise and the reaction was stirred at 0 oC for 5 
hours. The mixture was quenched NH4Cl, extracted Et2O (3 × 5 mL), washed brine (5 mL), 
dried Na2SO4, filtered and concentrated undr reduced pressure. The residue was purified by 
column chromatography (8:2 hexane:EtOAc) to afford the title compound 487a (145 mg, 67 






Operator:Shimadzu  Timebase:LC_System1   Sequence:25%MeCN v 2 Page 1-1 
29/11/2014  2:16 PM 
 4 MB rac sulfoxide 
Amylose 2, 25% MeCN, 1 ml/min, 25 degrees 
   
Sampl e Name: MB rac sulfoxide 
 
Injection V olume: 10.0   
Vial Number: 1_2  Channel: UV_VIS_1 
Sample Type: unknown  Wavelength: n.a. 
Control Program: 25% MeCN v 2  Bandwidth: n.a. 
Quantif. Method: 25% MeCN v 2  Dilution Factor: 1.0000   
Recording Time: 29/11/2014 10:48  Sample Weight: 1.0000   
Run Time (min): 65.01  Sample Amount: 1.0000   
 
No.  Ret.Time  Peak Name  Height  Area  Rel.Area  Amount  Type  


















 min  mAU mAU*min %   
1   3.22      n.a.  13.925  3.154  1.13     n.a. BMB 
2   48.65      n.a.  114.871  137.907  49.37     n.a. BM  
3   51.84      n.a.  100.922  138.273  49.50     n.a.  MB 
Total:   229.718  279.333  100.00     0.000   




Operator:Shimadzu  Timebase:LC_System1   Sequence:25%MeCN v 2 Page 1-1 
29/11/2014  2:22 PM 
 5 MB sulfoxide 461b 
Amylose 2, 25% MeCN, 1 ml/min, 25 degrees 
   
Sampl e Name: MB sulfoxide a 
 
Injection V olume: 10.0   
Vial Number: 1_3  Channel: UV_VIS_1 
Sample Type: unknown  Wavelength: n.a. 
Control Program: 25% MeCN v 2  Bandwidth: n.a. 
Quantif. Method: 25% MeCN v 2  Dilution Factor: 1.0000   
Recording Time: 29/11/2014 11:54  Sample Weight: 1.0000   
Run Time (min): 65.01  Sample Amount: 1.0000   
 
No.  Ret.Time  Peak Name  Height  Area  Rel.Area  Amount  Type  
 min mAU mAU*min %   
1   48.28      n.a. 162.033  215.210  98.49     n.a. BMB 
2   52.28      n.a. 3.127  3.297  1.51     n.a. BMB* 


















Total:  165.160  218.507  100.00     0.000   
Operator:Shimadzu  Timebase:LC_System1   Sequence:25%MeCN v 2 Page 1-1 
29/11/2014  2:20 PM 
 6 MB sulfoxide 461a 
Amylose 2, 25% MeCN, 1 ml/min, 25 degrees 
   
Sampl e Name: MB sulfoxide b 
 
Injection V olume: 10.0   
Vial Number: 1_4  Channel: UV_VIS_1 
Sample Type: unknown  Wavelength: n.a. 
Control Program: 25% MeCN v 2  Bandwidth: n.a. 
Quantif. Method: 25% MeCN v 2  Dilution Factor: 1.0000   
Recording Time: 29/11/2014 12:59  Sample Weight: 1.0000   
Run Time (min): 65.01  Sample Amount: 1.0000   
 
No.  Ret.Time  Peak Name  Height  Area  Rel.Area  Amount  Type  
 min mAU mAU*min %   

















1   48.82      n.a. 26.527  27.782  15.60     n.a. BM  
2   51.52      n.a. 109.894  150.295  84.40     n.a.  MB 
Total:  136.421  178.077  100.00     0.000   
Operator:Shimadzu  Timebase:GC2010_SYSTEM1   Sequence:General Method Page 1-1 
18/2/2015  11:24 AM 
11 462a 
Chirasil-Dex CB column 
   
Sampl 
e Name: MB CAT P 1238  
Injection Vol ume: 
2.0   
Vial Number: 4  Channel: FID 
Sample Type: unknown  Wavelength: n.a. 
Control Program: Chiral Method  Bandwidth: n.a. 
Quantif. Method: General Method  Dilution Factor: 1.0000   
Recording Time: 18/2/2015 9:23  Sample Weight: 1.0000   
Run Time (min): 25.00  Sample Amount: 1.0000   











25,000,000 General Method #11 [modified by Shimadzu] MB CAT P 1238 FID 
µV 
min 
1 - 20.056 2 - 20.304 
3 - 20.608 
4 - 20.988 
266 
 
No.  Ret.Time   Peak  Height  Area  Rel.Area  Amount  Type  
 min  Name  µV µV*min %   
1   20.06        n.a. 2195453.00 107832.94 4.16     n.a. BMB* 
2   20.30        n.a. 1925581.00 98037.92 3.78     n.a. BMB* 
3   20.61        n.a. ########## 1166803.44 45.00     n.a. BMB* 
4   20.99        n.a. ########## 1219994.83 47.06     n.a. BMB* 
Total:    ########## 2592669.14 100.00     0.000   
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18/2/2015  11:25 AM 
12 MB 462b 
Chirasil-Dex CB column 
   
Sampl 
e Name: MB CAT P 1239  
Injection Vol ume: 
2.0   
Vial Number: 5  Channel: FID 
Sample Type: unknown  Wavelength: n.a. 
Control Program: Chiral Method  Bandwidth: n.a. 
Quantif. Method: General Method  Dilution Factor: 1.0000   
Recording Time: 18/2/2015 9:55  Sample Weight: 1.0000   
Run Time (min): 25.00  Sample Amount: 1.0000   
 
No.  Ret.Time  Peak  Height  Area  Rel.Area  Amount  Type  
 min Name  µV µV*min %   
1   20.08       n.a. 581770.00 29117.14 3.85     n.a. BMB* 
2   20.33       n.a. 618634.00 31872.42 4.22     n.a. BMB* 









7,000,000 MB CAT P 1239 General Method #12 [modified by Shimadzu] FID 
µV 
min 
1 - 20.077 2 - 20.327 
3 - 20.627 
4 - 21.023 
268 
 
3   20.63       n.a. 6067093.00 351427.82 46.49     n.a. BMB* 
4   21.02       n.a. 5695222.00 343541.94 45.44     n.a. BMB* 
Total:   ########## 755959.32 100.00     0.000   
Chromeleon (c) Dionex 1996-2006 Default Test/Integration Version 6.80 SR8 Build 2623 
(156243) 
X-ray Crystallography 
The datasets for 160, 216, 230 and 369 were measured on an Agilent SuperNova 
diffractometer u sing an Atlas detector. The data collections were driven and processed and 
absorption corrections were applied using CrysAlisPro.1 The structures were solved using 
ShelXS2 and refined by a full-matrix least-squares procedure  on F2 in ShelXL.2 All non-
hydrogen atoms were refined with anisotropic displacement parameters. All hydrogen atoms 
were added at calculated positions and refined by use of a riding model with isotropic 
displacement parameters based on the equivalent isotropic displacement parameter (Ueq) of 
the parent atom. Figures were produced using OLEX2.3 The structure of 216 contains two 
crystallographically-independent molecules. 
 
Crystal structure determination of 160 
Crystal Data for C22H20O4S (M =380.44 g/mol): triclinic, space group P-1 (no. 2), a = 
9.0122(4) Å, b = 10.2942(6) Å, c = 10.6266(5) Å, α = 75.079(5)°, β = 73.655(4)°, γ = 
75.040(5)°, V = 895.61(8) Å3, Z = 2, T = 100.00(10) K, μ(Cu Kα) = 1.826 mm-1, Dcalc = 
1.411 g/cm3, 4974 reflections measured (15.16° ≤ 2Θ ≤ 136.48°), 3189 unique (Rint = 0.0141, 
Rsigma = 0.0202) which were used in all calculations. The final R1 was 0.0290 (>2σ(I)) and wR2 




Crystal structure determination of 216 
Crystal Data for C18H12OS2 (M =308.40 g/mol): monoclinic, space group P21/c (no. 14), a = 
15.8775(4) Å, b = 14.1420(2) Å, c = 13.9094(3) Å, β = 115.825(3)°, V = 2811.29(12) Å3, Z = 
8, T = 100.01(10) K, μ(Cu Kα) = 3.378 mm-1, Dcalc = 1.457 g/cm3, 13662 reflections measured 
(12.728° ≤ 2Θ ≤ 148.922°), 5420 unique (Rint = 0.0254, Rsigma = 0.0280) which were used in all 
calculations. The final R1 was 0.0309 (I > 2σ(I)) and wR2 was 0.0813 (all data).  
Crystal structure determination of 369 
Crystal Data for C12H12O2S (M =220.28): triclinic, space group P-1 (no. 2), a = 6.2782(3) Å, 
b = 7.1917(3) Å, c = 12.4920(6) Å, α = 86.275(4)°, β = 75.966(4)°, γ = 66.086(4)°, V = 
499.87(4) Å3, Z = 2, T = 100.01(11) K, μ(CuKα) = 2.667 mm-1, Dcalc = 1.463 g/mm3, 7549 
reflections measured (13.478 ≤ 2Θ ≤ 140.082), 1883 unique (Rint = 0.0222, Rsigma = 0.0169) 
which were used in all calculations. The final R1 was 0.0394 (I > 2σ(I)) and wR2 was 0.0986 
(all data).  
1    CrysAlisPro, Version 1.171.37.33c, Agilent Technologies, 2014. 
2    Sheldrick, G. M. Acta Cryst., 2008, A64, 112-122. 
3   Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. J. Appl. 





Crystal data and structure refinement for 160 
 
Identification code  MB-4-464 
Empirical formula  C22H20O4S 
Formula weight  380.44 
Temperature  100.00(10) K 
Wavelength  1.5418 Å 
Crystal system  Triclinic 
Space group  P-1 (no. 2) 
Unit cell dimensions a = 9.0122(4) Å 75.079(5)°. 
 b =10.2942(6) Å 73.655(3)°. 
 c = 10.6266(5) Å 75.040(5)°. 
Volume 895.61(8) Å3 
Z 2 
Density (calculated) 1.411 g/cm3 






C1 C 0.20594(15) 0.35298(13) -0.11429(13) 0.0125(3) Uani 1 1 d . . . 
C2 C 0.25730(15) 0.35624(13) -0.25180(13) 0.0134(3) Uani 1 1 d . . . 
C3 C 0.35897(16) 0.44437(14) -0.32511(14) 0.0161(3) Uani 1 1 d . . . 
H3 H 0.3958 0.4491 -0.4189 0.019 Uiso 1 1 calc R . . 
C4 C 0.40864(16) 0.52625(14) -0.26477(14) 0.0169(3) Uani 1 1 d . . . 
H4 H 0.4783 0.5853 -0.3177 0.020 Uiso 1 1 calc R . . 
C5 C 0.35682(16) 0.52162(13) -0.12836(14) 0.0149(3) Uani 1 1 d . . . 
H5 H 0.3910 0.5769 -0.0874 0.018 Uiso 1 1 calc R . . 
C6 C 0.25361(15) 0.43472(13) -0.05146(13) 0.0128(3) Uani 1 1 d . . . 
C7 C 0.18282(15) 0.41536(13) 0.09116(13) 0.0134(3) Uani 1 1 d . . . 
C8 C 0.20304(16) 0.47629(13) 0.18668(14) 0.0153(3) Uani 1 1 d . . . 
H8 H 0.2702 0.5407 0.1612 0.018 Uiso 1 1 calc R . . 
C9 C 0.12419(17) 0.44187(14) 0.31878(14) 0.0172(3) Uani 1 1 d . . . 
H9 H 0.1380 0.4827 0.3842 0.021 Uiso 1 1 calc R . . 
C10 C 0.02451(16) 0.34766(14) 0.35710(13) 0.0165(3) Uani 1 1 d . . . 
H10 H -0.0289 0.3261 0.4483 0.020 Uiso 1 1 calc R . . 
C11 C 0.00181(15) 0.28492(13) 0.26480(13) 0.0138(3) Uani 1 1 d . . . 
C12 C 0.08228(15) 0.32063(13) 0.13140(13) 0.0130(3) Uani 1 1 d . . . 
C13 C -0.09785(16) 0.17685(14) 0.30836(13) 0.0152(3) Uani 1 1 d . . . 
H13A H -0.1497 0.1831 0.2357 0.018 Uiso 1 1 calc R . . 
H13B H -0.1820 0.1977 0.3876 0.018 Uiso 1 1 calc R . . 
C14 C -0.00857(16) 0.02980(13) 0.34319(12) 0.0134(3) Uani 1 1 d . . . 
C15 C 0.17015(16) 0.00563(13) 0.30819(13) 0.0148(3) Uani 1 1 d . . . 
H15A H 0.2073 0.0334 0.2101 0.018 Uiso 1 1 calc R . . 
H15B H 0.2036 0.0647 0.3509 0.018 Uiso 1 1 calc R . . 
C16 C 0.25410(16) -0.21848(13) 0.25850(13) 0.0165(3) Uani 1 1 d . . . 
H16A H 0.1475 -0.2122 0.2461 0.020 Uiso 1 1 calc R . . 
H16B H 0.2940 -0.3150 0.2984 0.020 Uiso 1 1 calc R . . 
C17 C 0.36125(16) -0.17951(13) 0.12464(14) 0.0166(3) Uani 1 1 d . . . 
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H17 H 0.4679 -0.1802 0.1212 0.020 Uiso 1 1 calc R . . 
C18 C 0.31414(16) -0.14421(14) 0.01100(14) 0.0175(3) Uani 1 1 d . . . 
H18 H 0.2064 -0.1413 0.0162 0.021 Uiso 1 1 calc R . . 
C19 C 0.41738(17) -0.10867(14) -0.12471(14) 0.0183(3) Uani 1 1 d . . . 
H19A H 0.5204 -0.0984 -0.1168 0.022 Uiso 1 1 calc R . . 
H19B H 0.4363 -0.1823 -0.1750 0.022 Uiso 1 1 calc R . . 
C20 C 0.41523(16) 0.04633(14) -0.33045(13) 0.0163(3) Uani 1 1 d . . . 
H20A H 0.4097 -0.0256 -0.3745 0.020 Uiso 1 1 calc R . . 
H20B H 0.5279 0.0447 -0.3390 0.020 Uiso 1 1 calc R . . 
C21 C 0.33955(16) 0.18476(14) -0.39973(13) 0.0151(3) Uani 1 1 d . . . 
C22 C 0.20090(16) 0.27128(14) -0.31927(13) 0.0145(3) Uani 1 1 d . . . 
H22A H 0.1342 0.3328 -0.3793 0.017 Uiso 1 1 calc R . . 
H22B H 0.1357 0.2107 -0.2506 0.017 Uiso 1 1 calc R . . 
O1 O -0.07860(11) -0.06302(10) 0.39713(10) 0.0178(2) Uani 1 1 d . . . 
O2 O 0.24287(11) -0.13229(9) 0.34913(9) 0.0161(2) Uani 1 1 d . . . 
O3 O 0.33893(12) 0.01735(10) -0.19292(9) 0.0201(2) Uani 1 1 d . . . 
O4 O 0.39480(12) 0.22571(10) -0.51703(10) 0.0222(2) Uani 1 1 d . . . 
S1 S 0.07645(4) 0.25214(3) -0.00139(3) 0.01308(10) Uani 1 1 d . . . 
 
C1 0.0104(6) 0.0103(6) 0.0153(6) -0.0013(5) -0.0024(5) -0.0015(5) 
C2 0.0126(6) 0.0118(6) 0.0149(6) -0.0026(5) -0.0039(5) 0.0001(5) 
C3 0.0153(7) 0.0163(6) 0.0141(6) -0.0017(5) -0.0011(5) -0.0026(5) 
C4 0.0149(7) 0.0140(6) 0.0199(7) -0.0011(5) -0.0010(5) -0.0050(5) 
C5 0.0140(6) 0.0118(6) 0.0196(7) -0.0035(5) -0.0042(5) -0.0031(5) 
C6 0.0110(6) 0.0104(6) 0.0159(6) -0.0024(5) -0.0039(5) 0.0003(5) 
C7 0.0125(6) 0.0101(6) 0.0161(7) -0.0018(5) -0.0041(5) 0.0005(5) 
C8 0.0154(7) 0.0122(6) 0.0190(7) -0.0031(5) -0.0053(5) -0.0024(5) 
C9 0.0222(7) 0.0148(6) 0.0163(7) -0.0051(5) -0.0073(6) -0.0015(5) 
C10 0.0183(7) 0.0149(6) 0.0133(6) -0.0028(5) -0.0024(5) 0.0003(5) 
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C11 0.0124(6) 0.0109(6) 0.0154(6) -0.0019(5) -0.0025(5) 0.0007(5) 
C12 0.0129(6) 0.0110(6) 0.0150(6) -0.0032(5) -0.0042(5) -0.0003(5) 
C13 0.0136(6) 0.0163(7) 0.0141(6) -0.0021(5) -0.0015(5) -0.0032(5) 
C14 0.0164(7) 0.0154(6) 0.0098(6) -0.0039(5) -0.0027(5) -0.0047(5) 
C15 0.0143(7) 0.0128(6) 0.0163(6) -0.0026(5) -0.0020(5) -0.0032(5) 
C16 0.0189(7) 0.0126(6) 0.0182(7) -0.0035(5) -0.0049(6) -0.0024(5) 
C17 0.0152(7) 0.0132(6) 0.0205(7) -0.0043(5) -0.0037(5) -0.0010(5) 
C18 0.0166(7) 0.0145(6) 0.0210(7) -0.0028(5) -0.0038(6) -0.0037(5) 
C19 0.0196(7) 0.0147(6) 0.0187(7) -0.0021(5) -0.0043(6) -0.0014(5) 
C20 0.0153(7) 0.0177(7) 0.0145(6) -0.0041(5) -0.0005(5) -0.0031(5) 
C21 0.0162(7) 0.0162(6) 0.0151(7) -0.0049(5) -0.0031(5) -0.0061(5) 
C22 0.0141(6) 0.0154(6) 0.0137(6) -0.0027(5) -0.0037(5) -0.0024(5) 
O1 0.0188(5) 0.0165(5) 0.0191(5) -0.0029(4) -0.0027(4) -0.0079(4) 
O2 0.0184(5) 0.0129(5) 0.0165(5) -0.0027(4) -0.0055(4) -0.0007(4) 
O3 0.0236(5) 0.0177(5) 0.0133(5) -0.0013(4) -0.0015(4) 0.0009(4) 
O4 0.0276(6) 0.0204(5) 0.0146(5) -0.0029(4) 0.0014(4) -0.0055(4) 
S1 0.01424(17) 0.01339(17) 0.01233(17) -0.00275(12) -0.00141(12) -0.00565(12) 
  
Table.   Bond lengths [Å] and angles [°] for 160. 
C1 C2 1.3974(18) . ? 
C1 C6 1.4057(18) . ? 
C1 S1 1.7535(13) . ? 
C2 C3 1.3903(19) . ? 
C2 C22 1.5149(18) . ? 
C3 C4 1.3987(19) . ? 
C3 H3 0.9500 . ? 
C4 C5 1.3843(19) . ? 
C4 H4 0.9500 . ? 
C5 C6 1.3994(18) . ? 
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C5 H5 0.9500 . ? 
C6 C7 1.4524(18) . ? 
C7 C8 1.3957(19) . ? 
C7 C12 1.4065(18) . ? 
C8 C9 1.3834(19) . ? 
C8 H8 0.9500 . ? 
C9 C10 1.398(2) . ? 
C9 H9 0.9500 . ? 
C10 C11 1.3886(19) . ? 
C10 H10 0.9500 . ? 
C11 C12 1.4005(18) . ? 
C11 C13 1.5084(18) . ? 
C12 S1 1.7505(13) . ? 
C13 C14 1.5252(18) . ? 
C13 H13A 0.9900 . ? 
C13 H13B 0.9900 . ? 
C14 O1 1.2106(16) . ? 
C14 C15 1.5159(18) . ? 
C15 O2 1.4130(16) . ? 
C15 H15A 0.9900 . ? 
C15 H15B 0.9900 . ? 
C16 O2 1.4366(16) . ? 
C16 C17 1.4999(19) . ? 
C16 H16A 0.9900 . ? 
C16 H16B 0.9900 . ? 
C17 C18 1.324(2) . ? 
C17 H17 0.9500 . ? 
C18 C19 1.4927(19) . ? 
C18 H18 0.9500 . ? 
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C19 O3 1.4279(16) . ? 
C19 H19A 0.9900 . ? 
C19 H19B 0.9900 . ? 
C20 O3 1.4189(16) . ? 
C20 C21 1.5096(19) . ? 
C20 H20A 0.9900 . ? 
C20 H20B 0.9900 . ? 
C21 O4 1.2115(17) . ? 
C21 C22 1.5172(18) . ? 
C22 H22A 0.9900 . ? 
C22 H22B 0.9900 . ? 
  
C2 C1 C6 122.13(12) . . ? 
C2 C1 S1 125.57(10) . . ? 
C6 C1 S1 112.30(10) . . ? 
C3 C2 C1 117.03(12) . . ? 
C3 C2 C22 121.23(12) . . ? 
C1 C2 C22 121.71(12) . . ? 
C2 C3 C4 121.89(13) . . ? 
C2 C3 H3 119.1 . . ? 
C4 C3 H3 119.1 . . ? 
C5 C4 C3 120.34(12) . . ? 
C5 C4 H4 119.8 . . ? 
C3 C4 H4 119.8 . . ? 
C4 C5 C6 119.37(12) . . ? 
C4 C5 H5 120.3 . . ? 
C6 C5 H5 120.3 . . ? 
C5 C6 C1 119.24(12) . . ? 
C5 C6 C7 128.70(12) . . ? 
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C1 C6 C7 112.06(11) . . ? 
C8 C7 C12 119.21(12) . . ? 
C8 C7 C6 128.89(12) . . ? 
C12 C7 C6 111.90(12) . . ? 
C9 C8 C7 119.29(12) . . ? 
C9 C8 H8 120.4 . . ? 
C7 C8 H8 120.4 . . ? 
C8 C9 C10 120.78(13) . . ? 
C8 C9 H9 119.6 . . ? 
C10 C9 H9 119.6 . . ? 
C11 C10 C9 121.48(12) . . ? 
C11 C10 H10 119.3 . . ? 
C9 C10 H10 119.3 . . ? 
C10 C11 C12 117.19(12) . . ? 
C10 C11 C13 121.10(12) . . ? 
C12 C11 C13 121.61(12) . . ? 
C11 C12 C7 122.05(12) . . ? 
C11 C12 S1 125.48(10) . . ? 
C7 C12 S1 112.45(10) . . ? 
C11 C13 C14 115.14(11) . . ? 
C11 C13 H13A 108.5 . . ? 
C14 C13 H13A 108.5 . . ? 
C11 C13 H13B 108.5 . . ? 
C14 C13 H13B 108.5 . . ? 
H13A C13 H13B 107.5 . . ? 
O1 C14 C15 121.84(12) . . ? 
O1 C14 C13 120.91(12) . . ? 
C15 C14 C13 117.25(11) . . ? 
O2 C15 C14 113.42(11) . . ? 
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O2 C15 H15A 108.9 . . ? 
C14 C15 H15A 108.9 . . ? 
O2 C15 H15B 108.9 . . ? 
C14 C15 H15B 108.9 . . ? 
H15A C15 H15B 107.7 . . ? 
O2 C16 C17 112.49(11) . . ? 
O2 C16 H16A 109.1 . . ? 
C17 C16 H16A 109.1 . . ? 
O2 C16 H16B 109.1 . . ? 
C17 C16 H16B 109.1 . . ? 
H16A C16 H16B 107.8 . . ? 
C18 C17 C16 123.08(13) . . ? 
C18 C17 H17 118.5 . . ? 
C16 C17 H17 118.5 . . ? 
C17 C18 C19 125.01(13) . . ? 
C17 C18 H18 117.5 . . ? 
C19 C18 H18 117.5 . . ? 
O3 C19 C18 107.87(11) . . ? 
O3 C19 H19A 110.1 . . ? 
C18 C19 H19A 110.1 . . ? 
O3 C19 H19B 110.1 . . ? 
C18 C19 H19B 110.1 . . ? 
H19A C19 H19B 108.4 . . ? 
O3 C20 C21 111.29(11) . . ? 
O3 C20 H20A 109.4 . . ? 
C21 C20 H20A 109.4 . . ? 
O3 C20 H20B 109.4 . . ? 
C21 C20 H20B 109.4 . . ? 
H20A C20 H20B 108.0 . . ? 
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O4 C21 C20 119.00(12) . . ? 
O4 C21 C22 121.81(12) . . ? 
C20 C21 C22 119.14(11) . . ? 
C2 C22 C21 110.87(11) . . ? 
C2 C22 H22A 109.5 . . ? 
C21 C22 H22A 109.5 . . ? 
C2 C22 H22B 109.5 . . ? 
C21 C22 H22B 109.5 . . ? 
H22A C22 H22B 108.1 . . ? 
C15 O2 C16 113.44(10) . . ? 
C20 O3 C19 111.50(10) . . ? 
C12 S1 C1 91.27(6) . . ? 
C6 C1 C2 C3 0.13(19) . . . . ? 
Table 6.  Torsion angles [°] for MB-4-464. 
S1 C1 C2 C3 179.28(10) . . . . ? 
C6 C1 C2 C22 -177.91(12) . . . . ? 
S1 C1 C2 C22 1.24(18) . . . . ? 
C1 C2 C3 C4 0.17(19) . . . . ? 
C22 C2 C3 C4 178.21(12) . . . . ? 
C2 C3 C4 C5 -0.1(2) . . . . ? 
C3 C4 C5 C6 -0.3(2) . . . . ? 
C4 C5 C6 C1 0.59(19) . . . . ? 
C4 C5 C6 C7 -178.81(13) . . . . ? 
C2 C1 C6 C5 -0.51(19) . . . . ? 
S1 C1 C6 C5 -179.76(10) . . . . ? 
C2 C1 C6 C7 178.99(12) . . . . ? 
S1 C1 C6 C7 -0.27(14) . . . . ? 
C5 C6 C7 C8 -1.6(2) . . . . ? 
C1 C6 C7 C8 179.01(13) . . . . ? 
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C5 C6 C7 C12 178.75(13) . . . . ? 
C1 C6 C7 C12 -0.69(16) . . . . ? 
C12 C7 C8 C9 0.20(19) . . . . ? 
C6 C7 C8 C9 -179.49(13) . . . . ? 
C7 C8 C9 C10 -0.3(2) . . . . ? 
C8 C9 C10 C11 0.4(2) . . . . ? 
C9 C10 C11 C12 -0.39(19) . . . . ? 
C9 C10 C11 C13 176.13(12) . . . . ? 
C10 C11 C12 C7 0.30(19) . . . . ? 
C13 C11 C12 C7 -176.20(12) . . . . ? 
C10 C11 C12 S1 178.23(10) . . . . ? 
C13 C11 C12 S1 1.73(18) . . . . ? 
C8 C7 C12 C11 -0.21(19) . . . . ? 
C6 C7 C12 C11 179.52(12) . . . . ? 
C8 C7 C12 S1 -178.38(10) . . . . ? 
C6 C7 C12 S1 1.35(14) . . . . ? 
C10 C11 C13 C14 -90.30(15) . . . . ? 
C12 C11 C13 C14 86.06(15) . . . . ? 
C11 C13 C14 O1 169.44(12) . . . . ? 
C11 C13 C14 C15 -10.23(17) . . . . ? 
O1 C14 C15 O2 -2.24(18) . . . . ? 
C13 C14 C15 O2 177.42(11) . . . . ? 
O2 C16 C17 C18 -121.69(14) . . . . ? 
C16 C17 C18 C19 -178.11(12) . . . . ? 
C17 C18 C19 O3 -130.70(14) . . . . ? 
O3 C20 C21 O4 177.88(12) . . . . ? 
O3 C20 C21 C22 0.44(17) . . . . ? 
C3 C2 C22 C21 55.32(16) . . . . ? 
C1 C2 C22 C21 -126.73(13) . . . . ? 
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O4 C21 C22 C2 -91.59(15) . . . . ? 
C20 C21 C22 C2 85.77(14) . . . . ? 
C14 C15 O2 C16 81.28(13) . . . . ? 
C17 C16 O2 C15 65.56(14) . . . . ? 
C21 C20 O3 C19 -175.57(11) . . . . ? 
C18 C19 O3 C20 -169.59(11) . . . . ? 
C11 C12 S1 C1 -179.38(12) . . . . ? 
C7 C12 S1 C1 -1.28(10) . . . . ? 
C2 C1 S1 C12 -178.35(12) . . . . ? 




Table 1.  Crystal data and structure refinement for 216. 
 
Identification code  MB-4-560 
Empirical formula  C18H12OS2 
Formula weight  308.40 
Temperature  100.01(10) K 
Wavelength  1.5418 Å 
Crystal system  Monoclinic 
Space group  P 21/c 
Unit cell dimensions a = 15.8775(4) Å  
 b = 14.1420(2) Å  
 c = 13.9094(3) Å  
Volume 2811.29(12) Å3 
Z 8 
Density (calculated) 1.457 Mg/m3 
Absorption coefficient 3.378 mm-1 
F(000) 1280 
Crystal size 0.340 × 0.200 × 0.100 mm3 
Theta range for data collection 6.364 to 74.461°. 
Index ranges -19<=h<=17, -17<=k<=12, -16<=l<=17 
Reflections collected 13662 
Independent reflections 5420 [R(int) = 0.0254] 
Completeness to theta = 67.684° 96.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.66201 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5420 / 0 / 379 
Goodness-of-fit on F2 1.030 
Final R indices [I>2sigma(I)] R1 = 0.0309, wR2 = 0.0776 
R indices (all data) R1 = 0.0351, wR2 = 0.0813 
Extinction coefficient n/a 
Largest diff. peak and hole 0.306 and -0.276 e.Å-3 
 
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for MB-4-560.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 





C(1) 4293(1) 3192(1) 3420(1) 17(1) 
C(2) 3455(1) 3270(1) 3483(1) 20(1) 
C(3) 3417(1) 3600(1) 4417(1) 22(1) 
C(4) 4221(1) 3844(1) 5284(1) 21(1) 
C(5) 5937(1) 3976(1) 6191(1) 23(1) 
C(6) 6790(1) 3879(1) 6188(1) 25(1) 
C(7) 6852(1) 3584(1) 5255(1) 23(1) 
C(8) 6063(1) 3378(1) 4334(1) 19(1) 
C(9) 5155(1) 3434(1) 4311(1) 17(1) 
C(10) 5104(1) 3757(1) 5263(1) 19(1) 
C(11) 5193(1) 3247(1) 2108(1) 18(1) 
C(12) 4983(1) 4302(1) 1877(1) 18(1) 
C(13) 4345(1) 4608(1) 765(1) 18(1) 
C(14) 4117(1) 5566(1) 597(1) 22(1) 
C(15) 3546(1) 5896(1) -419(1) 26(1) 
C(16) 3196(1) 5275(1) -1278(1) 26(1) 
C(17) 3423(1) 4321(1) -1120(1) 26(1) 
C(18) 3998(1) 3986(1) -103(1) 21(1) 
O(1) 5311(1) 4870(1) 2599(1) 27(1) 
S(1) 4216(1) 2683(1) 2224(1) 19(1) 
S(2) 6278(1) 3003(1) 3251(1) 22(1) 
C(101) -742(1) 3112(1) 8781(1) 21(1) 
C(102) -1520(1) 3204(1) 8973(1) 27(1) 
C(103) -1462(1) 3631(1) 9911(2) 32(1) 
C(104) -633(1) 3992(1) 10642(1) 29(1) 
C(105) 1053(1) 4270(1) 11262(1) 27(1) 
C(106) 1846(1) 4190(1) 11122(1) 28(1) 
C(107) 1824(1) 3727(1) 10216(1) 24(1) 
C(108) 1008(1) 3348(1) 9461(1) 20(1) 
C(109) 148(1) 3445(1) 9548(1) 19(1) 
C(110) 190(1) 3910(1) 10488(1) 22(1) 
C(111) 27(1) 2885(1) 7333(1) 21(1) 
C(112) 4(1) 3911(1) 6962(1) 21(1) 
C(113) 676(1) 4183(1) 6526(1) 20(1) 
C(114) 734(1) 5139(1) 6308(1) 23(1) 
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C(115) 1362(1) 5435(1) 5921(1) 26(1) 
C(116) 1931(1) 4784(1) 5743(1) 27(1) 
C(117) 1865(1) 3829(1) 5934(1) 25(1) 
C(118) 1240(1) 3529(1) 6322(1) 21(1) 
O(101) -540(1) 4473(1) 7038(1) 29(1) 
S(101) -955(1) 2544(1) 7565(1) 25(1) 





Table 3.   Bond lengths [Å] and angles [°] for MB-4-560. 
_____________________________________________________ 
C(1)-C(2)  1.376(2) 
C(1)-C(9)  1.432(2) 
C(1)-S(1)  1.7669(15) 
C(2)-C(3)  1.406(2) 
C(2)-H(2)  0.9500 
C(3)-C(4)  1.366(2) 
C(3)-H(3)  0.9500 
C(4)-C(10)  1.420(2) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.364(2) 
C(5)-C(10)  1.422(2) 
C(5)-H(5)  0.9500 
C(6)-C(7)  1.406(2) 
C(6)-H(6)  0.9500 
C(7)-C(8)  1.377(2) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.429(2) 
C(8)-S(2)  1.7664(16) 
C(9)-C(10)  1.437(2) 
C(11)-C(12)  1.532(2) 
C(11)-S(2)  1.7966(15) 
C(11)-S(1)  1.8141(15) 
C(11)-H(11)  1.0000 
C(12)-O(1)  1.2122(19) 
C(12)-C(13)  1.496(2) 
C(13)-C(14)  1.395(2) 
C(13)-C(18)  1.399(2) 
C(14)-C(15)  1.386(2) 
C(14)-H(14)  0.9500 
C(15)-C(16)  1.389(2) 
C(15)-H(15)  0.9500 
C(16)-C(17)  1.388(3) 
C(16)-H(16)  0.9500 
C(17)-C(18)  1.390(2) 
C(17)-H(17)  0.9500 
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C(18)-H(18)  0.9500 
C(101)-C(102)  1.378(2) 
C(101)-C(109)  1.429(2) 
C(101)-S(101)  1.7682(17) 
C(102)-C(103)  1.405(3) 
C(102)-H(102)  0.9500 
C(103)-C(104)  1.364(3) 
C(103)-H(103)  0.9500 
C(104)-C(110)  1.418(2) 
C(104)-H(104)  0.9500 
C(105)-C(106)  1.361(3) 
C(105)-C(110)  1.418(2) 
C(105)-H(105)  0.9500 
C(106)-C(107)  1.407(2) 
C(106)-H(106)  0.9500 
C(107)-C(108)  1.372(2) 
C(107)-H(107)  0.9500 
C(108)-C(109)  1.429(2) 
C(108)-S(102)  1.7611(16) 
C(109)-C(110)  1.438(2) 
C(111)-C(112)  1.535(2) 
C(111)-S(101)  1.7906(16) 
C(111)-S(102)  1.8127(16) 
C(111)-H(111)  1.0000 
C(112)-O(101)  1.2127(19) 
C(112)-C(113)  1.489(2) 
C(113)-C(114)  1.397(2) 
C(113)-C(118)  1.399(2) 
C(114)-C(115)  1.388(2) 
C(114)-H(114)  0.9500 
C(115)-C(116)  1.387(2) 
C(115)-H(115)  0.9500 
C(116)-C(117)  1.389(2) 
C(116)-H(116)  0.9500 
C(117)-C(118)  1.386(2) 





































































































































Table 4.   Anisotropic displacement parameters (Å2x 103)for MB-4-560.  The anisotropic 
displacement factor exponent takes the form: - 2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
___________________________________________________________________________
___ 
 U11 U22 U33 U23 U13 U12 
___________________________________________________________________________
___ 
C(1) 22(1)  14(1) 17(1)  2(1) 10(1)  0(1) 
C(2) 21(1)  19(1) 19(1)  1(1) 9(1)  -2(1) 
C(3) 25(1)  21(1) 26(1)  3(1) 17(1)  0(1) 
C(4) 31(1)  17(1) 21(1)  1(1) 16(1)  -1(1) 
C(5) 33(1)  19(1) 17(1)  1(1) 9(1)  -3(1) 
C(6) 27(1)  21(1) 19(1)  3(1) 3(1)  -4(1) 
C(7) 20(1)  21(1) 26(1)  5(1) 7(1)  0(1) 
C(8) 22(1)  15(1) 20(1)  3(1) 9(1)  1(1) 
C(9) 21(1)  14(1) 17(1)  3(1) 8(1)  0(1) 
C(10) 27(1)  14(1) 17(1)  3(1) 10(1)  -2(1) 
C(11) 19(1)  21(1) 17(1)  0(1) 9(1)  0(1) 
C(12) 20(1)  20(1) 19(1)  -1(1) 12(1)  -2(1) 
C(13) 16(1)  22(1) 19(1)  0(1) 11(1)  -1(1) 
C(14) 22(1)  23(1) 23(1)  -1(1) 13(1)  1(1) 
C(15) 24(1)  26(1) 31(1)  6(1) 15(1)  6(1) 
C(16) 17(1)  37(1) 22(1)  6(1) 8(1)  2(1) 
C(17) 22(1)  32(1) 21(1)  -3(1) 7(1)  -5(1) 
C(18) 21(1)  23(1) 22(1)  -2(1) 11(1)  -4(1) 
O(1) 40(1)  21(1) 19(1)  -3(1) 12(1)  -2(1) 
S(1) 21(1)  20(1) 17(1)  -3(1) 10(1)  -4(1) 
S(2) 19(1)  27(1) 23(1)  2(1) 11(1)  5(1) 
C(101) 22(1)  17(1) 26(1)  6(1) 13(1)  2(1) 
C(102) 21(1)  28(1) 36(1)  13(1) 16(1)  3(1) 
C(103) 33(1)  33(1) 44(1)  20(1) 30(1)  14(1) 
C(104) 42(1)  24(1) 32(1)  13(1) 27(1)  14(1) 
C(105) 42(1)  18(1) 20(1)  4(1) 12(1)  5(1) 
C(106) 30(1)  24(1) 23(1)  5(1) 5(1)  -2(1) 
C(107) 21(1)  26(1) 25(1)  9(1) 9(1)  3(1) 
C(108) 22(1)  19(1) 20(1)  6(1) 12(1)  4(1) 
C(109) 22(1)  16(1) 21(1)  6(1) 13(1)  3(1) 
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C(110) 32(1)  17(1) 23(1)  8(1) 16(1)  7(1) 
C(111) 25(1)  22(1) 19(1)  0(1) 11(1)  1(1) 
C(112) 24(1)  20(1) 16(1)  -1(1) 7(1)  0(1) 
C(113) 23(1)  20(1) 14(1)  -2(1) 6(1)  -2(1) 
C(114) 26(1)  20(1) 20(1)  -1(1) 7(1)  -1(1) 
C(115) 31(1)  20(1) 27(1)  1(1) 11(1)  -5(1) 
C(116) 30(1)  28(1) 26(1)  -2(1) 15(1)  -7(1) 
C(117) 30(1)  25(1) 23(1)  -2(1) 14(1)  -1(1) 
C(118) 27(1)  19(1) 18(1)  -1(1) 10(1)  -2(1) 
O(101) 38(1)  25(1) 34(1)  5(1) 24(1)  8(1) 
S(101) 24(1)  24(1) 27(1)  -1(1) 10(1)  -6(1) 













H(2) 2892 3097 2886 23 
H(3) 2831 3653 4444 26 
H(4) 4190 4075 5909 26 
H(5) 5898 4192 6817 28 
H(6) 7344 4012 6817 30 
H(7) 7450 3524 5261 28 
H(11) 5238 2965 1472 22 
H(14) 4354 5993 1182 26 
H(15) 3393 6549 -528 31 
H(16) 2803 5502 -1973 31 
H(17) 3185 3897 -1708 31 
H(18) 4155 3333 1 26 
H(102) -2106 2974 8461 32 
H(103) -2003 3668 10038 38 
H(104) -607 4303 11260 34 
H(105) 1077 4570 11884 33 
H(106) 2417 4447 11638 34 
H(107) 2381 3676 10125 29 
H(111) 14 2474 6742 26 
H(114) 342 5587 6424 27 
H(115) 1401 6086 5778 32 
H(116) 2368 4991 5490 33 
H(117) 2247 3383 5799 30 















































































































Table 1 Crystal data and structure refinement for 230.  
 
Identification code  MB-7-1424P  
Empirical formula  C29H30OS2  
Formula weight  458.65  
Temperature/K  99.97(13)  
Crystal system  monoclinic  
Space group  C2/c  
a/Å  18.6964(3)  
b/Å  11.3269(2)  
c/Å  22.8717(4)  
α/°  90  
β/°  93.2236(18)  
γ/°  90  
Volume/Å3  4835.93(14)  
Z  8  
ρcalcg/cm
3  1.260  
μ/mm-1  2.129  
F(000)  1952.0  
Crystal size/mm3  0.183 × 0.0399 × 0.0379  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  7.744 to 136.454  
Index ranges  -22 ≤ h ≤ 22, -9 ≤ k ≤ 13, -18 ≤ l ≤ 27  
Reflections collected  9586  
Independent reflections  4425 [Rint = 0.0328, Rsigma = 0.0395]  
Data/restraints/parameters  4425/0/291  
Goodness-of-fit on F2  1.075  
Final R indexes [I>=2σ (I)]  R1 = 0.0353, wR2 = 0.0823  
Final R indexes [all data]  R1 = 0.0446, wR2 = 0.0867  
Largest diff. peak/hole / e Å-3  0.35/-0.23  
 
Table 2 Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for MB-7-1424P. Ueq is defined as 1/3 of of the trace of the 
orthogonalised UIJ tensor. 
Atom x y z U(eq) 
C1 1317.6(9) 10008.2(15) 2880.8(7) 18.4(3) 
C2 1029.4(9) 10687.9(16) 2411.1(8) 21.8(4) 
C3 1406.3(10) 11593.4(17) 2166.8(8) 23.2(4) 
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C4 2095.4(9) 11857.2(16) 2391.4(7) 21.4(4) 
C5 2388.9(9) 11188.4(15) 2850.4(7) 18.3(3) 
C6 3129.9(9) 11355.4(15) 3134.5(7) 18.4(3) 
C7 3164.9(9) 10372.2(15) 3578.9(7) 17.9(3) 
C8 3758.2(9) 10074.1(16) 3939.9(7) 20.7(4) 
C9 3723.5(9) 9088.0(16) 4298.9(8) 22.5(4) 
C10 3097.8(9) 8430.6(16) 4296.6(8) 21.4(4) 
C11 2497.7(9) 8722.2(15) 3933.2(7) 18.1(3) 
C12 2523.6(9) 9706.1(15) 3561.5(7) 17.2(3) 
C13 2022.6(9) 10239.3(15) 3103.0(7) 17.1(3) 
C14 1009.1(9) 8659.8(16) 3856.0(8) 19.6(3) 
C15 392.4(9) 8006.7(16) 4130.0(8) 21.6(4) 
C16 222.7(9) 8259.6(15) 4745.7(8) 20.3(4) 
C17 -437.9(10) 7854.6(16) 4926.8(8) 23.9(4) 
C18 -635.1(10) 8069.6(17) 5490.9(8) 26.5(4) 
C19 -169.7(11) 8666.3(17) 5884.1(8) 26.3(4) 
C20 483.6(10) 9068.1(16) 5706.8(8) 25.1(4) 
C21 677.6(9) 8878.5(16) 5139.6(8) 22.1(4) 
C22 3707.4(9) 11202.8(16) 2679.6(8) 20.4(4) 
C23 3761.2(9) 9974.0(16) 2413.1(8) 23.5(4) 
C24 4250(1) 9973.1(18) 1903.3(8) 27.9(4) 
C25 4444.6(11) 8742.0(19) 1701.4(9) 33.4(5) 
C26 3216.2(9) 12595.6(16) 3411.6(8) 20.5(4) 
C27 2678.9(10) 12897.6(16) 3864.9(8) 24.1(4) 
C28 2776.2(11) 14138.5(18) 4106.3(9) 30.3(4) 
C29 2245.9(13) 14460(2) 4561(1) 39.0(5) 
O1 56.1(7) 7283.6(12) 3835.3(6) 28.4(3) 
S1 718.6(2) 8904.4(4) 3099.0(2) 19.40(11) 
S2 1785.8(2) 7702.9(4) 3962.8(2) 20.46(11) 
  
Table 3 Anisotropic Displacement Parameters (Å2×103) for MB-7-1424P. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
C1 19.0(8) 19.5(8) 16.9(8) -2.5(7) 3.1(6) 0.3(6) 
C2 18.7(8) 26.4(9) 20.0(8) -1.4(7) -1.6(7) 0.4(7) 
C3 25.3(9) 25.6(9) 18.6(8) 2.5(7) -1.0(7) 4.0(7) 
C4 24.7(9) 21.8(9) 17.8(8) 1.9(7) 2.5(7) -1.0(7) 
C5 19.4(8) 20.5(8) 15.4(8) -3.0(7) 4.0(6) 0.6(7) 
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C6 17.6(8) 19.1(8) 18.5(8) -0.4(7) 1.5(6) -0.9(6) 
C7 18.4(8) 18.3(8) 17.1(8) -2.9(7) 2.3(6) -0.5(6) 
C8 17.0(8) 23.1(9) 22.0(9) -1.9(7) -0.1(6) -0.8(7) 
C9 19.1(8) 25.9(9) 22.0(9) -1.5(7) -2.4(7) 2.8(7) 
C10 22.8(8) 20.1(9) 21.2(8) 1.9(7) 0.8(7) 2.2(7) 
C11 16.5(8) 20.1(8) 18.1(8) -2.4(7) 3.2(6) -0.2(6) 
C12 16.8(8) 18.0(8) 16.9(8) -3.1(6) 1.9(6) 0.8(6) 
C13 18.7(8) 18.1(8) 14.8(8) -2.4(6) 2.4(6) 1.0(6) 
C14 18.2(8) 19.8(8) 20.9(8) -0.4(7) 0.8(6) -0.7(7) 
C15 18.2(8) 21.4(9) 25.1(9) 1.0(7) -0.8(7) -0.7(7) 
C16 20.6(8) 17.4(8) 22.9(9) 3.8(7) 0.3(7) 2.1(7) 
C17 22.8(9) 23.2(9) 25.5(9) 1.9(7) -0.7(7) -1.9(7) 
C18 27.1(9) 26.3(10) 26.8(10) 6.1(8) 6.5(7) -0.4(8) 
C19 37.4(10) 22.6(9) 19.5(9) 2.9(7) 6.5(8) 4.0(8) 
C20 32.1(10) 19.8(9) 22.7(9) 3.1(7) -3.0(7) -0.4(7) 
C21 21.7(8) 19.0(9) 25.4(9) 2.4(7) 0.0(7) 0.4(7) 
C22 18.6(8) 21.3(9) 21.7(9) 1.1(7) 3.5(7) -2.3(7) 
C23 21.3(8) 23.0(9) 26.4(9) -1.1(7) 2.8(7) -1.6(7) 
C24 28.7(9) 30.1(10) 25.4(9) -2.9(8) 6.6(8) -3.3(8) 
C25 29.7(10) 36.1(11) 35.1(11) -12.7(9) 8.0(8) -3.5(8) 
C26 19.7(8) 19.5(8) 22.1(8) 0.8(7) 0.0(7) -2.7(7) 
C27 25.0(9) 21.4(9) 25.8(9) -1.5(7) 1.2(7) -0.9(7) 
C28 34.3(10) 25(1) 31.6(10) -4.1(8) 1.2(8) -0.7(8) 
C29 53.4(13) 30.5(11) 33.6(11) -9.1(9) 7.7(10) 5(1) 
O1 25.3(6) 31.6(7) 28.4(7) -5.8(6) 4.1(5) -10.5(6) 
S1 17.4(2) 21.7(2) 18.9(2) -0.43(16) -1.09(15) -2.57(15) 
S2 18.1(2) 18.2(2) 25.0(2) 3.25(16) 0.75(15) -1.14(15) 
  
Table 4 Bond Lengths for MB-7-1424P. 
Atom Atom Length/Å   Atom Atom Length/Å 
C1 C2 1.404(2)   C12 C13 1.494(2) 
C1 C13 1.410(2)   C14 C15 1.533(2) 
C1 S1 1.7690(17)   C14 S1 1.8066(18) 
C2 C3 1.380(3)   C14 S2 1.8175(17) 
C3 C4 1.392(3)   C15 C16 1.489(3) 
C4 C5 1.383(3)   C15 O1 1.214(2) 
C5 C6 1.509(2)   C16 C17 1.402(2) 
C5 C13 1.415(2)   C16 C21 1.393(3) 
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C6 C7 1.507(2)   C17 C18 1.383(3) 
C6 C22 1.550(2)   C18 C19 1.391(3) 
C6 C26 1.546(2)   C19 C20 1.385(3) 
C7 C8 1.387(2)   C20 C21 1.383(3) 
C7 C12 1.415(2)   C22 C23 1.525(3) 
C8 C9 1.390(3)   C23 C24 1.521(2) 
C9 C10 1.386(3)   C24 C25 1.519(3) 
C10 C11 1.398(2)   C26 C27 1.523(2) 
C11 C12 1.404(2)   C27 C28 1.517(3) 
C11 S2 1.7662(17)   C28 C29 1.521(3) 
  
Table 5 Bond Angles for MB-7-1424P. 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
C2 C1 C13 118.98(16)   C11 C12 C13 134.77(15) 
C2 C1 S1 112.43(13)   C1 C13 C5 117.24(15) 
C13 C1 S1 128.55(14)   C1 C13 C12 135.60(16) 
C3 C2 C1 122.31(16)   C5 C13 C12 107.16(14) 
C2 C3 C4 119.53(16)   C15 C14 S1 105.85(12) 
C5 C4 C3 118.82(16)   C15 C14 S2 105.72(12) 
C4 C5 C6 125.01(16)   S1 C14 S2 114.52(9) 
C4 C5 C13 123.07(16)   C16 C15 C14 119.93(15) 
C13 C5 C6 111.91(15)   O1 C15 C14 118.47(16) 
C5 C6 C22 110.76(14)   O1 C15 C16 121.59(16) 
C5 C6 C26 111.26(14)   C17 C16 C15 117.05(16) 
C7 C6 C5 101.64(14)   C21 C16 C15 123.63(16) 
C7 C6 C22 111.39(14)   C21 C16 C17 119.32(17) 
C7 C6 C26 113.30(14)   C18 C17 C16 120.23(18) 
C26 C6 C22 108.42(14)   C17 C18 C19 119.91(17) 
C8 C7 C6 125.77(15)   C20 C19 C18 120.02(17) 
C8 C7 C12 122.34(16)   C21 C20 C19 120.36(18) 
C12 C7 C6 111.75(15)   C20 C21 C16 120.13(17) 
C7 C8 C9 119.01(16)   C23 C22 C6 115.72(14) 
C10 C9 C8 119.79(16)   C24 C23 C22 111.28(15) 
C9 C10 C11 121.62(17)   C25 C24 C23 113.45(16) 
C10 C11 C12 119.58(16)   C27 C26 C6 115.20(14) 
C10 C11 S2 113.84(13)   C28 C27 C26 112.69(16) 
C12 C11 S2 126.43(13)   C27 C28 C29 113.65(17) 
C7 C12 C13 107.52(15)   C1 S1 C14 102.58(8) 
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C11 C12 C7 117.66(15)   C11 S2 C14 101.72(8) 
  
Table 6 Torsion Angles for MB-7-1424P. 
A B C D Angle/˚   A B C D Angle/˚ 
C1 C2 C3 C4 -0.4(3)   C12 C11 S2 C14 -38.01(16) 
C2 C1 C13 C5 2.6(2)   C13 C1 C2 C3 -1.5(3) 
C2 C1 C13 C12 -176.60(17)   C13 C1 S1 C14 27.48(17) 
C2 C1 S1 C14 -154.74(13)   C13 C5 C6 C7 1.12(18) 
C2 C3 C4 C5 1.0(3)   C13 C5 C6 C22 119.56(15) 
C3 C4 C5 C6 179.15(16)   C13 C5 C6 C26 -119.78(16) 
C3 C4 C5 C13 0.3(3)   C14 C15 C16 C17 165.47(16) 
C4 C5 C6 C7 -177.82(16)   C14 C15 C16 C21 -13.8(3) 
C4 C5 C6 C22 -59.4(2)   C15 C14 S1 C1 163.33(11) 
C4 C5 C6 C26 61.3(2)   C15 C14 S2 C11 -156.11(12) 
C4 C5 C13 C1 -2.1(2)   C15 C16 C17 C18 -179.25(17) 
C4 C5 C13 C12 177.30(15)   C15 C16 C21 C20 -179.40(17) 
C5 C6 C7 C8 175.59(16)   C16 C17 C18 C19 -1.5(3) 
C5 C6 C7 C12 -0.11(18)   C17 C16 C21 C20 1.3(3) 
C5 C6 C22 C23 -64.6(2)   C17 C18 C19 C20 1.5(3) 
C5 C6 C26 C27 57.10(19)   C18 C19 C20 C21 -0.1(3) 
C6 C5 C13 C1 178.90(14)   C19 C20 C21 C16 -1.3(3) 
C6 C5 C13 C12 -1.66(18)   C21 C16 C17 C18 0.1(3) 
C6 C7 C8 C9 -175.41(16)   C22 C6 C7 C8 57.6(2) 
C6 C7 C12 C11 176.77(14)   C22 C6 C7 C12 -118.10(16) 
C6 C7 C12 C13 -0.86(19)   C22 C6 C26 C27 179.13(15) 
C6 C22 C23 C24 170.40(15)   C22 C23 C24 C25 168.23(16) 
C6 C26 C27 C28 -178.18(15)   C26 C6 C7 C8 -65.0(2) 
C7 C6 C22 C23 47.7(2)   C26 C6 C7 C12 119.35(16) 
C7 C6 C26 C27 -56.7(2)   C26 C6 C22 C23 173.02(14) 
C7 C8 C9 C10 -0.8(3)   C26 C27 C28 C29 -179.91(17) 
C7 C12 C13 C1 -179.19(18)   O1 C15 C16 C17 -15.0(3) 
C7 C12 C13 C5 1.53(18)   O1 C15 C16 C21 165.67(18) 
C8 C7 C12 C11 0.9(2)   S1 C1 C2 C3 -179.48(14) 
C8 C7 C12 C13 -176.73(15)   S1 C1 C13 C5 -179.72(13) 
C8 C9 C10 C11 1.0(3)   S1 C1 C13 C12 1.1(3) 
C9 C10 C11 C12 -0.2(3)   S1 C14 C15 C16 -143.74(14) 
C9 C10 C11 S2 175.55(14)   S1 C14 C15 O1 36.8(2) 
C10 C11 C12 C7 -0.7(2)   S1 C14 S2 C11 87.77(10) 
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C10 C11 C12 C13 176.11(17)   S2 C11 C12 C7 -175.91(12) 
C10 C11 S2 C14 146.54(13)   S2 C11 C12 C13 0.9(3) 
C11 C12 C13 C1 3.8(3)   S2 C14 C15 C16 94.38(16) 
C11 C12 C13 C5 -175.51(18)   S2 C14 C15 O1 -85.12(18) 
C12 C7 C8 C9 -0.1(3)   S2 C14 S1 C1 -80.62(11) 
  
Table 7 Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for MB-7-1424P. 
Atom x y z U(eq) 
H2 568 10522 2259 26 
H3 1201 12024 1854 28 
H4 2354 12472 2236 26 
H8 4173 10527 3942 25 
H9 4119 8870 4540 27 
H10 3077 7780 4543 26 
H14 1099 9416 4055 24 
H17 -745 7440 4667 29 
H18 -1078 7815 5607 32 
H19 -297 8796 6266 32 
H20 793 9468 5971 30 
H21 1113 9165 5021 27 
H22A 3609 11763 2365 24 
H22B 4170 11405 2867 24 
H23A 3946 9427 2711 28 
H23B 3287 9708 2277 28 
H24A 4015 10394 1577 33 
H24B 4687 10396 2019 33 
H25A 4736 8800 1370 50 
H25B 4015 8312 1592 50 
H25C 4706 8336 2014 50 
H26A 3695 12659 3595 25 
H26B 3175 13179 3101 25 
H27A 2198 12819 3687 29 
H27B 2730 12337 4185 29 
H28A 2725 14696 3785 36 
H28B 3259 14215 4282 36 
H29A 1767 14406 4389 58 
H29B 2336 15252 4695 58 
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H29C 2300 13924 4886 58 
Table 1 Crystal data and structure refinement for 369.  
 
Identification code  MB-6-985 Rx  
Empirical formula  C12H12O2S  
Formula weight  220.28  
Temperature/K  100.01(11)  
Crystal system  triclinic  
Space group  P-1  
a/Å  6.2782(3)  
b/Å  7.1917(3)  
c/Å  12.4920(6)  
α/°  86.275(4)  
β/°  75.966(4)  
γ/°  66.086(4)  
Volume/Å3  499.87(4)  
Z  2  
ρcalcmg/mm
3  1.463  
m/mm-1  2.667  
F(000)  232.0  
Crystal size/mm3  0.2526 × 0.171 × 0.0864  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection  13.478 to 140.082°  
Index ranges  -7 ≤ h ≤ 7, -8 ≤ k ≤ 8, -14 ≤ l ≤ 15  
Reflections collected  7549  
Independent reflections  1883 [Rint = 0.0222, Rsigma = 0.0169]  
Data/restraints/parameters  1883/0/136  
Goodness-of-fit on F2  1.195  
Final R indexes [I>=2σ (I)]  R1 = 0.0394, wR2 = 0.0983  
Final R indexes [all data]  R1 = 0.0403, wR2 = 0.0986  
Largest diff. peak/hole / e Å-3  0.77/-0.32  
 
Table 2 Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for MB-6-985 Rx. Ueq is defined as 1/3 of of the trace of the 
orthogonalised UIJ tensor. 
Atom x y z U(eq) 
C1 4368(4) 7867(3) 3086.4(19) 13.9(5) 
C2 1605(4) 8738(4) 3429(2) 18.3(5) 
C3 719(4) 7042(4) 3511(2) 19.3(5) 
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C4 2712(4) 5098(4) 3766.6(19) 16.8(5) 
C5 2999(5) 8817(4) 4227(2) 19.3(5) 
C6 5672(4) 8914(3) 2295.7(19) 14.4(5) 
C7 6621(4) 8150(3) 1118.3(19) 13.9(5) 
C8 8768(4) 8236(4) 527(2) 15.9(5) 
C9 9662(4) 7607(4) -574(2) 17.9(5) 
C10 8381(4) 6944(4) -1110(2) 16.9(5) 
C11 6226(4) 6874(4) -529(2) 16.1(5) 
C12 5361(4) 7450(3) 585.4(19) 14.7(5) 
O1 7411(3) 4201(3) 3597.1(14) 18.5(4) 
O2 5966(3) 10345(3) 2602.0(14) 20.0(4) 
S1 5525.1(10) 5124.9(8) 2949.5(4) 13.30(16) 
  
Table 3 Anisotropic Displacement Parameters (Å2×103) for MB-6-985 Rx. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
C1 16.0(12) 11.1(11) 12.6(11) 0.0(8) -3.0(9) -3.7(9) 
C2 14.9(12) 16.5(12) 16.8(12) 0.8(9) 1.5(9) -2.6(10) 
C3 15.1(12) 21.5(13) 19.2(12) 2.5(10) -1.2(9) -7(1) 
C4 18.4(12) 18.2(12) 13.8(11) 1.9(9) -1.0(9) -9.1(10) 
C5 23.6(13) 16.2(12) 15.0(12) -2.7(9) 0.9(10) -7.6(10) 
C6 11.5(11) 12.3(11) 17.4(12) 2.3(9) -4.4(9) -2.5(9) 
C7 13.5(11) 10.1(11) 16.5(12) 3.6(9) -3.8(9) -3.5(9) 
C8 13.6(11) 13.5(11) 21.2(12) 3.7(9) -5.9(9) -5.5(9) 
C9 12.6(11) 14.5(12) 21.8(13) 3.1(9) 1.3(9) -4.0(9) 
C10 18.5(12) 13.0(11) 13.9(12) 1.8(9) -1.0(9) -3.1(9) 
C11 17.2(12) 14.9(12) 16.0(12) 2.4(9) -6.1(9) -5.3(10) 
C12 11.5(11) 14.4(11) 17.2(12) 4.2(9) -3.5(9) -4.7(9) 
O1 16.4(8) 19.2(9) 17.1(9) 4.3(7) -5.0(7) -4.4(7) 
O2 22.8(9) 17.6(9) 20.3(9) -0.1(7) -3.5(7) -9.7(7) 
S1 14.5(3) 12.3(3) 11.1(3) 1.0(2) -1.4(2) -4.3(2) 
  
Table 4 Bond Lengths for MB-6-985 Rx. 
Atom Atom Length/Å   Atom Atom Length/Å 
C1 C2 1.542(3)   C6 O2 1.217(3) 
C1 C5 1.514(3)   C7 C8 1.395(3) 
C1 C6 1.491(3)   C7 C12 1.394(3) 
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C1 S1 1.808(2)   C8 C9 1.382(3) 
C2 C3 1.521(3)   C9 C10 1.391(4) 
C2 C5 1.494(4)   C10 C11 1.391(3) 
C3 C4 1.529(3)   C11 C12 1.389(3) 
C4 S1 1.820(2)   O1 S1 1.5015(17) 
C6 C7 1.495(3)         
  
Table 5 Bond Angles for MB-6-985 Rx. 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
C2 C1 S1 109.08(16)   O2 C6 C1 120.9(2) 
C5 C1 C2 58.53(16)   O2 C6 C7 120.9(2) 
C5 C1 S1 116.72(17)   C8 C7 C6 118.7(2) 
C6 C1 C2 121.8(2)   C12 C7 C6 121.8(2) 
C6 C1 C5 119.7(2)   C12 C7 C8 119.4(2) 
C6 C1 S1 117.46(17)   C9 C8 C7 120.4(2) 
C3 C2 C1 110.74(19)   C8 C9 C10 120.1(2) 
C5 C2 C1 59.77(16)   C9 C10 C11 119.8(2) 
C5 C2 C3 118.7(2)   C12 C11 C10 120.1(2) 
C2 C3 C4 107.3(2)   C11 C12 C7 120.1(2) 
C3 C4 S1 106.40(16)   C1 S1 C4 91.91(11) 
C2 C5 C1 61.69(16)   O1 S1 C1 109.08(10) 
C1 C6 C7 118.3(2)   O1 S1 C4 108.88(10) 
  
Table 6 Torsion Angles for MB-6-985 Rx. 
A B C D Angle/˚   A B C D Angle/˚ 
C1 C2 C3 C4 26.3(3)   C6 C1 C5 C2 111.2(2) 
C1 C6 C7 C8 -145.8(2)   C6 C1 S1 C4 -162.54(19) 
C1 C6 C7 C12 37.3(3)   C6 C1 S1 O1 86.73(19) 
C2 C1 C6 C7 -99.6(3)   C6 C7 C8 C9 -177.8(2) 
C2 C1 C6 O2 80.7(3)   C6 C7 C12 C11 175.9(2) 
C2 C1 S1 C4 -18.61(17)   C7 C8 C9 C10 2.1(4) 
C2 C1 S1 O1 -129.35(16)   C8 C7 C12 C11 -1.0(3) 
C2 C3 C4 S1 -39.4(2)   C8 C9 C10 C11 -1.4(3) 
C3 C2 C5 C1 98.5(2)   C9 C10 C11 C12 -0.5(3) 
C3 C4 S1 C1 33.73(18)   C10 C11 C12 C7 1.7(3) 
C3 C4 S1 O1 144.66(16)   C12 C7 C8 C9 -0.9(3) 
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C5 C1 C2 C3 -111.9(2)   O2 C6 C7 C8 33.9(3) 
C5 C1 C6 C7 -168.9(2)   O2 C6 C7 C12 -143.0(2) 
C5 C1 C6 O2 11.4(3)   S1 C1 C2 C3 -1.6(2) 
C5 C1 S1 C4 45.0(2)   S1 C1 C2 C5 110.25(18) 
C5 C1 S1 O1 -65.7(2)   S1 C1 C5 C2 -96.95(19) 
C5 C2 C3 C4 -39.7(3)   S1 C1 C6 C7 39.5(3) 
C6 C1 C2 C3 140.4(2)   S1 C1 C6 O2 -140.2(2) 
C6 C1 C2 C5 -107.7(2)             
  
Table 7 Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for MB-6-985 Rx. 
Atom x y z U(eq) 
H2 692 10040 3103 22 
H3A 359 6857 2807 23 
H3B -761 7379 4106 23 
H4A 2509 3882 3563 20 
H4B 2681 5074 4563 20 
H5A 3070 7897 4854 23 
H5B 2946 10162 4400 23 
H8 9623 8729 884 19 
H9 11152 7628 -964 21 
H10 8978 6541 -1870 20 
H11 5343 6432 -895 19 









1) D. J. Gorin and F. D. Toste, Nature, 2007, 446, 395-403. 
2) A. Fürstner and P. W. Davies, Angew. Chem. Int. Ed., 2007, 46, 3410-3439. 
3) a) M. J. S. Dewar, Bull. Chem. Soc. Chim. Fr, 1951, 18, C71-C79. b) J. Chatt, L. A. 
Duncanson, J. Chem. Soc. 1953, 2939-2947. 
4) R. H. Hertwig, W. Koch, D. Schröder, H. Schwarz, J. Hrušák and P. Schwerdtfeger, J. Phys. 
Chem., 1996, 100, 12253–12260.  
5) M. S. Nechaev, V. M. Rayón and G. Frenking, J. Phys. Chem. A., 2004, 108, 3134–3142. 
6) M. P. Doyle, Chem. Rev., 1986, 86, 919-939.  
7) A. S. K. Hashmi, A. M. Schuster and F. Rominger, Angew. Chem., Int. Ed., 2009, 48, 8247-
8249. 
8) a) G. Seidel, R. Mynott and A. Fürstner, Angew. Chem., Int. Ed., 2009, 48, 2510-2513. 
b) A. M. Echaverren, Nature Chem., 2009, 1, 431-433. c) A. Federov, M.-E. Moret and P. Chen, 
J. Am. Chem. Soc., 2008, 130, 8880-8881. d) A. S. K. Hashmi, Angew. Chem. Int. Ed., 2008, 
47, 6754-6756. e) A. S. K. Hashmi, Angew. Chem. Int. Ed. 2008, 47, 6754-6756; f) A. Fürstner, 
L. Morency, Angew. Chem. Int. Ed., 2008, 47, 5030-5033; g) A. Correa, N. Marion, L. 
Fensterbank, M. Malacria, S. P. Nolan, L. Cavallo, Angew. Chem. Int. Ed. 2008, 47, 718-721.  
9) S. López, E. Herrero-Gómez, P. Pérez-Galán, C. Nieto-Oberhuber and A. M. Echaverren, 
Angew. Chem., Int. Ed., 2006, 45, 6029-6032. 
10) E. Jiménez-Núñez and A. M. Echavarren, Chem. Rev. 2008, 108, 3326-3350.  
11) D. Benitez, N. D. Shapiro, E. Tkatchouk, Y. Wang, W. A. Goddard and F. D. Toste, Nat. 
Chem. 2009, 1, 482-486.  
12) L. Zhang, J. Sun and S. A. Kozmin, Adv. Synth. Catal., 2006, 348, 2271–2296 
13) C. A. Witham, P. Mauleón, N. D. Shapiro, B. D. Sherry and F. D. Toste, J. Am. Chem. Soc., 
2007, 129, 5838–5839. 
14) H.-S. Yeom and S. Shin, Org. Biomol. Chem., 2013, 11, 1089-1092. 
15) N. D. Shapiro and F. D. Toste, J. Am. Chem. Soc., 2007, 129, 4160-4161. 
16) G. Li and L. Zhang, Angew. Chem., Int. Ed., 2007, 46, 5156-5159. 
17) P. W. Davies and S. J. C. Albrecht, Agnew. Chem., Int. Ed., 2009, 48, 8372-8375. 
18) A. B. Cuenca, S. Montserrat, K. M. Hossain, G. Mancha, A. Lledόs, M. Mediό-Simon, G. 
Ujaque and G. Asensio, Org. Lett., 2009, 11, 4906-4909. 
19) C. Li, K. Pati, G. Lin, S. Md, A. Sohel, H, Hung and R.-S. Liu, Angew. Chem., Int. Ed., 
2010, 49, 9891-9894. 
20) R. K. Bowman and J. S. Johnson, Org. Lett., 2006, 8, 573-576. 
21) K.-B. Wang, R.-Q. Ran, S.-D. Xiu and C.-Y. Li, Org. Lett., 2013, 15, 2374-2377. 
22) B. Lu, Y. Li, Y. Wang, D. H. Aue, Y. Luo and L. Zhang, J. Am. Chem. Soc., 2013, 135, 
8512-8524. 
23) M. Murai, S. Kitibata, K. Okamoto and K. Ohe, Chem. Commun., 2012, 48, 7622-7624. 
24) H. S. Yeom, Y. Lee, J. E. Lee and S. Shin, Org. Biomol. Chem., 2009, 7, 4744-4752.  
25) H. S. Yeom, J. E. Lee and S. Shin, Angew. Chem., Int. Ed., 2008, 47, 7040-7043. 
26) H. S. Yeom, Y. Lee, J. Jeong, E. So, S. Hwang, J. Lee, S. Lee and S. Shin, Angew. Chem. 
Int. Ed., 2010, 49, 1611-1614. 
27) N. Asao, K. Sato and Y. Yamamoto, Tetrahedron Lett., 2003, 44, 5675-5678. 




29) L. Cui, Y. Peng and L. Zhang, J. Am. Chem. Soc., 2009, 131, 8394-8395. 
30) G. Y. Lin, C. W. Li, S. H. Hung and R.-S. Liu, Org. Lett., 2008, 10, 5059-5062.  
31) A. S. K. Hashmi, M. Bührle, R. Salathé and J. W. Bats, Adv. Synth. Catal., 2008, 350, 2059. 
32) L. Cui, G. Zhang, Y. Peng and L. Zhang, Org. Lett., 2009, 11, 1225-1228. 
33) P. W. Davies, A. Cremonesi and N. Martin, Chem. Commun., 2011, 47, 379-381. 
34) C. Xu, M. Xu, Y. Jia and C. Li, Org. Lett., 2011, 13, 1556-1559. 
35) L. Ye, L. Cui, G. Zhang and L. Zhang, J. Am. Chem. Soc., 2010, 132, 3258-3259. 
36) K. Ji, J. Nelson and L. Zhang, Beilstein. J. Org. Chem., 2013, 9, 1925-1930. 
37) L. Ye, W. He and L. Zhang, J. Am. Chem. Soc., 2010, 132, 8550-8551. 
38) B. Lu, C. Li and L. Zhang, J. Am. Chem. Soc., 2010, 132, 14070-14072. 
39) L. Ye, W. He and L. Zhang, Angew. Chem., Int. Ed., 2011, 50, 3236-3239. 
40) C. Shu, L. Li, Y-F. Yu, S. Jiang and L. Ye, Chem. Commun., 2014, 50, 2522-2525. 
41) H. M. L. Davies and R. E. J. Beckwith, Chem. Rev., 2003, 103, 2861-2903. 
42) S. Bhunia, S. Ghorpade, D. B. Huple, and R.-S. Liu, Angew. Chem., Int. Ed., 2012, 51, 
2939–2942.  
43) Y. Wang, K. Ji, S. Lam and L. Zhang, Angew. Chem., Int. Ed., 2012, 51, 1915-1918. 
44) G. Henrion, T. E. J. Chavas, X. Le Goff and F. Gagosz, Angew. Chem., Int. Ed., 2013, 52, 
6277-6282. 
45) D. Qian and J. Zhang, Chem. Commun., 2012, 48, 7082-7084. 
46) L.-Q. Yang, K.-B. Wang and C.-B. Li, Eur. J. Org. Chem., 2013, 2775–2779. 
47) A. S. K. Hashmi, T. Wang, S. Shi and M. Rudolph, J. Org. Chem., 2012, 77, 7761-7767.  
48) M. Xu, T.-T. Ren and C.-Y. Li, Org. Lett., 2012, 14, 4902-4906. 
49) M. Xu, T.-T. Ren, K.-B. Wang and C-Y. Li, Adv. Synth. Catal., 2013, 355, 2488-2494. 
50) H.-H. Hung, Y.-C. Liao and R.-S. Liu, J. Org. Chem., 2013, 78, 7970-7976. 
51) S. Ghorpade, M.-D. Su and R.-S. Liu, Angew. Chem., Int. Ed., 2013, 52, 4229–4234. 
52) J. Fu, H. Shang, Z. Wang, L. Chang, W. Shao, Z. Yang and Y. Tang, Angew. Chem., Int. 
Ed., 2013, 52, 4198-4202. 
53) Y. Wang, L. Ye and L. Zhang, Chem. Commun., 2011, 47, 7815-7817. 
54) E. P. A. Talbot, M. Richardson, J. M. McKenna and F. D. Toste, Adv. Synth. Catal., 2014, 
356, 687-691. 
55) C.-H. Chen, Y.-C. Tsai and R.-S. Liu, Angew. Chem., Int. Ed., 2013, 52, 4599-4603.  
56) P. Nösel, L. Nunes dos Santos Comprido, T. Lauterbach, F. Rominger and A. S. K. Hashmi, 
J. Am. Chem. Soc., 2013, 135, 15662-15666. 
57) P. Nösel, S. Moghimi, C. Hendrich, M. Haupt, M. Rudolph, F. Rominger and A. S. K. 
Hashmi, Adv. Synth. Catal., 2014, 356, 3755-3760. 
58) H. M. L. Davies, N. J. S. Huby, W. R. Cantrell Jr and J. L. Olive., J. Am. Chem. Soc. 1993, 
115, 9468. 
59) D. Vasu, H.-H. Hung, S. Bhunia, S. A. Gawade, A. Das and R.-S. Liu, Angew. Chem., Int. 
Ed., 2011, 50, 6911-6914. 
60) D. Qian and J. Zhang, Chem. Commun., 2011, 47, 11152-11154. 
61) K. Ji and L. Zhang, Org. Chem. Front., 2014, 1, 34-38. 
62) K. Ji, Z. Zheng, Z. Wang and L. Zhang, Angew. Chem., Int. Ed., 2015, 54, 1245-1249. 
63) D. Qian, H. Hu, F. Liu, B. Tang, W. Ye, Y. Wang and J. Zhang. Angew. Chem., Int. Ed., 
2014, 53, 13751–13756. 
64) L. Ye, C. Li and L. Zhang, J. Am. Chem. Soc., 2011, 133, 8482-8485. 
65) W. He, L. Xie, Y. Xu, J. Xiang and L. Zhang, Org. Biomol. Chem., 2012, 10, 3168-3171. 
66) Y. Luo, K. Ji, Y. Li and L. Zhang, J. Am. Chem. Soc., 2012, 134, 17412-17515. 
67) G. Wu, R. Zheng, J. Nelson and L. Zhang, Adv. Synth. Catal., 2014, 356, 1229–1234. 
309 
 
68) J. Li, K. Ji, R. Zheng, J. Nelson and L. Zhang, Chem. Commun., 2014, 50, 4130-4132. 
69) K. Ji, Y. Zhao and L. Zhang, Angew. Chem., Int. Ed., 2013, 52, 6508-6512. 
70) M. D. Santos and P. W. Davies, Chem. Commun., 2014, 50, 6001-6004. 
71) L. Li, C. Shu, B. Zhou, Y.-F. Yu, X.-Y. Xiao and L.-W. Ye, Chem. Sci., 2014, 5, 4057-
4064. 
72) For recent examples see: a) S.-C Dong, L. Zhang, J. Liang, L.-S. Cui, Q. Li, Z.-Q. Jiang, 
L.-S. Liao, J. Phys. Chem. C., 2014, 118, 2375-2384; b) L. Yao, S. Sun, S. Xue, S. Zhang, X. 
Wu, H. Zhang, Y. Pan, C. Gu, F. Li and Y. Ma, J. Phys. Chem. C., 2013, 117, 14189-14196; c) 
L. Yu, J. Liu, S. Hu, R. He, W. Yang, H. Wu, J. Peng, R. Xia and D. D. C. Bradley, Adv. Funct. 
Mater., 2013, 23, 4366–4376; d) L. Ying, Y.-H. Li, C.-H. Wei, M.-Q. Wang, W. Yang, H.-B. 
Wu and Y. Cao, Chin. J. Polym. Sci., 2013, 31, 88-97; e) S. Cai, X. Hu, J. Han, Z. Zhang, X. 
Li, C. Wang and J. Su, Tetrahedron, 2013, 69, 1970-1977. 
73) Some recent examples a) Y. Gao, K. J. Kellar, R. P. Yasuda, T. Tran, Y. Xiao, R. F. 
Dannals, A. G. Horti, J. Med. Chem., 2013, 56, 7574−7589; b) J. Korang, I. Emahi, W. R. 
Grither, S. M. Baumann, D. A. Baum and R. D. McCulla, RSC Adv., 2013, 3, 12390–12397; e) 
M. Zhang, G. E. Ravilious, L. M. Hicks, J. M. Jez and R. D. McCulla, J. Am. Chem. Soc., 2012, 
134, 16979−16982. 
74) D. Vasu, H. Yorimitsu and A. Osuka, Angew. Chem., Int. Ed., 2015, 42, 7162-7166. 
75) T. Umemoto and S. Ishihara, J. Am. Chem. Soc., 1993, 115, 2156-2164; For a Synlett 
spotlight see H. Li, Synlett, 2012, 23, 2289–2290. a) Some recent examples, J. Korang, W. R. 
Grither and R. D. McCulla, J. Am. Chem. Soc., 2010, 132, 4466–4476; b) D. D. Gregory, Z. 
Wan and W. S. Jenks, J. Am. Chem. Soc., 1997, 119, 94–102; b) T. Nakahodo, M. Okuda, H. 
Morita, T. Yoshimura, M. O. Ishitsuka, T. Tuchiya, Y. Maeda, H. Fujihara, T. Akasaka, X. Gao 
and S. Nagase, Angew. Chem., Int. Ed., 2008, 47, 1298–1300. 
76) a) X.-D. Xiong, C.-L. Deng, X.-S. Peng, Q. Miao and H. N. C. Wong, Org. Lett., 2014, 16, 
3252−3255; b) R. Samanta and A. P. Antonchick, Angew. Chem., Int. Ed., 2011, 50, 5217-
5220; c) M. Kienle, A. Unsinn and P. Knochel, Angew. Chem., Int. Ed., 2010, 49, 4751 –4754. 
77) a) R. Che, Z. Wu, Z. Li, H. Xiang and X. Zhou, Chem. Eur. J., 2014, 20, 7258-7261; b) S. 
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